Original Article
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
N Engl J Med 2002; 346:393-403February 7, 2002
- Abstract
Background
Type 2 diabetes affects approximately 8 percent of adults in the United States. Some risk factors — elevated plasma glucose concentrations in the fasting state and after an oral glucose load, overweight, and a sedentary lifestyle — are potentially reversible. We hypothesized that modifying these factors with a lifestyle-intervention program or the administration of metformin would prevent or delay the development of diabetes.
Methods
We randomly assigned 3234 nondiabetic persons with elevated fasting and post-load plasma glucose concentrations to placebo, metformin (850 mg twice daily), or a lifestyle-modification program with the goals of at least a 7 percent weight loss and at least 150 minutes of physical activity per week. The mean age of the participants was 51 years, and the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 34.0; 68 percent were women, and 45 percent were members of minority groups.
Results
The average follow-up was 2.8 years. The incidence of diabetes was 11.0, 7.8, and 4.8 cases per 100 person-years in the placebo, metformin, and lifestyle groups, respectively. The lifestyle intervention reduced the incidence by 58 percent (95 percent confidence interval, 48 to 66 percent) and metformin by 31 percent (95 percent confidence interval, 17 to 43 percent), as compared with placebo; the lifestyle intervention was significantly more effective than metformin. To prevent one case of diabetes during a period of three years, 6.9 persons would have to participate in the lifestyle-intervention program, and 13.9 would have to receive metformin.
Conclusions
Lifestyle changes and treatment with metformin both reduced the incidence of diabetes in persons at high risk. The lifestyle intervention was more effective than metformin.
Media in This Article
Figure 3
Fasting Plasma Glucose Concentrations (Panel A) and Glycosylated Hemoglobin Values (Panel B) According to Study Group.Figure 2
Cumulative Incidence of Diabetes According to Study Group.Article Activity
- Article
Type 2 diabetes mellitus, formerly called non-insulin-dependent diabetes mellitus, is a serious, costly disease affecting approximately 8 percent of adults in the United States.1 Treatment prevents some of its devastating complications2,3 but does not usually restore normoglycemia or eliminate all the adverse consequences. The diagnosis is often delayed until complications are present.4 Since current methods of treating diabetes remain inadequate, prevention is preferable. The hypothesis that type 2 diabetes is preventable5,6 is supported by observational studies and two clinical trials of diet, exercise, or both in persons at high risk for the disease7,8 but not by studies of drugs used to treat diabetes.5
The validity of generalizing the results of previous prevention studies is uncertain.9 Interventions that work in some societies may not work in others, because social, economic, and cultural forces influence diet and exercise. This is a special concern in the United States, where there is great regional and ethnic diversity in lifestyle patterns and where diabetes is especially frequent in certain racial and ethnic groups, including American Indians, Hispanics, African Americans, Asians, and Pacific Islanders.10
The Diabetes Prevention Program Research Group conducted a large, randomized clinical trial involving adults in the United States who were at high risk for the development of type 2 diabetes. The study was designed to answer the following primary questions: Does a lifestyle intervention or treatment with metformin, a biguanide antihyperglycemic agent, prevent or delay the onset of diabetes? Do these two interventions differ in effectiveness? Does their effectiveness differ according to age, sex, or race or ethnic group?
Methods
We conducted a clinical trial involving persons at 27 centers who were at high risk for diabetes. The methods have been described in detail elsewhere,6 and the protocol is available at http://www.bsc.gwu.edu/dpp. The institutional review board at each center approved the protocol, and all participants gave written informed consent.
Participants
Eligibility criteria included an age of at least 25 years, a body-mass index (the weight in kilograms divided by the square of the height in meters) of 24 or higher (22 or higher in Asians), and a plasma glucose concentration of 95 to 125 mg per deciliter (5.3 to 6.9 mmol per liter) in the fasting state (≤125 mg per deciliter in the American Indian clinics) and 140 to 199 mg per deciliter (7.8 to 11.0 mmol per liter) two hours after a 75-g oral glucose load. These concentrations are elevated but are not diagnostic of diabetes according to the 1997 criteria of the American Diabetes Association.11 Before June 1997, the criterion for plasma glucose in the fasting state was 100 to 139 mg per deciliter (5.6 to 7.7 mmol per liter), or ≤139 mg per deciliter in the American Indian clinics. Eligible persons were excluded if they were taking medicines known to alter glucose tolerance or if they had illnesses that could seriously reduce their life expectancy or their ability to participate in the trial. Recruitment was designed to enroll approximately half the participants from racial or ethnic minority groups. A four-step screening and recruitment process was developed to identify eligible participants.6,12,13
Interventions
Eligible participants were randomly assigned to one of three interventions: standard lifestyle recommendations plus metformin (Glucophage) at a dose of 850 mg twice daily, standard lifestyle recommendations plus placebo twice daily, or an intensive program of lifestyle modification. The study initially included a fourth intervention, troglitazone, which was discontinued in 1998 because of the drug's potential liver toxicity.6 The results in the troglitazone group are not reported here.
Treatment with metformin was initiated at a dose of 850 mg taken orally once a day, with placebo tablets also given once a day initially. At one month, the dose of metformin was increased to 850 mg twice daily, unless gastrointestinal symptoms warranted a longer titration period. The initiation of treatment with half a tablet was optional. Adherence to the treatment regimen was assessed quarterly on the basis of pill counts and structured interviews. The standard lifestyle recommendations for the medication groups were provided in the form of written information and in an annual 20-to-30-minute individual session that emphasized the importance of a healthy lifestyle. Participants were encouraged to follow the Food Guide Pyramid14 and the equivalent of a National Cholesterol Education Program Step 1 diet,15 to reduce their weight, and to increase their physical activity.
The goals for the participants assigned to the intensive lifestyle intervention were to achieve and maintain a weight reduction of at least 7 percent of initial body weight through a healthy low-calorie, low-fat diet and to engage in physical activity of moderate intensity, such as brisk walking, for at least 150 minutes per week. A 16-lesson curriculum covering diet, exercise, and behavior modification was designed to help the participants achieve these goals. The curriculum, taught by case managers on a one-to-one basis during the first 24 weeks after enrollment, was flexible, culturally sensitive, and individualized. Subsequent individual sessions (usually monthly) and group sessions with the case managers were designed to reinforce the behavioral changes.
Outcome Measures
The primary outcome was diabetes, diagnosed on the basis of an annual oral glucose-tolerance test or a semiannual fasting plasma glucose test, according to the 1997 criteria of the American Diabetes Association: a value for plasma glucose of 126 mg per deciliter (7.0 mmol per liter) or higher in the fasting state or 200 mg per deciliter (11.1 mmol per liter) or higher two hours after a 75-g oral glucose load.11 In addition to the semiannual measurements, fasting plasma glucose was measured if symptoms suggestive of diabetes developed. The diagnosis required confirmation by a second test, usually within six weeks, according to the same criteria. If diabetes was diagnosed, the participants and their physicians were informed and glucose-tolerance tests were discontinued, but fasting plasma glucose was measured every six months, with glycosylated hemoglobin measured annually. As long as the fasting plasma glucose concentration was less than 140 mg per deciliter, participants were asked to monitor their blood glucose and to continue their assigned study treatment. If the fasting plasma glucose concentration reached or exceeded 140 mg per deciliter, the study medication was discontinued and the participant was referred to his or her physician for treatment. Measurements of glucose and glycosylated hemoglobin (HbA1c) were performed centrally. All tests were performed without interrupting the assigned treatment, except that placebo or metformin was not taken on the morning of the test. The investigators and the participants were unaware of the results of these measurements and were informed only if the results exceeded the specified threshold for a change in the treatment.
Self-reported levels of leisure physical activity were assessed annually with the Modifiable Activity Questionnaire.16 The physical-activity level was calculated as the product of the duration and frequency of each activity (in hours per week), weighted by an estimate of the metabolic equivalent of that activity (MET) and summed for all activities performed, with the result expressed as the average MET-hours per week for the previous year. Usual daily caloric intake during the previous year, including calories from fat, carbohydrate, protein, and other nutrients, was assessed at base line and at one year with the use of a modified version of the Block food-frequency questionnaire.17
Statistical Analysis and Early Closure
Random treatment assignments were stratified according to the clinical center. Assignments to metformin and placebo were double-blinded. The study design and analysis followed the intention-to-treat principle. Nominal (unadjusted) P values and confidence intervals are reported.
The blinded treatment phase was terminated one year early, in May 2001, on the advice of the data monitoring board, on the basis of data obtained through March 31, 2001, the closing date for this report. By then, we had obtained evidence of efficacy on the basis of 65 percent of the planned person-years of observation. To maintain a type I error level of 0.05 for significance in pairwise comparisons of the risk of diabetes between groups, with adjustment for repeated interim analyses, the group-sequential log-rank test18 required a P value of less than 0.0159. For pairwise comparisons of other outcomes, a Bonferroni-adjusted criterion of P<0.0167 was used. The study design provided 90 percent power to detect a 33 percent reduction from an incidence of 6.5 cases of diabetes per 100 person-years, with a 10 percent rate of loss to follow-up per year.
The time to the outcome was assessed with the use of life-table methods.19 Modified product-limit curves for the cumulative incidence of diabetes were compared with the use of the log-rank test. The estimated cumulative incidence at three years and the Greenwood estimate of the standard error were used to calculate the number of persons who would need to be treated in order to prevent one case of confirmed diabetes during a period of three years and the associated 95 percent confidence interval. Risk reduction, heterogeneity among strata, and interactions between treatment assignments and covariates were assessed by proportional-hazards regression. Fixed-effects models with the assumption of normally distributed errors20 were used to assess differences over time in body weight and plasma glucose and glycosylated hemoglobin values among the three groups.
Results
Study Cohort and Follow-up
From 1996 to 1999, we randomly assigned 3234 study participants to one of the three interventions (1082 to placebo, 1073 to metformin, and 1079 to the intensive lifestyle intervention). Base-line characteristics, including all measured risk factors for diabetes, were similar among the three study groups (Table 1Table 1
Base-Line Characteristics of the Study Participants.).12 The participants were followed for an average of 2.8 years (range, 1.8 to 4.6). At the close of the study, 99.6 percent of the participants were alive, of whom 92.5 percent had attended a scheduled visit within the previous five months.Adherence to Interventions
Fifty percent of the participants in the lifestyle-intervention group had achieved the goal of weight loss of 7 percent or more by the end of the curriculum (at 24 weeks), and 38 percent had a weight loss of at least 7 percent at the time of the most recent visit; the proportion of participants who met the goal of at least 150 minutes of physical activity per week (assessed on the basis of logs kept by the participants) was 74 percent at 24 weeks and 58 percent at the most recent visit. Dietary change was assessed only at one year. Daily energy intake decreased by a mean (±SE) of 249±27 kcal in the placebo group, 296±23 kcal in the metformin group, and 450±26 kcal in the lifestyle-intervention group (P<0.001). Average fat intake, which was 34.1 percent of total calories at base line, decreased by 0.8±0.2 percent in the placebo and metformin groups and by 6.6±0.2 percent in the lifestyle-intervention group (P<0.001). The proportion of participants who took at least 80 percent of the prescribed dose of the study medication was slightly higher in the placebo group than in the metformin group (77 percent vs. 72 percent, P<0.001). Ninety-seven percent of the participants taking placebo and 84 percent of those taking metformin were given the full dose of one tablet (850 mg in the case of metformin) twice a day; the remainder were given one tablet a day to limit side effects.
Changes in weight and leisure physical activity in all three groups and adherence to the medication regimen in the metformin and placebo groups are shown in Figure 1Figure 1
Changes in Body Weight (Panel A) and Leisure Physical Activity (Panel B) and Adherence to Medication Regimen (Panel C) According to Study Group.. Participants assigned to the lifestyle intervention had much greater weight loss and a greater increase in leisure physical activity than did participants assigned to receive metformin or placebo. The average weight loss was 0.1, 2.1, and 5.6 kg in the placebo, metformin, and lifestyle-intervention groups, respectively (P<0.001).Incidence of Diabetes
The cumulative incidence of diabetes was lower in the metformin and lifestyle-intervention groups than in the placebo group throughout the follow-up period (Figure 2Figure 2
Cumulative Incidence of Diabetes According to Study Group.). The crude incidence was 11.0, 7.8, and 4.8 cases per 100 person-years for the placebo, metformin, and lifestyle-intervention groups, respectively (Table 2Table 2
Incidence of Diabetes.). The incidence of diabetes was 58 percent lower (95 percent confidence interval, 48 to 66 percent) in the lifestyle-intervention group and 31 percent lower (95 percent confidence interval, 17 to 43 percent) in the metformin group than in the placebo group. The incidence of diabetes was 39 percent lower (95 percent confidence interval, 24 to 51 percent) in the lifestyle-intervention group than in the metformin group. The results of all three pairwise group comparisons were statistically significant by the group-sequential log-rank test. None of these results were materially affected by adjustment for base-line characteristics. The estimated cumulative incidence of diabetes at three years was 28.9 percent, 21.7 percent, and 14.4 percent in the placebo, metformin, and lifestyle-intervention groups, respectively. On the basis of these rates, the estimated number of persons who would need to be treated for three years to prevent one case of diabetes during this period is 6.9 (95 percent confidence interval, 5.4 to 9.5) for the lifestyle intervention and 13.9 (95 percent confidence interval, 8.7 to 33.9) for metformin.Treatment Effects among Subgroups
Incidence rates and risk reductions within subgroups of participants and the results of tests of the homogeneity of risk reduction among subgroups are shown in Table 2; 95 percent confidence intervals for the subgroup data indicate the precision of the risk-reduction estimate for each stratum. The study had inadequate power to assess the significance of effects within the subgroups, nor were such tests planned. Significant heterogeneity indicates that treatment effects differed according to the values of the covariates. Treatment effects did not differ significantly according either to sex or to race or ethnic group (Table 2). The lifestyle intervention was highly effective in all subgroups. Its effect was significantly greater among persons with lower base-line glucose concentrations two hours after a glucose load than among those with higher base-line glucose values. The effect of metformin was less with a lower body-mass index or a lower fasting glucose concentration than with higher values for those variables. Neither interaction was explained by the other variable or by age. The advantage of the lifestyle intervention over metformin was greater in older persons and those with a lower body-mass index than in younger persons and those with a higher body-mass index.
Glycemic Changes
In the first year, there was a similar reduction in the mean fasting plasma glucose values in the metformin and lifestyle-intervention groups, whereas the values rose in the placebo group (Figure 3Figure 3
Fasting Plasma Glucose Concentrations (Panel A) and Glycosylated Hemoglobin Values (Panel B) According to Study Group.). The values rose in parallel in all three groups in subsequent years. There was a similar temporal pattern in the values for glycosylated hemoglobin, except that the values in the metformin group were in between those in the lifestyle-intervention and placebo groups. Figure 4Figure 4
Participants with Normal Plasma Glucose Values, According to Study Group. shows the percentage of participants who had normal glucose concentrations (fasting values, post-load values, and both) at each annual examination. Metformin and the lifestyle intervention were similarly effective in restoring normal fasting glucose values, but the lifestyle intervention was more effective in restoring normal post-load glucose values.Adverse Events
The rate of gastrointestinal symptoms was highest in the metformin group, and the rate of musculoskeletal symptoms was highest in the lifestyle-intervention group (Table 3Table 3
Adverse Events.). Hospitalization and mortality rates were unrelated to treatment. No deaths were attributed to the study intervention.Discussion
Our results support the hypothesis that type 2 diabetes can be prevented or delayed in persons at high risk for the disease. The incidence of diabetes was reduced by 58 percent with the lifestyle intervention and by 31 percent with metformin, as compared with placebo. These effects were similar in men and women and in all racial and ethnic groups. The intensive lifestyle intervention was at least as effective in older participants as it was in younger participants. The results of our study extend previous data showing that lifestyle interventions can reduce the incidence of diabetes7,8 and demonstrate the applicability of this finding to the ethnically and culturally diverse population of the United States. The risk reduction associated with the lifestyle intervention in our study was the same as that in a study conducted in Finland,8 and was higher than the reductions associated with diet (31 percent), exercise (46 percent), and diet plus exercise (42 percent) in a study in China.7
Our lifestyle intervention was systematic and intensive, with the study participants receiving detailed, individualized counseling. The study, however, was not designed to test the relative contributions of dietary changes, increased physical activity, and weight loss to the reduction in the risk of diabetes, and the effects of these components remain to be determined.
The incidence of diabetes in our placebo group (11.0 cases per 100 person-years) was higher than we had anticipated6 and was higher than the incidence in observational studies,21 perhaps owing to the greater frequency of glucose testing or to the selection of persons at higher risk in our study. The incidence of diabetes in the placebo group was similar among racial and ethnic groups despite differences in these subgroups in observational, population-based studies.10 Racial and ethnic-group differences in the incidence of diabetes were presumably reduced in our study by the selection of persons who were overweight and had elevated fasting and post-load glucose concentrations — three of the strongest risk factors for diabetes.
Previous studies have not demonstrated that drugs used to treat diabetes are effective for its prevention, perhaps because of small samples and the lack of data on adherence to the prescribed regimens.5 In contrast, metformin was effective in our study, although less so than the lifestyle intervention. Metformin was less effective in persons with a lower base-line body-mass index or a lower fasting plasma glucose concentration than in those with higher values for these variables. The reduction in the average fasting plasma glucose concentration was similar in the lifestyle-intervention and metformin groups, but the lifestyle intervention had a greater effect than metformin on glycosylated hemoglobin, and a larger proportion of participants in the lifestyle-intervention group had normal post-load glucose values at follow-up. These findings are consistent with the observation that metformin suppresses endogenous glucose production, the main determinant of fasting plasma glucose concentrations.22
Rates of adverse events, hospitalization, and mortality were similar in the three groups, except that the rate of gastrointestinal symptoms was highest in the metformin group and the rate of musculoskeletal symptoms was highest in the lifestyle-intervention group. Thus, the interventions were safe in addition to being effective.
An estimated 10 million persons in the United States resemble the participants in the Diabetes Prevention Program in terms of age, body-mass index, and glucose concentrations, according to data from the third National Health and Nutrition Examination Survey.23 If the study's interventions were implemented among these people, there would be a substantial reduction in the incidence of diabetes. Ultimately, the benefits would depend on whether glucose concentrations could be maintained at levels below those that are diagnostic of diabetes and whether the maintenance of these lower levels improved the long-term outcome. These questions should be addressed by continued follow-up of the study participants and by analysis of the main secondary outcomes — reductions in risk factors for cardiovascular disease, in the proportion of participants with atherosclerosis, and in the proportion with cardiovascular disease, which is the leading cause of death among patients with type 2 diabetes.24,25
Optimal approaches to identifying candidates for preventive measures remain to be determined. Although elevation of either the fasting or the post-load glucose concentration strongly predicts diabetes,26,27 both were required for eligibility in this study. Whether the results would be similar in persons with an isolated elevation of the fasting or post-load glucose concentration or other risk factors for diabetes is likely but unknown.
In summary, our study showed that treatment with metformin and modification of lifestyle were two highly effective means of delaying or preventing type 2 diabetes. The lifestyle intervention was particularly effective, with one case of diabetes prevented per seven persons treated for three years. Thus, it should also be possible to delay or prevent the development of complications, substantially reducing the individual and public health burden of diabetes.
Supported by the National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases, the Office of Research on Minority Health, the National Institute of Child Health and Human Development, and the National Institute on Aging; the Indian Health Service; the Centers for Disease Control and Prevention; the General Clinical Research Center Program, National Center for Research Resources; the American Diabetes Association; Bristol-Myers Squibb; and Parke-Davis.
Dr. Hamman owns stock in Bristol-Myers Squibb, which sells metformin in the United States.
We are indebted to the participants in the study for their dedication to the goal of preventing diabetes; to Lipha Pharmaceuticals for the metformin and placebo; to LifeScan, Health-O-Meter, Hoechst Marion Roussel, Merck-Medco Managed Care, Merck, Nike, Slim-Fast Foods, and Quaker Oats for materials, equipment, and medicines for concomitant conditions; and to McKesson BioServices, Mathews Media Group, and the Henry M. Jackson Foundation for support services provided under subcontract with the Coordinating Center.
Source Information
The writing group (William C. Knowler, M.D., Dr.P.H., Elizabeth Barrett-Connor, M.D., Sarah E. Fowler, Ph.D., Richard F. Hamman, M.D., Dr.P.H., John M. Lachin, Sc.D., Elizabeth A. Walker, D.N.Sc., and David M. Nathan, M.D.) takes responsibility for the content of this article.
Address reprint requests to the Diabetes Prevention Program Coordinating Center, Biostatistics Center, George Washington University, 6110 Executive Blvd., Suite 750, Rockville, MD 20852.
The members of the Diabetes Prevention Program Research Group are listed in the Appendix.
Appendix
The following investigators were members of the Diabetes Prevention Program Research Group (asterisks indicate principal investigators, and daggers program coordinators): Pennington Biomedical Research Center — G.A. Bray,* I.W. Culbert,† C.M. Champagne, M.D. Crow, L. Dawson, B. Eberhardt, F.L. Greenway, F.G. Guillory, A.A. Hebert, M.L. Jeffirs, K. Joyce, B.M. Kennedy, J.C. Lovejoy, S. Mancuso, L.E. Melancon, L.H. Morris, L. Reed, J. Perault, K. Rau, D.H. Ryan, D.A. Sanford, K.G. Smith, L.L. Smith, S.R. Smith, J.A. St. Amant, M. Terry, E. Tucker, R.T. Tulley, P.C. Vicknair, D. Williamson, and J.J. Zachwieja; University of Chicago — D.A. Ehrmann,* M.J. Matulik,† B. Clarke, D.A. Collins, K.B. Czech, C. DeSandre, G. Geiger, S. Grief, B. Harding-Clay, R.M. Hilbrich, D. le Grange, M.R. McCormick, W.L. McNabb, K.S. Polonsky, N.P. Sauter, A.R. Semenske, K.A. Stepp, and J.A. Tobian; Jefferson Medical College — P.G. Watson,* J.T. Mendoza,† K.A. Smith,† J. Caro, B. Goldstein, C. Lark, L. Menefee, L. Murphy, C. Pepe, and J.M. Spandorfer; University of Miami — R.B. Goldberg,* P. Rowe,† J. Calles, P. Casanova, R.P. Donahue, H.J. Florez, A. Giannella, G. Larreal, V. McLymont, J. Mendez, P. O'Hara, J. Ojito, R. Prineas, and P.G. Saab; The University of Texas Health Science Center — S.M. Haffner,* M.G. Montez,† C. Lorenzo, H. Miettinen, C.M. Mobley, L.A. Mykkanen, and M.M. Rozek; University of Colorado — R.F. Hamman,* P.V. Nash,† L. Testaverde,† D.R. Anderson, L.B. Ballonoff, A. Bouffard, B.N. Calonge, M. Farago, W.J. Georgitis, J.O. Hill, S.R. Hoyer, B.T. Jortberg, J.A. Merenich, M. Miller, J.G. Regensteiner, H.M. Seagle, C.M. Smith, S.C. Steinke, and B. VanDorsten; Joslin Diabetes Center — E.S. Horton,* K.E. Lawton,† R.A. Arky, M. Bryant, J.P. Burke, E. Caballero, K.M. Callaghan, D. Devlin, T. Franklin, O.P. Ganda, A.E. Goebel-Fabbri, M. Harris, S.D. Jackson, A.M. Jacobsen, L.M. Kula, M. Kocal, S. Ledbury, M.A. Malloy, C. Mullooly, M. Nicosia, C.F. Oldmixon, J. Pan, C. Pomposelli, M. Quitongan, S. Rubtchinsky, D. Schweizer, E.W. Seely, D. Simonson, F. Smith, C.G. Solomon, J. Tyson, and J. Warram; University of Washington and Veterans Affairs Puget Sound Health Care System — S.E. Kahn,* B.K. Montgomery,† M. Alger, E. Allen, T. Barrett, D. Bhanji, J. Cowan, J. Cullen, W.Y. Fujimoto, B. Katz, R.H. Knopp, E.W. Lipkin, M. Marr, B.S. McCann, J.P. Palmer, R.S. Schwartz, and D. Uyema; University of Tennessee — A.E. Kitabchi,* M.E. Murphy,† W.B. Applegate, M. Bryer-Ash, J.H. Coble, A. Crisler, G. Cunningham, A.W. Franklin, S.L. Frieson, D.L. Green, R. Imseis, C.L. Kennedy, H.C. Lambeth, K.A. Latif, L.C. Lichtermann, M.D. McIntyre, J.D. Nault, H. Oktaei, M.L. O'Toole, H. Ricks, L.M.K. Rutledge, S.C. Schussler, A.R. Sherman, C.M. Smith, J.E. Soberman, K.J. Stewart, D.L. VanBrunt, and B.J. Williams-Cleaves; Northwestern University Medical School — B.E. Metzger,* M.K. Johnson,† C. Behrends, M.L. Cook, M. Fitzgibbon, M.M. Giles, D. Heard, C. Johnson, D. Larsen, A. Lowe, M. Lyman, D. McPherson, M.E. Molitch, T. Pitts, R. Reinhart, S. Roston, and P.A. Schinleber; Massachusetts General Hospital — D.M. Nathan,* C. McKitrick,† K. Abbott, E. Anderson, L. Bissett, E. Cagliero, S. Crowell, L. Delahanty, S. Fritz, K. Hayward, E. Levina, T. Michel, D. Norman, J. O'Keefe, A. Poulos, L. Ronan, M. Rosal, M. Salerno, M. Schneider, C. Shagensky, B. Steiner, H. Turgeon, and A. Young; University of California, San Diego — J.M. Olefsky,* M.L. Carrion-Petersen,† E. Barrett-Connor, M. Beltran, K. Caenepeel-Mills, S.V. Edelman, R.O. Ford, J. Garcia, M. Hagerty, R.R. Henry, M. Hill, J. Horne, D. Leos, J. Matney, S. Mudaliar, G. Petersen, A. Pollard, W. Polonsky, S. Szerdi, J. Torio-Hurley, and K. Vejvoda; St. Luke's–Roosevelt Hospital — F.X. Pi-Sunyer,* J.E. Lee,† D.B. Allison, N. Agharanya, N.J. Aronoff, M. Baldo, S.T. Foo, S. Hagamen, C. Pal, K. Parkes, M. Pena, and G.E.H. Van Wye; Indiana University — D.G. Marrero,* M.S. Kukman-Kelly,† Y.F. Dotson, S.E. Fineberg, J.C. Guare, A. Hadden, B. Hills, J.M. Ignaut, M.A. Jackson, M.S. Kirkman, K. Mather, G. McAtee, B.D. Porter, M.J. Prince, and M.L. Wheeler; Medstar Research Institute — R.E. Ratner,* G. Youssef,† S. Shapiro,† A. Bonar, M. Bronsord, E. Brown, W.W. Cheatham, S. Cola, A. Comfort, G. Boggs, C. Eagle, C. Evans, E. Gorman, R. Johnson, C. Levetan, T. Kellum, M. Lagarda, A.K. Nair, M.D. Passaro, and W. Phillips; UCLA Medical School — M.F. Saad,* M. Budgett,† S. Fahmi,† S.D. Jinagouda,† B. Bernaba, S.L. Bodkin, V. Ciobanu, R. Commisso, C. Cosenza, T. Dinh, M. Gonzalez, A. Khan, D. Kumar, G. Lui, V. Mehta, A. Sharma, S. Soukiazian, K. Szamos, A. Tramanian, A. Vargas, and N. Zambrana; Washington University, St. Louis — N.H. White,* A.S. Santiago,† S. Das,† A.L. Brown, S. Dagogo-Jack, E.B. Fisher, E. Hurt, T. Jones, M. Kerr, L. Ryder, J.V. Santiago (deceased), and C. Wernimont; Johns Hopkins School of Medicine — C.D. Saudek,* V.L. Bradley,† T. Fowlkes,† H. Joseph,† F.L. Brancati, J.B. Charleston, J.M. Clark, K. Horak, D. Jiggetts, H. Mosley, R.R. Rubin, A. Samuels, K.J. Stewart, L. Thomas, and P. Williamson; University of New Mexico School of Medicine — D.S. Schade,* K.S. Adams,† L.F. Atler, A. Bland, D.A. Bowling, P.J. Boyle, M.R. Burge, L. Butler, J.L. Canady, L. Chai, K.M. Colleran, M. Guillen, Y. Gonzales, M. Gutierrez, D. Hornbeck, C. Johannes, P. Katz, C. King, E.N. Libby III, R. McCalman, D.A. Montoya, A. Rassam, S. Rubinchik, and W. Senter; Albert Einstein College of Medicine — H. Shamoon,* J.O. Brown,† J. Adames, E. Blanco, L. Cox, J.P. Crandall, H. Duffy, S. Engel, A. Friedler, T. Harroun, C.J. Howard-Century, S. Kloiber, N. Longchamp, D. Pompi, E. Violino, E.A. Walker, J. Wylie-Rosett, E. Zimmerman, and J. Zonszein; University of Pittsburgh — R.R. Wing,* M.K. Kramer,† S. Barr, M.A. Boraz, L. Clifford, R. Culyba, M. Frazier, R. Gilligan, L. Harris, S. Harrier, W. Henderson, S. Jeffries, G. Koenning, A.M. Kriska, K. Maholic, Q. Manjoo, M. Mullen, A. Noel, T.J. Orchard, A. Otto, L.N. Semler, C. Smith, M. Smith, V. Stapinski, J. Viteri, T. Wilson, K.V. Williams, and J. Zgibor; University of Hawaii — R.F. Arakaki,* R.W. Latimer,† N.K. Baker-Ladao, R.M. Beddow, R. Braginsky, M. Calizar, L.M. Dias, N. Durham, D.A. Dupont, L.L. Fukuhara, J. Inouye, M.K. Mau, K. Mikami, P. Mohideen, S.K. Odom, B. Sinkule-Kam, J.S. Tokunaga, R.U. Twiggs, C.Y. Wang, and J. Vita; Southwest American Indian Center for Diabetes Prevention — W.C. Knowler,* N.J. Cooeyate,† M.A. Hoskin,† C.A. Percy,† K.J. Acton, V.L. Andre, S. Antone, N.M. Baptisto, R. Barber, S. Begay, P.H. Bennett, M.B. Benson, S. Beyale, E.C. Bird, B.A. Broussard, M. Chavez, T.S. Dacawyma, M.S. Doughty, R. Duncan, C. Edgerton, J.M. Ghahate, M. Glass, D. Gohdes, W. Grant, R.L. Hanson, E. Horse, G. Hughte, L.E. Ingraham, M.C. Jackson, P.A. Jay, R.S. Kaskalla, D. Kessler, K.M. Kobus, J. Krakoff, C. Manus, T. Morgan, Y. Nashboo (deceased), J. Nelson, G.L. Pauk, S. Poirier, E. Polczynski, M. Reidy, J. Roumain, D.H. Rowse, R.J. Roy, S. Sangster, J. Sewemaenewa, D. Tonemah, C. Wilson, and M. Yazzie; George Washington University Biostatistics Center — S. Fowler,* T. Brenneman,† S. Abebe, R. Bain, J. Bamdad, J. Callaghan, S.L. Edelstein, Y. Gao, K.L. Grimes, N. Grover, K. Hirst, S. Jones, T.L. Jones, R.J. Katz, J.M. Lachin, R. Orlosky, C.E. Stimpson, C. Suiter, M.G. Temprosa, and F.E.M. Walker-Murray; National Institute of Diabetes and Digestive and Kidney Diseases Program Office — S. Garfield,† R. Eastman, and J. Fradkin; National Institute on Aging — R. Andres; Centers for Disease Control and Prevention — M.M. Engelgau, K.M. Venkat Narayan, and D.F. Williamson; University of Michigan — W.H. Herman; Central Biochemistry Laboratory (University of Washington) — S.M. Marcovina,* A. Aldrich, and W.L. Chandler; Central ECG Reading Center (Wake Forest University) — P.M. Rautaharju,* N.T. Pemberton, R. Prineas, F.S.R. Rautaharju, and Z. Zhang; Nutrition Coding Center (University of South Carolina) — E.J. Mayer-Davis,* T. Costacou, M. Martin, and K.L. Sparks; Central Carotid Ultrasound Unit (New England Medical Center) — D.H. O'Leary,* L.R.C. Funk, K.A. O'Leary, and J.F. Polak; CT-Scan Reading Unit (University of Colorado) — E.R. Stamm* and A.L. Scherzinger; Lifestyle Resource Core (University of Pittsburgh) — R.R. Wing,* B.P. Gillis, C. Huffmyer, A.M. Kriska, and E.M. Venditti; Medication Resource Workgroup (Albert Einstein College of Medicine) — E.A. Walker* and T. Harroun; Quality of Well Being Reading Unit (University of California, San Diego) — T.G. Ganiats,* E.J. Groessl, P.R. Beerman, K.M. David, R.M. Kaplan, and W.J. Sieber; Data Monitoring Board — S.M. Genuth (chair), G.F. Cahill, F.L. Ferris III, J.R. Gavin III, J.B. Halter, and J. Wittes; Ancillary Studies Subcommittee — R.R. Henry and S.M. Haffner (chairs); Behavioral Scientists — R.R. Rubin (chair); Clinic Operations — B.K. Montgomery (chair); Concomitant Conditions — R.E. Ratner (chair); Economic Evaluation — W.H. Herman (chair); Interventions — S.E. Kahn, J.V. Santiago (deceased), and J. Olefsky (chairs); Lifestyle Advisory Group — R.R. Wing (chair); Outcomes — C. Saudek (chair); Outcomes Classification — R.E. Ratner (chair); Program Coordinators Subcommittee — M. Montez and K. Kramer (chairs); Protocol Oversight — R.F. Hamman (chair); Publications and Presentations — W.C. Knowler (chair); Quality Control — R.B. Goldberg (chair); Recruitment — W.Y. Fujimoto (chair); Recruitment Coordinators Subcommittee — J. Charleston (chair); Retention — R.R. Rubin (chair); Screening and Eligibility — R.F. Hamman (chair); Study Chair and Vice Chair — D.M. Nathan and R.F. Hamman.
- References
References
1
Harris MI ,Flegal KM ,Cowie CC , et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;28:518-524
CrossRef | Web of Science2
UK Prospective Diabetes Study (UKPDS) Group
CrossRef | Web of Science | Medline3
UK Prospective Diabetes Study (UKPDS) Group
CrossRef | Web of Science | Medline4
Harris MI ,Eastman RC . Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 2001;16:230-236
CrossRef | Web of Science5
Knowler WC ,Narayan KMV ,Hanson RL , et al. Preventing non-insulin-dependent diabetes. Diabetes 1995;44:483-488
CrossRef | Web of Science | Medline6
The Diabetes Prevention Program Research Group
CrossRef | Web of Science | Medline7
Pan XR ,Li GW ,Hu YH , et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544
CrossRef | Web of Science | Medline8
Tuomilehto J ,Lindstrom J ,Eriksson JG , et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
Full Text | Web of Science | Medline9
Tataranni PA ,Bogardus C . Changing habits to delay diabetes. N Engl J Med 2001;344:1390-1392
Full Text | Web of Science | Medline10
Diabetes in America. 2nd ed. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 1995. (NIH publication no. 95-1468.)
11
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197
Web of Science | Medline12
The Diabetes Prevention Program Research Group
CrossRef | Web of Science | Medline13
The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: recruitment methods and results. Control Clin Trials (in press).
14
The Food Guide Pyramid. Washington, D.C.: Department of Agriculture, Center for Nutrition Policy and Promotion, 1996. (Home and Garden Bulletin no. 252.)
15
Step by step: eating to lower your high blood cholesterol. Bethesda, Md.: National Heart, Lung, and Blood Institute Information Center, 1987.
16
Kriska AM ,Caspersen CJ . Introduction to a collection of physical activity questionnaires. Med Sci Sports Exerc 1997;29:Suppl:S5-S917
Mayer-Davis EJ ,Vitolins MZ ,Carmichael SL , et al. Validity and reproducibility of a food frequency interview in a multi-cultural epidemiology study. Ann Epidemiol 1999;9:314-324
CrossRef | Web of Science | Medline18
Lan KKG ,Lachin JM . Implementation of group sequential logrank tests in a maximum duration trial. Biometrics 1990;46:759-770
CrossRef | Web of Science | Medline19
Lachin JM. Biostatistical methods: the assessment of relative risks. New York: John Wiley, 2000.
20
Diggle PJ, Liang K-Y, Zeger SL. Analysis of longitudinal data. New York: Oxford University Press, 1994.
21
Edelstein SL ,Knowler WC ,Bain RP , et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997;46:701-710
CrossRef | Web of Science | Medline22
DeFronzo RA . Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303
Web of Science | Medline23
Trends in the prevalence and incidence of self-reported diabetes mellitus -- United States, 1980-1994. MMWR Morb Mortal Wkly Rep 1997;46:1014-1018
Medline24
Gillum RF ,Mussolino ME ,Madans JH . Diabetes mellitus, coronary heart disease incidence, and death from all causes in African American and European American women: the NHANES I epidemiologic follow-up study. J Clin Epidemiol 2000;53:511-518
CrossRef | Web of Science | Medline25
Kuller LH ,Velentgas P ,Barzilay J ,Beauchamp NJ ,O'Leary DH ,Savage PJ . Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 2000;20:823-829
CrossRef | Web of Science | Medline26
Gabir MM ,Hanson RL ,Dabelea D , et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes mellitus. Diabetes Care 2000;23:1108-1112
CrossRef | Web of Science | Medline27
de Vegt F ,Dekker JM ,Jager A , et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 2001;285:2109-2113
CrossRef | Web of Science | Medline
- Citing Articles (2927)
Citing Articles
1
Nathan V. Matusheski, Siamak Bidel, Jaakko Tuomilehto. 2012. Coffee and Type 2 Diabetes Risk. , 141-179.
CrossRef2
Benoit Viollet, Bruno Guigas, Nieves Sanz Garcia, Jocelyne Leclerc, Marc Foretz, Fabrizio Andreelli. (2012) Cellular and molecular mechanisms of metformin: an overview. Clinical Science 122:6, 253-270
CrossRef3
Qiuping Pearl Zhou, Kyeung Mi Oh. (2012) Comparison of lifestyle behaviors and related factors between Asian American and white adults with prediabetes. Nursing & Health Sciencesno-no
CrossRef4
Jeffrey I. Mechanick, Albert E. Marchetti, Caroline Apovian, Alexander Koglin Benchimol, Peter H. Bisschop, Alexis Bolio-Galvis, Refaat A. Hegazi, David Jenkins, Enrique Mendoza, Miguel Leon Sanz, Wayne Huey-Herng Sheu, Patrizio Tatti, Man-Wo Tsang, Osama Hamdy. (2012) Diabetes-Specific Nutrition Algorithm: A Transcultural Program to Optimize Diabetes and Prediabetes Care. Current Diabetes Reports
CrossRef5
, B. Costa, F. Barrio, J.-J. Cabré, J.-L. Piñol, X. Cos, C. Solé, B. Bolíbar, J. Basora, C. Castell, O. Solà-Morales, J. Salas-Salvadó, J. Lindström, J. Tuomilehto. (2012) Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention. Diabetologia
CrossRef6
Y. Sato, K. Kondo, T. Watanabe, H. Sone, M. Kobayashi, R. Kawamori, Y. Tamura, Y. Atsumi, Y. Oshida, S. Tanaka, S. Suzuki, S. Makita, I. Ohsawa, S. Imamura. (2012) Present situation of exercise therapy for patients with diabetes mellitus in Japan: a nationwide survey. Diabetology International
CrossRef7
Daniella D.G. Curi, Angela Maggio Fonseca, José Antônio M. Marcondes, José Alcione M. Almeida, Vicente R. Bagnoli, José Maria Soares, Edmund Chada Baracat. (2012) Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecological Endocrinology1-4
CrossRef8
C. R. Mikus, D. J. Oberlin, J. Libla, L. J. Boyle, J. P. Thyfault. (2012) Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes. Diabetologia
CrossRef9
Susann Blüher, Jana Markert, Sabine Herget, Thomas Yates, Melanie Davis, Gabriele Müller, Thomas Waldow, Peter E. H. Schwarz. (2012) Who Should We Target for Diabetes Prevention and Diabetes Risk Reduction?. Current Diabetes Reports
CrossRef10
Robyn Gallagher, Ann Kirkness, Elizabeth Armari, Patricia M Davidson. (2012) Participants' perspectives of a multi-component, group-based weight loss programme supplement for cardiac rehabilitation: A qualitative study. International Journal of Nursing Practice 18:1, 28-35
CrossRef11
L. J. Gray, N. Cooper, A. Dunkley, F. C. Warren, R. Ara, K. Abrams, M. J. Davies, K. Khunti, A. Sutton. (2012) A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity. Obesity Reviewsno-no
CrossRef12
Y. Sui, H. L. Zhao, V. C. W. Wong, N. Brown, X. L. Li, A. K. L. Kwan, H. L. W. Hui, E. T. C. Ziea, J. C. N. Chan. (2012) A systematic review on use of Chinese medicine and acupuncture for treatment of obesity. Obesity Reviewsno-no
CrossRef13
Scott M. Grundy. (2012) Pre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk. Journal of the American College of Cardiology 59:7, 635-643
CrossRef14
Yoshimasa Aso. (2012) Author reply. Translational Research
CrossRef15
William R. Rowley, Clement Bezold. (2012) Creating Public Awareness: State 2025 Diabetes Forecasts. Population Health Management120127081311005
CrossRef16
(2012) Long-Term Hormonal Adaptations to Weight Loss. New England Journal of Medicine 366:4, 380-382
Full Text17
Chihiro Toji, Naoko Okamoto, Tomomi Kobayashi, Yoko Furukawa, Sanae Tanaka, Kayoko Ueji, Mitsuru Fukui, Chigusa Date. (2012) Effectiveness of diet versus exercise intervention on weight reduction in local Japanese residents. Environmental Health and Preventive Medicine
CrossRef18
J. A. Hawley, M. J. Gibala. (2012) What’s new since Hippocrates? Preventing type 2 diabetes by physical exercise and diet. Diabetologia
CrossRef19
Anne-Laure Borel, Julie-Anne Nazare, Jessica Smith, Natalie Alméras, Angelo Tremblay, Jean Bergeron, Paul Poirier, Jean-Pierre Després. (2012) Visceral and Not Subcutaneous Abdominal Adiposity Reduction Drives the Benefits of a 1-Year Lifestyle Modification Program. Obesity
CrossRef20
Peter E. Schwarz, Colin J. Greaves, Jaana Lindström, Thomas Yates, Melanie J. Davies. (2012) Nonpharmacological interventions for the prevention of type 2 diabetes mellitus. Nature Reviews Endocrinology
CrossRef21
Khadija I. Khawaja, Aziz Fatima, Saqib A. Mian, Usman Mumtaz, Amena Moazzum, Muhammad Ghias, Faisal Masud. (2012) Glycaemic, insulin and ghrelin responses to traditional South Asian flatbreads in diabetic and healthy subjects. British Journal of Nutrition1-8
CrossRef22
, A. Nicolucci, S. Balducci, P. Cardelli, S. Cavallo, S. Fallucca, A. Bazuro, P. Simonelli, C. Iacobini, S. Zanuso, G. Pugliese. (2012) Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES). Diabetologia
CrossRef23
Alexander Bartelt, Martin Merkel, Joerg Heeren. (2012) A new, powerful player in lipoprotein metabolism: brown adipose tissue. Journal of Molecular Medicine
CrossRef24
Bernhard Ludvik, Guntram Schernthaner. (2012) Diabetes Care Austria 2009: Register an allgemeinmedizinischen Ordinationen für PatientInnen mit Typ 2 Diabetes mellitus in Österreich. Wiener klinische Wochenschrift
CrossRef25
Sandra A. Billinger, Eileen Coughenour, Marilyn J. MacKay-Lyons, Frederick M. Ivey. (2012) Reduced Cardiorespiratory Fitness after Stroke: Biological Consequences and Exercise-Induced Adaptations. Stroke Research and Treatment 2012, 1-11
CrossRef26
Abdulnabi Alattar, Hana Al-Majed, Thaier Almuaili, Obaid Almutairi, Amnah Shaghouli, Wehad Altorah. (2012) Prevalence of Impaired Glucose Regulation in Asymptomatic Kuwaiti Young Adults. Medical Principles and Practice 21:1, 51-55
CrossRef27
Heather D Clark, Erin Keely. (2012) Getting mothers with gestational diabetes to return for postpartum testing: what works and what does not. Diabetes Management 2:1, 33-39
CrossRef28
Normand G Boulé. (2012) Complex relationship between metformin and exercise in diabetes treatment: should we reconsider our recommendations?. Diabetes Management 2:1, 5-8
CrossRef29
John C. Marshall, Andrea Dunaif. (2012) Should all women with PCOS be treated for insulin resistance?. Fertility and Sterility 97:1, 18-22
CrossRef30
Sylvia E. Rosas, Peter P. Reese, Yonghong Huan, Cataldo Doria, Philip T. Cochetti, Alden Doyle. (2012) Pretransplant Physical Activity Predicts All-Cause Mortality in Kidney Transplant Recipients. American Journal of Nephrology 35:1, 17-23
CrossRef31
Angela Mazza, Barbara Fruci, Giorgia Anna Garinis, Stefania Giuliano, Roberta Malaguarnera, Antonino Belfiore. (2012) The Role of Metformin in the Management of NAFLD. Experimental Diabetes Research 2012, 1-13
CrossRef32
Steven G. Gabbe, Mark B. Landon, Elizabeth Warren-Boulton, Judith Fradkin. (2012) Promoting Health After Gestational Diabetes. Obstetrics & Gynecology 119:1, 171-176
CrossRef33
K. M. Ross Middleton, S. M. Patidar, M. G. Perri. (2012) The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obesity Reviewsno-no
CrossRef34
Mari K. Hopper, Gordon W. Brown, Katharine A. Funke, Leslie R. Pike Brown. (2012) Prevalence of Hyperinsulinemia Associated With Body Mass Index, Genetic Predisposition, and Lifestyle in College Freshmen Students. Journal of American College Health 60:1, 27-36
CrossRef35
Amanda Reichard, Hayley Stolzle, Ana Carolina Sella, Theresa I. Shireman. (2012) Quality of diabetes care for adults with physical disabilities in Kansas. Disability and Health Journal 5:1, 34-40
CrossRef36
Lawrence H. Kushi, Colleen Doyle, Marji McCullough, Cheryl L. Rock, Wendy Demark-Wahnefried, Elisa V. Bandera, Susan Gapstur, Alpa V. Patel, Kimberly Andrews, Ted Gansler, . (2012) American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians 62:1, 30-67
CrossRef37
Danielle R. Bouchard, Jean-Patrice Baillargeon, Claudia Gagnon, Christine Brown, Marie-France Langlois. (2012) Impact of health professionals’ contact frequency on response to a lifestyle intervention with individuals at high risk for diabetes. Diabetes Research and Clinical Practice
CrossRef38
Janice S. Dorman, Rodolfo Valdez, Tiebin Liu, Catharine Wang, Wendy S. Rubinstein, Suzanne M. O’Neill, Louise S. Acheson, Mack T. Ruffin, Muin J. Khoury. (2012) Health beliefs among individuals at increased familial risk for type 2 diabetes: Implications for prevention. Diabetes Research and Clinical Practice
CrossRef39
B. Kumaravel, M.O. Bachmann, N. Murray, K. Dhatariya, M. Fenech, W.G. John, T.J. Scarpello, M.J. Sampson. (2012) Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population. Diabetes Research and Clinical Practice
CrossRef40
Ike S. Okosun, Monique Davis-Smith, J. Paul Seale. (2012) Awareness of diabetes risks is associated with healthy lifestyle behavior in diabetes free American adults: Evidence from a nationally representative sample. Primary Care Diabetes
CrossRef41
Viveca Gyberg, Dan Hasson, Jaakko Tuomilehto, Lars Rydén. (2012) Measuring risk online—Feasibility of using FINDRISC in an online workplace survey. Primary Care Diabetes
CrossRef42
Patrice Carter, Kamlesh Khunti, Melanie J. Davies. (2012) Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on?. Journal of Nutrition and Metabolism 2012, 1-6
CrossRef43
Wilfred Y Fujimoto, Edward J Boyko, Tomoshige Hayashi, Steven E Kahn, Donna L Leonetti, Marguerite J McNeely, William P Shuman. (2012) Risk factors for type 2 diabetes: Lessons learned from Japanese Americans in Seattle. Journal of Diabetes Investigationno-no
CrossRef44
Philip. A. Ades, Diann E. Gaalema. (2012) Coronary heart disease as a case study in prevention: Potential role of incentives. Preventive Medicine
CrossRef45
Meeke Hoedjes, Durk Berks, Ineke Vogel, Arie Franx, Anke Oenema, Johannes J. Duvekot, J. Dik F. Habbema, Eric A.P. Steegers, Hein Raat. (2012) Postpartum physical activity after preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health
CrossRef46
M. D. Young, P. J. Morgan, R. C. Plotnikoff, R. Callister, C. E. Collins. (2012) Effectiveness of male-only weight loss and weight loss maintenance interventions: a systematic review with meta-analysis. Obesity Reviewsno-no
CrossRef47
K. Backholer, L. Chen, J. Shaw. (2012) Screening for diabetes. Pathology1
CrossRef48
John Armato, Ralph A. DeFronzo, Muhammad Abdul-Ghani, Ron Ruby. (2012) Successful Treatment of Prediabetes in Clinical Practice: Targeting Insulin Resistance and Beta Cell Dysfunction. Endocrine Practice 1:-1, 1-21
CrossRef49
Christine M. Swanson, Sophie Bersoux, Marcia H. Larson, Ruth T. Aponte-Furlow, Sandra S. Flatten, Cari L. Olsen, Carolyn LaRosa, Patricia M. Verona, Kimberly A. Jameson, Curtiss B. Cook. (2012) An Outpatient-Based Clinical Program for Diabetes Prevention: An Update. Endocrine Practice 1:-1, 1-26
CrossRef50
Philip J. Morgan, Clare E. Collins, Ronald C. Plotnikoff, Alyce T. Cook, Bronwyn Berthon, Simon Mitchell, Robin Callister. (2012) The Impact of a Workplace-Based Weight Loss Program on Work-Related Outcomes in Overweight Male Shift Workers. Journal of Occupational and Environmental Medicine1
CrossRef51
S. van Dieren, S. Czernichow, J. Chalmers, A.P. Kengne, B.E. de Galan, N. Poulter, M. Woodward, J.W.J. Beulens, D.E. Grobbee, Y.T. van der Schouw, S. Zoungas. (2012) Weight changes and their predictors amongst 11,140 patients with type 2 diabetes in the ADVANCE trial. Diabetes, Obesity and Metabolismno-no
CrossRef52
Christie A. Befort, Jennifer R. Klemp, Heather L. Austin, Michael G. Perri, Kathryn H. Schmitz, Debra K. Sullivan, Carol J. Fabian. (2011) Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Research and Treatment
CrossRef53
M. Chimen, A. Kennedy, K. Nirantharakumar, T. T. Pang, R. Andrews, P. Narendran. (2011) What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia
CrossRef54
Jessica L. Bachman, Hollie A. Raynor. (2011) Effects of Manipulating Eating Frequency During a Behavioral Weight Loss Intervention: A Pilot Randomized Controlled Trial. Obesity
CrossRef55
Judith G. P. van Can, Luc J. C. van Loon, Fred Brouns, Ellen E. Blaak. (2011) Reduced glycaemic and insulinaemic responses following trehalose and isomaltulose ingestion: implications for postprandial substrate use in impaired glucose-tolerant subjects. British Journal of Nutrition1-8
CrossRef56
Ira S. Ockene, Trinidad L. Tellez, Milagros C. Rosal, George W. Reed, John Mordes, Philip A. Merriam, Barbara C. Olendzki, Garry Handelman, Robert Nicolosi, Yunsheng Ma. (2011) Outcomes of a Latino Community-Based Intervention for the Prevention of Diabetes: The Lawrence Latino Diabetes Prevention Project. American Journal of Public Healthe1-e7
CrossRef57
A. R. Cooper, S. Sebire, A. A. Montgomery, T. J. Peters, D. J. Sharp, N. Jackson, K. Fitzsimons, C. M. Dayan, R. C. Andrews. (2011) Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia
CrossRef58
Benoit J. Arsenault, Emilie Pelletier Beaumont, Jean-Pierre Després, Eric Larose. (2011) Mapping body fat distribution: A key step towards the identification of the vulnerable patient?. Annals of Medicine1-15
CrossRef59
Angela Marinilli Pinto, Leslee L. Subak, Sanae Nakagawa, Eric Vittinghoff, Rena R. Wing, John W. Kusek, William H. Herman, Delia Smith West, Miriam Kuppermann. (2011) The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence. Quality of Life Research
CrossRef60
Paul W. Franks. (2011) Gene × Environment Interactions in Type 2 Diabetes. Current Diabetes Reports 11:6, 552-561
CrossRef61
Jilin Dong, Fengli Cai, Ruiling Shen, Yanqi Liu. (2011) Hypoglycaemic effects and inhibitory effect on intestinal disaccharidases of oat beta-glucan in streptozotocin-induced diabetic mice. Food Chemistry 129:3, 1066-1071
CrossRef62
Annie Ferland, Robert H. Eckel. (2011) Does Sustained Weight Loss Reverse the Metabolic Syndrome?. Current Hypertension Reports 13:6, 456-464
CrossRef63
Trond Jenssen, Anders Hartmann. (2011) Prevention and management of transplant-associated diabetes. Expert Opinion on Pharmacotherapy 12:17, 2641-2655
CrossRef64
Zhi-Yin Yang, Zhen Yang, Lifang Zhu, Chengxuan Qiu. (2011) Human Behaviors Determine Health: Strategic Thoughts on the Prevention of Chronic Non-communicable Diseases in China. International Journal of Behavioral Medicine 18:4, 295-301
CrossRef65
Meghan L. Butryn, Victoria Webb, Thomas A. Wadden. (2011) Behavioral Treatment of Obesity. Psychiatric Clinics of North America 34:4, 841-859
CrossRef66
George A. Bray, Donna H. Ryan. (2011) Drug Treatment of Obesity. Psychiatric Clinics of North America 34:4, 871-880
CrossRef67
Mark B. Landon, Steven G. Gabbe. (2011) Gestational Diabetes Mellitus. Obstetrics & Gynecology 118:6, 1379-1393
CrossRef68
David R. McCance. (2011) Pregnancy and diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 25:6, 945-958
CrossRef69
Benoit J Arsenault, Jean-Pierre Després, S Matthijs Boekholdt. (2011) Hypertriglyceridemic waist: missing piece of the global cardiovascular risk assessment puzzle?. Clinical Lipidology 6:6, 639-651
CrossRef70
Polly H. Noël, Chen-Pin Wang, Mary J. Bollinger, Mary J. Pugh, Laurel A. Copeland, Joel Tsevat, Karin M. Nelson, Margaret M. Dundon, Helen P. Hazuda. (2011) Intensity and Duration of Obesity-Related Counseling: Association With 5-Year BMI Trends Among Obese Primary Care Patients. Obesity
CrossRef71
S. M. Kansagra, T. A. Farley. (2011) Public Health Research: Lost in Translation or Speaking the Wrong Language?. American Journal of Public Health 101:12, 2203-2206
CrossRef72
Suzanne E. Mahady, Angela C. Webster, Sarah Walker, Arun Sanyal, Jacob George. (2011) The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis. Journal of Hepatology 55:6, 1383-1390
CrossRef73
Claudia M. Toledo-Corral, Lisa G. Vargas, Michael I. Goran, Marc J. Weigensberg. (2011) Hemoglobin A1c above Threshold Level is Associated with Decreased β-Cell Function in Overweight Latino Youth. The Journal of Pediatrics
CrossRef74
Marie C. Audelin, Patrick D. Savage, Michael J. Toth, Jean Harvey-Berino, David J. Schneider, Janice Y. Bunn, Maryann Ludlow, Philip A. Ades. (2011) Change of energy expenditure from physical activity is the most powerful determinant of improved insulin sensitivity in overweight patients with coronary artery disease participating in an intensive lifestyle modification program. Metabolism
CrossRef75
A.J. Palmer, D.M.D. Tucker. (2011) Cost and clinical implications of diabetes prevention in an Australian setting: A long-term modeling analysis. Primary Care Diabetes
CrossRef76
Catherine M. Champagne, Stephanie T. Broyles, Laura D. Moran, Katherine C. Cash, Erma J. Levy, Pao-Hwa Lin, Bryan C. Batch, Lillian F. Lien, Kristine L. Funk, Arlene Dalcin, Catherine Loria, Valerie H. Myers. (2011) Dietary Intakes Associated with Successful Weight Loss and Maintenance during the Weight Loss Maintenance Trial. Journal of the American Dietetic Association 111:12, 1826-1835
CrossRef77
RC Andrews, AR Cooper, AA Montgomery, TJ Peters, DJ Sharp, CM Dayan. (2011) Diet or diet plus physical activity in patients with early type 2 diabetes – Authors' reply. The Lancet 378:9809, 2067-2068
CrossRef78
Lorraine A. Brooking, Sheila M. Williams, Jim I. Mann. (2011) Effects of macronutrient composition of the diet on body fat in indigenous people at high risk of type 2 diabetes. Diabetes Research and Clinical Practice
CrossRef79
Laura Pelaz-Berdullas, Alfonso Luis Calle-Pascual. (2011) Dieta proteinada en la diabetes de tipo 2. No. Avances en Diabetología
CrossRef80
Antoni J. Duleba. (2011) Medical management of metabolic dysfunction in PCOS. Steroids
CrossRef81
Tiina Laatikainen, Benjamin Philpot, Nelli Hankonen, Risto Sippola, James A. Dunbar, Pilvikki Absetz, Prasuna Reddy, Nathalie Davis-Lameloise, Erkki Vartiainen. (2011) Predicting changes in lifestyle and clinical outcomes in preventing diabetes: The Greater Green Triangle Diabetes Prevention Project. Preventive Medicine
CrossRef82
Leon I. Igel, Amanda G. Powell, Caroline M. Apovian, Louis J. Aronne. (2011) Advances in Medical Therapy for Weight Loss and the Weight-Centric Management of Type 2 Diabetes Mellitus. Current Atherosclerosis Reports
CrossRef83
Wadden, Thomas A., Volger, Sheri, Sarwer, David B., Vetter, Marion L., Tsai, Adam G., Berkowitz, Robert I., Kumanyika, Shiriki, Schmitz, Kathryn H., Diewald, Lisa K., Barg, Ronald, Chittams, Jesse, Moore, Reneé H., . (2011) A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice. New England Journal of Medicine 365:21, 1969-1979
Full Text84
Appel, Lawrence J., Clark, Jeanne M., Yeh, Hsin-Chieh, Wang, Nae-Yuh, Coughlin, Janelle W., Daumit, Gail, Miller, Edgar R. III, Dalcin, Arlene, Jerome, Gerald J., Geller, Steven, Noronha, Gary, Pozefsky, Thomas, Charleston, Jeanne, Reynolds, Jeffrey B., Durkin, NowellaRubin, Richard R., Louis, Thomas A., Brancati, Frederick L., . (2011) Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice. New England Journal of Medicine 365:21, 1959-1968
Full Text85
Keon E. Menzies, Patrick D. Savage, Philip A. Ades. (2011) Cardiovascular Effects of Weight Loss. Current Cardiovascular Risk Reports
CrossRef86
Ming-Chieh Wu, Ying-Lan Tsai, Chih-Yang Huang, Chung-Lan Kao, Chien-Wen Hou, Chung-Yu Chen, Mallikarjuna Korivi, Wei-Horng Jean, Shin-Da Lee, Chia-Hua Kuo. (2011) Hyperinsulinemia and overweight in obese Zucker rats effectively suppressed by exercise training with hypoxia recovery. European Journal of Sport Science1-10
CrossRef87
S. H. Shah, D. R. Crosslin, C. S. Haynes, S. Nelson, C. B. Turer, R. D. Stevens, M. J. Muehlbauer, B. R. Wenner, J. R. Bain, B. Laferrère, P. Gorroochurn, J. Teixeira, P. J. Brantley, V. J. Stevens, J. F. Hollis, L. J. Appel, L. F. Lien, B. Batch, C. B. Newgard, L. P. Svetkey. (2011) Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia
CrossRef88
Shankaracharya, Devang Odedra, Medhavi Mallick, Prateek Shukla, Subir Samanta, Ambarish S. Vidyarthi. (2011) Java-Based Diabetes Type 2 Prediction Tool for Better Diagnosis. Diabetes Technology & Therapeutics111107070638004
CrossRef89
Shiriki K. Kumanyika, Jennifer E. Fassbender, David B. Sarwer, Etienne Phipps, Kelly C. Allison, Russell Localio, Knashawn H. Morales, Lisa Wesby, Tina Harralson, Ronni Kessler, Susan Tan-Torres, Xiaoyan Han, Adam G. Tsai, Thomas A. Wadden. (2011) One-Year Results of the Think Health! Study of Weight Management in Primary Care Practices. Obesity
CrossRef90
M.S. Player, V.A. Diaz, A.G. Mainous III, S.H. Gregorie, M.E. Knoll, C.J. Everett. (2011) Ethnic differences in the relationship of prediabetes with the presence of target-organ disease. Diabetes & Metabolism 37:5, 403-409
CrossRef91
M. Seguí Díaz, J.J. Mediavilla Bravo, J.M. Comas Samper, A. Barquilla García, F. Carramiñana Barrera. (2011) Prevención de la diabetes mellitus 2. SEMERGEN - Medicina de Familia 37:9, 496-503
CrossRef92
Anagha Nadkarni, Suzan N. Kucukarslan, Richard P. Bagozzi, J. Frank Yates, Steven R. Erickson. (2011) Examining determinants of self management behaviors in patients with diabetes: An application of the Theoretical Model of Effortful Decision Making and Enactment. Patient Education and Counseling 85:2, 148-153
CrossRef93
Amy D. Rickman, Donald A. Williamson, Corby K. Martin, Cheryl H. Gilhooly, Richard I. Stein, Connie W. Bales, Susan Roberts, Sai Krupa Das. (2011) The CALERIE Study: Design and methods of an innovative 25% caloric restriction intervention. Contemporary Clinical Trials 32:6, 874-881
CrossRef94
Hassanabbas Z Mohamedali, Shabbir MH Alibhai. (2011) Does androgen deprivation therapy increase diabetes risk?. Diabetes Management 1:6, 551-553
CrossRef95
A Muramoto, K Tsushita, A Kato, N Ozaki, M Tabata, M Endo, Y Oike, Y Oiso. (2011) Angiopoietin-like protein 2 sensitively responds to weight reduction induced by lifestyle intervention on overweight Japanese men. Nutrition and Diabetes 1:11, e20
CrossRef96
R. A. Fielding, W. J. Rejeski, S. Blair, T. Church, M. A. Espeland, T. M. Gill, J. M. Guralnik, F.-C. Hsu, J. Katula, A. C. King, S. B. Kritchevsky, M. M. McDermott, M. E. Miller, S. Nayfield, A. B. Newman, J. D. Williamson, D. Bonds, S. Romashkan, E. Hadley, M. Pahor, . (2011) The Lifestyle Interventions and Independence for Elders Study: Design and Methods. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 66A:11, 1226-1237
CrossRef97
P. Narender Raju, Dharam Pal. (2011) Effect of bulking agents on the quality of artificially sweetened misti dahi (caramel colored sweetened yoghurt) prepared from reduced fat buffalo milk. LWT - Food Science and Technology 44:9, 1835-1843
CrossRef98
Nicolai Lohse, Elliot Marseille, James G. Kahn. (2011) Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. International Journal of Gynecology & Obstetrics 115, S20-S25
CrossRef99
Isabel Garcia de Quevedo, Linda Siminerio, Ronan L’Heveder, K.M. Venkat Narayan. (2011) Challenges in real-life diabetes translation research: Early lessons from BRIDGES projects. Diabetes Research and Clinical Practice
CrossRef100
Hyehyung Shin, Jihying Shin, Pei-Yang Liu, Gareth R. Dutton, Doris A. Abood, Jasminka Z. Ilich. (2011) Self-efficacy improves weight loss in overweight/obese postmenopausal women during a 6-month weight loss intervention. Nutrition Research 31:11, 822-828
CrossRef101
Richard K. Lee, Bilal Chughtai, Alexis E. Te, Steven A. Kaplan. (2011) Sexual Function in Men with Metabolic Syndrome. Urologic Clinics of North America
CrossRef102
Rita M Sneeringer, Vasiliki A Moragianni. 2011. Polycystic ovary syndrome. , 117-126.
CrossRef103
C. J. Yates, S. Fourlanos, J. Hjelmesaeth, P. G. Colman, S. J. Cohney. (2011) New-Onset Diabetes After Kidney Transplantation-Changes and Challenges. American Journal of Transplantationno-no
CrossRef104
Alan J. Sinclair, Giuseppe Paolisso, Marta Castro, Isabelle Bourdel-Marchasson, Roger Gadsby, Leocadio Rodriguez Mañas. (2011) European Diabetes Working Party for Older People 2011 Clinical Guidelines for Type 2 Diabetes Mellitus. Executive Summary. Diabetes & Metabolism 37, S27-S38
CrossRef105
Charlisa D. Gibson, Wahida Karmally, Donald J. McMahon, Sharon L. Wardlaw, Judith Korner. (2011) Randomized Pilot Study of Cabergoline, a Dopamine Receptor Agonist: Effects on Body Weight and Glucose Tolerance in Obese Adults. Diabetes, Obesity and Metabolismno-no
CrossRef106
Alan J. Garber. (2011) Obesity and type 2 diabetes: which patients are at risk?. Diabetes, Obesity and Metabolismno-no
CrossRef107
N.S. Lobato, F.P. Filgueira, G.N. Hagihara, E.H. Akamine, J.R. Pariz, R.C. Tostes, M.H.C. Carvalho, Z.B. Fortes. (2011) Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats. Life Sciences
CrossRef108
S.P. Lin, M.J. Wang. (2011) Strategic management of behavioural change in type 2 diabetic patients. Public Health
CrossRef109
Ying Zhang, Richard Cooke. (2011) Using a combined motivational and volitional intervention to promote exercise and healthy dietary behaviour among undergraduates. Diabetes Research and Clinical Practice
CrossRef110
V. Blue Bird Jernigan, A. L. Salvatore, D. M. Styne, M. Winkleby. (2011) Addressing food insecurity in a Native American reservation using community-based participatory research. Health Education Research
CrossRef111
M.A. Sabin, C.G. Magnussen, M. Juonala, M.J. Cowley, J.P.H. Shield. (2011) The role of pharmacotherapy in the prevention and treatment of paediatric metabolic syndrome – Implications for long-term health. Pharmacological Research
CrossRef112
Savitha Subramanian, Alan Chait. (2011) Hypertriglyceridemia secondary to obesity and diabetes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
CrossRef113
Michela Barichella, Alexis E Malavazos, Giuseppe Fatati, Emanuele Cereda. (2011) Awareness and knowledge about weight status and management: results from the 1 d sensitization campaign ‘Obesity Day’ in northern Italy. Public Health Nutrition 14:10, 1813-1822
CrossRef114
Mónica Acevedo, Verónica Kramer, María José Bustamante, Fernando Yañez. (2011) Cardiac Rehabilitation and Exercise in Secondary Prevention. Current Cardiovascular Risk Reports 5:5, 391-398
CrossRef115
Chen-Yu Yueh, Jung-Hsiang Chen, Li-Wen Lee, Cheng-Wei Lu, Bhavin Parekh, Ching-Chi Chi. (2011) Elevated alanine aminotransferase is associated with metabolic syndrome but not consistently associated with impaired fasting glucose or type 2 diabetes mellitus. Diabetes Research and Clinical Practice 94:1, 64-70
CrossRef116
Cenk Tek, Joseph C. Ratliff, Lydia Chwastiak. (2011) Pharmacological Treatment of Obesity. Psychiatric Annals 41:10, 489-495
CrossRef117
Michael Pfeiffer, Rüdiger Bauer, Peter P. Nawroth. (2011) The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies. Langenbeck's Archives of Surgery 396:7, 941-947
CrossRef118
R. Pfister, D. Barnes, R. Luben, N. G. Forouhi, M. Bochud, K.-T. Khaw, N. J. Wareham, C. Langenberg. (2011) No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach. Diabetologia 54:10, 2561-2569
CrossRef119
L. Djoussé, J.A. Driver, J.M. Gaziano, J.E. Buring, I.M. Lee. (2011) Association between modifiable lifestyle factors and residual lifetime risk of diabetes. Nutrition, Metabolism and Cardiovascular Diseases
CrossRef120
Kenneth Cusi, Gloria L. Ocampo. (2011) Unmet Needs in Hispanic/Latino Patients with Type 2 Diabetes Mellitus. The American Journal of Medicine 124:10, S2-S9
CrossRef121
Manuel Ros Pérez, Gema Medina-Gómez. (2011) Obesity, adipogenesis and insulin resistance. Endocrinología y Nutrición (English Edition)
CrossRef122
Thomas A. Wadden, Rebecca H. Neiberg, Rena R. Wing, Jeanne M. Clark, Linda M. Delahanty, James O. Hill, Jonathan Krakoff, Amy Otto, Donna H. Ryan, Mara Z. Vitolins. (2011) Four-Year Weight Losses in the Look AHEAD Study: Factors Associated With Long-Term Success. Obesity 19:10, 1987-1998
CrossRef123
, A. R. Majithia, K. A. Jablonski, J. B. McAteer, K. J. Mather, R. B. Goldberg, S. E. Kahn, J. C. Florez. (2011) Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program. Diabetologia 54:10, 2570-2574
CrossRef124
Delia Smith West, Zoran Bursac, Carol E. Cornell, Holly C. Felix, Jennifer K. Fausett, Rebecca A. Krukowski, Shelly Lensing, ShaRhonda J. Love, T. Elaine Prewitt, Cornelia Beck. (2011) Lay Health Educators Translate a Weight-Loss Intervention in Senior Centers. American Journal of Preventive Medicine 41:4, 385-391
CrossRef125
Caitlin Mason, Karen E. Foster-Schubert, Ikuyo Imayama, Angela Kong, Liren Xiao, Carolyn Bain, Kristin L. Campbell, Ching-Yun Wang, Catherine R. Duggan, Cornelia M. Ulrich, Catherine M. Alfano, George L. Blackburn, Anne McTiernan. (2011) Dietary Weight Loss and Exercise Effects on Insulin Resistance in Postmenopausal Women. American Journal of Preventive Medicine 41:4, 366-375
CrossRef126
Elisavet Moutzouri, Vasilis Tsimihodimos, Evangelos Rizos, Moses Elisaf. (2011) Prediabetes: To treat or not to treat?. European Journal of Pharmacology
CrossRef127
Lora E. Burke, Jing Wang. (2011) Treatment Strategies for Overweight and Obesity. Journal of Nursing Scholarshipno-no
CrossRef128
Sean D. Sullivan, Louis P. Garrison, Harald Rinde, Janice Kolberg, Edward J. Moler. (2011) Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score. Journal of Medical Economics 14:5, 609-616
CrossRef129
D. Parra-Medina, S. Wilcox, J. Salinas, C. Addy, E. Fore, M. Poston, D. K. Wilson. (2011) Results of the Heart Healthy and Ethnically Relevant Lifestyle Trial: A Cardiovascular Risk Reduction Intervention for African American Women Attending Community Health Centers. American Journal of Public Health 101:10, 1914-1921
CrossRef130
F. Santilli, N. Vazzana, R. Liani, M. T. Guagnano, G. Davì. (2011) Platelet activation in obesity and metabolic syndrome. Obesity Reviewsno-no
CrossRef131
I. Ismail, S. E. Keating, M. K. Baker, N. A. Johnson. (2011) A systematic review and meta-analysis of the effect of aerobic vs. resistance exercise training on visceral fat. Obesity Reviewsno-no
CrossRef132
P. Andújar-Plata, X. Pi-Sunyer, B. Laferrère. (2011) Metformin effects revisited. Diabetes Research and Clinical Practice
CrossRef133
Hakkı Uzun, Orhan Ünal Zorba. (2011) Metabolic Syndrome in Female Patients With Overactive Bladder. Urology
CrossRef134
P. T. Katzmarzyk, S. A. Lear. (2011) Physical activity for obese individuals: a systematic review of effects on chronic disease risk factors. Obesity Reviewsno-no
CrossRef135
Martine Stead, Stephen Caswell, Angela M. Craigie, Douglas Eadie, Annie S. Anderson. (2011) Understanding the potential and challenges of adenoma treatment as a prevention opportunity: Insights from the BeWEL formative study. Preventive Medicine
CrossRef136
Yi-Ming Mu, Anoop Misra, John M.F. Adam, Siew Pheng Chan, Francis C.C. Chow, Elaine Cheeay Cunanan, Chaicharn Deerochanawong, Hak Chul Jang, Nguyen Thy Khue, Wayne H.-H. Sheu, Kevin E.K. Tan. (2011) Managing diabetes in Asia: Overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Research and Clinical Practice
CrossRef137
, J. Logue, J. J. Walker, H. M. Colhoun, G. P. Leese, R. S. Lindsay, J. A. McKnight, A. D. Morris, D. W. Pearson, J. R. Petrie, S. Philip, S. H. Wild, N. Sattar. (2011) Do men develop type 2 diabetes at lower body mass indices than women?. Diabetologia
CrossRef138
Jia-Yi Dong, Lijun Zhang, Yong-Hong Zhang, Li-Qiang Qin. (2011) Dietary glycaemic index and glycaemic load in relation to the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. British Journal of Nutrition1-6
CrossRef139
Kesha Baptiste-Roberts, Payal Ghosh, Wanda K. Nicholson. (2011) Pregravid Physical Activity, Dietary Intake, and Glucose Intolerance During Pregnancy. Journal of Women's Health110927132724000
CrossRef140
Manolete Mora. (2011) Negotiation and hybridity in new Balinese music: Sanggar Bona Alit, a case study. Perfect Beat 12:1,
CrossRef141
O. Tschritter, H. Preissl, A. M. Hennige, T. Sartorius, K. T. Stingl, M. Heni, C. Ketterer, N. Stefan, J. Machann, E. Schleicher, A. Fritsche, H.-U. Häring. (2011) High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention. Diabetologia
CrossRef142
Milagros C Rosal, Stephenie C Lemon, Oahn H T Nguyen, Nelly E Driscoll, Lynn DiTaranto. (2011) Translation of the diabetes prevention program lifestyle intervention for promoting postpartum weight loss among low-income women. Translational Behavioral Medicine
CrossRef143
Glenn Laverack. (2011) Parallel-tracking bottom-up approaches within chronic disease prevention programmes. International Journal of Public Health
CrossRef144
Paul Estabrooks, Sherry Pagoto, Jennifer Otten, Lori Pbert, Amy Stone, Abby King, Kathy Goggin, Karen Emmons. (2011) The Society of Behavioral Medicine (SBM) and public policy advocacy: a call to action. Translational Behavioral Medicine
CrossRef145
Soji Okada. (2011) Effects of lifestyle education on Type 2 diabetes with an emphasis on a traditional Japanese diet. Diabetes Management1-4
CrossRef146
B. Kowall, W. Rathmann, R. Landgraf. (2011) Is HbA1c a valid and feasible tool for the diagnosis of diabetes?. Diabetes Research and Clinical Practice 93:3, 314-316
CrossRef147
Sanna M. Salmela, Kati Vähäsarja, Jari Villberg, Mauno Vanhala, Timo Saaristo, Jaana Lindström, Heikki Oksa, Eeva Korpi-Hyövälti, Leo Niskanen, Sirkka Keinänen-Kiukaanniemi, Marita Poskiparta. (2011) The reporting of previous lifestyle counseling by persons at high risk of Type 2 diabetes. Patient Education and Counseling
CrossRef148
Emily Jane Gallagher, Derek LeRoith, Eddy Karnieli. (2011) The Metabolic Syndrome—from Insulin Resistance to Obesity and Diabetes. Medical Clinics of North America 95:5, 855-873
CrossRef149
Lu Xia, Jing Hua, Xavier Dray, Mouen A. Khashab, Shuwen Liang, Yong-sik Kim, Cristina Jimeno-Ayllon, Anthony N. Kalloo, Zhiping Li. (2011) Endoscopic visceral fat removal as therapy for obesity and metabolic syndrome: a sham-controlled pilot study (with video). Gastrointestinal Endoscopy 74:3, 637-644
CrossRef150
J. Salas-Salvadó, M.Á. Martinez-González, M. Bulló, E. Ros. (2011) The role of diet in the prevention of type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases 21, B32-B48
CrossRef151
A. E. Buyken, P. Mitchell, A. Ceriello, J. Brand-Miller. (2011) Prevention strategies for type 2 diabetes should be based on evidence-based medical nutrition data. Reply to Uusitupa M, Lindström J, Tuomilehto J [letter]. Diabetologia 54:9, 2471-2472
CrossRef152
Catherine Ibarra-Drendall, Eric C. Dietze, Victoria L. Seewaldt. (2011) Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?. Current Breast Cancer Reports 3:3, 142-150
CrossRef153
Kirsten J. Coppell, Janet (EunHwa) Lee, Sheila M. Williams, Jim I. Mann. (2011) Progression of glycaemia and cardiovascular risk factors in patients of different age groups with new type 2 diabetes over 5 years of follow-up in a diabetes quality improvement initiative. Diabetes Research and Clinical Practice 93:3, 357-362
CrossRef154
A. N. Prasad. (2011) Type 2 diabetes mellitus in young: Need for early screening. Indian Pediatrics 48:9, 683-688
CrossRef155
Sean Carroll, Costas Tsakirides, James Hobkirk, James W.A. Moxon, James W.D. Moxon, Michael Dudfield, Lee Ingle. (2011) Differential Improvements in Lipid Profiles and Framingham Recurrent Risk Score in Patients With and Without Diabetes Mellitus Undergoing Long-Term Cardiac Rehabilitation. Archives of Physical Medicine and Rehabilitation 92:9, 1382-1387
CrossRef156
J Mitri, M D Muraru, A G Pittas. (2011) Vitamin D and type 2 diabetes: a systematic review. European Journal of Clinical Nutrition 65:9, 1005-1015
CrossRef157
Glen E. Duncan, Jonathan Lester, Sean Migotsky, Jorming Goh, Lisa Higgins, Gaetano Borriello. (2011) Accuracy of a novel multi-sensor board for measuring physical activity and energy expenditure. European Journal of Applied Physiology 111:9, 2025-2032
CrossRef158
Kerstyn C. Zalesin, Barry A. Franklin, Wendy M. Miller, Eric D. Peterson, Peter A. McCullough. (2011) Impact of Obesity on Cardiovascular Disease. Medical Clinics of North America 95:5, 919-937
CrossRef159
Helle Terkildsen Maindal, Mette Vinther Skriver, Marit Kirkevold, Torsten Lauritzen, Annelli Sandbaek. (2011) Comorbidity and lack of education countered participation in a diabetes prevention self-management program. Journal of Nursing and Healthcare of Chronic Illness 3:3, 293-301
CrossRef160
Louis J Aronne, Amanda G Powell, Caroline M Apovian. (2011) Emerging pharmacotherapy for obesity. Expert Opinion on Emerging Drugs 16:3, 587-596
CrossRef161
André Marette, Gary Sweeney. (2011) Cardiovascular complications of diabetes: recent insights in pathophysiology and therapeutics. Expert Review of Endocrinology & Metabolism 6:5, 689-696
CrossRef162
Melinda K. MORRISON, Clare E. COLLINS, Julia M. LOWE. (2011) Dietetic practice in the management of gestational diabetes mellitus: A survey of Australian dietitians. Nutrition & Dietetics 68:3, 189-194
CrossRef163
Brent Van Dorsten, Emily M. Lindley. (2011) Cognitive and Behavioral Approaches in the Treatment of Obesity. Medical Clinics of North America 95:5, 971-988
CrossRef164
Kelly H. Webber, Lisa Quintiliani. (2011) Development of a Weight Loss Program for Appalachian Kentucky Adults: A Formative Research Survey. Family and Consumer Sciences Research Journal 40:1, 74-84
CrossRef165
Bilal Chughtai, Richard K. Lee, Alexis E. Te, Steven A. Kaplan. (2011) Metabolic syndrome and sexual dysfunction. Current Opinion in Urology1
CrossRef166
George A. Bray. (2011) Medications for Weight Reduction. Medical Clinics of North America 95:5, 989-1008
CrossRef167
Sherry Pagoto. (2011) The current state of lifestyle intervention implementation research: where do we go next?. Translational Behavioral Medicine 1:3, 401-405
CrossRef168
Edward Chambers, Nicola Guess, Alexander Viardot, Gary Frost. (2011) Dietary starch and fiber: potential benefits to body weight and glucose metabolism. Diabetes Management 1:5, 521-528
CrossRef169
Antonio Hernández-Mijares, Celia Bañuls, Lorena Bellod, Ana Jover, Eva Solá, Carlos Morillas, Víctor M Víctor, Milagros Rocha. (2011) Effect of weight loss on C3 and C4 components of complement in obese patients. European Journal of Clinical Investigationno-no
CrossRef170
Barbara A. Gower, Laura Lee Goree, Paula C. Chandler-Laney, Amy C. Ellis, Krista Casazza, Wesley M. Granger. (2011) A higher-carbohydrate, lower-fat diet reduces fasting glucose concentration and improves β-cell function in individuals with impaired fasting glucose. Metabolism
CrossRef171
Linda Siminerio, Jean Claude Mbanya. (2011) Translating diabetes research into global communities. Diabetes Research and Clinical Practice 93:3, 443-445
CrossRef172
E. Succurro, F. Arturi, A. Grembiale, F. Iorio, T.V. Fiorentino, F. Andreozzi, A. Sciacqua, M.L. Hribal, F. Perticone, G. Sesti. (2011) One-hour post-load plasma glucose levels are associated with elevated liver enzymes. Nutrition, Metabolism and Cardiovascular Diseases 21:9, 713-718
CrossRef173
D. R. Webb, L. J. Gray, K. Khunti, B. Srinivasan, N. Taub, S. Campbell, J. Barnett, A. Farooqi, J. B. Echouffo-Tcheugui, S. J. Griffin, N. J. Wareham, M. J. Davies. (2011) Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 54:9, 2237-2246
CrossRef174
M. Trombetta, L. Boselli, A. Cretti, A. Calì, M. Vettore, B. Caruso, R. Dorizzi, A. Avogaro, M. Muggeo, E. Bonora, R.C. Bonadonna. (2011) Type 2 diabetes mellitus: A disease of the governance of the glucose-insulin system. Nutrition, Metabolism and Cardiovascular Diseases
CrossRef175
Brian R. Smith, Phil Schauer, Ninh T. Nguyen. (2011) Surgical Approaches to the Treatment of Obesity: Bariatric Surgery. Medical Clinics of North America 95:5, 1009-1030
CrossRef176
Liudmila Miyar Otero, Maylene Fong, Danielle Papineau, Sally Thorne, Maria Lucia Zanetti. (2011) Testing a prediabetes screening approach for a Latin American population in Vancouver, Canada. Journal of Nursing and Healthcare of Chronic Illness 3:3, 329-338
CrossRef177
J. M. Pauli, N. Raja-Khan, X. Wu, R. S. Legro. (2011) Current perspectives of insulin resistance and polycystic ovary syndrome. Diabetic Medicineno-no
CrossRef178
Vicki DiLillo, Delia Smith West. (2011) Motivational Interviewing for Weight Loss. Psychiatric Clinics of North America
CrossRef179
Lisa J. Moran, Jodie Dodd, Victoria Nisenblat, Robert J. Norman. (2011) Obesity and Reproductive Dysfunction in Women. Endocrinology & Metabolism Clinics of North America
CrossRef180
Min Dong, Zhi-Cheng Gong, Xing-Ping Dai, Guang-Hua Lei, Hong-Bin Lu, Lan Fan, Jian Qu, Hong-Hao Zhou, Zhao-Qian Liu. (2011) The SRR rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with type 2 diabetes. Clinical and Experimental Pharmacology and Physiologyno-no
CrossRef181
Wei Li, Yujie Wang, Liwei Chen, Ronald Horswell, Ke Xiao, Jay Besse, Jolene Johnson, Donna H. Ryan, Gang Hu. (2011) Increasing prevalence of diabetes in middle or low income residents in Louisiana from 2000 to 2009. Diabetes Research and Clinical Practice
CrossRef182
Helena J. TEEDE, Cheryce L. HARRISON, Wan T. TEH, Eldho PAUL, Carolyn A. ALLAN. (2011) Gestational diabetes: Development of an early risk prediction tool to facilitate opportunities for prevention. Australian and New Zealand Journal of Obstetrics and Gynaecologyno-no
CrossRef183
C. Lau, D. Vistisen, U. Toft, I. Tetens, C. Glümer, O. Pedersen, T. Jørgensen, K. Borch-Johnsen. (2011) The effects of adding group-based lifestyle counselling to individual counselling on changes in plasma glucose levels in a randomized controlled trial: The Inter99 study. Diabetes & Metabolism
CrossRef184
Carmen D. Samuel-Hodge, Beverly A. Garcia, Larry F. Johnston, Jennifer L. Kraschnewski, Alison A. Gustafson, Arnita F. Norwood, Russell E. Glasgow, Alison D. Gold, John W. Graham, Kelly R. Evenson, Sally C. Stearns, Ziya Gizlice, Thomas C. Keyserling. (2011) Rationale, design, and sample characteristics of a practical randomized trial to assess a weight loss intervention for low-income women: The Weight-Wise II Program. Contemporary Clinical Trials
CrossRef185
Meropi D. Kontogianni, Stavros Liatis, Sofia Grammatikou, Despoina Perrea, Nikolaos Katsilambros, Konstantinos Makrilakis. (2011) Changes in dietary habits and their association with metabolic markers after a non-intensive, community-based lifestyle intervention to prevent type 2 diabetes, in Greece. The DEPLAN study. Diabetes Research and Clinical Practice
CrossRef186
Susan A Jebb, Amy L Ahern, Ashley D Olson, Louise M Aston, Christina Holzapfel, Julia Stoll, Ulrike Amann-Gassner, Annie E Simpson, Nicholas R Fuller, Suzanne Pearson, Namson S Lau, Adrian P Mander, Hans Hauner, Ian D Caterson. (2011) Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. The Lancet
CrossRef187
G. Hawthorne. (2011) Diabetes, the glycaemic index and older people. Age and Ageing
CrossRef188
Nobutaka Hirooka, Teiichi Takedai, Frank D’Amico. (2011) Lifestyle Characteristics Assessment of Japanese in Pittsburgh, USA. Journal of Community Health
CrossRef189
T. Beljic Zivkovic, M. Vuksanovic, M. Andjelic Jelic, J. Stojanovic, B. Buric, B. Jojic, N. Milic, S. Vujovic. (2011) Obesity and metabolic syndrome during the menopause transition in Serbian women. Climacteric1-6
CrossRef190
B Kowall, W Rathmann, M Heier, R Holle, A Peters, B Thorand, C Herder, K Strassburger, G Giani, C Meisinger. (2011) Impact of weight and weight change on normalization of prediabetes and on persistence of normal glucose tolerance in an older population: the KORA S4/F4 study. International Journal of Obesity
CrossRef191
H. Florez, Y. Ma, J. P. Crandall, L. Perreault, S. M. Marcovina, G. A. Bray, C. D. Saudek, E. Barrett-Connor, W. C. Knowler, . (2011) Parental Longevity and Diabetes Risk in the Diabetes Prevention Program. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
CrossRef192
A Astrup, R Carraro, N Finer, A Harper, M Kunesova, M E J Lean, L Niskanen, M F Rasmussen, A Rissanen, S Rössner, M J Savolainen, L Van Gaal. (2011) Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. International Journal of Obesity
CrossRef193
Carol R Horowitz, Sarah Eckhardt, Sandra Talavera, Crispin Goytia, Kate Lorig. (2011) Effectively translating diabetes prevention: a successful model in a historically underserved community. Translational Behavioral Medicine
CrossRef194
Markolf Hanefeld, Ulrike Schatz, Frank Schaper. 2011. Treatments for the Metabolic Syndrome. , 327-346.
CrossRef195
Naveed Sattar. 2011. Polycystic Ovary Syndrome. , 278-296.
CrossRef196
Richard I. G. Holt, Robert C. Peveler. 2011. Metabolic Syndrome and Mental Illness. , 177-193.
CrossRef197
Lisa Te Morenga, Jim Mann. 2011. Nutrition: Its Relevance in Development and Treatment of the Metabolic Syndrome. , 297-326.
CrossRef198
Marisa Laura Armeno, Andrea Gabriela Krochik, Carmen Sylvia Mazza. (2011) Evaluation of two dietary treatments in obese hyperinsulinemic adolescents. Journal of Pediatric Endocrinology and Metabolism---
CrossRef199
Eliana M Wendland, Juliana B Hilgert, Bruce B Duncan, Maria I Schmidt, Eliana M Wendland. 2011. Interventions for the prevention of type 2 diabetes mellitus in women with previous gestational diabetes. .
CrossRef200
Shanshan Han, Caroline A Crowther, Philippa Middleton, Shanshan Han. 2011. Different types of dietary advice for women with gestational diabetes mellitus. .
CrossRef201
Kevin Patrick, Karen J. Calfas, Gregory J. Norman, Dori Rosenberg, Marion F. Zabinski, James F. Sallis, Cheryl L. Rock, Lindsay W. Dillon. (2011) Outcomes of a 12-Month Web-Based Intervention for Overweight and Obese Men. Annals of Behavioral Medicine
CrossRef202
David S Morrison, Susan Boyle, Caroline Morrison, Gwen Allardice, Nicola Greenlaw, Lorna Forde. (2011) Evaluation of the first phase of a specialist weight management programme in the UK National Health Service: prospective cohort study. Public Health Nutrition1-11
CrossRef203
Erica B. Oberg, Ryan D. Bradley, Jason Allen, Megan A. McCrory. (2011) CAM: Naturopathic dietary interventions for patients with Type 2 diabetes. Complementary Therapies in Clinical Practice 17:3, 157-161
CrossRef204
T. Psaltopoulou, D.B. Panagiotakos, C. Pitsavos, C. Chrysochoou, P. Detopoulou, J. Skoumas, C. Stefanadis. (2011) Dietary antioxidant capacity is inversely associated with diabetes biomarkers: The ATTICA study. Nutrition, Metabolism and Cardiovascular Diseases 21:8, 561-567
CrossRef205
Rebecca A. Krukowski, J. Mick Tilford, Jean Harvey-Berino, Delia S. West. (2011) Comparing Behavioral Weight Loss Modalities: Incremental Cost-Effectiveness of an Internet-Based Versus an In-Person Condition. Obesity 19:8, 1629-1635
CrossRef206
Vincent Kaddai, Francesco Negro. (2011) Current understanding of insulin resistance in hepatitis C. Expert Review of Gastroenterology & Hepatology 5:4, 503-516
CrossRef207
Manuel Ros Pérez, Gema Medina-Gómez. (2011) Obesidad, adipogénesis y resistencia a la insulina. Endocrinología y Nutrición 58:7, 360-369
CrossRef208
BR Shah, LL Lipscombe, DS Feig, JM Lowe. (2011) Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study. BJOG: An International Journal of Obstetrics & Gynaecologyno-no
CrossRef209
O. J. Phung, N. A. Sood, B. E. Sill, C. I. Coleman. (2011) Oral anti-diabetic drugs for the prevention of Type 2 diabetes. Diabetic Medicine 28:8, 948-964
CrossRef210
Whadi-ah Parker, Nelia P Steyn, Naomi S Levitt, Carl J Lombard. (2011) They think they know but do they? Misalignment of perceptions of lifestyle modification knowledge among health professionals. Public Health Nutrition 14:08, 1429-1438
CrossRef211
Meritxell Rosell, Marius C. Jones, Malcolm G. Parker. (2011) Role of nuclear receptor corepressor RIP140 in metabolic syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:8, 919-928
CrossRef212
Nancy M. Petry, Danielle Barry, Linda Pescatello, William B. White. (2011) A Low-Cost Reinforcement Procedure Improves Short-Term Weight Loss Outcomes. The American Journal of Medicine
CrossRef213
S. S. Torekov, S. Madsbad, J. J. Holst. (2011) Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential. Obesity Reviews 12:8, 593-601
CrossRef214
Catherine Kim, Sharon L. Edelstein, Jill P. Crandall, Dana Dabelea, Abbas E. Kitabchi, Richard F. Hamman, Maria G. Montez, Leigh Perreault, Mary A. Foulkes, Elizabeth Barrett-Connor. (2011) Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause 18:8, 857-868
CrossRef215
Javier Díez Espino. (2011) Prevención de la diabetes tipo 2 mediante el tratamiento farmacológico con pioglitazona en personas con intolerancia a la glucosa. FMC - Formación Médica Continuada en Atención Primaria 18:7, 461-462
CrossRef216
Mary P. McGowan. (2011) Polycystic Ovary Syndrome: A Common Endocrine Disorder and Risk Factor for Vascular Disease. Current Treatment Options in Cardiovascular Medicine 13:4, 289-301
CrossRef217
Ralph A. DeFronzo, Muhammad Abdul-Ghani. (2011) Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose. The American Journal of Cardiology 108:3, 3B-24B
CrossRef218
EVA ANDERBERG, MONA LANDIN-OLSSON, JOHAN KALÉN, ANDERS FRID, DAG URSING, KERSTIN BERNTORP. (2011) Prevalence of impaired glucose tolerance and diabetes after gestational diabetes mellitus comparing different cut-off criteria for abnormal glucose tolerance during pregnancy. Acta Obstetricia et Gynecologica Scandinavicano-no
CrossRef219
Simone Ramos Deconte, Renato José da Silva Oliveira, Luciana Karen Calábria, Vanessa Neves de Oliveira, Neire Moura de Gouveia, Alberto da Silva Moraes, Foued Salmen Espindola. (2011) Alterations of antioxidant biomarkers and type I collagen deposition in the parotid gland of streptozotocin-induced diabetic rats. Archives of Oral Biology 56:8, 744-751
CrossRef220
Catherine Ulbricht, Manisha Chandalia, Sheri R. Colberg, Jacob Teitelbaum, Frederic J. Vagnini. (2011) Roundtable Discussion: An Integrative Approach to Diabetes. Alternative and Complementary Therapies 17:5, 261-269
CrossRef221
Shailesh Nandish, Jamison Wyatt, Oscar Bailon, Mike Smith, Rene Oliveros, Robert Chilton. (2011) Implementing Cardiovascular Risk Reduction in Patients with Cardiovascular Disease and Diabetes Mellitus. The American Journal of Cardiology 108:3, 42B-51B
CrossRef222
Maxine Johnson, Emma Everson-Hock, Roy Jones, Helen Buckley Woods, Nick Payne, Elizabeth Goyder. (2011) What are the barriers to primary prevention of type 2 diabetes in black and minority ethnic groups in the UK? A qualitative evidence synthesis. Diabetes Research and Clinical Practice 93:2, 150-158
CrossRef223
Kittichai Promrat, Lisa Longato, Jack R. Wands, Suzanne M. de la Monte. (2011) Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels. Hepatology Research 41:8, 754-762
CrossRef224
Justyna Szostak, Pascal Laurant. (2011) The forgotten face of regular physical exercise: a ‘natural’ anti-atherogenic activity. Clinical Science 121:3, 91-106
CrossRef225
Melissa Wellons. (2011) Lifestyle intervention in postmenopausal women. Menopause 18:8, 837-838
CrossRef226
Xin Liu, Yvette D. Miller, Nicola W. Burton, Jiun-Horng Chang, Wendy J. Brown. (2011) Qi-Gong Mind–Body Therapy and Diabetes Control. American Journal of Preventive Medicine 41:2, 152-158
CrossRef227
James Matthew Luther, Nancy J. Brown. (2011) The renin–angiotensin–aldosterone system and glucose homeostasis. Trends in Pharmacological Sciences
CrossRef228
D. L. Katz, M. Murimi, A. Gonzalez, V. Njike, L. W. Green. (2011) From Controlled Trial to Community Adoption: The Multisite Translational Community Trial. American Journal of Public Health 101:8, e17-e27
CrossRef229
E. J. Trickett. (2011) Community-Based Participatory Research as Worldview or Instrumental Strategy: Is It Lost in Translation(al) Research?. American Journal of Public Health 101:8, 1353-1355
CrossRef230
C. Kim, M. Draska, M.L. Hess, E.J. Wilson, C.R. Richardson. (2011) A web-based pedometer programme in women with a recent history of gestational diabetes. Diabetic Medicineno-no
CrossRef231
Anne-Laure Borel, Julie-Anne Nazare, Jessica Smith, Natalie Alméras, Angelo Tremblay, Jean Bergeron, Paul Poirier, Jean-Pierre Després. (2011) Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity. Metabolism
CrossRef232
Frederick Vuvor, Matilda Steiner-Asiedu, Margaret Armar-Klemesu, Seth Armah. (2011) Population-based study of diabetic mellitus prevalence and its associated factors in adult Ghanaians in the greater Accra region. International Journal of Diabetes in Developing Countries
CrossRef233
Robin Whittemore. (2011) A systematic review of the translational research on the Diabetes Prevention Program. Translational Behavioral Medicine
CrossRef234
Bart F. Geerts, Marloes G.J. van Dongen, Baukje Flameling, Matthijs M. Moerland, Marieke L. de Kam, Adam F. Cohen, Johannes A. Romijn, Cindy C. Gerhardt, Joris Kloek, Jacobus Burggraaf. (2011) Hydrolyzed Casein Decreases Postprandial Glucose Concentrations in T2DM Patients Irrespective of Leucine Content. Journal of Dietary Supplements110726015932000
CrossRef235
R. Doerr, U. Hoffmann, W. Otter, L. Heinemann, W. Hunger-Battefeld, B. Kulzer, A. Klinge, V. Lodwig, I. Amann-Zalan, D. Sturm, D. Tschoepe, S. G. Spitzer, J. Stumpf, T. Lohmann, O. Schnell. (2011) Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia
CrossRef236
(2011) Pioglitazone for Diabetes Prevention. New England Journal of Medicine 365:2, 182-184
Full Text237
Laura J. Zimmermann, Jason A. Thompson, Stephen D. Persell. (2011) Electronic health record identification of prediabetes and an assessment of unmet counselling needs. Journal of Evaluation in Clinical Practiceno-no
CrossRef238
Steven P. Engebretson, Judith Hey-Hadavi. (2011) Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: A pilot study. Pharmacological Research
CrossRef239
Susan Sam, Theodore Mazzone. (2011) Reducing the risk of macrovascular complications of diabetes: focus on visceral fat. Diabetes Management 1:4, 439-449
CrossRef240
Claude Bouchard, Tuomo Rankinen, James A. Timmons. 2011. Genomics and Genetics in the Biology of Adaptation to Exercise. .
CrossRef241
Atsushi Goto, Simin Liu. (2011) Is caffeine protective against Type 2 diabetes?. Diabetes Management 1:4, 351-353
CrossRef242
Irene J. Ngatena, Jane Faith Kapustin. (2011) Preventing Type 2 Diabetes: What Really Works?. The Journal for Nurse Practitioners 7:7, 550-558
CrossRef243
Baptist Gallwitz. (2011) Sitagliptin and metformin combination therapy for the treatment of Type 2 diabetes. Expert Review of Endocrinology & Metabolism 6:4, 543-556
CrossRef244
Christopher J Nolan, Peter Damm, Marc Prentki. (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. The Lancet 378:9786, 169-181
CrossRef245
Theodore C. Friedman. (2011) Vitamin D supplementation to prevent the progression of prediabetes to diabetes: Getting closer to a recommendation. Translational Research
CrossRef246
Daphne Antillon, Amytis Towfighi. (2011) No time to ‘weight’: the link between obesity and stroke in women. Women's Health 7:4, 453-463
CrossRef247
R. J. Joseph, M. Alonso-Alonso, D. S. Bond, A. Pascual-Leone, G. L. Blackburn. (2011) The neurocognitive connection between physical activity and eating behaviour. Obesity Reviewsno-no
CrossRef248
Devjit Tripathy, Ralph A DeFronzo. (2011) Can we prevent diabetes with a single pill?. Diabetes Management 1:4, 355-358
CrossRef249
J Logue, N Sattar. (2011) Childhood Obesity: A Ticking Time Bomb for Cardiovascular Disease?. Clinical Pharmacology & Therapeutics 90:1, 174-178
CrossRef250
Stuart A. Ross, Grzegorz Dzida, Jiten Vora, Kamlesh Khunti, Marcel Kaiser, Robert J. Ligthelm. (2011) Impact of weight gain on outcomes in type 2 diabetes. Current Medical Research and Opinion 27:7, 1431-1438
CrossRef251
Michael C. Riddell, Jamie Burr. (2011) Evidence-based risk assessment and recommendations for physical activity clearance: diabetes mellitus and related comorbidities 1 1 This paper is one of a selection of papers published in this Special Issue, entitled Evidence-based risk assessment and recommendations for physical activity clearance, and has undergone the Journal’s usual peer review process.. Applied Physiology, Nutrition, and Metabolism 36:S1, S154-S189
CrossRef252
Laura L. Hayman, Liz Helden, Deborah A. Chyun, Lynne T. Braun. (2011) A life course approach to cardiovascular disease prevention. European Journal of Cardiovascular Nursing 10, S20-S31
CrossRef253
H. Robert Superko, Kathryn M. Momary, Lakshmana K. Pendyala, Paul T. Williams, Steven Frohwein, Brenda C. Garrett, Cathy Skrifvars, Radhika Gadesam, Spencer B. King, Steve Rolader, Bill Meyers, David Dusik, Stoney Polite. (2011) Firefighters, Heart Disease, and Aspects of Insulin Resistance. Journal of Occupational and Environmental Medicine 53:7, 758-764
CrossRef254
Sagit Zolotov, Dafna Ben Yosef, Naphtali D Rishe, Yelena Yesha, Eddy Karnieli. (2011) Metabolic profiling in personalized medicine: bridging the gap between knowledge and clinical practice in Type 2 diabetes. Personalized Medicine 8:4, 445-456
CrossRef255
Gregory Vyssoulis, Evangelia Karpanou, Dionysios Adamopoulos, Vassiliki Tzamou, Christodoulos Stefanadis, Ulrich M. Vischer. (2011) Effect of Age on Interdependence and Hierarchy of Cardiovascular Risk Factors in Hypertensive Patients. The American Journal of Cardiology 108:2, 240-245
CrossRef256
J. B. Echouffo-Tcheugui, M. K. Ali, S. J. Griffin, K. M. V. Narayan. (2011) Screening for Type 2 Diabetes and Dysglycemia. Epidemiologic Reviews 33:1, 63-87
CrossRef257
Jean-Louis Chiasson, Sophie Bernard. (2011) Reducing cardiovascular risk factors in patients with prediabetes. Diabetes Management 1:4, 423-438
CrossRef258
B. Buijsse, R. K. Simmons, S. J. Griffin, M. B. Schulze. (2011) Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes. Epidemiologic Reviews 33:1, 46-62
CrossRef259
A. J. Viera. (2011) Predisease: When Does it Make Sense?. Epidemiologic Reviews 33:1, 122-134
CrossRef260
A. Sharif. (2011) Should Metformin Be Our Antiglycemic Agent of Choice Post-transplantation?. American Journal of Transplantation 11:7, 1376-1381
CrossRef261
Lance Bollinger, Tom LaFontaine. (2011) Exercise and Insulin Resistance. Strength and Conditioning Journal1
CrossRef262
RC Andrews, AR Cooper, AA Montgomery, AJ Norcross, TJ Peters, DJ Sharp, N Jackson, K Fitzsimons, J Bright, K Coulman, CY England, J Gorton, A McLenaghan, E Paxton, A Polet, C Thompson, CM Dayan. (2011) Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. The Lancet 378:9786, 129-139
CrossRef263
Todd S. Harwell, Karl K. Vanderwood, Taryn O. Hall, Marcene K. Butcher, Steven D. Helgerson. (2011) Factors associated with achieving a weight loss goal among participants in an adapted Diabetes Prevention Program. Primary Care Diabetes 5:2, 125-129
CrossRef264
Trevor Archer, Anders Fredriksson, Erica Schϋtz, Richard M. Kostrzewa. (2011) Influence of Physical Exercise on Neuroimmunological Functioning and Health: Aging and Stress. Neurotoxicity Research 20:1, 69-83
CrossRef265
Ha T. Nguyen, Kyriakos S. Markides, Marilyn A. Winkleby. (2011) Physician Advice on Exercise and Diet in a U.S. Sample of Obese Mexican-American Adults. American Journal of Health Promotion 25:6, 402-409
CrossRef266
Christian S. Göbl, Latife Bozkurt, Thomas Prikoszovich, Christine Winzer, Giovanni Pacini, Alexandra Kautzky-Willer. (2011) Early Possible Risk Factors for Overt Diabetes After Gestational Diabetes Mellitus. Obstetrics & Gynecology 118:1, 71-78
CrossRef267
Abd A Tahrani, Clifford J Bailey, Stefano Del Prato, Anthony H Barnett. (2011) Management of type 2 diabetes: new and future developments in treatment. The Lancet 378:9786, 182-197
CrossRef268
Monique M. Hedderson, Jeanne A. Darbinian, Charles P. Quesenberry, Assiamira Ferrara. (2011) Pregravid cardiometabolic risk profile and risk for gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 205:1, 55.e1-55.e7
CrossRef269
Sahadev A. Shankarappa, Erika S. Piedras-Rentería, Evan B. Stubbs. (2011) Forced-exercise delays neuropathic pain in experimental diabetes: effects on voltage-activated calcium channels. Journal of Neurochemistry 118:2, 224-236
CrossRef270
R. Landgraf, B. Kowall, W. Rathmann. (2011) HbA1c – ein Alleskönner?. Der Diabetologe 7:5, 335-346
CrossRef271
Satoshi Tsuboi, Takehito Hayakawa, Hideyuki Kanda, Tetsuhito Fukushima. (2011) Physical Activity in the Context of Clustering Patterns of Health-Promoting Behaviors. American Journal of Health Promotion 25:6, 410-416
CrossRef272
Fiona Gillison, Colin Greaves, Afroditi Stathi, Rosemary Ramsay, Paul Bennett, Gordon Taylor, Margaret Francis, Roger Chandler. (2011) ‘Waste the waist’: The development of an intervention to promote changes in diet and physical activity for people with high cardiovascular risk. British Journal of Health Psychologyno-no
CrossRef273
Wieke H. Heideman, Barend J.C. Middelkoop, Vera Nierkens, Karien Stronks, Arnoud P. Verhoeff, Suzanne C.M. van Esch, Frank J. Snoek. (2011) Changing the odds. What do we learn from prevention studies targeted at people with a positive family history of type 2 diabetes?. Primary Care Diabetes
CrossRef274
Emanuele Cereda, Alexis Elias Malavazos, Riccardo Caccialanza, Mariangela Rondanelli, Giuseppe Fatati, Michela Barichella. (2011) Weight cycling is associated with body weight excess and abdominal fat accumulation: A cross-sectional study. Clinical Nutrition
CrossRef275
C. Leotta, V. Fedele, C. Schifilliti, C. Ingegnosi, G. Savoca, L. Cucinotta, K. Strauss. (2011) Movement in Health: Housing a diabetes centre within a gym (and vice versa). Journal of Diabetesno-no
CrossRef276
Adam G. Tsai, Sue Felton, James O. Hill, Adam J. Atherly. (2011) A Randomized Pilot Trial of a Full Subsidy vs. a Partial Subsidy for Obesity Treatment. Obesity
CrossRef277
Marjukka Kolehmainen, Pirkka Kirjavainen. 2011. Cytokines in Metabolic Syndrome. , 307-325.
CrossRef278
Stephen Sutton. (2011) The contribution of behavioural science to primary care research: development and evaluation of behaviour change interventions. Primary Health Care Research & Development1-9
CrossRef279
Kitti Sranacharoenpong, Rhona M. Hanning. (2011) Developing a diabetes prevention education programme for community health-care workers in Thailand: formative findings. Primary Health Care Research & Development1-13
CrossRef280
Sonja K Billes, Frank L Greenway. (2011) Combination therapy with naltrexone and bupropion for obesity. Expert Opinion on Pharmacotherapy1-14
CrossRef281
Joshua I. Barzilay, Phyllis K. Stein. (2011) Association of the Metabolic Syndrome with Age-Related, Nonatherosclerotic, Chronic Medical Conditions. Metabolic Syndrome and Related Disorders110616140307037
CrossRef282
Lijun Peng, Jiyao Wang, Feng Li, Jiyao Wang. 2011. Weight reduction for non-alcoholic fatty liver disease. .
CrossRef283
Clare Whitton, Sonja K. Nicholson, Caireen Roberts, Celia J. Prynne, Gerda K. Pot, Ashley Olson, Emily Fitt, Darren Cole, Birgit Teucher, Beverley Bates, Helen Henderson, Sarah Pigott, Claire Deverill, Gillian Swan, Alison M. Stephen. (2011) National Diet and Nutrition Survey: UK food consumption and nutrient intakes from the first year of the rolling programme and comparisons with previous surveys. British Journal of Nutrition1-16
CrossRef284
Sherry L. Pagoto, Kristin L. Schneider, Jessica L. Oleski, Juliana M. Luciani, Jamie S. Bodenlos, Matt C. Whited. (2011) Male Inclusion in Randomized Controlled Trials of Lifestyle Weight Loss Interventions. Obesity
CrossRef285
Christi Deaton, Mamas A. Mamas, Martin K. Rutter, Martin Gibson, Susie Bowell, Ruth Byrne, Kath Coezy, Jennifer Gow, Sarah Williams. (2011) Glucose and insulin abnormalities in patients with heart failure. European Journal of Cardiovascular Nursing 10:2, 75-87
CrossRef286
Cynthia D Rothenberger. (2011) Chronic Illness Self-Management in prediabetes: a concept analysis. Journal of Nursing and Healthcare of Chronic Illness 3:2, 77-86
CrossRef287
Deborah J. Toobert, Lisa A. Strycker, Manuel Barrera, Diego Osuna, Diane K. King, Russell E. Glasgow. (2011) Outcomes from a Multiple Risk Factor Diabetes Self-Management Trial for Latinas: ¡Viva Bien!. Annals of Behavioral Medicine 41:3, 310-323
CrossRef288
A C Tierney, J McMonagle, D I Shaw, H L Gulseth, O Helal, W H M Saris, J A Paniagua, I Gołąbek-Leszczyñska, C Defoort, C M Williams, B Karsltröm, B Vessby, A Dembinska-Kiec, J López-Miranda, E E Blaak, C A Drevon, M J Gibney, J A Lovegrove, H M Roche. (2011) Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a European randomized dietary intervention study. International Journal of Obesity 35:6, 800-809
CrossRef289
G Erez, A Tirosh, A Rudich, V Meiner, D Schwarzfuchs, N Sharon, S Shpitzen, M Blüher, M Stumvoll, J Thiery, G M Fiedler, Y Friedlander, E Leiterstdorf, I Shai. (2011) Phenotypic and genetic variation in leptin as determinants of weight regain. International Journal of Obesity 35:6, 785-792
CrossRef290
Gwinnett Ladson, William C. Dodson, Stephanie D. Sweet, Anthony E. Archibong, Allen R. Kunselman, Laurence M. Demers, Peter A. Lee, Nancy I. Williams, Ponjola Coney, Richard S. Legro. (2011) Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study. Fertility and Sterility 95:8, 2595-2598.e6
CrossRef291
Yan-Hui Lu, Ju-Ming Lu, Shu-Yu Wang, Chun-Lin Li, Run-Ping Zheng, Hui Tian, Xian-Ling Wang. (2011) Outcome of intensive integrated intervention in participants with impaired glucose regulation in China. Advances in Therapy 28:6, 511-519
CrossRef292
Freij Gobal, Abhishek Deshmukh, Sudhir Shah, Jawahar L. Mehta. (2011) Triad of Metabolic Syndrome, Chronic Kidney Disease, and Coronary Heart Disease With a Focus on Microalbuminuria. Journal of the American College of Cardiology 57:23, 2303-2308
CrossRef293
Heather M. Campbell, Nasreen Khan, Catherine Cone, Dennis W. Raisch. (2011) Relationship between diet, exercise habits, and health status among patients with diabetes. Research in Social and Administrative Pharmacy 7:2, 151-161
CrossRef294
Mona H. Ismail. (2011) Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic. The American Journal of the Medical Sciences 341:6, 485-492
CrossRef295
P. Ravikumar, A. Bhansali, M. Ravikiran, S. Bhansali, R. Walia, G. Shanmugasundar, J.S. Thakur, S. Kumar Bhadada, P. Dutta. (2011) Prevalence and risk factors of diabetes in a community-based study in North India: The Chandigarh Urban Diabetes Study (CUDS). Diabetes & Metabolism 37:3, 216-221
CrossRef296
F. Zhang, L. Dong, C.P. Zhang, B. Li, J. Wen, W. Gao, S. Sun, F. Lv, H. Tian, J. Tuomilehto, L. Qi, C. L. Zhang, Z. Yu, X. Yang, G. Hu. (2011) Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabetic Medicine 28:6, 652-657
CrossRef297
Marte K. Råberg Kjøllesdal, Victoria T. Hjellset, Benedikte Bjørge, Gerd Holmboe-Ottesen, Margareta Wandel. (2011) Perceptions of risk factors for diabetes among Norwegian-Pakistani women participating in a culturally adapted intervention. Ethnicity & Health 16:3, 279-297
CrossRef298
Kyeongra Yang, Young-Shin Lee, Eileen R. Chasens. (2011) Outcomes of Health Care Providers' Recommendations for Healthy Lifestyle Among U.S. Adults with Prediabetes. Metabolic Syndrome and Related Disorders 9:3, 231-237
CrossRef299
T. Fritz, K. Caidahl, M. Osler, C. G. Östenson, J. R. Zierath, P. Wändell. (2011) Effects of Nordic walking on health-related quality of life in overweight individuals with Type 2 diabetes mellitus, impaired or normal glucose tolerance. Diabetic Medicineno-no
CrossRef300
J. Santoyo-Olsson, J. Cabrera, R. Freyre, M. Grossman, N. Alvarez, D. Mathur, M. Guerrero, A. T. Delgadillo, A. M. Kanaya, A. L. Stewart. (2011) An Innovative Multiphased Strategy to Recruit Underserved Adults into a Randomized Trial of a Community-Based Diabetes Risk Reduction Program. The Gerontologist 51:Supplement 1, S82-S93
CrossRef301
Prasuna Reddy, Andrea L. Hernan, Karl K. Vanderwood, Diane Arave, Mark L. Niebylski, Todd S. Harwell, James A. Dunbar. (2011) Implementation of diabetes prevention programs in rural areas: Montana and south-eastern Australia compared. Australian Journal of Rural Health 19:3, 125-134
CrossRef302
Hitomi Fujii, Seiichiro Yamamoto, Fujimi Takeda-Imai, Manami Inoue, Shoichiro Tsugane, Takashi Kadowaki, Mitsuhiko Noda. (2011) Validity and applicability of a simple questionnaire for the estimation of total and domain-specific physical activity. Diabetology International 2:2, 47-54
CrossRef303
Brian Oldenburg, Pilvikki Absetz, James A Dunbar, Prasuna Reddy, Adrienne O’Neil. (2011) The spread and uptake of diabetes prevention programs around the world: a case study from Finland and Australia. Translational Behavioral Medicine 1:2, 270-282
CrossRef304
Jacqueline L Webster, Elizabeth K Dunford, Corinna Hawkes, Bruce C Neal. (2011) Salt reduction initiatives around the world. Journal of Hypertension 29:6, 1043-1050
CrossRef305
Rodger Kessler, Russell E. Glasgow. (2011) A Proposal to Speed Translation of Healthcare Research Into Practice. American Journal of Preventive Medicine 40:6, 637-644
CrossRef306
Y. Doi, T. Ninomiya, J. Hata, Y. Hirakawa, N. Mukai, M. Iwase, Y. Kiyohara. (2011) Two risk score models for predicting incident Type 2 diabetes in Japan. Diabetic Medicineno-no
CrossRef307
Filip J. Larsen, Martin Anderson, Björn Ekblom, Thomas Nyström. (2011) Cardiorespiratory fitness predicts insulin action and secretion in healthy individuals. Metabolism
CrossRef308
G Osei-Assibey, C Boachie. (2011) Dietary interventions for weight loss and cardiovascular risk reduction in people of African ancestry (blacks): a systematic review. Public Health Nutrition1-6
CrossRef309
Airani Sathananthan, Chiara Dalla Man, Alan R. Zinsmeister, Michael Camilleri, Richard J. Rodeheffer, Gianna Toffolo, Claudio Cobelli, Robert A. Rizza, Adrian Vella. (2011) A Concerted Decline in Insulin Secretion and Action occurs across the Spectrum of Fasting and Post-Challenge Glucose Concentrations. Clinical Endocrinologyno-no
CrossRef310
Lal B. Rawal, Robyn J. Tapp, Emily D. Williams, Carina Chan, Shajahan Yasin, Brian Oldenburg. (2011) Prevention of Type 2 Diabetes and Its Complications in Developing Countries: A Review. International Journal of Behavioral Medicine
CrossRef311
C Roumen, E J M Feskens, E Corpeleijn, M Mensink, W H M Saris, E E Blaak. (2011) Predictors of lifestyle intervention outcome and dropout: the SLIM study. European Journal of Clinical Nutrition
CrossRef312
Adriana Cezaretto, Antonela Siqueira-Catania, Camila Risso Barros, Emanuel Péricles Salvador, Sandra Roberta G. Ferreira. (2011) Benefits on quality of life concomitant to metabolic improvement in intervention program for prevention of diabetes mellitus. Quality of Life Research
CrossRef313
S. Capewell, M. O'Flaherty. (2011) Can dietary changes rapidly decrease cardiovascular mortality rates?. European Heart Journal 32:10, 1187-1189
CrossRef314
David S.H. Bell. (2011) Protean Manifestations of Vitamin D Deficiency, Part 2. Southern Medical Journal 104:5, 335-339
CrossRef315
Melissa A. Kalarchian, Marsha D. Marcus, Anita P. Courcoulas, Yu Cheng, Michele D. Levine, Deborah Josbeno. (2011) Optimizing long-term weight control after bariatric surgery: a pilot study. Surgery for Obesity and Related Diseases
CrossRef316
Min Liu, Changyu Pan, Mengmeng Jin. (2011) A Chinese Diabetes Risk Score for Screening of Undiagnosed Diabetes and Abnormal Glucose Tolerance. Diabetes Technology & Therapeutics 13:5, 501-507
CrossRef317
A. Klein, N. Chernyak, R. Brinks, J. Genz, A. Icks. (2011) Kosteneffektivität der Primärprävention des Typ-2-Diabetes. Prävention und Gesundheitsförderung 6:2, 102-110
CrossRef318
M J Shram, K A Schoedel, C Bartlett, R L Shazer, C M Anderson, E M Sellers. (2011) Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug Users. Clinical Pharmacology & Therapeutics 89:5, 683-692
CrossRef319
Amparo B. Gonzalez, Daniela Salas, Guillermo E. Umpierrez. (2011) Special considerations on the management of Latino patients with type 2 diabetes mellitus. Current Medical Research and Opinion 27:5, 969-979
CrossRef320
N. Holman, N. G. Forouhi, E. Goyder, S. H. Wild. (2011) The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabetic Medicine 28:5, 575-582
CrossRef321
Paul W Franks, Dmitry Shungin. (2011) The interplay of lifestyle and genetic susceptibility in Type 2 diabetes risk. Diabetes Management 1:3, 299-307
CrossRef322
Masanori Munakata, Hiroki Honma, Mitugu Akasi, Takaharu Araki, Takahiko Kawamura, Masashi Kubota, Tomoko Yokokawa, Yoshihiro Numata, Toshihiro Toyonaga. (2011) Repeated counselling improves the antidiabetic effects of limited individualized lifestyle guidance in metabolic syndrome: J-STOP-METS final results. Hypertension Research 34:5, 612-616
CrossRef323
Haruhito Tsutsui, Toshio Maeda, Jun Zhe Min, Shinsuke Inagaki, Tatsuya Higashi, Yoshiyuki Kagawa, Toshimasa Toyo'oka. (2011) Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry. Clinica Chimica Acta 412:11-12, 861-872
CrossRef324
M. Uusitupa, J. Tuomilehto, P. Puska. (2011) Are we really active in the prevention of obesity and type 2 diabetes at the community level?. Nutrition, Metabolism and Cardiovascular Diseases 21:5, 380-389
CrossRef325
R. Scott Wright, Jeffrey L. Anderson, Cynthia D. Adams, Charles R. Bridges, Donald E. Casey, Steven M. Ettinger, Francis M. Fesmire, Theodore G. Ganiats, Hani Jneid, A. Michael Lincoff, Eric D. Peterson, George J. Philippides, Pierre Theroux, Nanette K. Wenger, James Patrick Zidar. (2011) 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 57:19, e215-e367
CrossRef326
Carl J. Lavie, Richard V. Milani, James H. OʼKeefe. (2011) Dyslipidemia Intervention in Metabolic Syndrome: Emphasis on Improving Lipids and Clinical Event Reduction. The American Journal of the Medical Sciences 341:5, 388-393
CrossRef327
C. E. Adams, F. L. Greenway, P. J. Brantley. (2011) Lifestyle factors and ghrelin: critical review and implications for weight loss maintenance. Obesity Reviews 12:5, e211-e218
CrossRef328
Nancy C. Chescheir. (2011) Global Obesity and the Effect on Womenʼs Health. Obstetrics & Gynecology 117:5, 1213-1222
CrossRef329
E. Cosson, M. T. Nguyen, E. Hamo-Tchatchouang, I. Banu, S. Chiheb, N. Charnaux, P. Valensi. (2011) What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our pratice in 1998-2006?. Diabetic Medicine 28:5, 567-574
CrossRef330
D. S. Bond, J. Roth, J. M. Nash, R. R. Wing. (2011) Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obesity Reviews 12:5, e362-e371
CrossRef331
Paul Trayhurn, Christian A. Drevon, Jürgen Eckel. (2011) Secreted proteins from adipose tissue and skeletal muscle – adipokines, myokines and adipose/muscle cross-talk. Archives Of Physiology And Biochemistry 117:2, 47-56
CrossRef332
Ying-Tai Wu, Chueh-Lung Hwang, Chiao-Nan Chen, Lee-Ming Chuang. (2011) Home-based exercise for middle-aged Chinese at diabetic risk: A randomized controlled trial. Preventive Medicine 52:5, 337-343
CrossRef333
Adnan Sharif. (2011) New-onset diabetes after transplantation: focus on strategies to reduce risk. Diabetes Management 1:3, 271-280
CrossRef334
Arash Asher. (2011) Cognitive Dysfunction Among Cancer Survivors. American Journal of Physical Medicine & Rehabilitation 90:Suppl 1, S16-S26
CrossRef335
Samir Malkani, John P. Mordes. (2011) Implications of Using Hemoglobin A1C for Diagnosing Diabetes Mellitus. The American Journal of Medicine 124:5, 395-401
CrossRef336
Mary Beth Weber, Harish Ranjani, Gaya Celeste Meyers, Viswanathan Mohan, K.M. Venkat Narayan. (2011) A model of translational research for diabetes prevention in low and middle-income countries: The Diabetes Community Lifestyle Improvement Program (D-CLIP) trial. Primary Care Diabetes
CrossRef337
T. Rutledge, L. M. Groesz, S. E. Linke, G. Woods, K. L. Herbst. (2011) Behavioural weight management for the primary careprovider. Obesity Reviews 12:5, e290-e297
CrossRef338
Richard M Watanabe. (2011) Drugs, diabetes and pharmacogenomics: the road to personalized therapy. Pharmacogenomics 12:5, 699-701
CrossRef339
Ejaz Ahmad, Aqeel Ahmad, Saurabh Singh, Md Arshad, Abdul Hameed Khan, Rizwan Hasan Khan. (2011) A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes. Biochimie 93:5, 793-805
CrossRef340
Kathleen M. McTigue, Tina Bhargava, Cindy L. Bryce, Molly Conroy, Gary S. Fischer, Rachel Hess, Laurey R. Simkin-Silverman, Susan Zickmund. (2011) Patient perspectives on the integration of an intensive online behavioral weight loss intervention into primary care. Patient Education and Counseling 83:2, 261-264
CrossRef341
Ameena T. Ahmed, Thomas R. W. Blair, Roger S. McIntyre. (2011) Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda. Advances in Therapy 28:5, 389-400
CrossRef342
, M. Alssema, D. Vistisen, M. W. Heymans, G. Nijpels, C. Glümer, P. Z. Zimmet, J. E. Shaw, M. Eliasson, C. D. A. Stehouwer, A. G. Tabák, S. Colagiuri, K. Borch-Johnsen, J. M. Dekker. (2011) The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia 54:5, 1004-1012
CrossRef343
Tim Church. (2011) Exercise in Obesity, Metabolic Syndrome, and Diabetes. Progress in Cardiovascular Diseases 53:6, 412-418
CrossRef344
Gunver Sophia Kienle, Hans-Ulrich Albonico, Lorenz Fischer, Martin Frei-Erb, Harald J. Hamre, Peter Heusser, Peter F. Matthiessen, Adrian Renfer, Helmut Kiene. (2011) Complementary Therapy Systems and Their Integrative Evaluation. EXPLORE: The Journal of Science and Healing 7:3, 175-187
CrossRef345
Edwin B. Fisher, Marian L. Fitzgibbon, Russell E. Glasgow, Debra Haire-Joshu, Laura L. Hayman, Robert M. Kaplan, Marilyn S. Nanney, Judith K. Ockene. (2011) Behavior Matters. American Journal of Preventive Medicine 40:5, e15-e30
CrossRef346
Nathan T. Jenkins, James M. Hagberg. (2011) Aerobic Training Effects on Glucose Tolerance in Prediabetic and Normoglycemic Humans. Medicine & Science in Sports & Exercise1
CrossRef347
Hirohide Yokokawa, Ikiko Kinoshita, Takeo Hashiguchi, Masako Kako, Kahoru Sasaki, Akira Tamura, Yuri Kintaka, Yoko Suzuki, Noriko Ishizuka, Katsumi Arai, Yoshiko Kasahara, Mikiko Kishi, Yoko Kobayashi, Tosei Takahashi, Hiroyuki Shimizu, Shuji Inoue. (2011) Enhanced exercise-induced muscle damage and muscle protein degradation in streptozotocin-induced type 2 diabetic rats. Journal of Diabetes Investigationno-no
CrossRef348
Matthew D. Hordern, David W. Dunstan, Johannes B. Prins, Michael K. Baker, Maria A. Fiatarone Singh, Jeff S. Coombes. (2011) Exercise prescription for patients with type 2 diabetes and pre-diabetes: A position statement from exercise and sport science Australia. Journal of Science and Medicine in Sport
CrossRef349
Laura P. Svetkey, Jamy D. Ard, Victor J. Stevens, Catherine M. Loria, Deb Y. Young, Jack F. Hollis, Lawrence J. Appel, Phillip J. Brantley, Betty M. Kennedy, Shiriki K. Kumanyika, Bryan C. Batch, Leonor Corsino, Lillian F. Lien, William M. Vollmer. (2011) Predictors of Long-Term Weight Loss in Adults With Modest Initial Weight Loss, by Sex and Race. Obesity
CrossRef350
Vanessa Watts Simonds, Rima E. Rudd, Thomas D. Sequist, Graham Colditz. (2011) An Assessment of Printed Diabetes-Prevention Materials Available to a Northern Plains Tribe. Journal of Health Communication 16:4, 431-447
CrossRef351
Amy Sutton. 2011. Life Care Planning for Children with Diabetes. , 503-515.
CrossRef352
Stephen B. Thomas, Sandra Crouse Quinn, James Butler, Craig S. Fryer, Mary A. Garza. (2011) Toward a Fourth Generation of Disparities Research to Achieve Health Equity. Annual Review of Public Health 32:1, 399-416
CrossRef353
Karen E. Foster-Schubert, Catherine M. Alfano, Catherine R. Duggan, Liren Xiao, Kristin L. Campbell, Angela Kong, Carolyn E. Bain, Ching-Yun Wang, George L. Blackburn, Anne McTiernan. (2011) Effect of Diet and Exercise, Alone or Combined, on Weight and Body Composition in Overweight-to-Obese Postmenopausal Women. Obesity
CrossRef354
John M. Jakicic, Anne E. Mishler, Renee Rogers. (2011) Fitness, Fatness, and Cardiovascular Disease Risk and Outcomes. Current Cardiovascular Risk Reports 5:2, 113-119
CrossRef355
Thomas J Wang, Martin G Larson, Ramachandran S Vasan, Susan Cheng, Eugene P Rhee, Elizabeth McCabe, Gregory D Lewis, Caroline S Fox, Paul F Jacques, Céline Fernandez, Christopher J O'Donnell, Stephen A Carr, Vamsi K Mootha, Jose C Florez, Amanda Souza, Olle Melander, Clary B Clish, Robert E Gerszten. (2011) Metabolite profiles and the risk of developing diabetes. Nature Medicine 17:4, 448-453
CrossRef356
Hsiang-Ju Pan, Beatriz M. Cole, Allan Geliebter. (2011) The benefits of body weight loss on health-related quality of life. Journal of the Chinese Medical Association 74:4, 169-175
CrossRef357
Kishore M Gadde, David B Allison, Donna H Ryan, Craig A Peterson, Barbara Troupin, Michael L Schwiers, Wesley W Day. (2011) Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. The Lancet 377:9774, 1341-1352
CrossRef358
K. Makrilakis, S. Liatis, S. Grammatikou, D. Perrea, C. Stathi, P. Tsiligros, N. Katsilambros. (2011) Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes & Metabolism 37:2, 144-151
CrossRef359
Tsvetalina Tankova, Nevena Chakarova, Iliana Atanassova, Lilia Dakovska. (2011) Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Research and Clinical Practice 92:1, 46-52
CrossRef360
Allison Longenberger, Jeong Youn Lim, Todd T Brown, Alison Abraham, Frank J Palella, Rita B Effros, Trevor Orchard, Maria Mori Brooks, Lawrence A Kingsley. (2011) Low physical function as a risk factor for incident diabetes mellitus and insulin resistance. Future Virology 6:4, 439-449
CrossRef361
Osama Hamdy. (2011) Nonsurgical Diabetes Weight Management: Be Prepared for Sustainable and Practical Interventions. Current Diabetes Reports 11:2, 75-76
CrossRef362
John Weinman, Ronan O'Carroll, Keith J. Petrie. 2011. Clinical Health Psychology. , 53-82.
CrossRef363
Julie D. Lamb, Erica B. Johnstone, Julie-Anne Rousseau, Christopher L. Jones, Lauri A. Pasch, Marcelle I. Cedars, Heather G. Huddleston. (2011) Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health associations. American Journal of Obstetrics and Gynecology 204:4, 352.e1-352.e6
CrossRef364
Michele C. Clark, Hoang Nguyen, L. Maria Belalcazar. (2011) Evaluating if patient self-perceptions of competencies have an influence on biological indicators for cardio-metabolic health. Diabetes Research and Clinical Practice 92:1, e3-e6
CrossRef365
C. Gagnon, C. Brown, C. Couture, C.N. Kamga-Ngande, M.F. Hivert, J.P. Baillargeon, A.C. Carpentier, M.F. Langlois. (2011) A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes. Diabetes & Metabolism
CrossRef366
MARLENE N. SILVA, DAVID MARKLAND, ELIANA V. CARRAÇA, PAULO N. VIEIRA, SÍLVIA R. COUTINHO, CLÁUDIA S. MINDERICO, MARGARIDA G. MATOS, LUÍS B. SARDINHA, PEDRO J. TEIXEIRA. (2011) Exercise Autonomous Motivation Predicts 3-yr Weight Loss in Women. Medicine & Science in Sports & Exercise 43:4, 728-737
CrossRef367
Masayuki Kato, Yoshihiko Takahashi, Yumi Matsushita, Tetsuya Mizoue, Manami Inoue, Takashi Kadowaki, Shoichiro Tsugane, Mitsuhiko Noda. (2011) Diabetes mellitus defined by hemoglobin A1c value: Risk characterization for incidence among Japanese subjects in the JPHC Diabetes Study. Journal of Diabetes Investigationno-no
CrossRef368
Lindsay Zilliox, James W. Russell. (2011) Treatment of Diabetic Sensory Polyneuropathy. Current Treatment Options in Neurology 13:2, 143-159
CrossRef369
Bruce H. Francis, Xue Song, L. M. Andrews, Das Purkayastha, Nicole Princic, Robert Sedgley, Amy E. Rudolph. (2011) Progression to type 2 diabetes, healthcare utilization, and cost among pre-diabetic patients with or without comorbid hypertension. Current Medical Research and Opinion 27:4, 809-819
CrossRef370
Judith H. M. Helmink, Stef P. J. Kremers, Leonieke C. van Boekel, Femke N. van Brussel-Visser, Nanne K. de Vries. (2011) Factors determining the motivation of primary health care professionals to implement and continue the ‘Beweegkuur’ lifestyle intervention programme. Journal of Evaluation in Clinical Practiceno-no
CrossRef371
J. Flanagan, P. K. Gray, N. Hahn, J. Hayes, L. J. Myers, C. Carney-Doebbeling, C. J. Sweeney. (2011) Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer. Annals of Oncology 22:4, 801-807
CrossRef372
Samiullah Shaikh, Gani Hanif, Kashif, Mona Humera. (2011) Frequency of prediabetes and influence of various risk factors on the development of prediabetes: a tertiary care hospital experience. International Journal of Diabetes in Developing Countries 31:2, 65-69
CrossRef373
A. Wirth. (2011) Antidiabetika. Der Internist 52:4, 451-461
CrossRef374
L. Chen, D. J. Magliano, B. Balkau, R. Wolfe, L. Brown, A. M. Tonkin, P. Z. Zimmet, J. E. Shaw. (2011) Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study. Diabetic Medicine 28:4, 414-423
CrossRef375
Shao-Yuan Chuang, Wen-Ting Yeh, Yi-Lin Wu, Hsing-Yi Chang, Wen-Harn Pan, Chwen-Keng Tsao. (2011) Prediction equations and point system derived from large-scale health check-up data for estimating diabetic risk in the Chinese population of Taiwan. Diabetes Research and Clinical Practice 92:1, 128-136
CrossRef376
Frédérique Thomas, Bruno Pannier, Athanase Benetos, Ulrich M Vischer. (2011) The impact of the metabolic syndrome – but not of hypertension – on all-cause mortality disappears in the elderly. Journal of Hypertension 29:4, 663-668
CrossRef377
Peter W.F. Wilson, Ralph B. D’Agostino, Caroline S. Fox, Lisa M. Sullivan, James B. Meigs. (2011) Type 2 diabetes risk in persons with dysglycemia: The Framingham Offspring Study. Diabetes Research and Clinical Practice 92:1, 124-127
CrossRef378
Simona Moscatiello, Raffaella Di Luzio, Elisabetta Bugianesi, Alessandro Suppini, Ingrid J. Hickman, Silvia Di Domizio, Riccardo Dalle Grave, Giulio Marchesini. (2011) Cognitive-Behavioral Treatment of Nonalcoholic Fatty Liver Disease: A Propensity Score-Adjusted Observational Study. Obesity 19:4, 763-770
CrossRef379
N.W. Cheung, B.J. Smith, H.P. van der Ploeg, N. Cinnadaio, A. Bauman. (2011) A pilot structured behavioural intervention trial to increase physical activity among women with recent gestational diabetes. Diabetes Research and Clinical Practice 92:1, e27-e29
CrossRef380
Richard R Saunders, Muriel D Saunders, Joseph E Donnelly, Bryan K Smith, Debra K Sullivan, Brianne Guilford, Mary F Rondon. (2011) Evaluation of an Approach to Weight Loss in Adults With Intellectual or Developmental Disabilities. Intellectual and Developmental Disabilities 49:2, 103-112
CrossRef381
Jude U. Ohaeri, Abayomi O. Akanji. (2011) Metabolic Syndrome in Severe Mental Disorders. Metabolic Syndrome and Related Disorders 9:2, 91-98
CrossRef382
Shannon D. Sullivan, Robert E. Ratner. (2011) Should the Metabolic Syndrome Patient with Prediabetes Be Offered Pharmacotherapy?. Current Diabetes Reports 11:2, 91-98
CrossRef383
Alok K Gupta, Meghan M Brashear, William D Johnson. (2011) Coexisting prehypertension and prediabetes in healthy adults: a pathway for accelerated cardiovascular events. Hypertension Research 34:4, 456-461
CrossRef384
Dariush Mozaffarian. (2011) Achieving Cardiovascular Health. Journal of the American College of Cardiology 57:16, 1697-1699
CrossRef385
L. L. Berry, A. M. Mirabito. (2011) Partnering for Prevention With Workplace Health Promotion Programs. Mayo Clinic Proceedings 86:4, 335-337
CrossRef386
Manpreet S. Mundi, Michael D. Jensen. 2011. Primary Therapy for Obesity as the Treatment of Type 2 Diabetes. , 105-115.
CrossRef387
Galina Smushkin, F. John Service. 2011. How to Determine when to Pursue Lifestyle Change Alone Versus Pharmacotherapy at Diagnosis?. , 64-70.
CrossRef388
Kalpana Muthusamy, Adrian Vella. 2011. Is Prediabetes a Risk Factor or is it a Disease?. , 1-10.
CrossRef389
William Cefalu, Jaqueline Stephens, David Ribnicky. 2011. Diabetes and Herbal (Botanical) Medicine. , 405-418.
CrossRef390
2011. References. , 283-360.
CrossRef391
DeFronzo, Ralph A., Tripathy, Devjit, Schwenke, Dawn C., Banerji, MaryAnn, Bray, George A., Buchanan, Thomas A., Clement, Stephen C., Henry, Robert R., Hodis, Howard N., Kitabchi, Abbas E., Mack, Wendy J., Mudaliar, Sunder, Ratner, Robert E., Williams, Ken, Stentz, Frankie B., Musi, Nicolas, Reaven, Peter D., . (2011) Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance. New England Journal of Medicine 364:12, 1104-1115
Full Text392
Anne Lang Dunlop, Divya Narayan, Vita Lam Mayes. 2011. Preparing for Pregnancy: Special Considerations for the Obese Woman. , 33-50.
CrossRef393
S. Gastinger, H. Sefati, G. Nicolas, A. Sorel, A. Gratas-Delamarche, J. Prioux. (2011) A new method to estimate energy expenditure from abdominal and rib cage distances. European Journal of Applied Physiology
CrossRef394
Fiona Wong, Denise Stevens, Kathleen O'Connor-Duffany, Karen Siegel, Yue Gao. (2011) Community Health Environment Scan Survey (CHESS): a novel tool that captures the impact of the built environment on lifestyle factors. Global Health Action 4:0,
CrossRef395
William H. Herman. (2011) The Economics of Diabetes Prevention. Medical Clinics of North America 95:2, 373-384
CrossRef396
Robert E. Ratner, Anpalakan Sathasivam. (2011) Treatment Recommendations for Prediabetes. Medical Clinics of North America 95:2, 385-395
CrossRef397
Lawrence A. Leiter, David H. Fitchett, Richard E. Gilbert, Milan Gupta, G.B. John Mancini, Philip A. McFarlane, Robert Ross, Hwee Teoh, Subodh Verma, Sonia Anand, Kathryn Camelon, Chi-Ming Chow, Jafna L. Cox, Jean-Pierre Després, Jacques Genest, Stewart B. Harris, David C.W. Lau, Richard Lewanczuk, Peter P. Liu, Eva M. Lonn, Ruth McPherson, Paul Poirier, Shafiq Qaadri, Rémi Rabasa-Lhoret, Simon W. Rabkin, Arya M. Sharma, Andrew W. Steele, James A. Stone, Jean-Claude Tardif, Sheldon Tobe, Ehud Ur. (2011) Identification and Management of Cardiometabolic Risk in Canada: A Position Paper by the Cardiometabolic Risk Working Group (Executive Summary). Canadian Journal of Cardiology 27:2, 124-131
CrossRef398
Lawrence A. Leiter, David H. Fitchett, Richard E. Gilbert, Milan Gupta, G.B. John Mancini, Philip A. McFarlane, Robert Ross, Hwee Teoh, Subodh Verma, Sonia Anand, Kathryn Camelon, Chi-Ming Chow, Jafna L. Cox, Jean-Pierre Després, Jacques Genest, Stewart B. Harris, David C.W. Lau, Richard Lewanczuk, Peter P. Liu, Eva M. Lonn, Ruth McPherson, Paul Poirier, Shafiq Qaadri, Rémi Rabasa-Lhoret, Simon W. Rabkin, Arya M. Sharma, Andrew W. Steele, James A. Stone, Jean-Claude Tardif, Sheldon Tobe, Ehud Ur. (2011) Cardiometabolic Risk in Canada: A Detailed Analysis and Position Paper by the Cardiometabolic Risk Working Group. Canadian Journal of Cardiology 27:2, e1-e33
CrossRef399
Bu B Yeap. (2011) Osteocalcin: an endocrine link between bone and glucose metabolism. Expert Review of Endocrinology & Metabolism 6:2, 177-185
CrossRef400
(2011) Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. Diabetologia 54:3, 487-495
CrossRef401
Gregg Simonson, Robert Cuddihy, Diane Reader, Richard Bergenstal. (2011) International Diabetes Center Treatment of Type 2 Diabetes Glucose Algorithm. Diabetes Management 1:2, 175-189
CrossRef402
Jaya P Buddineni, Kunal Chaudhary, Adam Whaley-Connell. (2011) Biomarkers in diabetic kidney disease. Therapy 8:2, 121-127
CrossRef403
Christoph H Saely, Veronika Drexel, Alexander Vonbank, Heinz Drexel. (2011) Lipid management in Type 2 diabetes: the case for combination therapy?. Therapy 8:2, 129-141
CrossRef404
A. Icks, N. Chernyak, A. Klein, R. Brinks, J. Genz, G. Giani. (2011) Kosteneffektivität der Primärprävention des Typ-2-Diabetes. Der Diabetologe 7:2, 92-98
CrossRef405
R Kouki, U Schwab, M Hassinen, P Komulainen, H Heikkilä, T A Lakka, R Rauramaa. (2011) Food consumption, nutrient intake and the risk of having metabolic syndrome: the DR's EXTRA Study. European Journal of Clinical Nutrition 65:3, 368-377
CrossRef406
A Forbes. (2011) Progressing diabetes nursing in Europe: the next steps. European Diabetes Nursing 8:1, 8-10
CrossRef407
Luca Busetto, Mariangela Marangon, Fabio De Stefano. (2011) High-protein low-carbohydrate diets: what is the rationale?. Diabetes/Metabolism Research and Reviews 27:3, 230-232
CrossRef408
Gwinnett Ladson, William C. Dodson, Stephanie D. Sweet, Anthony E. Archibong, Allen R. Kunselman, Laurence M. Demers, Nancy I. Williams, Ponjola Coney, Richard S. Legro. (2011) The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertility and Sterility 95:3, 1059-1066.e7
CrossRef409
N. Napoli, F. Costanza, E. Di Stasio, R. Strollo, S. Manfrini, E. Cipponeri, A. Picardi, F. Carrano, V. Dell’Anna, W. Macino, P. Pozzilli. (2011) Blood glucose monitoring in the normal population: the PREDICA study. Acta Diabetologica 48:1, 29-34
CrossRef410
James D. Lane. (2011) Caffeine, Glucose Metabolism, and Type 2 Diabetes. Journal of Caffeine Research 1:1, 23-28
CrossRef411
C. Lamanna, M. Monami, N. Marchionni, E. Mannucci. (2011) Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Diabetes, Obesity and Metabolism 13:3, 221-228
CrossRef412
Claudia Brufani, Danilo Fintini, Valerio Nobili, Patrizia Ippolita Patera, Marco Cappa, Mario Brufani. (2011) Use of metformin in pediatric age. Pediatric Diabetesno-no
CrossRef413
G. P. Carnevale Schianca, R. Mella, E. Scaglia, M. Bigliocca, E. Colli, Gian Paolo Fra, E. Bartoli. (2011) Expanding the clinical use of standard OGTT: the percentage increment of 2 h with respect to fasting glucose as an index of β-cell dysfunction. Diabetes/Metabolism Research and Reviews 27:3, 262-268
CrossRef414
Hari S Conjeevaram, Dina G Tiniakos. (2011) Editorial: Exercise for NAFLD: Does Intensity Matter?. The American Journal of Gastroenterology 106:3, 470-475
CrossRef415
Alison C. HOLLOWAY, Bart P. HETTINGA, Hertzel C. GERSTEIN. (2011) Effect of combining rosiglitazone with either metformin or insulin on β-cell mass and function in an animal model of Type 2 diabetes characterized by reduced β-cell mass at birth. Journal of Diabetes 3:1, 74-81
CrossRef416
A. Ramachandran, C. Snehalatha. (2011) Diabetes Prevention Programs. Medical Clinics of North America 95:2, 353-372
CrossRef417
Toshihide Oizumi, Makoto Daimon, Shigeru Karasawa, Wataru Kaino, Kaoru Takase, Yumi Jimbu, Kiriko Wada, Wataru Kameda, Shinji Susa, Takeo Kato. (2011) Assessment of plasma glucose cutoff values to predict the development of type 2 diabetes in a Japanese sample: the Funagata Study. Diabetology International 2:1, 26-31
CrossRef418
Jonathan Shaw. (2011) Diagnosis of Prediabetes. Medical Clinics of North America 95:2, 341-352
CrossRef419
Mark D DeBoer. (2011) Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Review of Endocrinology & Metabolism 6:2, 279-289
CrossRef420
Bertrand Cariou. (2011) Efficacité métabolique d’une intervention hygiéno-diététique « intensifiée » à 4 ans : les données de l’étude Look AHEAD. Médecine des Maladies Métaboliques 5:1, H65-H66
CrossRef421
Donna Spruijt-Metz. (2011) Etiology, Treatment, and Prevention of Obesity in Childhood and Adolescence: A Decade in Review. Journal of Research on Adolescence 21:1, 129-152
CrossRef422
C. L. Harrison, C. B. Lombard, L. J. Moran, H. J. Teede. (2011) Exercise therapy in polycystic ovary syndrome: a systematic review. Human Reproduction Update 17:2, 171-183
CrossRef423
Vincent Wai-Sun Wong, Henry Lik-Yuen Chan. (2011) Should all patients with nonalcoholic fatty liver disease undergo oral glucose tolerance test?. Journal of Gastroenterology and Hepatology 26:3, 419-420
CrossRef424
Peter E.H. Schwarz. (2011) Public Health Implications: Translation into Diabetes Prevention Initiatives—Four-Level Public Health Concept. Medical Clinics of North America 95:2, 397-407
CrossRef425
Linda A. Jaber, Nicole R. Pinelli, Morton B. Brown, Martha M. Funnell, Robert Anderson, Adnan Hammad, William H. Herman. (2011) Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans. Diabetes Research and Clinical Practice 91:3, 307-315
CrossRef426
Jeff Unger. (2011) Comparing the efficacy, safety, and utility of intensive insulin algorithms for a primary care practice. Diabetes Therapy 2:1, 40-50
CrossRef427
Nia S. Mitchell, L. Miriam Dickinson, Allison Kempe, Adam G. Tsai. (2011) Determining the Effectiveness of Take Off Pounds Sensibly (TOPS), a Nationally Available Nonprofit Weight Loss Program. Obesity 19:3, 568-573
CrossRef428
Michael P O'Donnell. (2011) Reflections on the 25th Anniversary of Publishing the American Journal of Health Promotion : People, Scientific Progress, and Missteps. American Journal of Health Promotion 25:4, iv-xi
CrossRef429
Bonnie Spring. (2011) Translational Behavioral Medicine: a pathway to better health. Translational Behavioral Medicine
CrossRef430
Wolfgang Rathmann, Bernd Kowall, Teresa Tamayo, Guido Giani, Rolf Holle, Barbara Thorand, Margit Heier, Cornelia Huth, Christa Meisinger. (2011) Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study. Annals of Medicine1-8
CrossRef431
A N Fabricatore, T A Wadden, A J Higginbotham, L F Faulconbridge, A M Nguyen, S B Heymsfield, M S Faith. (2011) Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis. International Journal of Obesity
CrossRef432
Joel N. Hirschhorn, Zofia K. Z. Gajdos. (2011) Genome-Wide Association Studies: Results from the First Few Years and Potential Implications for Clinical Medicine. Annual Review of Medicine 62:1, 11-24
CrossRef433
Lisa J Moran, Samantha K Hutchison, Robert J Norman, Helena J Teede, Lisa J Moran. 2011. Lifestyle changes in women with polycystic ovary syndrome. .
CrossRef434
Minghan Wang. 2011. Current Antidiabetic Therapies and Mechanisms. , 253-278.
CrossRef435
Taxiarchis V. Kourelis, Robert D. Siegel. (2011) Metformin and cancer: new applications for an old drug. Medical Oncology
CrossRef436
M Hatami, F Hadaegh, D Khalili, F Sheikholeslami, F Azizi. (2011) Family history of diabetes modifies the effect of blood pressure for incident diabetes in Middle Eastern women: Tehran Lipid and Glucose Study. Journal of Human Hypertension
CrossRef437
Jocelyne G. Karam, Samy I. McFarlane. (2011) Update on the Prevention of Type 2 Diabetes. Current Diabetes Reports 11:1, 56-63
CrossRef438
D S West, A A Gorin, L L Subak, G Foster, C Bragg, J Hecht, M Schembri, R R Wing. (2011) A motivation-focused weight loss maintenance program is an effective alternative to a skill-based approach. International Journal of Obesity 35:2, 259-269
CrossRef439
N Gianotti, F Visco, L Galli, B Barda, P Piatti, S Salpietro, A Bigoloni, C Vinci, S Nozza, G Gallotta, A Lazzarin, A Castagna. (2011) Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients. HIV Medicine 12:2, 109-117
CrossRef440
Jürgen Machann, Norbert Stefan, Andreas Fritsche, Fritz Schick. (2011) Magnetic resonance techniques for mapping fat deposits and directing therapy. Clinical Lipidology 6:1, 93-107
CrossRef441
Stephen Franks. (2011) When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?. Clinical Endocrinology 74:2, 148-151
CrossRef442
Y. M. Cho, T. J. Kieffer. (2011) New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser. Diabetologia 54:2, 219-222
CrossRef443
Deborah Walton Smith, Quinn Griffin, Joyce Fitzpatrick. (2011) Exercise and exercise intentions among obese and overweight individuals. Journal of the American Academy of Nurse Practitioners 23:2, 92-100
CrossRef444
Karl K. Vanderwood, Taryn O. Hall, Todd S. Harwell, Diane Arave, Marcene K. Butcher, Steven D. Helgerson. (2011) Factors associated with the maintenance or achievement of the weight loss goal at follow-up among participants completing an adapted diabetes prevention program. Diabetes Research and Clinical Practice 91:2, 141-147
CrossRef445
Robert Rountree. (2011) Roundoc Rx: A Functional Medicine Approach to Metabolic Syndrome: Part 2—The Top 5 Lifestyle Interventions. Alternative and Complementary Therapies 17:1, 14-20
CrossRef446
Sharon J. Herring, Emily Oken. (2011) Obesity and Diabetes in Mothers and Their Children: Can We Stop the Intergenerational Cycle?. Current Diabetes Reports 11:1, 20-27
CrossRef447
Alan L. Hinderliter, Michael A. Babyak, Andrew Sherwood, James A. Blumenthal. (2011) The DASH Diet and Insulin Sensitivity. Current Hypertension Reports 13:1, 67-73
CrossRef448
Peter E.H. Schwarz, Jaana Lindström. (2011) From evidence to practice—the IMAGE project—new standards in the prevention of type 2 diabetes. Diabetes Research and Clinical Practice 91:2, 138-140
CrossRef449
P. Chamnan, R. K. Simmons, R. Jackson, K. T. Khaw, N. J. Wareham, S. J. Griffin. (2011) Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia 54:2, 291-299
CrossRef450
Clare Grace. (2011) Nutrition-related health management in a Bangladeshi community. Proceedings of the Nutrition Society 70:01, 129-134
CrossRef451
Inger Christine Munch, Michael Larsen, Line Kessel, Knut Borch-Johnsen, Henrik Lund-Andersen, Charlotte Glümer. (2011) Cumulative glycemia and microangiopathy in subjects with impaired glucose regulation in the Inter99 study. Diabetes Research and Clinical Practice 91:2, 226-232
CrossRef452
Q. Gong, E. W. Gregg, J. Wang, Y. An, P. Zhang, W. Yang, H. Li, H. Li, Y. Jiang, Y. Shuai, B. Zhang, J. Zhang, R. B. Gerzoff, G. Roglic, Y. Hu, G. Li, P. H. Bennett. (2011) Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 54:2, 300-307
CrossRef453
David A. Booth, Phil Booth. (2011) Targeting cultural changes supportive of the healthiest lifestyle patterns. A biosocial evidence-base for prevention of obesity. Appetite 56:1, 210-221
CrossRef454
Maite Figueras, Mireia Olivan, Sílvia Busquets, Francisco J. López-Soriano, Josep M. Argilés. (2011) Effects of Eicosapentaenoic Acid (EPA) Treatment on Insulin Sensitivity in an Animal Model of Diabetes: Improvement of the Inflammatory Status. Obesity 19:2, 362-369
CrossRef455
U. Lindblad, G. Lindberg, N.-O. Månsson, J. Ranstam, M. Tyrberg, S. Jansson, K. Lindwall, M. Svärdh, L. Kindmalm, A. Melander. (2011) Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY). Diabetes, Obesity and Metabolism 13:2, 185-188
CrossRef456
K. Esefeld, M. Halle, S.N. Blair. (2011) Eingeschränkte Fitness vs. Adipositas. Der Diabetologe 7:1, 9-14
CrossRef457
Philip J. Saylor, Nancy L. Keating, Stephen J. Freedland, Matthew R. Smith. (2011) Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer. Drugs 71:3, 255-261
CrossRef458
C. Grace. (2011) A review of one-to-one dietetic obesity management in adults. Journal of Human Nutrition and Dietetics 24:1, 13-22
CrossRef459
B. Schneider, S. Martin, W. A. Scherbaum, L. Heinemann, V. Lodwig, H. Kolb. (2011) Immortal time bias does not invalidate the association of self-monitoring of blood glucose with better survival of patients with type 2 diabetes in the epidemiological study ROSSO (Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes). Diabetologia 54:2, 475-476
CrossRef460
S Bo, G Ciccone, M Durazzo, L Ghinamo, P Villois, S Canil, R Gambino, M Cassader, L Gentile, P Cavallo-Perin. (2011) Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort. International Journal of Obesity
CrossRef461
Mary E. Cox, William S. Yancy, Cynthia J. Coffman, Truls Østbye, James A. Tulsky, Stewart C. Alexander, Rebecca J. Namenek Brouwer, Rowena J. Dolor, Kathryn I. Pollak. (2011) Effects of counseling techniques on patients’ weight-related attitudes and behaviors in a primary care clinic. Patient Education and Counseling
CrossRef462
Leslie K. John, George Loewenstein, Andrea B. Troxel, Laurie Norton, Jennifer E. Fassbender, Kevin G. Volpp. (2011) Financial Incentives for Extended Weight Loss: A Randomized, Controlled Trial. Journal of General Internal Medicine
CrossRef463
Shah Ebrahim, Fiona Taylor, Kirsten Ward, Andrew Beswick, Margaret Burke, George Davey Smith, Shah Ebrahim. 2011. Multiple risk factor interventions for primary prevention of coronary heart disease. .
CrossRef464
James A. Timmons, Jorn W. Helge. 2011. A Primer on Systems Biology, as Applied to Exercise Physiology and Metabolism. , 307-318.
CrossRef465
Manuel Barrera, Felipe González Castro, Lori K. Holleran Steiker. (2011) A Critical Analysis of Approaches to the Development of Preventive Interventions for Subcultural Groups. American Journal of Community Psychology
CrossRef466
Kieun Moon, Ill Keun Park, Yeon Sang Jo, Yun Kyun Chang, Yun Mi Paek, Tae In Choi. (2011) The Effects of 12-Weeks Intensive Intervention Program on Cardiovascular Risk Factors, Adipocytokines and Nutrients Intakes in Industrial Male Workers. The Korean Journal of Nutrition 44:4, 292
CrossRef467
L. M. Tussing-Humphreys, M. L. Fitzgibbon, J. S. Porter, I. K. Martin, A. Odoms-Young, L. K. Sharp. (2011) Weight loss and African-American women: a systematic review of the behavioural weight loss intervention literature : Weight loss in African-American women. Obesity Reviewsno
CrossRef468
Peter Kokkinos, Helen Sheriff, Raya Kheirbek. (2011) Physical Inactivity and Mortality Risk. Cardiology Research and Practice 2011, 1-10
CrossRef469
Colin J Greaves, Kate E Sheppard, Charles Abraham, Wendy Hardeman, Michael Roden, Philip H Evans, Peter Schwarz, . (2011) Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health 11:1, 119
CrossRef470
Rita M Sneeringer, Vasiliki A Moragianni. 2011. , 117.
CrossRef471
Yoshimi Fukuoka, Emiko Kamitani, Kemberlee Bonnet, Teri Lindgren. (2011) Real-Time Social Support Through a Mobile Virtual Community to Improve Healthy Behavior in Overweight and Sedentary Adults: A Focus Group Analysis. Journal of Medical Internet Research 13:3,
CrossRef472
Simon G. Anderson, Novie Younger, Adrian H. Heald, Marshall K. Tulloch-Reid, Wiyumile P. Simukonda, Jean-Claude Mbanya, Maria D. Jackson, Beverley Balkau, Sangita Sharma, Agatha Tanya, Terrence Forrester, Rainford Wilks, J. Kennedy Cruickshank. (2011) Nutrient intakes and dysglycaemia in populations of West African origin. British Journal of Nutrition 105:02, 297-306
CrossRef473
M. Nishigaki, A. Ota, T. Kusakabe, C. Matsuzaki, S. Taguchi, K. Kazuma. (2011) Feasibility and Efficiency of Indirect Lifestyle Interventions in Offspring of Type 2 Diabetic Patients. Public Health Genomics 14:2, 77-84
CrossRef474
Chung-Jung Chiu, Allen Taylor. (2011) Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Progress in Retinal and Eye Research 30:1, 18-53
CrossRef475
Suzanne Phelan, Kris Jankovitz, Todd Hagobian, Barbara Abrams. (2011) Reducing excessive gestational weight gain: lessons from the weight control literature and avenues for future research. Women s Health 7:6, 641
CrossRef476
Janice A Kolberg, Robert W Gerwien, Steve M Watkins, Linda J Wuestehube, Mickey Urdea. (2011) Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx<sup>®</sup> Diabetes Risk Score. Expert Review of Molecular Diagnostics 11:8, 775
CrossRef477
A. Palermo, N. Napoli, S. Manfrini, A. Lauria, R. Strollo, P. Pozzilli. (2011) Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study. Diabetes, Obesity and Metabolism 13:1, 42-46
CrossRef478
Simon J Griffin, Rebecca K Simmons, Kate M Williams, A Toby Prevost, Wendy Hardeman, Julie Grant, Fiona Whittle, Sue Boase, Imogen Hobbis, Soren Brage, Kate Westgate, Tom Fanshawe, Stephen Sutton, Nicholas J Wareham, Ann Kinmonth, . (2011) Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care. BMC Public Health 11:1, 211
CrossRef479
Eileen Smith Anderson-Bill, Richard A Winett, Janet R Wojcik, Sheila G Winett. (2011) Web-Based Guide to Health: Relationship of Theoretical Variables to Change in Physical Activity, Nutrition and Weight at 16-Months. Journal of Medical Internet Research 13:1,
CrossRef480
Magda Antal, Andrea Regöly-Mérei. (2011) Táplálkozás, életmód időskorban – kockázati tényezők és ajánlások. Orvosi Hetilap 152:5, 182-189
CrossRef481
Stefan S. Fajans, William H. Herman, Elif A. Oral. (2011) Insufficient sensitivity of hemoglobin A1C determination in diagnosis or screening of early diabetic states. Metabolism 60:1, 86-91
CrossRef482
Velio Bocci, Iacopo Zanardi, Maya S.P. Huijberts, Valter Travagli. (2011) Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 5:1, 45-49
CrossRef483
Maria Marino, Roberta Masella, Pamela Bulzomi, Ilaria Campesi, Walter Malorni, Flavia Franconi. (2011) Nutrition and human health from a sex–gender perspective. Molecular Aspects of Medicine
CrossRef484
Vicky Cheng, Sangeeta R. Kashyap. (2011) Weight Considerations in Pharmacotherapy for Type 2 Diabetes. Journal of Obesity 2011, 1-9
CrossRef485
Angela M Craigie, Stephen Caswell, Caron Paterson, Shaun Treweek, Jill JF Belch, Fergus Daly, Jackie Rodger, Joyce Thompson, Alison Kirk, Anne Ludbrook, Martine Stead, Jane Wardle, Robert JC Steele, Annie S Anderson. (2011) Study protocol for BeWEL: The impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas. BMC Public Health 11:1, 184
CrossRef486
J. Lindström, S. M. Virtanen. 2011. Functional foods and prevention of diabetes. , 261-276.
CrossRef487
Hak Chul Jang. (2011) Gestational Diabetes in Korea: Incidence and Risk Factors of Diabetes in Women with Previous Gestational Diabetes. Diabetes & Metabolism Journal 35:1, 1
CrossRef488
Supriya Kumar, Sandra C. Quinn, Andrea M. Kriska, Stephen B. Thomas. (2011) “Food is directed to the area”: African Americans’ perceptions of the neighborhood nutrition environment in Pittsburgh. Health & Place 17:1, 370-378
CrossRef489
Chidambarann Sudhakaran, Utkal Kishore, Ranjit Mohan Anjana, Ranjit Unnikrishnan, Viswanathan Mohan. (2011) Effectiveness of Sitagliptin in Asian Indian Patients with Type 2 Diabetes—An Indian Tertiary Diabetes Care Center Experience. Diabetes Technology & Therapeutics 13:1, 27-32
CrossRef490
J. I. Pedersen, B. Kirkhus. 2011. Health aspects of saturated fatty acids. , 77-97.
CrossRef491
Mário Raimundo, José António Lopes. (2011) Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease: A Dynamic and Life-Threatening Triad. Cardiology Research and Practice 2011, 1-16
CrossRef492
2011. , 77.
CrossRef493
Lucy F. Faulconbridge, Thomas A. Wadden, Robert I. Berkowitz, Melissa E. Pulcini, Thomas Treadwell. (2011) Treatment of Comorbid Obesity and Major Depressive Disorder: A Prospective Pilot Study for their Combined Treatment. Journal of Obesity 2011, 1-5
CrossRef494
Helena J. TEEDE, Cheryce L. HARRISON, Wan T. TEH, Eldho PAUL, Carolyn A. ALLAN. (2011) Gestational diabetes: Development of an early risk prediction tool to facilitate opportunities for prevention : Development of an early risk GDM prediction tool. Australian and New Zealand Journal of Obstetrics and Gynaecologyno
CrossRef495
Nicola Egan, Anna Read, Paddy Riley, William Atiomo. (2011) Evaluating compliance to a low glycaemic index (GI) diet in women with polycystic ovary syndrome (PCOS). BMC Research Notes 4:1, 53
CrossRef496
Thomas A. Wadden, John P. Foreyt, Gary D. Foster, James O. Hill, Samuel Klein, Patrick M. O'Neil, Michael G. Perri, F. Xavier Pi-Sunyer, Cheryl L. Rock, Janelle S. Erickson, Holly N. Maier, Dennis D. Kim, Eduardo Dunayevich. (2011) Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial. Obesity 19:1, 110-120
CrossRef497
Eveliina Korkiakangas, Anja M. Taanila, Sirkka Keinänen-Kiukaanniemi. (2011) Motivation to physical activity among adults with high risk of type 2 diabetes who participated in the Oulu substudy of the Finnish Diabetes Prevention Study. Health & Social Care in the Community 19:1, 15-22
CrossRef498
James G. Christian, Tim E. Byers, Kyle K. Christian, Michael G. Goldstein, Beth C. Bock, Brandon Prioreschi, Daniel H. Bessesen. (2011) A Computer Support Program that Helps Clinicians Provide Patients with Metabolic Syndrome Tailored Counseling to Promote Weight Loss. Journal of the American Dietetic Association 111:1, 75-83
CrossRef499
Takuya Tamura, Kazuyuki Kida, Futoshi Suetsuna, Nobuhiko Kasai, Takako Seki. (2011) Follow-up Study of Continuation versus Discontinuation of Home Exercise in Type 2 Diabetes Patients. Journal of Physical Therapy Science 23:1, 91-96
CrossRef500
Niki A. Georgiou, Johan Garssen, Renger F. Witkamp. (2011) Pharma–nutrition interface: The gap is narrowing. European Journal of Pharmacology 651:1-3, 1-8
CrossRef501
Sunghwan Suh, Kwang-Won Kim. (2011) Diabetes and Cancer: Is Diabetes Causally Related to Cancer?. Diabetes & Metabolism Journal 35:3, 193
CrossRef502
Mariela Glandt, Itamar Raz. (2011) Present and Future: Pharmacologic Treatment of Obesity. Journal of Obesity 2011, 1-13
CrossRef503
B. F. Vind, C. Pehmøller, J. T. Treebak, J. B. Birk, M. Hey-Mogensen, H. Beck-Nielsen, J. R. Zierath, J. F. P. Wojtaszewski, K. Højlund. (2011) Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Diabetologia 54:1, 157-167
CrossRef504
Noboru HIROSE, Hiroshi MATSUO, Masahiro HIRANO, Naohiro USUKI, Hitoshi MARUYAMA, Naotake HASHIMOTO. (2011) A survey of Daily Activity Characteristics Affecting the Exercise Habits of Type 2 Diabetes Mellitus Patients. Rigakuryoho Kagaku 26:1, 143-147
CrossRef505
Erik Øfjord, Arne Skag, Steinar Helberg, Dagfinn Aarskog, Knut Risberg, Trine Jacobsen, Samuel Nasrala, Sjur Bakken, Unni Syversen, Trond Jenssen. (2011) Medikamentell forebygging ved prediabetes - ingen hensikt?. Tidsskrift for Den norske legeforening 131:15, 1418-1419
CrossRef506
Jackie L. Boucher, Alison Evert, Anne Daly, Karmeen Kulkarni, Jo-Anne Rizzotto, Kathryn Burton, Beverly G. Bradshaw. (2011) American Dietetic Association Revised Standards of Practice and Standards of Professional Performance for Registered Dietitians (Generalist, Specialty, and Advanced) in Diabetes Care. Journal of the American Dietetic Association 111:1, 156-166.e27
CrossRef507
ShaRhonda J. Love, Christine E. Sheffer, Zoran Bursac, T. Elaine Prewitt, Rebecca A. Krukowski, Delia Smith West. (2011) Offer of a Weight Management Program to Overweight and Obese Weight-Concerned Smokers Improves Tobacco Dependence Treatment Outcomes. The American Journal on Addictions 20:1, 1-8
CrossRef508
S. B. Myrie, P. J. H. Jones. 2011. Functional foods and obesity. , 234-260.
CrossRef509
Kesha Baptiste-Roberts, Payal Ghosh, Wanda K. Nicholson. (2011) Pregravid Physical Activity, Dietary Intake, and Glucose Intolerance During Pregnancy. Journal of Women s Health110927132724000
CrossRef510
Melinda Neve, Philip J Morgan, Clare E Collins. (2011) Weight Change in a Commercial Web-Based Weight Loss Program and its Association With Website Use: Cohort Study. Journal of Medical Internet Research 13:4,
CrossRef511
Lorenzo Iughetti, Mariachiara China, Rossella Berri, Barbara Predieri. (2011) Pharmacological Treatment of Obesity in Children and Adolescents: Present and Future. Journal of Obesity 2011, 1-13
CrossRef512
Ji Hun Choi, Won-Young Lee. (2011) What Is the Optimal Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients?: The Practical Evidence of Antidiabetic Monotherapy Study. Diabetes & Metabolism Journal 35:1, 23
CrossRef513
Capri G. Foy, Cora E. Lewis, Kristen G. Hairston, Gary D. Miller, Wei Lang, John M. Jakicic, W. Jack Rejeski, Paul M. Ribisl, Michael P. Walkup, Lynne E. Wagenknecht. (2011) Intensive Lifestyle Intervention Improves Physical Function Among Obese Adults With Knee Pain: Findings From the Look AHEAD Trial. Obesity 19:1, 83-93
CrossRef514
Yoshio Nakata, Masafumi Okada, Koichi Hashimoto, Yoshinori Harada, Hirohito Sone, Kiyoji Tanaka. (2011) Comparison of Education-Only versus Group-Based Intervention in Promoting Weight Loss: A Randomised Controlled Trial. Obesity Facts 4:3, 222-228
CrossRef515
Kwok Leung Ong, Annette W.K. Tso, Raymond Y.H. Leung, Stacey S. Cherny, Pak Chung Sham, Tai Hing Lam, Bernard M.Y. Cheung, Karen S.L. Lam. (2011) A genetic variant in the gene encoding adrenomedullin predicts the development of dysglycemia over 6.4years in Chinese. Clinica Chimica Acta 412:3-4, 353-357
CrossRef516
Lisa M Younk, Maia Mikeladze, Donna Tate, Stephen N Davis. (2011) Exercise-related hypoglycemia in diabetes mellitus. Expert Review of Endocrinology & Metabolism 6:1, 93-108
CrossRef517
Horng-Rong Chang, Shun-Fa Yang, Jen-Pi Tsai, Ming-Chia Hsieh, Sheng-Wen Wu, Hui-Ching Tsai, Tung-Wei Hung, Jun-Huang Huang, Jong-Da Lian. (2011) Plasminogen activator inhibitor-1 5G/5G genotype is a protecting factor preventing posttransplant diabetes mellitus. Clinica Chimica Acta 412:3-4, 322-326
CrossRef518
Caroline S. Blackwell, Kara A. Foster, Scott Isom, Jeffrey A. Katula, Mara Z. Vitolins, Erica L. Rosenberger, David C. Goff. (2011) Healthy Living Partnerships to Prevent Diabetes: Recruitment and baseline characteristics. Contemporary Clinical Trials 32:1, 40-49
CrossRef519
Soo Lim, Jean-Pierre Despres, Kwang Kon Koh. (2011) Prevention of Atherosclerosis in Overweight/Obese Patients. Circulation Journal 75:5, 1019-1027
CrossRef520
Joseph M. Pappachan, Elias C. Chacko, Ganesan Arunagirinathan, Rajagopalan Sriraman. (2011) Management of Hypertension and Diabetes in Obesity: Non-Pharmacological Measures. International Journal of Hypertension 2011, 1-6
CrossRef521
Ather Ali, Yingying Ma, Jesse Reynolds, John Pierce Wise, Silvio E. Inzucchi, David L. Katz. (2011) Chromium Effects on Glucose Tolerance and Insulin Sensitivity in Persons at Risk for Diabetes Mellitus. Endocrine Practice 17:1, 16-25
CrossRef522
Takuya Tamura, Kazuyuki Kida, Takako Seki, Futoshi Suetsuna, Nobuhiko Kasai. (2011) Study of the Relationship between Exercise Therapy and Diet Therapy in Type 2 Diabetes Mellitus Patients. Journal of Physical Therapy Science 23:3, 485-488
CrossRef523
Eun-Jung Rhee, Ji-Hun Choi, Seung-Hyun Yoo, Ji-Cheol Bae, Won-Jun Kim, Eun-Suk Choi, Se Eun Park, Cheol-Young Park, Seok Won Park, Ki-Won Oh, Sung-Woo Park, Sun-Woo Kim, Won-Young Lee. (2011) The Association of Unintentional Changes in Weight, Body Composition, and Homeostasis Model Assessment Index with Glycemic Progression in Non-Diabetic Healthy Subjects. Diabetes & Metabolism Journal 35:2, 138
CrossRef524
Michael K. Baker, Kylie Simpson, Bradley Lloyd, Adrian E. Bauman, Maria A. Fiatarone Singh. (2011) Behavioral strategies in diabetes prevention programs: A systematic review of randomized controlled trials. Diabetes Research and Clinical Practice 91:1, 1-12
CrossRef525
Marie-Claude Battista, Marie-France Hivert, Karine Duval, Jean-Patrice Baillargeon. (2011) Intergenerational Cycle of Obesity and Diabetes: How Can We Reduce the Burdens of These Conditions on the Health of Future Generations?. Experimental Diabetes Research 2011, 1-19
CrossRef526
Sang Youl Rhee, Jeong-Taek Woo. (2011) The Prediabetic Period: Review of Clinical Aspects. Diabetes & Metabolism Journal 35:2, 107
CrossRef527
Kathleen M McTigue, Rachel Hess. (2011) What role can the internet play in preventing diabetes?. Diabetes Management 1:1, 9-12
CrossRef528
Ebenezer A. Nyenwe, Terri W. Jerkins, Guillermo E. Umpierrez, Abbas E. Kitabchi. (2011) Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 60:1, 1-23
CrossRef529
Daniela Geba, Thomas A. Pearson. (2011) Identification of Those at Risk for Diabetes Mellitus. American Journal of Preventive Medicine 40:1, 101-103
CrossRef530
Melissa A. Kalarchian, Michele D. Levine, Mary L. Klem, Lora E. Burke, Julia N. Soulakova, Marsha D. Marcus. (2011) Impact of Addressing Reasons for Weight Loss on Behavioral Weight-Control Outcome. American Journal of Preventive Medicine 40:1, 18-24
CrossRef531
Ronald T. Ackermann, Yiling J. Cheng, David F. Williamson, Edward W. Gregg. (2011) Identifying Adults at High Risk for Diabetes and Cardiovascular Disease Using Hemoglobin A1c. American Journal of Preventive Medicine 40:1, 11-17
CrossRef532
Mohammad Badran, Ismail Laher. (2011) Obesity in Arabic-Speaking Countries. Journal of Obesity 2011, 1-9
CrossRef533
B. A. Ormond, B. C. Spillman, T. A. Waidmann, K. J. Caswell, B. Tereshchenko. (2011) Potential National and State Medical Care Savings From Primary Disease Prevention. American Journal of Public Health 101:1, 157-164
CrossRef534
L. Schwingshackl, B. Strasser, G. Hoffmann. (2011) Effects of Monounsaturated Fatty Acids on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis. Annals of Nutrition and Metabolism 59:2-4, 176-186
CrossRef535
C. Ciangura, J.-M. Oppert. 2011. Activité physique et nutrition. , 79-86.
CrossRef536
J.-F. Blickle. 2011. Diabète. , 183-200.
CrossRef537
Sara D. Garduño-Diaz, Santosh Khokhar. (2011) Prevalence, risk factors and complications associated with type 2 diabetes in migrant South Asians. Diabetes/Metabolism Research and Reviewsn/a-n/a
CrossRef538
Mariko WATANABE, Kazue YAMAOKA, Toshiro TANGO. (2011) Dietary Assessment and Effectiveness of Dietary Education Based on Randomized Controlled Trial. Kodo Keiryogaku (The Japanese Journal of Behaviormetrics) 38:2, 107-116
CrossRef539
Anastassios G. Pittas, Bess Dawson-Hughes. 2011. The Role of Vitamin D in Type 2 Diabetes and Hypertension. , 1907-1930.
CrossRef540
Anujka Selea, Mirjana Sumarac-Dumanovic, Milica Pesic, Dusica Suluburic, Danica Stamenkovic-Pejkovic, Goran Cvijovic, Dragan Micic. (2011) The effects of education with printed material on glycemic control in patients with diabetes type 2 treated with different therapeutic regimens. Vojnosanitetski pregled 68:8, 676-683
CrossRef541
Alexandra Schmid. (2010) The Role of Meat Fat in the Human Diet. Critical Reviews in Food Science and Nutrition 51:1, 50-66
CrossRef542
C. Andersson, M. L. Norgaard, P. R. Hansen, E. L. Fosbol, M. Schmiegelow, P. Weeke, J. B. Olesen, J. Raunso, C. H. Jorgensen, A. Vaag, L. Kober, C. Torp-Pedersen, G. H. Gislason. (2010) Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study. European Journal of Heart Failure 12:12, 1333-1338
CrossRef543
Anna L. Marsland, Jeanne M. McCaffery, Matthew F. Muldoon, Stephen B. Manuck. (2010) Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism 59:12, 1801-1808
CrossRef544
Valmi D. Sousa, Nancy A. Ryan-Wenger, Martha Driessnack, Ala'a F. Jaber. (2010) Factorial structure of the perception of risk factors for type 2 diabetes scale: exploratory and confirmatory factor analyses. Journal of Evaluation in Clinical Practice 16:6, 1096-1102
CrossRef545
Kerstin Kempf, Stephan Martin. (2010) Kaffee und Diabetes. Medizinische Klinik 105:12, 910-915
CrossRef546
Ruben Schouten, Dorothee C. Wiryasaputra, Francois M. H. Dielen, Wim G. Gemert, Jan Willem M. Greve. (2010) Long-Term Results of Bariatric Restrictive Procedures: A Prospective Study. Obesity Surgery 20:12, 1617-1626
CrossRef547
Marian L. Fitzgibbon, Melinda R. Stolley, Linda Schiffer, Lisa K. Sharp, Vicky Singh, Alan Dyer. (2010) Obesity Reduction Black Intervention Trial (ORBIT): 18-Month Results. Obesity 18:12, 2317-2325
CrossRef548
José A. Luchsinger. (2010) Diabetes, related conditions, and dementia. Journal of the Neurological Sciences 299:1-2, 35-38
CrossRef549
Lysanne Pelletier, Jean-Patrice Baillargeon. (2010) Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice. Fertility and Sterility 94:7, 2665-2669
CrossRef550
Robin Whittemore, Gail D’Eramo Melkus, Nanette Alexander, Stacie Zibel, Elizabeth Visone, Ulrike Muench, Elizabeth Magenheimer, Stephanie Wilborne. (2010) Implementation of a lifestyle program in primary care by nurse practitioners. Journal of the American Academy of Nurse Practitioners 22:12, 684-693
CrossRef551
Alan Rozanski, Heidi Gransar, Sean W. Hayes, John D. Friedman, Rory Hachamovitch, Daniel S. Berman. (2010) Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT. Journal of Nuclear Cardiology 17:6, 999-1008
CrossRef552
Massimo Volpe, Claudio Borghi, Paolo Cavallo Perin, Massimo Chiariello, Enzo Manzato, Roberto Miccoli, Maria G. Modena, Gabriele Riccardi, Giorgio Sesti, Antonio Tiengo, Bruno Trimarco, Diego Vanuzzo, Paolo Verdecchia, Augusto Zaninelli, Stefano Del Prato. (2010) 2009 SIPREC Consensus Document – Executive Summary. High Blood Pressure & Cardiovascular Prevention 17:4, 237-247
CrossRef553
K. Waller, J. Kaprio, M. Lehtovirta, K. Silventoinen, M. Koskenvuo, U. M. Kujala. (2010) Leisure-time physical activity and type 2 diabetes during a 28 year follow-up in twins. Diabetologia 53:12, 2531-2537
CrossRef554
Ross L. Prentice. (2010) Chronic Disease Prevention Research Methods and Their Reliability, With Illustrations From the Women’s Health Initiative. Journal of the American Statistical Association 105:492, 1431-1443
CrossRef555
Koldo Santos-Rey, Patricia Fernández-Riejos, Joaquín Mateo, Victor Sánchez-Margalet, Raimundo Goberna. (2010) Glycated hemoglobin vs. the oral glucose tolerance test for the exclusion of impaired glucose tolerance in high-risk individuals. Clinical Chemistry and Laboratory Medicine 48:12, 1719-1722
CrossRef556
O. Verier-Mine. (2010) Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review. Diabetes & Metabolism 36:6, 595-616
CrossRef557
Philip Greenland, Joseph S. Alpert, George A. Beller, Emelia J. Benjamin, Matthew J. Budoff, Zahi A. Fayad, Elyse Foster, Mark A. Hlatky, John McB. Hodgson, Frederick G. Kushner, Michael S. Lauer, Leslee J. Shaw, Sidney C. Smith, Allen J. Taylor, William S. Weintraub, Nanette K. Wenger. (2010) 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary. Journal of the American College of Cardiology 56:25, 2182-2199
CrossRef558
A Menter, CEM Griffiths, PW Tebbey, EJ Horn, W Sterry, . (2010) Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. Journal of the European Academy of Dermatology and Venereology 24:12, 1371-1377
CrossRef559
R. A. Sulaiman, M. H. Labib. (2010) Is using WHO criteria for impaired fasting glycaemia appropriate as an indication for OGTT in patients at high risk of developing diabetes?. International Journal of Clinical Practice 64:13, 1793-1795
CrossRef560
M. Kaye Kramer, Andrea M. Kriska, Elizabeth M. Venditti, Linda N. Semler, Rachel G. Miller, Teresa McDonald, Linda M. Siminerio, Trevor J. Orchard. (2010) A novel approach to diabetes prevention: Evaluation of the Group Lifestyle Balance program delivered via DVD. Diabetes Research and Clinical Practice 90:3, e60-e63
CrossRef561
Philip Greenland, Joseph S. Alpert, George A. Beller, Emelia J. Benjamin, Matthew J. Budoff, Zahi A. Fayad, Elyse Foster, Mark A. Hlatky, John McB. Hodgson, Frederick G. Kushner, Michael S. Lauer, Leslee J. Shaw, Sidney C. Smith, Allen J. Taylor, William S. Weintraub, Nanette K. Wenger. (2010) 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. Journal of the American College of Cardiology 56:25, e50-e103
CrossRef562
Mohammadreza Bozorgmanesh, Farzad Hadaegh, Fereidoun Azizi. (2010) Transportability of the updated diabetes prediction model from Atherosclerosis Risk in Communities Study to a Middle Eastern adult population: community-based cohort study. Acta Diabetologica
CrossRef563
Martijn CGJ Brouwers, Jacqueline de Graaf, Marleen MJ van Greevenbroek, Nicolaas Schaper, Coen DA Stehouwer, Anton FH Stalenhoef. (2010) Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus. Current Opinion in Lipidology 21:6, 530-538
CrossRef564
Gerd Assmann, Rafael Carmena, Jean Davignon. (2010) Consommation de pommes de terre et risques de maladie cardiovasculaire. Cahiers de Nutrition et de Diététique 45:6, S68-S73
CrossRef565
&NA;. (2010) Exercise and Type 2 Diabetes. Medicine & Science in Sports & Exercise 42:12, 2282-2303
CrossRef566
R. R. Wing, M. M. Crane, J. G. Thomas, R. Kumar, B. Weinberg. (2010) Improving Weight Loss Outcomes of Community Interventions by Incorporating Behavioral Strategies. American Journal of Public Health 100:12, 2513-2519
CrossRef567
K. Wikstrom, J. Lindstrom, J. Tuomilehto, T. E. Saaristo, E. Korpi-Hyovalti, H. Oksa, M. Vanhala, L. Niskanen, S. Keinanen-Kiukaanniemi, M. Uusitupa, M. Peltonen. (2010) Socio-economic differences in dysglycemia and lifestyle-related risk factors in the Finnish middle-aged population. The European Journal of Public Health
CrossRef568
G. Osei-Assibey, I. Kyrou, Y. Adi, S. Kumar, K. Matyka. (2010) Dietary and lifestyle interventions for weight management in adults from minority ethnic/non-White groups: a systematic review. Obesity Reviews 11:11, 769-776
CrossRef569
Nicole R. Pinelli, William H. Herman, Morton B. Brown, Linda A. Jaber. (2010) Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab-Americans. Diabetes Research and Clinical Practice 90:2, e27-e29
CrossRef570
G.A. Kennett, P.G. Clifton. (2010) New approaches to the pharmacological treatment of obesity: Can they break through the efficacy barrier?. Pharmacology Biochemistry and Behavior 97:1, 63-83
CrossRef571
Liana K. Billings, Jose C. Florez. (2010) The genetics of type 2 diabetes: what have we learned from GWAS?. Annals of the New York Academy of Sciences 1212:1, 59-77
CrossRef572
E. J. Boyko, H. C. Gerstein, V. Mohan, S. Yusuf, P. Sheridan, S. Anand, J. E. Shaw, . (2010) Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetic Medicine 27:11, 1226-1232
CrossRef573
P. W. Franks, J. A. Nettleton. (2010) Invited Commentary: Gene x Lifestyle Interactions and Complex Disease Traits--Inferring Cause and Effect From Observational Data, Sine Qua Non. American Journal of Epidemiology 172:9, 992-997
CrossRef574
Kyoko Nomura, Mutsuhiro Nakao, Shinobu Tsurugano, Takeaki Takeuchi, Mariko Inoue, Yasuko Shinozaki, Eiji Yano. (2010) Job stress and healthy behavior among male Japanese office workers. American Journal of Industrial Medicine 53:11, 1128-1134
CrossRef575
Claudia Ruth Pischke, Steven Frenda, Dean Ornish, Gerdi Weidner. (2010) Lifestyle changes are related to reductions in depression in persons with elevated coronary risk factors. Psychology & Health 25:9, 1077-1100
CrossRef576
Annalouise O'Connor, James Gibney, Helen M. Roche. (2010) Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet. Proceedings of the Nutrition Society 69:04, 628-635
CrossRef577
Shih-Chueh Chen, Kwo-Chang Ueng, Shu-Hsin Lee, Kuo-Ting Sun, Meng-Chih Lee. (2010) Effect of T'ai Chi Exercise on Biochemical Profiles and Oxidative Stress Indicators in Obese Patients with Type 2 Diabetes. The Journal of Alternative and Complementary Medicine 16:11, 1153-1159
CrossRef578
C. Sanz, J.-F. Gautier, H. Hanaire. (2010) Physical exercise for the prevention and treatment of type 2 diabetes. Diabetes & Metabolism 36:5, 346-351
CrossRef579
Westly A. Bailey, Eric C. Westman, Megan L. Marquart, John R. Guyton. (2010) Low glycemic diet for weight loss in hypertriglyceridemic patients attending a lipid clinic. Journal of Clinical Lipidology 4:6, 508-514
CrossRef580
A. Neumann, P.E.H. Schwarz. (2010) Primäre Prävention des Typ-2-Diabetes. Prävention und Gesundheitsförderung 5:4, 319-325
CrossRef581
Darios Getahun, Michael J. Fassett, Steven J. Jacobsen. (2010) Gestational diabetes: risk of recurrence in subsequent pregnancies. American Journal of Obstetrics and Gynecology 203:5, 467.e1-467.e6
CrossRef582
N Racine, P Hamet, J S Sampalis, N Longo, N Bastien. (2010) A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome. Journal of Human Hypertension 24:11, 739-748
CrossRef583
Tahir Haque, Sujan Bhaheetharan, Bobby V Khan. (2010) Is there a role for pleiotropic effects of atorvastatin and fenofibrate in the metabolic syndrome and prediabetes?. Expert Review of Endocrinology & Metabolism 5:6, 835-837
CrossRef584
J L Kraschnewski, J Boan, J Esposito, N E Sherwood, E B Lehman, D K Kephart, C N Sciamanna. (2010) Long-term weight loss maintenance in the United States. International Journal of Obesity 34:11, 1644-1654
CrossRef585
Weilin Kong, Marie-France Langlois, Carole Kamga-Ngandé, Claudia Gagnon, Christine Brown, Jean-Patrice Baillargeon. (2010) Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes
. Diabetes Research and Clinical Practice 90:2, 147-153
CrossRef586
Q. Wan, F. Wang, F. Wang, Q. Guan, Y. Liu, C. Wang, L. Feng, G. Gao, L. Gao, J. Zhao. (2010) Regression to normoglycaemia by fenofibrate in pre-diabetic subjects complicated with hypertriglyceridaemia: a prospective randomized controlled trial. Diabetic Medicine 27:11, 1312-1317
CrossRef587
C. Hearnshaw, K. Matyka. (2010) Managing childhood obesity: when lifestyle change is not enough. Diabetes, Obesity and Metabolism 12:11, 947-957
CrossRef588
Bernt Lindahl, Hans Stenlund, Margareta Norberg. (2010) Increasing glucose concentrations and prevalence of diabetes mellitus in northern Sweden, 1990–2007. Global Health Action 3:0,
CrossRef589
Wei Tang, Huazong Zeng, Yongquan Shi, Zhimin Liu, Jinwei Cheng, Juan Xu, Wei Tang. 2010. Corticosteroids, somatostatin analogous or orbital radiotherapy for thyroid-associated ophthalmopathy. .
CrossRef590
Jim I. Mann. (2010) Evidence-based nutrition: Does it differ from evidence-based medicine?. Annals of Medicine 42:7, 475-486
CrossRef591
W. Rathmann, B. Kowall, M. Heier, C. Herder, R. Holle, B. Thorand, K. Strassburger, A. Peters, H.-E. Wichmann, G. Giani, C. Meisinger. (2010) Prediction models for incident Type 2 diabetes mellitus
in the older population: KORA S4/F4 cohort study. Diabetic Medicine 27:10, 1116-1123
CrossRef592
Leigh Perreault, Chiara Dalla Man, Devon M. Hunerdosse, Claudio Cobelli, Bryan C. Bergman. (2010) Incretin action maintains insulin secretion, but not hepatic insulin action, in people with impaired fasting glucose
CrossRef593
K. Esefeld, M. Halle. (2010) Körperliches Training bei metabolischem Syndrom und Typ-2-Diabetes mellitus. Gefässchirurgie 15:6, 480-484
CrossRef594
Maureen Sanderson, Gerson Peltz, Adriana Perez, Matthew Johnson, Sally W. Vernon, Maria E. Fernandez, Mary K. Fadden. (2010) Diabetes, physical activity and breast cancer among Hispanic women. Cancer Epidemiology 34:5, 556-561
CrossRef595
Roberto Testa, Anna Rita Bonfigli, Maurizio Marra, Ivano Testa. (2010) In the Light of the Metabolic Memory Theory, Should Not All Aged People with Dysglycemia Be Treated?. Rejuvenation Research 13:5, 599-605
CrossRef596
Mary L. Blackburn, Barbara Gillogy, Peggy Hauselt. (2010) Research is needed to assess the unique nutrition and wellness needs of aging Californians. California Agriculture 64:4, 167-173
CrossRef597
Kristen Farrell, Michael H. Antoni. (2010) Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertility and Sterility 94:5, 1565-1574
CrossRef598
Mary Weber. (2010) The Importance of Exercise for Individuals with Chronic Mental Illness. Journal of Psychosocial Nursing and Mental Health Services 48:10, 35-40
CrossRef599
Alice S Ryan. (2010) Exercise in aging: its important role in mortality, obesity and insulin resistance. Aging Health 6:5, 551-563
CrossRef600
R. Fischer-Betz, M. Halle, M. Schneider. (2010) Entzündungsbedingte kardiovaskuläre Morbidität. Zeitschrift für Rheumatologie 69:8, 680-688
CrossRef601
Eric S. Nylen, Peter Kokkinos, Jonathan Myers, Charles Faselis. (2010) Prognostic Effect of Exercise Capacity on Mortality in Older Adults with Diabetes Mellitus. Journal of the American Geriatrics Society 58:10, 1850-1854
CrossRef602
C P Campbell, A T Barnett, M S Boyne, S Soares-Wynter, C Osmond, R A Fraser, A V Badaloo, C Taylor-Bryan, T E Forrester. (2010) Predictors of physical activity energy expenditure in Afro-Caribbean children. European Journal of Clinical Nutrition 64:10, 1093-1100
CrossRef603
Ji Yeon Kang, Sang Woon Cho, Sook Hee Sung, Yoo Kyoung Park, Yun Mi Paek, Tae In Choi. (2010) Effect of a continuous diabetes lifestyle intervention program on male workers in Korea. Diabetes Research and Clinical Practice 90:1, 26-33
CrossRef604
Barbara Strasser, W. Schobersberger. (2010) Training in der Prävention und Therapie des Metabolischen Syndroms: State of the Art Review. Sport- und Präventivmedizin 40:3, 12-16
CrossRef605
George A Jelinek, Tracey J Weiland, Gaye Moore, Grace Tan, Marg Maslin, Kath Bowman, Glenn Ward, Kerin O'Dea. (2010) Screening for type 2 diabetes with random finger-prick glucose and bedside HbA1c in an Australian emergency department. Emergency Medicine Australasia 22:5, 427-434
CrossRef606
, B. Fontaine-Bisson, F. Renström, O. Rolandsson, F. Payne, G. Hallmans, I. Barroso, P. W. Franks. (2010) Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population. Diabetologia 53:10, 2155-2162
CrossRef607
E Youl, G Bardy, R Magous, G Cros, F Sejalon, A Virsolvy, S Richard, JF Quignard, R Gross, P Petit, D Bataille, C Oiry. (2010) Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. British Journal of Pharmacology 161:4, 799-814
CrossRef608
Andrew A. Bremer. (2010) Polycystic Ovary Syndrome in the Pediatric Population. Metabolic Syndrome and Related Disorders 8:5, 375-394
CrossRef609
Shamjeet Singh, Sanjiv Dhingra, Dan D. Ramdath, Sudesh Vasdev, Vicki Gill, Pawan K. Singal. (2010) Risk Factors Preceding Type 2 Diabetes and Cardiomyopathy. Journal of Cardiovascular Translational Research 3:5, 580-596
CrossRef610
Samiul A. Mostafa, Kamlesh Khunti, Balasubramanian Thiagarajan Srinivasan, David Webb, Laura J. Gray, Melanie J. Davies. (2010) The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Research and Clinical Practice 90:1, 100-108
CrossRef611
A. N. Brewer-Lowry, T. A. Arcury, R. A. Bell, S. A. Quandt. (2010) Differentiating Approaches to Diabetes Self-Management of Multi-ethnic Rural Older Adults at the Extremes of Glycemic Control. The Gerontologist 50:5, 657-667
CrossRef612
Gregory A. Nichols, Edward J. Moler. (2010) Diabetes incidence for all possible combinations of metabolic syndrome components. Diabetes Research and Clinical Practice 90:1, 115-121
CrossRef613
Yong In, Chae-Gwan Kong, Jung-Man Kim, Nam-Yong Choi, Yoo-Joon Sur. (2010) Effect of Total Knee Arthroplasty on Metabolic Syndrome. The Journal of Arthroplasty 25:7, 1110-1114
CrossRef614
Stefan Mustata, Sharon Groeneveld, Warren Davidson, Gordon Ford, Kristal Kiland, Braden Manns. (2010) Effects of exercise training on physical impairment, arterial stiffness and health-related quality of life in patients with chronic kidney disease: a pilot study. International Urology and Nephrology
CrossRef615
Marte Karoline Råberg Kjøllesdal, Victoria Telle Hjellset, Benedikte Bjørge, Gerd Holmboe-Ottesen, Margareta Wandel. (2010) Food perceptions in terms of health among Norwegian-Pakistani women participating in a culturally adapted intervention. International Journal of Public Health
CrossRef616
Jonathan Krakoff, Jeanne M. Clark, Jill P. Crandall, Charlton Wilson, Mark E. Molitch, Frederick L. Brancati, Sharon L. Edelstein, William C. Knowler. (2010) Effects of Metformin and Weight Loss on Serum Alanine Aminotransferase Activity in the Diabetes Prevention Program. Obesity 18:9, 1762-1767
CrossRef617
W. J. Rejeski, A. P. Marsh, E. Chmelo, J. J. Rejeski. (2010) Obesity, intentional weight loss and physical disability in older adults. Obesity Reviews 11:9, 671-685
CrossRef618
Ruth Freeman, Rena Pollack, Ella Rosenbloom. (2010) Assessing Impaired Glucose Tolerance and Insulin Resistance in Polycystic Ovarian Syndrome with a Muffin Test: An Alternative to the Glucose Tolerance Test. Endocrine Practice 16:5, 810-817
CrossRef619
Renata Damião, Daniela Saes Sartorelli, Amélia Hirai, Flávia Massimino, Juliana Poletto, Marselle Rodrigues Bevilacqua, Rita Chaim, Vera Lúcia Morais Antonio de Salvo, Leiko Asakura, Sandra Roberta Gouveia Ferreira, Solange Andreoni, Suely Godoy Agostinho Gimeno. (2010) Nutritional intervention programme among a Japanese-Brazilian community: procedures and results according to gender. Public Health Nutrition 13:09, 1453-1461
CrossRef620
Stephen A. Brietzke. (2010) A Personalized Approach to Metabolic Aspects of Obesity. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:5, 499-510
CrossRef621
Ivana Lukacova-Zib, Geetha Gopalakrishnan. (2010) Therapeutic Options for the Prevention of Type 2 Diabetes Mellitus in the Metabolic Syndrome. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:5, 524-532
CrossRef622
Amulya T. Siram, Robert Yanagisawa, Maria Skamagas. (2010) Weight Management in Type 2 Diabetes Mellitus. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:5, 533-548
CrossRef623
Deborah S. Porterfield, Laurie Hinnant, David M. Stevens, Ernest Moy. (2010) The Diabetes Primary Prevention Initiative Interventions Focus Area. American Journal of Preventive Medicine 39:3, 235-242
CrossRef624
Konstantinos Lois, Georgios Valsamakis, Georgio Mastorakos, Sudhesh Kumar. (2010) The impact of insulin resistance on woman's health and potential treatment options. Annals of the New York Academy of Sciences 1205:1, 156-165
CrossRef625
E. Cosson, E. Hamo-Tchatchouang, I. Banu, M.-T. Nguyen, S. Chiheb, H. Ba, P. Valensi. (2010) A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients. Diabetes & Metabolism 36:4, 312-318
CrossRef626
Rena R. Wing, Delia Smith West, Deborah Grady, Jennifer M. Creasman, Holly E. Richter, Deborah Myers, Kathryn L. Burgio, Frank Franklin, Amy A. Gorin, Eric Vittinghoff, Judith Macer, John W. Kusek, Leslee L. Subak. (2010) Effect of Weight Loss on Urinary Incontinence in Overweight and Obese Women: Results at 12 and 18 Months. The Journal of Urology 184:3, 1005-1010
CrossRef627
Zhong Xin, Jing Yuan, Lin Hua, Ya-Hong Ma, Lei Zhao, Yi Lu, Jin-Kui Yang. (2010) A simple tool detected diabetes and prediabetes in rural Chinese. Journal of Clinical Epidemiology 63:9, 1030-1035
CrossRef628
Axel Pressler, Uta Knebel, Sebastian Esch, Dominik Kölbl, Katrin Esefeld, Johannes Scherr, Bernhard Haller, Arno Schmidt-Trucksäss, Helmut Krcmar, Martin Halle, Jan Marco Leimeister. (2010) An internet-delivered exercise intervention for workplace health promotion in overweight sedentary employees: A randomized trial. Preventive Medicine 51:3-4, 234-239
CrossRef629
T. Yates, M.J. Davies, L.J. Gray, D. Webb, J. Henson, J.M.R. Gill, N. Sattar, K. Khunti. (2010) Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes. Preventive Medicine 51:3-4, 290-294
CrossRef630
A. Gastaldelli, G. Basta. (2010) Ectopic fat and cardiovascular disease: What is the link?. Nutrition, Metabolism and Cardiovascular Diseases 20:7, 481-490
CrossRef631
Alejandra DURÁN, Patricia MARTÍN, Isabelle RUNKLE, Natalia PÉREZ, Rosario ABAD, Mercedes FERNÁNDEZ, Laura DEL VALLE, Maria Fuencisla SANZ, Alfonso Luis CALLE-PASCUAL. (2010) Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. Journal of Diabetes 2:3, 203-211
CrossRef632
Kevin Korenblat. 2010. Nonalcoholic Fatty Liver Disease. , 301-314.
CrossRef633
A. V. Patel, L. Bernstein, A. Deka, H. S. Feigelson, P. T. Campbell, S. M. Gapstur, G. A. Colditz, M. J. Thun. (2010) Leisure Time Spent Sitting in Relation to Total Mortality in a Prospective Cohort of US Adults. American Journal of Epidemiology 172:4, 419-429
CrossRef634
Marion L. Vetter, Lucy F. Faulconbridge, Victoria L. Webb, Thomas A. Wadden. (2010) Behavioral and pharmacologic therapies for obesity. Nature Reviews Endocrinology
CrossRef635
Cyril W. C. Kendall, Andrea R. Josse, Amin Esfahani, David J. A. Jenkins. (2010) Nuts, metabolic syndrome and diabetes. British Journal of Nutrition 104:04, 465-473
CrossRef636
K. Z. Walker, K. O’Dea, M. Gomez, S. Girgis, R. Colagiuri. (2010) Diet and exercise in the prevention of diabetes. Journal of Human Nutrition and Dietetics 23:4, 344-352
CrossRef637
M. Uusitupa, J. Lindström, J. Tuomilehto. (2010) Prevention strategies for type 2 diabetes should be based on evidence-based medical nutrition data. Diabetologia 53:8, 1809-1810
CrossRef638
M. K. Morrison, J. M. Lowe, C. E. Collins. (2010) Perceived risk of Type 2 diabetes in Australian women with a recent history of gestational diabetes mellitus. Diabetic Medicine 27:8, 882-886
CrossRef639
L. J. Gray, N. A. Taub, K. Khunti, E. Gardiner, S. Hiles, D. R. Webb, B. T. Srinivasan, M. J. Davies. (2010) The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabetic Medicine 27:8, 887-895
CrossRef640
Ike S. Okosun, John M. Boltri, Rodney Lyn, Monique Davis-Smith. (2010) Continuous Metabolic Syndrome Risk Score, Body Mass Index Percentile, and Leisure Time Physical Activity in American Children. The Journal of Clinical Hypertension 12:8, 636-644
CrossRef641
Rena R. Wing, Jennifer M. Creasman, Delia Smith West, Holly E. Richter, Deborah Myers, Kathryn L. Burgio, Frank Franklin, Amy A. Gorin, Eric Vittinghoff, Judith Macer, John W. Kusek, Leslee L. Subak. (2010) Improving Urinary Incontinence in Overweight and Obese Women Through Modest Weight Loss. Obstetrics & Gynecology 116:2, Part 1, 284-292
CrossRef642
Sripal Bangalore, Franz H. Messerli. (2010) Valsartan Inefficacy or Ill-Effects of Concomitant Medications!. The American Journal of Cardiology 106:4, 602-603
CrossRef643
Leigh Perreault, Bryan C. Bergman, Devon M. Hunerdosse, Mary C. Playdon, Robert H. Eckel. (2010) Inflexibility in Intramuscular Triglyceride Fractional Synthesis Distinguishes Prediabetes From Obesity in Humans. Obesity 18:8, 1524-1531
CrossRef644
Abdallah Fazah, Christophe Jacob, Elie Moussa, Rawad El-Hage, Hala Youssef, Paul Delamarche. (2010) Activity, inactivity and quality of life among Lebanese adolescents. Pediatrics International 52:4, 573-578
CrossRef645
L. M. Delahanty. (2010) An expanded role for dietitians in maximising retention in nutrition and lifestyle intervention trials: implications for clinical practice. Journal of Human Nutrition and Dietetics 23:4, 336-343
CrossRef646
M. A. M. Jacobs-van der Bruggen, A. Spijkerman, P. H. M. van Baal, C. A. Baan, E. J. M. Feskens, H. S. J. Picavet, D. L. van der A, W. M. M. Verschuren. (2010) Weight Change and Incident Diabetes: Addressing an Unresolved Issue. American Journal of Epidemiology 172:3, 263-270
CrossRef647
Ramon Estruch. (2010) Anti-inflammatory effects of the Mediterranean diet: the experience of the PREDIMED study. Proceedings of the Nutrition Society 69:03, 333-340
CrossRef648
Raj S. Padwal, Arya M. Sharma. (2010) Prevention of cardiovascular disease: Obesity, diabetes and the metabolic syndrome. Canadian Journal of Cardiology 26, 18C-20C
CrossRef649
Yoshihiro Shimazaki, Yuko Egami, Takeshi Matsubara, George Koike, Sumio Akifusa, Sumie Jingu, Yoshihisa Yamashita. (2010) Relationship Between Obesity and Physical Fitness and Periodontitis. Journal of Periodontology 81:8, 1124-1131
CrossRef650
Jean Harvey-Berino, Delia West, Rebecca Krukowski, Elaine Prewitt, Alan VanBiervliet, Takamaru Ashikaga, Joan Skelly. (2010) Internet delivered behavioral obesity treatment. Preventive Medicine 51:2, 123-128
CrossRef651
Adam G. Tsai, Thomas A. Wadden, Marisa A. Rogers, Susan C. Day, Renee H. Moore, Buneka J. Islam. (2010) A Primary Care Intervention for Weight Loss: Results of a Randomized Controlled Pilot Study. Obesity 18:8, 1614-1618
CrossRef652
L. M. Delahanty. (2010) Research charting a course for evidence-based clinical dietetic practice in diabetes. Journal of Human Nutrition and Dietetics 23:4, 360-370
CrossRef653
Mohammadreza Bozorgmanesh, Farzad Hadaegh, Azadeh Zabetian, Fereidoun Azizi. (2010) San Antonio heart study diabetes prediction model applicable to a Middle Eastern population? Tehran glucose and lipid study. International Journal of Public Health 55:4, 315-323
CrossRef654
2010. Epidemiology and Aetiology of Type 2 Diabetes. , 44-52.
CrossRef655
2010. Public Health Aspects of Diabetes. , 16-21.
CrossRef656
Smith, Steven R., Weissman, Neil J., Anderson, Christen M., Sanchez, Matilde, Chuang, Emil, Stubbe, Scott, Bays, Harold, Shanahan, William R., the Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. (2010) Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management. New England Journal of Medicine 363:3, 245-256
Full Text657
Clifford J. Bailey, Andrew J. Krentz. 2010. Oral Antidiabetic Agents. , 452-477.
CrossRef658
Jane E. Yardley, Angela Alberga, Glen P. Kenny, Ronald J. Sigal. 2010. Lifestyle Issues: Exercise. , 358-379.
CrossRef659
Robert C. Peveler, Richard I. G. Holt. 2010. Psychiatric Disorders and Diabetes. , 940-956.
CrossRef660
Anne Dornhorst, Anita Banerjee. 2010. Diabetes in Pregnancy. , 888-921.
CrossRef661
Joseph A. Aloi, Anthony L. McCall. 2010. How to use Type 2 Diabetes Treatments in Clinical Practice: Combination Therapies. , 494-513.
CrossRef662
Ronald C. W. Ma, Peter C. Y. Tong. 2010. Epidemiology of Type 2 Diabetes. , 45-68.
CrossRef663
Kerstin Kempf, Johannes Kruse, Stephan Martin. (2010) ROSSO-in-praxi: A Self-Monitoring of Blood Glucose-Structured 12-Week Lifestyle Intervention Significantly Improves Glucometabolic Control of Patients with Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics 12:7, 547-553
CrossRef664
H. Sourij, C. H. Saely, F. Schmid, R. Zweiker, T. Marte, T. C. Wascher, H. Drexel. (2010) Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients. European Heart Journal 31:13, 1583-1590
CrossRef665
Nathan A. Johnson, Jacob George. (2010) Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 52:1, 370-380
CrossRef666
Nancy E. Sherwood, Robert W. Jeffery, Ericka M. Welsh, Jeff VanWormer, Ann Marie Hotop. (2010) The Drop It At Last Study: Six-Month Results of a Phone-Based Weight Loss Trial. American Journal of Health Promotion 24:6, 378-383
CrossRef667
G. Chodick, U. Elchalal, T. Sella, A. D. Heymann, A. Porath, E. Kokia, V. Shalev. (2010) The risk of overt diabetes mellitus among women with gestational diabetes: a population-based study. Diabetic Medicine 27:7, 779-785
CrossRef668
D. M. Mann, M. Woodward, P. Muntner. (2010) Preventing diabetes complications: are we too glucocentric?. International Journal of Clinical Practice 64:8, 1024-1027
CrossRef669
Bernard Zinman, Stewart B Harris, Jan Neuman, Hertzel C Gerstein, Ravi R Retnakaran, Janet Raboud, Ying Qi, Anthony JG Hanley. (2010) Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. The Lancet 376:9735, 103-111
CrossRef670
Yehuda Handelsman, Ronald B. Goldberg, W. Timothy Garvey, Vivian A. Fonseca, Julio Rosenstock, Michael R. Jones, Yu-Ling Lai, Xiaoping Jin, Soamnauth Misir, Sukumar Nagendran, Stacey L. Abby. (2010) Colesevelam Hydrochloride to Treat Hypercholesterolemia and Improve Glycemia in Prediabetes: A Randomized, Prospective Study. Endocrine Practice 16:4, 617-628
CrossRef671
Nicholas J. Wareham, Roman Pfister. (2010) Diabetes: Glycated hemoglobin is a marker of diabetes and CVD risk. Nature Reviews Cardiology 7:7, 367-368
CrossRef672
Thomas A Buchanan, Anny H Xiang. (2010) Preventing type 2 diabetes with low-dose combinations. The Lancet 376:9735, 72-74
CrossRef673
Sylvia Wassertheil-Smoller. (2010) Stroke in women. Nutrition, Metabolism and Cardiovascular Diseases 20:6, 419-425
CrossRef674
Kavitha Potluri, Susan Hou. (2010) Obesity in Kidney Transplant Recipients and Candidates. American Journal of Kidney Diseases 56:1, 143-156
CrossRef675
Lijun Peng, Jiyao Wang, Feng Li, Jiyao Wang. 2010. Weight reduction for non-alcoholic fatty liver disease. .
CrossRef676
Qingguo Lü, Lin -qiu Ke, Nanwei Tong, Li Cao, Taixiang Wu, Juying Zhang, Qingguo Lü. 2010. Metformin for people with impaired glucose tolerance or impaired fasting blood glucose. .
CrossRef677
Cláudio T. De Souza, Marisa J. S. Frederico, Gabrielle Da Luz, Dennys E. Cintra, Eduardo R. Ropelle, José R. Pauli, Lício A. Velloso. (2010) Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4α pathway in insulin resistant mice. The Journal of Physiology 588:12, 2239-2253
CrossRef678
Richard T. Oster, Kelli Ralph-Campbell, Tracy Connor, Mary Pick, Ellen L. Toth. (2010) What happens after community-based screening for diabetes in rural and Indigenous individuals?. Diabetes Research and Clinical Practice 88:3, e28-e31
CrossRef679
Edward A. Ruiz-Narváez, Lance Bare, Andre Arellano, Joseph Catanese, Hannia Campos. (2010) West African and Amerindian ancestry and risk of myocardial infarction and metabolic syndrome in the Central Valley population of Costa Rica. Human Genetics 127:6, 629-638
CrossRef680
Massimo Volpe, Claudio Borghi, Paolo Cavallo Perin, Massimo Chiariello, Enzo Manzato, Roberto Miccoli, Maria Grazia Modena, Gabriele Riccardi, Giorgio Sesti, Antonio Tiengo, Bruno Trimarco, Diego Vanuzzo, Paolo Verdecchia, Augusto Zaninelli, Stefano Del Prato. (2010) Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance. High Blood Pressure & Cardiovascular Prevention 17:2, 73-102
CrossRef681
Charles Elder, Cherri Gallison, Nangel M. Lindberg, Lynn DeBar, Kristine Funk, Cheryl Ritenbaugh, Victor J. Stevens. (2010) Randomized Trial of Tapas Acupressure Technique ® for Weight Loss Maintenance: Rationale and Study Design. The Journal of Alternative and Complementary Medicine 16:6, 683-690
CrossRef682
Lígia A Martini, Antonela S Catania, Sandra RG Ferreira. (2010) Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutrition Reviews 68:6, 341-354
CrossRef683
P. Vermunt, I. Milder, F. Wielaard, J. van Oers, G. Westert. (2010) An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study. Family Practice 27:3, 312-319
CrossRef684
Christoph Oberlinner, Andreas Zober, Peter P. Nawroth, Per M. Humpert, Michael Morcos. (2010) Alanine-aminotransferase levels predict impaired glucose tolerance in a worksite population. Acta Diabetologica 47:2, 161-165
CrossRef685
HELEN L PILMORE. (2010) Review: Metformin: Potential benefits and use in chronic kidney disease. Nephrology 15:4, 412-418
CrossRef686
G. P. Carnevale Schianca, E. Colli, S. Onolfo, R. Pedrazzoli, G. P. Fra, E. Bartoli. (2010) Individuation of different metabolic phenotypes in normal glucose tolerance test. Acta Diabetologica 47:2, 167-172
CrossRef687
Kelly J. Hunt, Sarah L. Logan, Deborah L. Conway, Jeffrey E. Korte. (2010) Postpartum Screening Following GDM: How Well Are We Doing?. Current Diabetes Reports 10:3, 235-241
CrossRef688
M. S. Kipnes, P. Hollander, K. Fujioka, I. Gantz, T. Seck, N. Erondu, Y. Shentu, K. Lu, S. Suryawanshi, M. Chou, A. O. Johnson-Levonas, S. B. Heymsfield, D. Shapiro, K. D. Kaufman, J. M. Amatruda. (2010) A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes. Diabetes, Obesity and Metabolism 12:6, 517-531
CrossRef689
Flavio Francini, María C. Castro, Guillermo Schinella, María E. García, Bárbara Maiztegui, María A. Raschia, Juan J. Gagliardino, María L. Massa. (2010) Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system. Life Sciences 86:25-26, 965-971
CrossRef690
Timothy J. O'Leary, Jean R. Slutsky, Marie A. Bernard. (2010) Comparative Effectiveness Research Priorities at Federal Agencies: The View from the Department of Veterans Affairs, National Institute on Aging, and Agency for Healthcare Research and Quality. Journal of the American Geriatrics Society 58:6, 1187-1192
CrossRef691
Claresa LEVETAN. (2010) Distinctions between islet neogenesis and β-cell replication: Implications for reversal of Type 1 and 2 diabetes. Journal of Diabetes 2:2, 76-84
CrossRef692
Thomas A. Buchanan. (2010) Stemming the Tide of Type 2 Diabetes: Bring on the “Big Guns”. Obesity 18:6, 1065-1067
CrossRef693
Mohsen Janghorbani, Masoud Amini. (2010) Normalization of glucose intolerance in first-degree relatives of patients with type 2 diabetes. Diabetes Research and Clinical Practice 88:3, 295-301
CrossRef694
M. Kastarinen, A. Juutilainen, H. Kastarinen, V. Salomaa, P. Karhapää, J. Tuomilehto, C. Grönhagen-Riska, P. Jousilahti, P. Finne. (2010) Original Article: Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25 821 men and women in eastern Finland. Journal of Internal Medicine 267:6, 612-620
CrossRef695
Donald K. Zettervall, Laura Shane-McWhorter, Curtis Triplitt. (2010) Diabetes in the Elderly: Exercising Your Clinical Skills. The Consultant Pharmacist 25:0, 1-37
CrossRef696
Jaana Lindström, Pilvikki Absetz, Katri Hemiö, Päivi Peltomäki, Markku Peltonen. (2010) Reducing the risk of type 2 diabetes with nutrition and physical activity – efficacy and implementation of lifestyle interventions in Finland. Public Health Nutrition 13:6A, 993-999
CrossRef697
T. Kanzleiter, E. Preston, D. Wilks, B. Ho, A. Benrick, J. Reznick, L. K. Heilbronn, N. Turner, G. J. Cooney. (2010) Overexpression of the orphan receptor Nur77 alters glucose metabolism in rat muscle cells and rat muscle in vivo. Diabetologia 53:6, 1174-1183
CrossRef698
Joanne M. Spahn, Rebecca S. Reeves, Kathryn S. Keim, Ida Laquatra, Molly Kellogg, Bonnie Jortberg, Nicole A. Clark. (2010) State of the Evidence Regarding Behavior Change Theories and Strategies in Nutrition Counseling to Facilitate Health and Food Behavior Change. Journal of the American Dietetic Association 110:6, 879-891
CrossRef699
Liane M. Vadheim, Kari A. Brewer, Darcy R. Kassner, Karl K. Vanderwood, Taryn O. Hall, Marcene K. Butcher, Steven D. Helgerson, Todd S. Harwell. (2010) Effectiveness of a Lifestyle Intervention Program Among Persons at High Risk for Cardiovascular Disease and Diabetes in a Rural Community. The Journal of Rural Health 26:3, 266-272
CrossRef700
Hadi Harati, Farzad Hadaegh, Amir Abbas Momenan, Laleh Ghanei, Mohammad Reza Bozorgmanesh, Arash Ghanbarian, Parvin Mirmiran, Fereidoun Azizi. (2010) Reduction in Incidence of Type 2 Diabetes by Lifestyle Intervention in a Middle Eastern Community. American Journal of Preventive Medicine 38:6, 628-636.e1
CrossRef701
Amy D. Otto. (2010) Cinnamon as a Supplemental Treatment for Impaired Glucose Tolerance and Type 2 Diabetes. Current Diabetes Reports 10:3, 170-172
CrossRef702
H. J. Teede, C. Lombard, A. A. Deeks. (2010) Obesity, metabolic complications and the menopause: an opportunity for prevention. Climacteric 13:3, 203-209
CrossRef703
S. Colagiuri. (2010) Diabesity: therapeutic options. Diabetes, Obesity and Metabolism 12:6, 463-473
CrossRef704
Rexford S. Ahima, Rotonya Carr. (2010) Alas! Ileal Interposition Surgery for Diabetes Prevention?. Gastroenterology 138:7, 2224-2226
CrossRef705
S. Y. Kim, L. England, H. G. Wilson, C. Bish, G. A. Satten, P. Dietz. (2010) Percentage of Gestational Diabetes Mellitus Attributable to Overweight and Obesity. American Journal of Public Health 100:6, 1047-1052
CrossRef706
Caroline M. Apovian, Richard M. Bergenstal, Robert M. Cuddihy, Yongming Qu, Sheila Lenox, Michelle S. Lewis, Leonard C. Glass. (2010) Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes. The American Journal of Medicine 123:5, 468.e9-468.e17
CrossRef707
K. Færch, K. Borch-Johnsen, A. Vaag, T. Jørgensen, D. R. Witte. (2010) Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 53:5, 858-865
CrossRef708
Linda G. Mellbin, Matteo Anselmino, Lars Rydén. (2010) Diabetes, prediabetes and cardiovascular risk. European Journal of Cardiovascular Prevention & Rehabilitation 17, S9-S14
CrossRef709
J. Tomlinson, A. Millward, E. Stenhouse, J. Pinkney. (2010) Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?. Diabetic Medicine 27:5, 498-515
CrossRef710
Kendra K. Kattelmann, Kibbe Conti, Cuirong Ren. (2010) The Medicine Wheel Nutrition Intervention: A Diabetes Education Study with the Cheyenne River Sioux Tribe. Journal of the American Dietetic Association 110:5, S44-S51
CrossRef711
Thilo M. Schaufler, Malte Wolff. (2010) Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in Germany. Applied Health Economics and Health Policy 8:3, 191-202
CrossRef712
Thomas A. Buchanan, Anny H. Xiang. (2010) Diabetes: Preventing type 2 diabetes mellitus: is metformin the answer?. Nature Reviews Endocrinology 6:5, 253-254
CrossRef713
Péter Apor. (2010) Az egészség ára. A gazdaságosság kérdései életmód-változtatás esetében. Orvosi Hetilap 151:19, 788-794
CrossRef714
Barbara Strasser, Uwe Siebert, Wolfgang Schobersberger. (2010) Resistance Training in the Treatment of the Metabolic Syndrome. Sports Medicine 40:5, 397-415
CrossRef715
N. Frank, R.J. Geor, S.R. Bailey, A.E. Durham, P.J. Johnson. (2010) Equine Metabolic Syndrome. Journal of Veterinary Internal Medicine 24:3, 467-475
CrossRef716
Kate Goodrich, Patrick H. Conway. (2010) Comparative effectiveness research: Implications for hospital medicine. Journal of Hospital Medicine 5:5, 257-260
CrossRef717
Elena Barengolts. (2010) Vitamin D Role and Use in Prediabetes. Endocrine Practice 16:3, 476-485
CrossRef718
S. M. Nelson, P. Matthews, L. Poston. (2010) Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Human Reproduction Update 16:3, 255-275
CrossRef719
Rosario Forlano, Antonio Massimo Ippolito, Angelo Iacobellis, Antonio Merla, Maria Rosa Valvano, Grazia Niro, Vito Annese, Angelo Andriulli. (2010) Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointestinal Endoscopy 71:6, 927-933
CrossRef720
Giovanni Targher, Alessandro Bellis, Paolo Fornengo, Francesca Ciaravella, Isabella Pichiri, Paolo Cavallo Perin, Bruno Trimarco, Giulio Marchesini. (2010) Prevention and treatment of nonalcoholic fatty liver disease. Digestive and Liver Disease 42:5, 331-340
CrossRef721
W. Rathmann, C. Meisinger. (2010) Wie häufig ist Typ-2-Diabetes in Deutschland?. Der Diabetologe 6:3, 170-176
CrossRef722
Michele Petruzzelli, Antonio Moschetta. (2010) Intestinal Ecology in the Metabolic Syndrome. Cell Metabolism 11:5, 345-346
CrossRef723
Melanie Jay, Sheira Schlair, Rob Caldwell, Adina Kalet, Scott Sherman, Colleen Gillespie. (2010) From the Patient’s Perspective: The Impact of Training on Resident Physician’s Obesity Counseling. Journal of General Internal Medicine 25:5, 415-422
CrossRef724
The NAVIGATOR Study Group. (2010) Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine 362:16, 1463-1476
Full Text725
The NAVIGATOR Study Group. (2010) Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine 362:16, 1477-1490
Full Text726
Kevin Niswender. (2010) Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay. Diabetes, Obesity and Metabolism 12:4, 267-287
CrossRef727
Catherine R. CHITTLEBOROUGH, Katherine L. BALDOCK, Anne W. TAYLOR, William M. HAGUE, Toni WILLSON, Wendy MARTIN, Jenny WOOD, Patrick J. PHILLIPS. (2010) Long-term follow-up of women with gestational diabetes mellitus: The South Australian Gestational Diabetes Mellitus Recall Register. Australian and New Zealand Journal of Obstetrics and Gynaecology 50:2, 127-131
CrossRef728
Henry Krum, John J.V. McMurray, Edward Horton, Teresa Gerlock, Bjoern Holzhauer, Lineke Zuurman, Steven M. Haffner, M. Angelyn Bethel, Rury R. Holman, Robert M. Califf. (2010) Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials. Cardiovascular Therapeutics 28:2, 124-132
CrossRef729
George A. Bray. (2010) There's More Than One Way to Skin A Cat: Response to “Reporting Weight Loss: Is Simple Better?”. Obesity 18:4, 651-651
CrossRef730
Agnes Yuen, Yulia Sugeng, Tracey J. Weiland, George A. Jelinek. (2010) Lifestyle and medication interventions for the prevention or delay of type 2 diabetes mellitus in prediabetes: a systematic review of randomised controlled trials. Australian and New Zealand Journal of Public Health 34:2, 172-178
CrossRef731
Richard Kahn, Peter Alperin, David Eddy, Knut Borch-Johnsen, John Buse, Justin Feigelman, Edward Gregg, Rury R Holman, M Sue Kirkman, Michael Stern, Jaakko Tuomilehto, Nick J Wareham. (2010) Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. The Lancet 375:9723, 1365-1374
CrossRef732
Linda S. Geiss, Cherie James, Edward W. Gregg, Ann Albright, David F. Williamson, Catherine C. Cowie. (2010) Diabetes Risk Reduction Behaviors Among U.S. Adults with Prediabetes. American Journal of Preventive Medicine 38:4, 403-409
CrossRef733
Isabella Russo, Monica Traversa, Katia Bonomo, Alessandro De Salve, Luigi Mattiello, Paola Del Mese, Gabriella Doronzo, Franco Cavalot, Mariella Trovati, Giovanni Anfossi. (2010) In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin. Obesity 18:4, 788-797
CrossRef734
Annie S. Anderson, Stephen Caswell, Mary Wells, Robert J. C. Steele, Susan MacAskill. (2010) “It makes you feel so full of life” LiveWell, a feasibility study of a personalised lifestyle programme for colorectal cancer survivors. Supportive Care in Cancer 18:4, 409-415
CrossRef735
K. Makrilakis, S. Liatis, S. Grammatikou, D. Perrea, N. Katsilambros. (2010) Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study. Diabetic Medicine 27:4, 459-465
CrossRef736
F. M. Finucane, S. J. Sharp, L. R. Purslow, K. Horton, J. Horton, D. B. Savage, S. Brage, H. Besson, E. Lucia Rolfe, A. Sleigh, H. J. Martin, A. Aihie Sayer, C. Cooper, U. Ekelund, S. J. Griffin, N. J. Wareham. (2010) The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial. Diabetologia 53:4, 624-631
CrossRef737
Ryan Lipscomb. (2010) American Dietetic Association Coding & Coverage Committee Report: Registered Dietitians as Preferred Providers for Diabetes Care. Journal of the American Dietetic Association 110:4, 639-644
CrossRef738
Jan L. Shifren, Isaac Schiff. (2010) Role of Hormone Therapy in the Management of Menopause. Obstetrics & Gynecology 115:4, 839-855
CrossRef739
Stephanie-May Ruchat, Marie-Claude Vohl, S. John Weisnagel, Tuomo Rankinen, Claude Bouchard, Louis Pérusse. (2010) Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism. Annals of Medicine 42:3, 196-206
CrossRef740
Frank L. Greenway, George A. Bray. (2010) Combination Drugs for Treating Obesity. Current Diabetes Reports 10:2, 108-115
CrossRef741
K. L. Johnston, E. L. Thomas, J. D. Bell, G. S. Frost, M. D. Robertson. (2010) Resistant starch improves insulin sensitivity in metabolic syndrome. Diabetic Medicine 27:4, 391-397
CrossRef742
Robert F. Kushner, Lisa M. Neff. (2010) Bariatric Surgery: A Key Role for Registered Dietitians. Journal of the American Dietetic Association 110:4, 524-526
CrossRef743
R. K. Simmons, K. G. M. M. Alberti, E. A. M. Gale, S. Colagiuri, J. Tuomilehto, Q. Qiao, A. Ramachandran, N. Tajima, I. Brajkovich Mirchov, A. Ben-Nakhi, G. Reaven, B. Hama Sambo, S. Mendis, G. Roglic. (2010) The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 53:4, 600-605
CrossRef744
P. Parikh, E. P. Simon, K. Fei, H. Looker, C. Goytia, C. R. Horowitz. (2010) Results of a Pilot Diabetes Prevention Intervention in East Harlem, New York City: Project HEED. American Journal of Public Health 100:S1, S232-S239
CrossRef745
Yang, Wenying, Lu, Juming, Weng, Jianping, Jia, Weiping, Ji, Linong, Xiao, Jianzhong, Shan, Zhongyan, Liu, Jie, Tian, Haoming, Ji, Qiuhe, Zhu, Dalong, Ge, Jiapu, Lin, Lixiang, Chen, Li, Guo, Xiaohui, Zhao, Zhigang, Li, Qiang, Zhou, Zhiguang, Shan, Guangliang, He, Jiang, . (2010) Prevalence of Diabetes among Men and Women in China. New England Journal of Medicine 362:12, 1090-1101
Full Text746
David J. Pettitt. 2010. Long-Term Implications for the Baby of the Hyperglycemic Mother. , 251-257.
CrossRef747
Anita Banerjee, Anne Dornhorst. 2010. Diet and Exercise in Diabetes in Pregnancy. , 128-136.
CrossRef748
Jorge H. Mestman. 2010. Long-Term Implications for the Mother with Hyperglycemia in Pregnancy. , 242-250.
CrossRef749
Mehrul Hasnain, W. Victor R. Vieweg, Sonja K. Fredrickson. (2010) Metformin for Atypical Antipsychotic-Induced Weight Gain and Glucose Metabolism Dysregulation. CNS Drugs 24:3, 193-206
CrossRef750
R. Paul Robertson, David M. Kendall, Elizabeth R. Seaquist. (2010) Diabetes: Strategies to prevent the type 2 diabetes mellitus epidemic. Nature Reviews Endocrinology 6:3, 128-129
CrossRef751
Sam Virtue, Antonio Vidal-Puig. (2010) Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1801:3, 338-349
CrossRef752
RIG Holt, RC Peveler. (2010) Diabetes and cardiovascular risk in severe mental illness: a missed opportunity and challenge for the future. Practical Diabetes International 27:2, 79-84ii
CrossRef753
Wenjing Ruan, Maode Lai. (2010) Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?. Acta Diabetologica 47:1, 5-14
CrossRef754
Robin L Southwood. (2010) Have Clinical Studies Demonstrated Diabetes Prevention or Delay of Diabetes Through Early Treatment?. American Journal of Therapeutics 17:2, 201-209
CrossRef755
B. Gonzalez, N. Brunetti, G. Lanfranchi, E. Lorisson, C. Verny. (2010) Activité physique et diabète chez les sujets âgés. Les cahiers de l'année gérontologique 2:1, 36-44
CrossRef756
D. Taner Ertugrul, B. Yavuz, K. Okhan Akin, A. Arif Yalcin, N. Ata, M. Kucukazman, B. Algul, K. Dal, O. Sinan Deveci, E. Tutal. (2010) An obesity drug sibutramine reduces brain natriuretic peptide (BNP) levels in severely obese patients. International Journal of Clinical Practice 64:4, 518-522
CrossRef757
Graham A. Colditz, Philip R. Taylor. (2010) Prevention Trials: Their Place in How We Understand the Value of Prevention Strategies. Annual Review of Public Health 31:1, 105-120
CrossRef758
, R. A. DeFronzo, M. A. Banerji, G. A. Bray, T. A. Buchanan, S. Clement, R. R. Henry, A. E. Kitabchi, S. Mudaliar, N. Musi, R. Ratner, P. Reaven, D. C. Schwenke, F. D. Stentz, D. Tripathy. (2010) Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. Diabetologia 53:3, 435-445
CrossRef759
T.O. Klemsdal, I. Holme, H. Nerland, T.R. Pedersen, S. Tonstad. (2010) Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases 20:3, 195-201
CrossRef760
Itziar Zazpe, Ramón Estruch, Estefanía Toledo, Ana Sánchez-Taínta, Dolores Corella, Mónica Bulló, Miquel Fiol, Pablo Iglesias, Enrique Gómez-Gracia, Fernando Arós, Emilio Ros, Helmut Schröder, Lluis Serra-Majem, Xavier Pintó, Rosa Lamuela-Raventós, Valentina Ruiz-Gutiérrez, Miguel Ángel Martínez-González. (2010) Predictors of adherence to a Mediterranean-type diet in the PREDIMED trial. European Journal of Nutrition 49:2, 91-99
CrossRef761
Robert G. Nelson, Katherine R. Tuttle. (2010) Prevention of Diabetic Kidney Disease: Negative Clinical Trials With Renin-Angiotensin System Inhibitors. American Journal of Kidney Diseases 55:3, 426-430
CrossRef762
Ruth Colagiuri. (2010) Diabetes: a pandemic, a development issue or both?. Expert Review of Cardiovascular Therapy 8:3, 305-309
CrossRef763
Makoto Fujimoto, Koichi Tsuneyama, Hideki Kinoshita, Hirozo Goto, Yasuo Takano, Carlo Selmi, Carl L. Keen, M. Eric Gershwin, Yutaka Shimada. (2010) The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease. Annals of the New York Academy of Sciences 1190:1, 151-158
CrossRef764
A. E. Buyken, P. Mitchell, A. Ceriello, J. Brand-Miller. (2010) Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. Diabetologia 53:3, 406-418
CrossRef765
John P. Sheehan. (2010) Bad Medicine: There Is a Lot Wrong with Diabetes Care in the United States. Culture, Medicine, and Psychiatry 34:1, 2-12
CrossRef766
, H. Sone, S. Tanaka, S. Iimuro, S. Tanaka, K. Oida, Y. Yamasaki, S. Oikawa, S. Ishibashi, S. Katayama, H. Yamashita, H. Ito, Y. Yoshimura, Y. Ohashi, Y. Akanuma, N. Yamada. (2010) Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 53:3, 419-428
CrossRef767
Ken Fujioka. (2010) Benefits of moderate weight loss in patients with type 2 diabetes. Diabetes, Obesity and Metabolism 12:3, 186-194
CrossRef768
M. E. Waring, C. B. Eaton, T. M. Lasater, K. L. Lapane. (2010) Incident Diabetes in Relation to Weight Patterns During Middle Age. American Journal of Epidemiology 171:5, 550-556
CrossRef769
Benoit J. Arsenault, Jamal S. Rana, Isabelle Lemieux, Jean-Pierre Després, Nicholas J. Wareham, John J.P. Kastelein, S. Matthijs Boekholdt, Kay-Tee Khaw. (2010) Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study. Atherosclerosis 209:1, 261-265
CrossRef770
Habiba I. Ali, Latifa M. Baynouna, Roos M. Bernsen. (2010) Barriers and facilitators of weight management: perspectives of Arab women at risk for type 2 diabetes. Health & Social Care in the Community 18:2, 219-228
CrossRef771
William Ricardo Komatsu, Régis B Andriolo, Álvaro N Atallah, Marcos Moraes Oliveira, Sérgio Atala Dib, William Ricardo Komatsu. 2010. Physical exercise for type 1 diabetes mellitus. .
CrossRef772
William I. Sivitz, Mark A. Yorek. (2010) Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities. Antioxidants & Redox Signaling 12:4, 537-577
CrossRef773
(2010) Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study. International Journal of Obesity 34:2, 217-226
CrossRef774
A Lapointe, S J Weisnagel, V Provencher, C Bégin, A-A Dufour-Bouchard, C Trudeau, S Lemieux. (2010) Using restrictive messages to limit high-fat foods or nonrestrictive messages to increase fruit and vegetable intake: what works better for postmenopausal women?. European Journal of Clinical Nutrition 64:2, 194-202
CrossRef775
K. M. Venkat Narayan, David F. Williamson. (2010) Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community. Journal of General Internal Medicine 25:2, 154-157
CrossRef776
Michelle Spence, Michelle C. McKinley, Steven J. Hunter. (2010) Session 4: CVD, diabetes and cancer Diet, insulin resistance and diabetes: the right (pro)portions. Proceedings of the Nutrition Society 69:01, 61
CrossRef777
Daniela S. Sartorelli, Renata Damião, Rita Chaim, Amélia Hirai, Suely G.A. Gimeno, Sandra R.G. Ferreira. (2010) Dietary ω-3 fatty acid and ω-3: ω-6 fatty acid ratio predict improvement in glucose disturbances in Japanese Brazilians. Nutrition 26:2, 184-191
CrossRef778
Lu Qi, Jun Liang. (2010) Interactions between genetic factors that predict diabetes and dietary factors that ultimately impact on risk of diabetes. Current Opinion in Lipidology 21:1, 31-37
CrossRef779
Rachel A. Nelson, Andrew A. Bremer. (2010) Insulin Resistance and Metabolic Syndrome in the Pediatric Population. Metabolic Syndrome and Related Disorders 8:1, 1-14
CrossRef780
Jaakko Tuomilehto, Jaana Lindström, Martin Hellmich, Walter Lehmacher, Torsten Westermeier, Thomas Evers, Andreas Brückner, Markku Peltonen, Qing Qiao, Jean-Louis Chiasson. (2010) Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus—The STOP-NIDDM risk-score. Diabetes Research and Clinical Practice 87:2, 267-274
CrossRef781
M. Tracy Bekx, Ellen C. Connor, David B. Allen. (2010) Characteristics of Adolescents Presenting to a Multidisciplinary Clinic for Polycystic Ovarian Syndrome. Journal of Pediatric and Adolescent Gynecology 23:1, 7-10
CrossRef782
Rolando G. Díaz, Julián Esparza-Romero, Silvia Y. Moya-Camarena, Alma E. Robles-Sardín, Mauro E. Valencia. (2010) Lifestyle Intervention in Primary Care Settings Improves Obesity Parameters among Mexican Youth. Journal of the American Dietetic Association 110:2, 285-290
CrossRef783
J. M. Edwards, Z. P. Neeb, M. A. Alloosh, X. Long, I. N. Bratz, C. R. Peller, J. P. Byrd, S. Kumar, A. G. Obukhov, M. Sturek. (2010) Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovascular Research 85:3, 631-640
CrossRef784
Sergio Huerta, Zhaoping Li, Thomas Anthony, Edward H. Livingston. (2010) Feasibility of a Supervised Inpatient Low-Calorie Diet Program for Massive Weight Loss Prior to RYGB in Superobese Patients. Obesity Surgery 20:2, 173-180
CrossRef785
, A. Gautier, B. Balkau, C. Lange, J. Tichet, F. Bonnet. (2010) Risk factors for incident type 2 diabetes in individuals with a BMI of <27 kg/m2: the role of γ-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetologia 53:2, 247-253
CrossRef786
Maarit A. Laaksonen, Paul Knekt, Harri Rissanen, Tommi Härkänen, Esa Virtala, Jukka Marniemi, Arpo Aromaa, Markku Heliövaara, Antti Reunanen. (2010) The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts. European Journal of Epidemiology 25:2, 115-124
CrossRef787
D. A Luis, D. Pacheco, R. Aller, M. González Sagrado, O. Izaola, M. C. Terroba, L. Cuellar, R. Conde, T. Martin. (2010) Influence of G308A Polymorphism of Tumor Necrosis Factor Alpha Gene on Surgical Results of Biliopancreatic Diversion. Obesity Surgery 20:2, 221-225
CrossRef788
D. Chernichovsky, A. A. Leibowitz. (2010) Integrating Public Health and Personal Care in a Reformed US Health Care System. American Journal of Public Health 100:2, 205-211
CrossRef789
Michael G. Perri, Lisa M. Nackers. 2010. Obesity. .
CrossRef790
Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin, Adam H Balen, Adam H Balen. 2010. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. .
CrossRef791
Hiroko Fujii, Takashi Muto, Yasuo Haruyama, Makiko Nakade, Emiko Kobayashi, Kaori Ishisaki. (2010) Community-Based Lifestyle Modification of Cardiovascular Disease Risks in Middle-Aged Japanese: A 27-Month Update. The Tohoku Journal of Experimental Medicine 220:4, 307-318
CrossRef792
Nada Sallam, Majid Khazaei, Ismail Laher. (2010) Effect of Moderate-Intensity Exercise on Plasma C-Reactive Protein and Aortic Endothelial Function in Type 2 Diabetic Mice. Mediators of Inflammation 2010, 1-7
CrossRef793
Q Qiao, R Nyamdorj. (2010) The optimal cutoff values and their performance of waist circumference and waist-to-hip ratio for diagnosing type II diabetes. European Journal of Clinical Nutrition 64:1, 23-29
CrossRef794
Claus Brandt, Bente K. Pedersen. (2010) The Role of Exercise-Induced Myokines in Muscle Homeostasis and the Defense against Chronic Diseases. Journal of Biomedicine and Biotechnology 2010, 1-7
CrossRef795
Wael E. Eid, James V. Pottala. (2010) Value of Hemoglobin A<sub>1c</sub> in Diagnosing Diabetes Mellitus within a Chronic Disease Management System Illustrated by the Receiver Operating Characteristic Curve. Endocrine Practice 16:1, 14-20
CrossRef796
Min-Jung Kang, Ji-Hye Kim, Ha-Neul Choi, Myoung-Jin Kim, Jung-Hee Han, Jai-Heon Lee, Jung-In Kim. (2010) Hypoglycemic effects of Welsh onion in an animal model of diabetes mellitus. Nutrition Research and Practice 4:6, 486
CrossRef797
Bryan Dowd, Michael McGrail, William H. Lohman, Brent Sheasby, Heidi OʼConnor, Marilou Calasanz, Robert Gorman, Stephen Parente. (2010) The Economic Impact of a Disability Prevention Program. Journal of Occupational and Environmental Medicine 52:1, 15-21
CrossRef798
F. S. Collins. (2010) Opportunities for Research and NIH. Science 327:5961, 36-37
CrossRef799
Min Goo Lee, Myung Ho Jeong, Youngkeun Ahn, Shung Chull Chae, Seung Ho Hur, Taek Jong Hong, Young Jo Kim, In Whan Seong, Jei Keon Chae, Jay Young Rhew, In Ho Chae, Myeong Chan Cho, Jang Ho Bae, Seung Woon Rha, Chong Jin Kim, Donghoon Choi, Yang Soo Jang, Junghan Yoon, Wook Sung Chung, Jeong Gwan Cho, Ki Bae Seung, Seung Jung Park. (2010) Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction. Journal of Korean Medical Science 25:10, 1456
CrossRef800
Per-Arne Svensson, Anders Gummesson, Lena M.S. Carlsson, Kajsa Sjöholm. (2010) Changes in Human Adipose Tissue Gene Expression during Diet-Induced Weight Loss. Journal of Nutrigenetics and Nutrigenomics 3:4-6, 239-250
CrossRef801
Stephan Dombrowski, Falko Sniehotta, Alison Avenell, Marie Johnston, Graeme MacLennan, Vera Araujo-Soares. (2010) Identifying active ingredients in complex behavioural interventions for obese adults with obesity-related co-morbidities or additional risk factors for co-morbidities: a systematic review. Health Psychology Review1-26
CrossRef802
M. Ghannem. (2010) La réadaptation cardiaque en post-infarctus du myocarde. Annales de Cardiologie et d Angéiologie 59:6, 367
CrossRef803
Melissa Kalarchian, Marsha Marcus. (2010) Preoperative Weight Loss in the Context of a Comprehensive Lifestyle Intervention. Obesity Surgery 20:1, 131-131
CrossRef804
Meghan L. Butryn, Thomas A. Wadden, Margaret R. Rukstalis, Chanelle Bishop-Gilyard, Melissa S. Xanthopoulos, Delroy Louden, Robert I. Berkowitz. (2010) Maintenance of Weight Loss in Adolescents: Current Status and Future Directions. Journal of Obesity 2010, 1-12
CrossRef805
Graziano Di Cianni, Alessandra Ghio, Veronica Resi, Laura Volpe. (2010) Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women. Women's Health 6:1, 97-105
CrossRef806
L. F. Van Gaal, I. D. Caterson, W. Coutinho, N. Finer, A. P. Maggioni, A. M. Sharma, C. Torp-Pedersen, H. Ge, S. A. Moran, G. M. Shepherd, W. P. T. James, . (2010) Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. Diabetes, Obesity and Metabolism 12:1, 26-34
CrossRef807
Akimitsu KIMURA, Hiroshi FUKUDA, Tomomi HANIU, Fukuko OKA, Miki OOIKE, Yasuo HARUYAMA. (2010) Efficacy of exercise class at a community clinic for middle-aged and elderly patients with lifestyle-related diseases treated at the clinic. Japanese Journal of Health and Human Ecology 76:5, 195-206
CrossRef808
Mario Rizzello, Francesca Abbatini, Giovanni Casella, Giorgio Alessandri, Aldo Fantini, Frida Leonetti, Nicola Basso. (2010) Early Postoperative Insulin-Resistance Changes After Sleeve Gastrectomy. Obesity Surgery 20:1, 50-55
CrossRef809
Tamara B. Horwich, Gregg C. Fonarow. (2010) Glucose, Obesity, Metabolic Syndrome, and Diabetes. Journal of the American College of Cardiology 55:4, 283-293
CrossRef810
Sophie Bersoux, Kara L. Asbury, Curtiss B. Cook, Joseph L. Verheijde, Marcia H. Larson, Ruth T. Aponte-Furlow, Sandra S. Flatten, Susan A. Hooley, Carolyn S. LaRosa, Karen M. Seifert, Patricia M. Verona, Janna C. Castro, Kimberly A. Jameson. (2010) An Outpatient-Based Clinical Program for Type 2 Diabetes Prevention. Endocrine Practice 16:1, 21-29
CrossRef811
Jozefien Buyze, Bart Van Rompaye, Els Goetghebeur. (2010) Designing a sequentially randomized study with adherence enhancing interventions for diabetes patients. Statistics in Medicinen/a-n/a
CrossRef812
E. J. Groessl, K. R. Weingart, C. J. Stepnowsky, A. L. Gifford, S. M. Asch, S. B. Ho. (2010) The hepatitis C self-management programme: a randomized controlled trial : The hepatitis C self-management programme. Journal of Viral Hepatitisno
CrossRef813
Pawan D Patel, Rohit R Arora. (2010) Practical Implications of ACC/AHA 2007 Guidelines for the Management of Unstable Angina/Non-ST Elevation Myocardial Infarction. American Journal of Therapeutics 17:1, e24-e40
CrossRef814
Rachel Dankner, Ann Danoff, Jesse Roth. (2010) Can ‘ personalized diagnostics ’ promote earlier intervention for dysglycaemia? Hypothesis ready for testing. Diabetes/Metabolism Research and Reviews 26:1, 7-9
CrossRef815
Jeffrey A. Katula, Mara Z. Vitolins, Erica L. Rosenberger, Caroline Blackwell, Mark A. Espeland, Michael S. Lawlor, W. Jack Rejeski, David C. Goff. (2010) Healthy Living Partnerships to Prevent Diabetes (HELP PD): Design and methods. Contemporary Clinical Trials 31:1, 71-81
CrossRef816
Michael Bergman. (2010) Inadequacies of absolute threshold levels for diagnosing prediabetes. Diabetes/Metabolism Research and Reviews 26:1, 3-6
CrossRef817
Nelli Hankonen, Pilvikki Absetz, Paolo Ghisletta, Britta Renner, Antti Uutela. (2010) Gender differences in social cognitive determinants of exercise adoption. Psychology & Health 25:1, 55-69
CrossRef818
Gurch Randhawa. (2010) Renal Health Disparities in the United Kingdom: A Focus on Ethnicity. Seminars in Nephrology 30:1, 8-11
CrossRef819
V. Pavlicek. (2010) Zehnjahresergebnisse der Diabetesinzidenz und der Gewichtsreduktion im „Diabetes Prevention Program“. Der Diabetologe 6:1, 44-45
CrossRef820
Nobuhiko TACHIBANA, Yasue IWAOKA, Motohiko HIROTSUKA, Fumihiko HORIO, Mitsutaka KOHNO. (2010) β-Conglycinin Lowers Very-Low-Density Lipoprotein-Triglyceride Levels by Increasing Adiponectin and Insulin Sensitivity in Rats. Bioscience, Biotechnology, and Biochemistry 74:6, 1250-1255
CrossRef821
Tadashi Moriuchi, Rie Oka, Kunimasa Yagi, Susumu Miyamoto, Hideki Nomura, Masakazu Yamagishi, Hiroshi Mabuchi, Junji Kobayashi, Junji Koizumi. (2010) Diabetes Progression from "High-Normal" Glucose in School Teachers. Internal Medicine 49:13, 1271-1276
CrossRef822
L.-N. Peng, M.-H. Lin, H.-Y. Lai, S.-J. Hwang, L.-K. Chen, S.-T. Chiou. (2010) Risk factors of new onset diabetes mellitus among elderly Chinese in rural Taiwan. Age and Ageing 39:1, 125-128
CrossRef823
Kittichai Promrat, David E. Kleiner, Heather M. Niemeier, Elizabeth Jackvony, Marie Kearns, Jack R. Wands, Joseph L. Fava, Rena R. Wing. (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51:1, 121-129
CrossRef824
Marie-Hélène Massicotte, Fabienne Langlois, Jean-Patrice Baillargeon. (2010) Current procedures for managing polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology 5:1, 77-91
CrossRef825
Konstantinos Tziomalos, Hariklia V. Dimitroula, Niki Katsiki, Christos Savopoulos, Apostolos I. Hatzitolios. (2010) Effects of Lifestyle Measures, Antiobesity Agents, and Bariatric Surgery on Serological Markers of Inflammation in Obese Patients. Mediators of Inflammation 2010, 1-14
CrossRef826
Q Qiao, R Nyamdorj. (2010) Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index?. European Journal of Clinical Nutrition 64:1, 30-34
CrossRef827
S. Engberg, C. Glümer, D. R. Witte, T. Jørgensen, K. Borch-Johnsen. (2010) Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study. Diabetologia 53:1, 70-78
CrossRef828
Tomoko Nakagami, Naoko Tajima, Toshihide Oizumi, Shigeru Karasawa, Kiriko Wada, Wataru Kameda, Shinji Susa, Takeo Kato, Makoto Daimon. (2010) Hemoglobin A1c in predicting progression to diabetes. Diabetes Research and Clinical Practice 87:1, 126-131
CrossRef829
Sadanori Okada, Aki Hiuge, Hisashi Makino, Ayako Nagumo, Hiroshi Takaki, Harumi Konishi, Yoichi Goto, Yasunao Yoshimasa, Yoshihiro Miyamoto. (2010) Effect of Exercise Intervention on Endothelial Function and Incidence of Cardiovascular Disease in Patients with Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis 17:8, 828-833
CrossRef830
Junji Koizumi. (2010) Diabetes in the elderly. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 47:5, 415-418
CrossRef831
Caroline R Richardson, Lorraine R Buis, Adrienne W Janney, David E Goodrich, Ananda Sen, Michael L Hess, Kathleen S Mehari, Laurie A Fortlage, Paul J Resnick, Brian J Zikmund-Fisher, Victor J Strecher, John D Piette. (2010) An Online Community Improves Adherence in an Internet-Mediated Walking Program. Part 1: Results of a Randomized Controlled Trial. Journal of Medical Internet Research 12:4,
CrossRef832
A. E. DURHAM, K. J. HUGHES, H. J. COTTLE, D. I. RENDLE, R. C. BOSTON. (2009) Type 2 diabetes mellitus with pancreatic β cell dysfunction in 3 horses confirmed with minimal model analysis. Equine Veterinary Journal 41:9, 924-929
CrossRef833
Peter M. Janiszewski, Robert Ross. (2009) The Utility of Physical Activity in the Management of Global Cardiometabolic Risk. Obesity 17:n3s, S3-S14
CrossRef834
Alan Cole, David M. Nathan, Elizabeth Savaria-Porter, Paul Copeland, Alexander Turchin, Melanie Brunt, Randall Zusman, Jo-Ann Barrett, Deborah Wexler, Emily Case, Graham T. McMahon, Elizabeth Mort. (2009) An Algorithm for the Care of Type 2 Diabetes. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 8:4, 156-165
CrossRef835
Mohammed K. Ali, K.M. Venkat Narayan, Viswanathan Mohan. (2009) Innovative research for equitable diabetes care in India. Diabetes Research and Clinical Practice 86:3, 155-167
CrossRef836
ANTHONY HARRIS. (2009) Diabetes, Cardiovascular Disease and Labour Force Participation in Australia: An Endogenous Multivariate Probit Analysis of Clinical Prevalence Data. Economic Record 85:271, 472-484
CrossRef837
M. Kaye Kramer, Andrea M. Kriska, Elizabeth M. Venditti, Rachel G. Miller, Maria M. Brooks, Lora E. Burke, Linda M. Siminerio, Francis X. Solano, Trevor J. Orchard. (2009) Translating the Diabetes Prevention Program. American Journal of Preventive Medicine 37:6, 505-511
CrossRef838
C. J. Bushe, A. J. Bradley, S. Doshi, J. Karagianis. (2009) Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies. International Journal of Clinical Practice 63:12, 1743-1761
CrossRef839
Christoph Handschin. (2009) Peroxisome proliferator-activated receptor-γ coactivator-1α in muscle links metabolism to inflammation. Clinical and Experimental Pharmacology and Physiology 36:12, 1139-1143
CrossRef840
Thierry Favrod-Coune, Humlerto Delgado, Stefania Sereni, Stéphane Jacquemet, Alain Golay. (2009) Facteurs motivant ou décourageant à pratiquer de l'activité physique chez des patients souffrant de maladies cardio-vasculaires et de diabète. Education thérapeutique du patient - Therapeutic patient education 1:2, S119-S125
CrossRef841
Terry Coyne, Torukiri I. Ibiebele, Peter D. Baade, Christine S. McClintock, Jonathan E. Shaw. (2009) Metabolic syndrome and serum carotenoids: findings of a cross-sectional study in Queensland, Australia. British Journal of Nutrition 102:11, 1668
CrossRef842
Elizabeth AC. Sellers, Kelly Moore, Heather J. Dean. (2009) Clinical Management of Type 2 Diabetes in Indigenous Youth. Pediatric Clinics of North America 56:6, 1441-1459
CrossRef843
Teresa J. Brady, Susan L. Jernick, Jennifer M. Hootman, Joseph E. Sniezek. (2009) Public Health Interventions for Arthritis: Expanding the Toolbox of Evidence-Based Interventions. Journal of Women's Health 18:12, 1905-1917
CrossRef844
Y. M. Jeanes, S. Barr, K. Smith, K. H. Hart. (2009) Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians. Journal of Human Nutrition and Dietetics 22:6, 551-558
CrossRef845
Madhu Kosuri, Gumpeny R. Sridhar. (2009) Yoga Practice in Diabetes Improves Physical and Psychological Outcomes. Metabolic Syndrome and Related Disorders 7:6, 515-518
CrossRef846
(2009) VERY-LOW-CALORIE DIETS. Nutrition & Dietetics 66:4, 252-254
CrossRef847
Kelly J. Acton, Ann Bullock. (2009) American Indians and Physical Activity. American Journal of Preventive Medicine 37:6, 572-573
CrossRef848
Lisa J. Moran, Renato Pasquali, Helena J. Teede, Kathleen M. Hoeger, Robert J. Norman. (2009) Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertility and Sterility 92:6, 1966-1982
CrossRef849
Pamela Vergara-Rodriguez, Sonia Vibhakar, Jeff Watts. (2009) Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness. Pharmacology & Therapeutics 124:3, 269-278
CrossRef850
George A. Bray. (2009) Preventing Diabetes: Lessons Learned from the Diabetes Prevention Program and Its Follow-Up. Obesity and Weight Management 5:6, 273-276
CrossRef851
Marius Trøseid, Knut T. Lappegård, Tom E. Mollnes, Harald Arnesen, Ingebjørg Seljeflot. (2009) The Effect of Exercise on Serum Levels of Interleukin-18 and Components of the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 7:6, 579-584
CrossRef852
E. E. Korkiakangas, M. A. Alahuhta, J. H. Laitinen. (2009) Barriers to regular exercise among adults at high risk or diagnosed with type 2 diabetes: a systematic review. Health Promotion International 24:4, 416-427
CrossRef853
Keith C. Ferdinand, Daphne P. Ferdinand. (2009) Trends in hypertension treatment in diabetes. Current Hypertension Reports 11:6, 437-443
CrossRef854
Ronald T. Ackermann, Sharon L. Edelstein, K.M. Venkat Narayan, Ping Zhang, Michael M. Engelgau, William H. Herman, David G. Marrero. (2009) Changes in Health State Utilities With Changes in Body Mass in the Diabetes Prevention Program. Obesity 17:12, 2176-2181
CrossRef855
Edward S. Horton. (2009) Effects of Lifestyle Changes to Reduce Risks of Diabetes and Associated Cardiovascular Risks: Results from Large Scale Efficacy Trials. Obesity 17:n3s, S43-S48
CrossRef856
Joseph Yaskin, Richard W. Toner, Neil Goldfarb. (2009) Obesity Management Interventions: A Review of the Evidence. Population Health Management 12:6, 305-316
CrossRef857
X. H. Zhou, L. N. Ji, Y. Y. Luo, X. Y. Zhang, X. Y. Han, Q. Qiao. (2009) Performance of HbA 1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing. Diabetic Medicine 26:12, 1262-1268
CrossRef858
Bruce C. Trapnell, Karen Maguiness, Gavin R. Graff, David Boyd, Katrin Beckmann, Steven Caras. (2009) Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis. Journal of Cystic Fibrosis 8:6, 370-377
CrossRef859
Sivan Ben-Avraham, Ilana Harman-Boehm, Dan Schwarzfuchs, Iris Shai. (2009) Dietary strategies for patients with type 2 diabetes in the era of multi-approaches; review and results from the Dietary Intervention Randomized Controlled Trial (DIRECT). Diabetes Research and Clinical Practice 86, S41-S48
CrossRef860
Kristi L. Storti, Vincent C. Arena, M. Michael Barmada, Clareann H. Bunker, Robert L. Hanson, Sandra L. Laston, Jeun-Liang Yeh, Joseph M. Zmuda, Barbara V. Howard, Andrea M. Kriska. (2009) Physical Activity Levels in American-Indian Adults. American Journal of Preventive Medicine 37:6, 481-487
CrossRef861
(2009) The Combined Effects of Exercise and Garlic Pill Intake on Body Composition, CRP and Adiponectin in Obese High School Male Students. Journal of Life Science 19:11, 1605-1610
CrossRef862
Vlad Ratziu, Shira Zelber-Sagi. (2009) Pharmacologic Therapy of Non-Alcoholic Steatohepatitis. Clinics in Liver Disease 13:4, 667-688
CrossRef863
Anoop Misra. (2009) Prevention of type 2 diabetes: the long and winding road. The Lancet 374:9702, 1655-1656
CrossRef864
José M. Baena-Díez, Roberto Elosua, Juan F. Cano, Rafael Masiá, Joan Sala, Jaume Marrugat, Helmut Schröder. (2009) Waist circumference and impaired fasting glucose screening in a Mediterranean population. Diabetes Research and Clinical Practice 86:2, e12-e14
CrossRef865
Jan Kopecky, Martin Rossmeisl, Pavel Flachs, Ondrej Kuda, Petr Brauner, Zuzana Jilkova, Barbora Stankova, Eva Tvrzicka, Morten Bryhn. (2009) n-3 PUFA: bioavailability and modulation of adipose tissue function. Proceedings of the Nutrition Society 68:04, 361
CrossRef866
R. Oertel, A. Walther, W. Kirch. (2009) Sport als Gesundheitsprävention und Gesundheitsrisiko. Prävention und Gesundheitsförderung 4:4, 240-244
CrossRef867
J. M. de la Hera, E. Delgado, E. Hernandez, J. M. Garcia-Ruiz, J. M. Vegas, P. Avanzas, I. Lozano, R. Barriales-Villa, S. Hevia, J. S. Martin, F. Alvarez, C. Moris. (2009) Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention. European Heart Journal 30:21, 2614-2621
CrossRef868
Zsuzsanna Putz, Péter Kempler, György Jermendy. (2009) Diabetesspecifikus szövődmények praediabetesben. Orvosi Hetilap 150:47, 2139-2145
CrossRef869
S Taheri, A Tahrani, A Barnett. (2009) Bariatric surgery: a cure for diabetes?. Practical Diabetes International 26:9, 356-358
CrossRef870
Julie Wagner, Nancy A. Allen, Leah M. Swalley, Gail D. Melkus, Robin Whittemore. (2009) Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes. Diabetes Research and Clinical Practice 86:2, 96-103
CrossRef871
T. Brown, A. Avenell, L. D. Edmunds, H. Moore, V. Whittaker, L. Avery, C. Summerbell, . (2009) Systematic review of long-term lifestyle interventions to prevent weight gain and morbidity in adults. Obesity Reviews 10:6, 627-638
CrossRef872
Christine T. Cigolle, Caroline S. Blaum, Jeffrey B. Halter. (2009) Diabetes and Cardiovascular Disease Prevention in Older Adults. Clinics in Geriatric Medicine 25:4, 607-641
CrossRef873
Kathleen M. McTigue, Molly B. Conroy, Rachel Hess, Cindy L. Bryce, Anthony B. Fiorillo, Gary S. Fischer, N. Carole Milas, Laurey R. Simkin-Silverman. (2009) Using the Internet to Translate an Evidence-Based Lifestyle Intervention into Practice. Telemedicine and e-Health 15:9, 851-858
CrossRef874
Denise K. Houston, Barbara J. Nicklas, Claire A. Zizza. (2009) Weighty Concerns: The Growing Prevalence of Obesity among Older Adults. Journal of the American Dietetic Association 109:11, 1886-1895
CrossRef875
David F. Williamson, K.M. Venkat Narayan. (2009) Identification of persons with dysglycemia: Terminology and practical significance. Primary Care Diabetes 3:4, 211-217
CrossRef876
Mohsen Janghorbani, Masoud Amini. (2009) Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran. Diabetes/Metabolism Research and Reviews 25:8, 748-755
CrossRef877
H. Hesham A-Kader. (2009) Nonalcoholic fatty liver disease in children living in the obeseogenic society. World Journal of Pediatrics 5:4, 245-254
CrossRef878
Biju Cherian, Naga Meka, Srikanth Katragadda, Rohit Arora. (2009) Therapeutic Implications of Diabetes in Cardiovascular Disease. American Journal of Therapeutics 16:6, e51-e59
CrossRef879
Philip J. Saylor, Nancy L. Keating, Matthew R. Smith. (2009) Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy. Journal of General Internal Medicine 24:S2, 389-394
CrossRef880
Christopher P.F. Marinangeli, Amira N. Kassis, Peter J.H. Jones. (2009) Glycemic Responses and Sensory Characteristics of Whole Yellow Pea Flour Added to Novel Functional Foods. Journal of Food Science 74:9, S385-S389
CrossRef881
E. Succurro, M.A. Marini, F. Arturi, A. Grembiale, M. Lugarà, F. Andreozzi, A. Sciacqua, R. Lauro, M.L. Hribal, F. Perticone, G. Sesti. (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207:1, 245-249
CrossRef882
A. Fontbonne, I. Diouf, M. Baccara-Dinet, E. Eschwege, M.-A. Charles. (2009) Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: A post-hoc analysis of the BIGPRO1 trial. Diabetes & Metabolism 35:5, 385-391
CrossRef883
(2009) The Harmful Effects of Prolonged Strenuous Treadmill Exercise on Bronchoalveolar System in Rats. Journal of Life Science 19:10, 1352-1359
CrossRef884
Suzanne J Grant, Alan Bensoussan, Dennis Chang, Hosen Kiat, Nerida L Klupp, Jian Ping Liu, Xun Li, Suzanne J Grant. 2009. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose. .
CrossRef885
Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin, Adam H Balen, Adam H Balen. 2009. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. .
CrossRef886
Sairat Noknoy, Parinya Chamnan, Thunyarat Anothaisintawee, Sairat Noknoy. 2009. Theory-based behavioural interventions for prediabetic state and people with diabetes mellitus. .
CrossRef887
Yasuji Arase, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada, Hiroshi Tsuji, Tetsuro Kobayashi. (2009) Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. Journal of Gastroenterology 44:10, 1064-1070
CrossRef888
C Vázquez, C Montagna, F Alcaraz, J A Balsa, I Zamarrón, F Arrieta, J I Botella-Carretero. (2009) Meal replacement with a low-calorie diet formula in weight loss maintenance after weight loss induction with diet alone. European Journal of Clinical Nutrition 63:10, 1226-1232
CrossRef889
A. L. Carey, B. A. Kingwell. (2009) Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with ‘exercise mimetics’. Diabetologia 52:10, 2015-2026
CrossRef890
Lalita Khaodhiar, Sue Cummings, Caroline M. Apovian. (2009) Treating diabetes and prediabetes by focusing on obesity management. Current Diabetes Reports 9:5, 348-354
CrossRef891
John B. Dixon. (2009) Obesity and Diabetes: The Impact of Bariatric Surgery on Type-2 Diabetes. World Journal of Surgery 33:10, 2014-2021
CrossRef892
Jeffrey Derbas, Marion Vetter, Sheri Volger, Zahra Khan, Eva Panigrahi, Adam G. Tsai, David B. Sarwer, Thomas A. Wadden. (2009) Improving Weight Management in Primary Care Practice: A Possible Role for Auxiliary Health Professionals Collaborating with Primary Care Physicians. Obesity and Weight Management 5:5, 210-215
CrossRef893
Peter A. Hall, Gary M. Rodin, T. Michael Vallis, Bruce A. Perkins. (2009) The consequences of anxious temperament for disease detection, self-management behavior, and quality of life in Type 2 diabetes mellitus. Journal of Psychosomatic Research 67:4, 297-305
CrossRef894
Nathan A. Johnson, Toos Sachinwalla, David W. Walton, Kate Smith, Ashley Armstrong, Martin W. Thompson, Jacob George. (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50:4, 1105-1112
CrossRef895
Marc B. Lande, Joseph T. Flynn. (2009) Treatment of hypertension in children and adolescents. Pediatric Nephrology 24:10, 1939-1949
CrossRef896
Robert Branch, Ann Chester. (2009) Community-Based Participatory Clinical Research in Obesity by Adolescents: Pipeline for Researchers of the Future. Clinical and Translational Science 2:5, 350-354
CrossRef897
Lionel H. Opie, Juhani Knuuti. (2009) The Adrenergic-Fatty Acid Load in Heart Failure. Journal of the American College of Cardiology 54:18, 1637-1646
CrossRef898
W. G. Gao, Q. Qiao, J. Pitkäniemi, S. Wild, D. Magliano, J. Shaw, S. Söderberg, P. Zimmet, P. Chitson, S. Knowlessur, G. Alberti, J. Tuomilehto. (2009) Risk prediction models for the development of diabetes in Mauritian Indians. Diabetic Medicine 26:10, 996-1002
CrossRef899
I.-Min Lee, Reid Ewing, Howard D. Sesso. (2009) The Built Environment and Physical Activity LevelsThe Harvard Alumni Health Study. American Journal of Preventive Medicine 37:4, 293-298
CrossRef900
Amy D. Otto. (2009) Using meal replacements as a nutritional strategy for weight loss in type 2 diabetes. Current Diabetes Reports 9:5, 329-330
CrossRef901
Nancy C.W. ter Bogt, Wanda J.E. Bemelmans, Frank W. Beltman, Jan Broer, Andries J. Smit, Klaas van der Meer. (2009) Preventing Weight GainOne-Year Results of a Randomized Lifestyle Intervention. American Journal of Preventive Medicine 37:4, 270-277
CrossRef902
Hadi Selimoglu, Cevdet Duran, Sinem Kiyici, Metin Guclu, Canan Ersoy, Guven Ozkaya, Erdinc Erturk, Ercan Tuncel, Sazi Imamoglu. (2009) Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects. Endocrine 36:2, 299-304
CrossRef903
Morali D. Sharma, Alan J. Garber. (2009) What is the best treatment for prediabetes?. Current Diabetes Reports 9:5, 335-341
CrossRef904
Ali Yazdanyar, Anne B. Newman. (2009) Evolving concepts of cardiovascular disease prevention in older adults. Current Cardiovascular Risk Reports 3:5, 366-373
CrossRef905
Martin Burtscher, Hannes Gatterer, Herwig Kunczicky, Elisabeth Brandstätter, Hanno Ulmer. (2009) Supervised Exercise in Patients with Impaired Fasting Glucose: Impact on Exercise Capacity. Clinical Journal of Sport Medicine 19:5, 394-398
CrossRef906
Elaine C. Rush, Nic Crook, David Simmons. (2009) Optimal waist cutpoint for screening for dysglycaemia and metabolic risk: evidence from a Maori cohort. British Journal of Nutrition 102:05, 786
CrossRef907
Scott Baker, George Jerums, Joseph Proietto. (2009) Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes
CrossRef908
Gerald F. Watts, Esther M.M. Ooi, Dick C. Chan. (2009) Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo. Pharmacology & Therapeutics 123:3, 281-291
CrossRef909
Thomas D. Giles. (2009) Prevention of Type 2 Diabetes Mellitus to Reduce Cardiovascular Morbidity and Mortality: A Review of the Evidence. The Journal of Clinical Hypertension 11:9, 512-519
CrossRef910
Veer Chahwala, Rohit Arora. (2009) Cardiovascular Manifestations of Insulin Resistance. American Journal of Therapeutics 16:5, e14-e28
CrossRef911
Michelle C. Venables, Asker E. Jeukendrup. (2009) Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews 25:S1, S18-S23
CrossRef912
Rickie Brawer, Nancy Brisbon, James Plumb. (2009) Obesity and Cancer. Primary Care: Clinics in Office Practice 36:3, 509-531
CrossRef913
S. Balducci, S. Zanuso, F. Fernando, S. Fallucca, F. Fallucca, G. Pugliese. (2009) Physical activity/exercise training in type 2 diabetes. The role of the Italian Diabetes and Exercise Study. Diabetes/Metabolism Research and Reviews 25:S1, S29-S33
CrossRef914
Deborah Vincent. (2009) Culturally tailored education to promote lifestyle change in Mexican Americans with type 2 diabetes. Journal of the American Academy of Nurse Practitioners 21:9, 520-527
CrossRef915
George A. Bray. (2009) Medications for Obesity: Mechanisms and Applications. Clinics in Chest Medicine 30:3, 525-538
CrossRef916
K. Færch, K. Borch-Johnsen, J. J. Holst, A. Vaag. (2009) Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?. Diabetologia 52:9, 1714-1723
CrossRef917
Dong-Churl Suh, Chul-Min Kim, In-Sun Choi, Craig A Plauschinat, Joseph A Barone. (2009) Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004. Journal of Hypertension 27:9, 1908-1916
CrossRef918
Beena Akolkar, Robert Karp, Paul L Kimmel, Catherine McKeon, Rebekah S Rasooly. (2009) Fostering translation of genetics research: an NIDDK perspective. Personalized Medicine 6:5, 579-588
CrossRef919
Kendra K. Kattelmann, Kibbe Conti, Cuirong Ren. (2009) The Medicine Wheel Nutrition Intervention: A Diabetes Education Study with the Cheyenne River Sioux Tribe. Journal of the American Dietetic Association 109:9, 1532-1539
CrossRef920
G. Pugliese, S. Zanuso, E. Alessi, P. Simonelli, S. Fallucca, F. Fallucca, S. Balducci. (2009) Self glucose monitoring and physical exercise in diabetes. Diabetes/Metabolism Research and Reviews 25:S1, S11-S17
CrossRef921
Michael R. Jones, Sunder Mudaliar, Eric Hernandez-Triana, Ambika G. Unnikrishnan, Yu-Ling Lai, Stacey L. Abby, Soamnauth Misir, Xiaoping Jin, Sukumar Nagendran. (2009) Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes. Current Medical Research and Opinion 25:9, 2239-2249
CrossRef922
C.J. Glueck,, N. Goldenberg,, P. Wang,. (2009) Metformin-Diet Ameliorates Coronary Heart Disease Risk Factors and Facilitates Resumption of Regular Menses in Adolescents with Polycystic Ovary Syndrome. Journal of Pediatric Endocrinology and Metabolism 22:9, 815-826
CrossRef923
Mark C. Houston, Sergio Fazio, Floyd H. Chilton, Dan E. Wise, Kathryn B. Jones, Thomas A. Barringer, Dean A. Bramlet. (2009) Nonpharmacologic Treatment of Dyslipidemia. Progress in Cardiovascular Diseases 52:2, 61-94
CrossRef924
Catherine ROLLAND, Michelle HESSION, Susan MURRAY, Alan WISE, Iain BROOM. (2009) Randomized clinical trial of standard dietary treatment versus a low-carbohydrate/high-protein diet or the LighterLife Programme in the management of obesity. Journal of Diabetes 1:3, 207-217
CrossRef925
P.E.H. Schwarz, D. Köhler, R. Hoffmann, R. Landgraf. (2009) Prävention des Diabetes mellitus Typ 2. Der Diabetologe 5:6, 471-486
CrossRef926
Arlen L. Rosenbloom, Janet H. Silverstein, Shin Amemiya, Phil Zeitler, Georgeanna J Klingensmith. (2009) Type 2 diabetes in children and adolescents. Pediatric Diabetes 10, 17-32
CrossRef927
Ed J. Hendricks, Richard B. Rothman, Frank L. Greenway. (2009) How Physician Obesity Specialists Use Drugs to Treat Obesity. Obesity 17:9, 1730-1735
CrossRef928
C. Noel Bairey Merz, Mark J. Alberts, Gary J. Balady, Christie M. Ballantyne, Kathy Berra, Henry R. Black, Roger S. Blumenthal, Michael H. Davidson, Sara B. Fazio, Keith C. Ferdinand, Lawrence J. Fine, Vivian Fonseca, Barry A. Franklin, Patrick E. McBride, George A. Mensah, Geno J. Merli, Patrick T. O'Gara, Paul D. Thompson, James A. Underberg. (2009) ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease. Journal of the American College of Cardiology 54:14, 1336-1363
CrossRef929
Silvano Zanuso, Stefano Balducci, Alfonso Jimenez. (2009) Physical activity, a key factor to quality of life in type 2 diabetic patients. Diabetes/Metabolism Research and Reviews 25:S1, S24-S28
CrossRef930
Emily J. Jones, Cathy C. Roche, Susan J. Appel. (2009) A Review of the Health Beliefs and Lifestyle Behaviors of Women with Previous Gestational Diabetes. Journal of Obstetric, Gynecologic, & Neonatal Nursing 38:5, 516-526
CrossRef931
Gregor McCombie, Lucy M. Browning, Christopher M. Titman, Molly Song, John Shockcor, Susan A. Jebb, Julian L. Griffin. (2009) ω-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids. Metabolomics 5:3, 363-374
CrossRef932
Katie Larson Ode, Brigitte I. Frohnert, Brandon M. Nathan. (2009) Identification and treatment of metabolic complications in pediatric obesity. Reviews in Endocrine and Metabolic Disorders 10:3, 167-188
CrossRef933
Adam Gilden Tsai, Thomas A. Wadden. (2009) Treatment of Obesity in Primary Care Practice in the United States: A Systematic Review. Journal of General Internal Medicine 24:9, 1073-1079
CrossRef934
M. De Hert, J.M. Dekker, D. Wood, K.G. Kahl, R.I.G. Holt, H.-J. Möller. (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 24:6, 412-424
CrossRef935
Lawrence J. Appel. (2009) ASH position paper: Dietary approaches to lower blood pressure. Journal of the American Society of Hypertension 3:5, 321-331
CrossRef936
Aaron L. Carrel, David B. Allen. (2009) The influence of fitness on insulin resistance in obese children. Reviews in Endocrine and Metabolic Disorders 10:3, 189-196
CrossRef937
William D.
C. Man, Paul Kemp, John Moxham, Michael I. Polkey. (2009) Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation. Clinical Science 117:8, 281-291
CrossRef938
T. Likhari, R. Gama. (2009) Algorithm combining HbA 1c and fasting plasma glucose for screening subjects for OGTT. Diabetic Medicine 26:8, 830-831
CrossRef939
Feng Sun, Qiushan Tao, Siyan Zhan. (2009) An accurate risk score for estimation 5-year risk of type 2 diabetes based on a health screening population in Taiwan. Diabetes Research and Clinical Practice 85:2, 228-234
CrossRef940
John B. Dixon, Kay Jones, Maureen Dixon. (2009) Medical versus surgical interventions for the metabolic complications of obesity in children. Seminars in Pediatric Surgery 18:3, 168-175
CrossRef941
Susan B. Racette, Susan S. Deusinger, Cindi L. Inman, Tamara L. Burlis, Gabrielle R. Highstein, Trent D. Buskirk, Karen Steger-May, Linda R. Peterson. (2009) Worksite Opportunities for Wellness (WOW): Effects on cardiovascular disease risk factors after 1 year. Preventive Medicine 49:2-3, 108-114
CrossRef942
Carole N. Kamga-Ngandé, André C. Carpentier, Frédérique Nadeau-Marcotte, Jean-Luc Ardilouze, Jean-Patrice Baillargeon, Diego Bellabarba, Ghislaine Houde, Marie-France Langlois. (2009) Effectiveness of a Multidisciplinary Program for Management of Obesity: The Unité d’Enseignement, de Traitement et de Recherche sur l’Obésité (UETRO) Database Study. Metabolic Syndrome and Related Disorders 7:4, 297-304
CrossRef943
Kirsten J. Coppell, David C. Tipene-Leach, Helen L.R. Pahau, Sheila M. Williams, Sally Abel, Mark Iles, Jennie Harré Hindmarsh, Jim I. Mann. (2009) Two-year results from a community-wide diabetes prevention intervention in a high risk indigenous community: The Ngati and Healthy project
CrossRef944
F.G. Masuccio,, P.M. Lattanzio,, S. Matera,, C. Giannini,, F. Chiarelli,, A. Mohn,. (2009) Insulin Sensitivity in Prepubertal Caucasian Normal Weight Children. Journal of Pediatric Endocrinology and Metabolism 22:8, 695-702
CrossRef945
Hugo Saner, David Wood. (2009) Practical organisation of preventive cardiology programmes: integrating prevention and rehabilitation. European Journal of Cardiovascular Prevention & Rehabilitation 16:Supplement 1, S37-S42
CrossRef946
Jonathan Q. Purnell. (2009) Obesity: Calories or content: what is the best weight-loss diet?. Nature Reviews Endocrinology 5:8, 419-420
CrossRef947
(2009) HEALTHY study rationale, design and methods: moderating risk of type 2 diabetes in multi-ethnic middle school students. International Journal of Obesity 33, S4-S20
CrossRef948
A. Kautzky-Willer, A. Handisurya. (2009) Metabolic diseases and associated complications: sex and gender matter!. European Journal of Clinical Investigation 39:8, 631-648
CrossRef949
Bryan K. Smith, Emily L. Van Walleghen, Galen Cook-Wiens, Rachael N. Martin, Chelsea R. Curry, Debra K. Sullivan, Cheryl A. Gibson, Joseph E. Donnelly. (2009) Comparison of two self-directed weight loss interventions: Limited weekly support vs. no outside support. Obesity Research & Clinical Practice 3:3, 149-157
CrossRef950
Jian-liang Zhang, Xing Zheng, Da-jin Zou, Jian-li Qiu, Xian-xian Zhao, Yong-wen Qin. (2009) Effect of Metformin on Weight Gain During Antihypertensive Treatment With a β-Blocker in Chinese Patients. American Journal of Hypertension 22:8, 884-890
CrossRef951
KATARINA T. BORER, ELIZABETH C. WUORINEN, JAMIE R. LUKOS, JOHN W. DENVER, STEPHEN W. PORGES, CHARLES F. BURANT. (2009) Two Bouts of Exercise before Meals, but Not after Meals, Lower Fasting Blood Glucose. Medicine & Science in Sports & Exercise 41:8, 1606-1614
CrossRef952
Kiyoshi Sanada, Motohiko Miyachi, Izumi Tabata, Katsuhiko Suzuki, Kenta Yamamoto, Hiroshi Kawano, Chiyoko Usui, Mitsuru Higuchi. (2009) Differences in body composition and risk of lifestyle-related diseases between young and older male rowers and sedentary controls. Journal of Sports Sciences 27:10, 1027-1034
CrossRef953
Faidon Magkos, Mary Yannakoulia, Jean L. Chan, Christos S. Mantzoros. (2009) Management of the Metabolic Syndrome and Type 2 Diabetes Through Lifestyle Modification. Annual Review of Nutrition 29:1, 223-256
CrossRef954
Sian Hoe Cheong, Linda J. McCargar, Breay W. Paty, Catrine Tudor-Locke, Rhonda C. Bell. (2009) The First Step First Bite Program: Guidance to Increase Physical Activity and Daily Intake of Low–Glycemic Index Foods. Journal of the American Dietetic Association 109:8, 1411-1416
CrossRef955
Denise S. Hill, Bogdan J. Wlodarczyk, Laura E. Mitchell, Richard H. Finnell. (2009) Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model. Toxicology and Applied Pharmacology 239:1, 29-36
CrossRef956
J. H. O'Keefe, M. D. Carter, C. J. Lavie. (2009) Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach. Mayo Clinic Proceedings 84:8, 741-757
CrossRef957
Andrew W. Norris, Joseph I. Wolfsdorf. 2009. Diabetes Mellitus. , 458-504.
CrossRef958
Michael Freemark. 2009. Childhood Obesity. , 530-558.
CrossRef959
Volpp, Kevin G., Das, Anup. (2009) Comparative Effectiveness — Thinking beyond Medication A versus Medication B. New England Journal of Medicine 361:4, 331-333
Full Text960
Nathan Y. Weltman, Susan A. Saliba, Eugene J. Barrett, Arthur Weltman. (2009) The Use of Exercise in the Management of Type 1 and Type 2 Diabetes. Clinics in Sports Medicine 28:3, 423-439
CrossRef961
Renata Kielnar, Edyta Selwa, Elżbieta Domka-Jopek, Sławomir Snela. (2009) Wpływ systematycznego ambulatoryjnego treningu fizycznego na wartości ciśnienia tętniczego u osób z chorobą niedokrwienną serca. Physiotherapy 17:3, 7-16
CrossRef962
Rebecca S Stiegler, Paul Z Zimmet, Adrian J Cameron, Jonathan E Shaw. (2009) Lifestyle management: preventing Type 2 diabetes and cardiovascular complications. Therapy 6:4, 489-496
CrossRef963
Miranda J. Velthuis, Albertine J. Schuit, Petra H.M. Peeters, Evelyn M. Monninkhof. (2009) Exercise program affects body composition but not weight in postmenopausal women. Menopause 16:4, 777-784
CrossRef964
Anthony McCall, Ramona Raj. (2009) Exercise for Prevention of Obesity and Diabetes in Children and Adolescents. Clinics in Sports Medicine 28:3, 393-421
CrossRef965
Wataru Fukuo, Kazuhiro Yoshiuchi, Ken Ohashi, Hitomi Togashi, Rie Sekine, Hiroe Kikuchi, Noriyuki Sakamoto, Shuji Inada, Fumiyo Sato, Takashi Kadowaki, Akira Akabayashi. (2009) Development of a Hand-Held Personal Digital Assistant–Based Food Diary with Food Photographs for Japanese Subjects. Journal of the American Dietetic Association 109:7, 1232-1236
CrossRef966
M. Rodríguez-Morán, F. Guerrero-Romero, R.A. Rascón-Pacheco. (2009) Dietary factors related to the increase of cardiovascular risk factors in traditional Tepehuanos communities from Mexico. A 10 year follow-up study. Nutrition, Metabolism and Cardiovascular Diseases 19:6, 409-416
CrossRef967
Souzana Choussein, Angeliki A. Makri, Constantinos C. Frangos, Eleni Th. Petridou, Stella S. Daskalopoulou. (2009) Effect of antiobesity medications in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 11:7, 641-664
CrossRef968
Dean Ornish. (2009) Intensive lifestyle changes and health reform. The Lancet Oncology 10:7, 638-639
CrossRef969
S. Bo, G. Ciccone, I. Baldi, R. Gambino, C. Mandrile, M. Durazzo, L. Gentile, M. Cassader, P. Cavallo-Perin, G. Pagano. (2009) Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers. Nutrition, Metabolism and Cardiovascular Diseases 19:6, 423-430
CrossRef970
Birna Bjarnason-Wehrens, Olaf Schulz, Stephan Gielen, Martin Halle, Martin Dürsch, Rainer Hambrecht, Heinz Lowis, Wilfried Kindermann, Robin Schulze, Bernhard Rauch. (2009) Leitlinie körperliche Aktivität zur Sekundärprävention und Therapie kardiovaskulärer Erkrankungen. Clinical Research in Cardiology Supplements 4:S3, 1-44
CrossRef971
David C. Lieb, Rodney E. Snow, Mark D. DeBoer. (2009) Socioeconomic Factors in the Development of Childhood Obesity and Diabetes. Clinics in Sports Medicine 28:3, 349-378
CrossRef972
N. Stefan, A. Fritsche, H.-U. Häring. (2009) Individualisierte Prävention des Typ-2-Diabetes. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 52:7, 677-682
CrossRef973
Timothy M. Dall, Victor L. Fulgoni, Yiduo Zhang, Kristin J. Reimers, Patricia T. Packard, James D. Astwood. (2009) Predicted National Productivity Implications of Calorie and Sodium Reductions in the American Diet. American Journal of Health Promotion 23:6, 423-430
CrossRef974
J. M. Gabriele, P. M. Dubbert, R. R. Reeves. (2009) Efficacy of behavioural interventions in managing atypical antipsychotic weight gain. Obesity Reviews 10:4, 442-455
CrossRef975
T J Wilkin. (2009) The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. International Journal of Obesity 33:7, 716-726
CrossRef976
Diana Redwood, Mary C. Schumacher, Anne P. Lanier, Elizabeth D. Ferucci, Elvin Asay, Laurie J. Helzer, Lillian Tom-Orme, Sandra L. Edwards, Maureen A. Murtaugh, Martha L. Slattery. (2009) Physical Activity Patterns of American Indian and Alaskan Native People Living in Alaska and the Southwestern United States. American Journal of Health Promotion 23:6, 388-395
CrossRef977
John M. MacKnight, Dilaawar J. Mistry, Joyce Green Pastors, Viola Holmes, Corey A. Rynders. (2009) The Daily Management of Athletes with Diabetes. Clinics in Sports Medicine 28:3, 479-495
CrossRef978
J. H. Jendle. (2009) Resource utilisation and costs for the treatment of diabetes in the developed world: an economical burden that needs to be solved. International Journal of Clinical Practice 63:7, 980-982
CrossRef979
Timothy M. Dall, Victor L. Fulgoni, Yiduo Zhang, Kristin J. Reimers, Patricia T. Packard, James D. Astwood. (2009) Potential Health Benefits and Medical Cost Savings From Calorie, Sodium, and Saturated Fat Reductions in the American Diet. American Journal of Health Promotion 23:6, 412-422
CrossRef980
Alexis St. George, Adrian Bauman, Amanda Johnston, Geoffrey Farrell, Tien Chey, Jacob George. (2009) Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 50:1, 68-76
CrossRef981
Lawrence J. Appel, . (2009) ASH Position Paper: Dietary Approaches to Lower Blood Pressure. The Journal of Clinical Hypertension 11:7, 358-368
CrossRef982
Adam G Tabák, Markus Jokela, Tasnime N Akbaraly, Eric J Brunner, Mika Kivimäki, Daniel R Witte. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. The Lancet 373:9682, 2215-2221
CrossRef983
Jack L. Leahy. (2009) Thiazolidinediones in prediabetes and early type 2 diabetes: What can be learned about that disease’s pathogenesis. Current Diabetes Reports 9:3, 215-220
CrossRef984
Lisa Rafalson, Richard P. Donahue, Jacek Dmochowski, Karol Rejman, Joan Dorn, Maurizio Trevisan. (2009) Cigarette Smoking Is Associated with Conversion from Normoglycemia to Impaired Fasting Glucose: The Western New York Health Study. Annals of Epidemiology 19:6, 365-371
CrossRef985
Gregory R. Steinberg. (2009) Role of the AMP-activated protein kinase in regulating fatty acid metabolism during exerciseThis paper is one of a selection of papers published in this Special Issue, entitled 14th International Biochemistry of Exercise Conference – Muscles as Molecular and Metabolic Machines, and has undergone the Journal’s usual peer review process.. Applied Physiology, Nutrition, and Metabolism 34:3, 315-322
CrossRef986
David R Matthews, Jonathan C Levy. (2009) Impending type 2 diabetes. The Lancet 373:9682, 2178-2179
CrossRef987
Myrto Eliades, Anastassios G. Pittas. (2009) Vitamin D and Type 2 Diabetes. Clinical Reviews in Bone and Mineral Metabolism 7:2, 185-198
CrossRef988
Tara Boinpally, Lois Jovanovič. (2009) Management of Type 2 Diabetes and Gestational Diabetes in Pregnancy. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76:3, 269-280
CrossRef989
Michiko MORIYAMA, Masumi NAKANO, Yuriko KUROE, Kazuko NIN, Mayumi NIITANI, Takashi NAKAYA. (2009) Efficacy of a self-management education program for people with type 2 diabetes: Results of a 12 month trial. Japan Journal of Nursing Science 6:1, 51-63
CrossRef990
Robert Ross, Alison J. Bradshaw. (2009) The future of obesity reduction: beyond weight loss. Nature Reviews Endocrinology 5:6, 319-326
CrossRef991
Yiduo Zhang, Timothy M. Dall, Yaozhu Chen, Alan Baldwin, Wenya Yang, Sarah Mann, Victoria Moore, Elisabeth Le Nestour, William W. Quick. (2009) Medical Cost Associated with Prediabetes. Population Health Management 12:3, 157-163
CrossRef992
Elin Olafsdottir, Thor Aspelund, Gunnar Sigurdsson, Bolli Thorsson, Rafn Benediktsson, Tamara B. Harris, Lenore J. Launer, Gudny Eiriksdottir, Vilmundur Gudnason. (2009) Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility—Reykjavik Study (AGES-Reykjavik). European Journal of Epidemiology 24:6, 307-314
CrossRef993
A. C. Dale, K. Midthjell, T. I. Nilsen, R. Wiseth, L. J. Vatten. (2009) Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway. European Heart Journal 30:11, 1372-1377
CrossRef994
Matthew Potenza, Elliot J. Rayfield. (2009) Targeting the Incretin System in Type 2 Diabetes Mellitus. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76:3, 244-256
CrossRef995
Masoud Amini, Mohsen Janghorbani. (2009) Comparison of metabolic syndrome with glucose measurement for prediction of type 2 diabetes: The Isfahan Diabetes Prevention Study. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 3:2, 84-89
CrossRef996
Eva Corpeleijn, Stephan J. L. Bakker, Ronald P. Stolk. (2009) Obesity and impaired renal function: potential for lifestyle intervention?. European Journal of Epidemiology 24:6, 275-280
CrossRef997
G. Forlani, C. Lorusso, S. Moscatiello, V. Ridolfi, N. Melchionda, S. Di Domizio, G. Marchesini. (2009) Are behavioural approaches feasible and effective in the treatment of type 2 diabetes? A propensity score analysis vs. prescriptive diet. Nutrition, Metabolism and Cardiovascular Diseases 19:5, 313-320
CrossRef998
Patrick M. Heck, David P. Dutka. (2009) Insulin resistance and heart failure. Current Heart Failure Reports 6:2, 89-94
CrossRef999
Heather D. Clark, Ian D. Graham, Alan Karovitch, Erin J. Keely. (2009) Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. American Journal of Obstetrics and Gynecology 200:6, 634.e1-634.e7
CrossRef1000
Nichola Davis, Bernice Forbes, Judith Wylie-Rosett. (2009) Nutritional Strategies in Type 2 Diabetes Mellitus. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76:3, 257-268
CrossRef1001
U.-M. Vischer, B. Bauduceau, I. Bourdel-Marchasson, J.-F. Blickle, T. Constans, A. Fagot-Campagna, E. Kaloustian, V. Lassman-Vague, P. Lecomte, D. Simon, D. Tessier, C. Verny, J. Doucet. (2009) A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly. Diabetes & Metabolism 35:3, 168-177
CrossRef1002
Prasanth N. Surampudi, Jennifer John-Kalarickal, Vivian A. Fonseca. (2009) Emerging Concepts in the Pathophysiology of Type 2 Diabetes Mellitus. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 76:3, 216-226
CrossRef1003
Jennifer M. Devine, Ross D. Zafonte. (2009) Physical Exercise and Cognitive Recovery in Acquired Brain Injury: A Review of the Literature. PM&R 1:6, 560-575
CrossRef1004
Huiguang Tian, Guide Song, Hongxiang Xie, Hong Zhang, Jaakko Tuomilehto, Gang Hu. (2009) Prevalence of diabetes and impaired fasting glucose among 769792 rural Chinese adults. Diabetes Research and Clinical Practice 84:3, 273-278
CrossRef1005
Patricio López-Jaramillo. (2009) Enfermedades cardiometabólicas en Iberoamérica: papel de la programación fetal en respuesta a la desnutrición materna. Revista Española de Cardiología 62:6, 670-676
CrossRef1006
Simona Giampaoli, Jeremiah Stamler, Chiara Donfrancesco, Salvatore Panico, Diego Vanuzzo, Giancarlo Cesana, Giuseppe Mancia, Lorenza Pilotto, Amalia Mattiello, Paolo Chiodini, Luigi Palmieri. (2009) The metabolic syndrome: A critical appraisal based on the CUORE epidemiologic study. Preventive Medicine 48:6, 525-531
CrossRef1007
Alethea N. Hill, Cathy Roche, Susan J. Appel. (2009) Signs of improvement. The Nurse Practitioner 34:6, 12-22
CrossRef1008
Barbara Schiltz, Deanna M. Minich, Robert H. Lerman, Joseph J. Lamb, Matthew L. Tripp, Jeffrey S. Bland. (2009) A Science-Based, Clinically Tested Dietary Approach for the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 7:3, 187-192
CrossRef1009
Richelle J. Koopman, Sarah J. Swofford, Mark N. Beard, Susan E. Meadows. (2009) Obesity and Metabolic Disease. Primary Care: Clinics in Office Practice 36:2, 257-270
CrossRef1010
A. Ramachandran, C. Snehalatha, S. Mary, S. Selvam, C. K. S. Kumar, A. C. Seeli, A. S. Shetty. (2009) Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia 52:6, 1019-1026
CrossRef1011
Tae-Yong Lee, Kwang-Hwan Kim. (2009) A Study on the Treatment Status and Treatment Compliance of Diabetics Who Visited the Health Centers of Daejeon City. Journal of the Korea Academia-Industrial cooperation Society 10:5, 1141-1147
CrossRef1012
M. Ristow, K. Zarse, A. Oberbach, N. Kloting, M. Birringer, M. Kiehntopf, M. Stumvoll, C. R. Kahn, M. Bluher. (2009) Antioxidants prevent health-promoting effects of physical exercise in humans. Proceedings of the National Academy of Sciences 106:21, 8665-8670
CrossRef1013
R. Ballard-Barbash, S. Hunsberger, M. H. Alciati, S. N. Blair, P. J. Goodwin, A. McTiernan, R. Wing, A. Schatzkin. (2009) Physical Activity, Weight Control, and Breast Cancer Risk and Survival: Clinical Trial Rationale and Design Considerations. JNCI Journal of the National Cancer Institute 101:9, 630-643
CrossRef1014
Carl J. Lavie, Richard V. Milani, Hector O. Ventura. (2009) Obesity and Cardiovascular Disease. Journal of the American College of Cardiology 53:21, 1925-1932
CrossRef1015
Laura L. Hayman, Mercy W. Kamau, Eileen M. Stuart-Shor. (2009) The heart of the matter. The Nurse Practitioner 34:5, 30-35
CrossRef1016
Shelly-Ann Hunte, Marshall Tulloch-Reid. (2009) Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program. Current Cardiovascular Risk Reports 3:3, 157-158
CrossRef1017
Keane K. Lee, Stephen P. Fortmann, Joan M. Fair, Carlos Iribarren, Geoffrey D. Rubin, Ann Varady, Alan S. Go, Thomas Quertermous, Mark A. Hlatky. (2009) Insulin resistance independently predicts the progression of coronary artery calcification. American Heart Journal 157:5, 939-945
CrossRef1018
A. N. Fabricatore, T. A. Wadden, R. H. Moore, M. L. Butryn, E. A. Gravallese, N. E. Erondu, S. B. Heymsfield, A. M. Nguyen. (2009) Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis. Obesity Reviews 10:3, 333-341
CrossRef1019
Yang-Xin Chen, Chong-Feng Fang, XiaoQiao Wang, Ru-Qiong Nie, GuoQi Li, LiJiang Tang, Shu-Xian Zhou, Jing-Feng Wang. (2009) Glucometabolic state of in-hospital primary hypertension patients with normal fasting blood glucose in a sub-population of China. Diabetes/Metabolism Research and Reviews 25:4, 357-362
CrossRef1020
Alison J. Huang, Anita L. Stewart, Alexandra L. Hernandez, Hui Shen, Leslee L. Subak. (2009) Sexual Function Among Overweight and Obese Women With Urinary Incontinence in a Randomized Controlled Trial of an Intensive Behavioral Weight Loss Intervention. The Journal of Urology 181:5, 2235-2242
CrossRef1021
Ronald C. Plotnikoff, Linda Trinh, Kerry S. Courneya, Nandini Karunamuni, Ronald J. Sigal. (2009) Predictors of aerobic physical activity and resistance training among Canadian adults with type 2 diabetes: An application of the Protection Motivation Theory. Psychology of Sport and Exercise 10:3, 320-328
CrossRef1022
Elena Succurro, Maria Adelaide Marini, Alessandro Grembiale, Marina Lugarà, Francesco Andreozzi, Angela Sciacqua, Marta Letizia Hribal, Renato Lauro, Francesco Perticone, Giorgio Sesti. (2009) Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. Diabetes/Metabolism Research and Reviews 25:4, 351-356
CrossRef1023
Ryuzo Kawamori, Naoko Tajima, Yasuhiko Iwamoto, Atsunori Kashiwagi, Kazuaki Shimamoto, Kohei Kaku. (2009) Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. The Lancet 373:9675, 1607-1614
CrossRef1024
Rena R. Wing, Angela M. Pinto, Melissa M. Crane, Rajiv Kumar, Brad M. Weinberg, Amy A. Gorin. (2009) A Statewide Intervention Reduces BMI in Adults: Shape Up Rhode Island Results. Obesity 17:5, 991-995
CrossRef1025
B. Viollet, B. Guigas, J. Leclerc, S. Hébrard, L. Lantier, R. Mounier, F. Andreelli, M. Foretz. (2009) AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiologica 196:1, 81-98
CrossRef1026
H. Kleinwechter. (2009) Diabetes und Schwangerschaft – Update 2009. Der Diabetologe 5:3, 200-208
CrossRef1027
Philip J. Saylor, Matthew R. Smith. (2009) Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer. The Journal of Urology 181:5, 1998-2008
CrossRef1028
Dale S. Bond, Rena R. Wing. (2009) Behavioral interventions for the treatment of obesity in women with or at risk for cardiovascular disease. Current Cardiovascular Risk Reports 3:3, 219-225
CrossRef1029
P. C. Calder, R. Albers, J.-M. Antoine, S. Blum, R. Bourdet-Sicard, G. A. Ferns, G. Folkerts, P. S. Friedmann, G. S. Frost, F. Guarner, M. Løvik, S. Macfarlane, P. D. Meyer, L. M'Rabet, M. Serafini, W. van Eden, J. van Loo, W. Vas Dias, S. Vidry, B. M. Winklhofer-Roob, J. Zhao. (2009) Inflammatory Disease Processes and Interactions with Nutrition. British Journal of Nutrition 101:S1, 1
CrossRef1030
István Barna. (2009) A prediabéteszhez társult hypertonia kezelése. Orvosi Hetilap 150:20, 917-923
CrossRef1031
Robert F. Kushner, Melissa Sujak. (2009) Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone. Obesity 17:5, 1017-1022
CrossRef1032
Jun Ma, Lan Xiao, Randall S. Stafford. (2009) Adult Obesity and Office-based Quality of Care in the United States. Obesity 17:5, 1077-1085
CrossRef1033
André J Scheen. (2009) Voglibose for prevention of type 2 diabetes mellitus. The Lancet 373:9675, 1579-1580
CrossRef1034
Vicki S. Conn, Adam R. Hafdahl, Shirley M. Moore, Paul J. Nielsen, Lori M. Brown. (2009) Meta-analysis of interventions to increase physical activity among cardiac subjects
CrossRef1035
J. N. Basile. (2009) Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. International Journal of Clinical Practice 63:4, 656-666
CrossRef1036
Thomas A. Wadden, Delia S. West, Rebecca H. Neiberg, Rena R. Wing, Donna H. Ryan, Karen C. Johnson, John P. Foreyt, James O. Hill, Dace L. Trence, Mara Z. Vitolins. (2009) One-year Weight Losses in the Look AHEAD Study: Factors Associated With Success. Obesity 17:4, 713-722
CrossRef1037
Mousa A. Abujbara, Kamel M. Ajlouni. (2009) Approach to dysglycemia: Do we need to treat impaired glucose tolerance and impaired fasting glucose?. International Journal of Diabetes Mellitus 1:1, 22-25
CrossRef1038
Ravi Retnakaran, Ying Qi, Mathew Sermer, Philip W. Connelly, Bernard Zinman, Anthony J. G. Hanley. (2009) Pre-gravid physical activity and reduced risk of glucose intolerance in pregnancy: the role of insulin sensitivity. Clinical Endocrinology 70:4, 615-622
CrossRef1039
Mira Aubuchon, Neil Laughbaum, Amy Poetker, Daniel Williams, Michael Thomas. (2009) Supervised short-term nutrition and exercise promotes weight loss in overweight and obese patients with polycystic ovary syndrome. Fertility and Sterility 91:4, 1336-1338
CrossRef1040
A. K. Gupta, S. R. Smith, F. L. Greenway, G. A. Bray. (2009) Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome. Diabetes, Obesity and Metabolism 11:4, 330-337
CrossRef1041
David B. Allison, John W. Newcomer, Andrea L. Dunn, James A. Blumenthal, Anthony N. Fabricatore, Gail L. Daumit, Mark B. Cope, William T. Riley, Betty Vreeland, Joseph R. Hibbeln, Jonathan E. Alpert. (2009) Obesity Among Those with Mental Disorders. American Journal of Preventive Medicine 36:4, 341-350
CrossRef1042
Yasuaki Hayashino, Charles H. Hennekens, Tobias Kurth. (2009) Aspirin Use and Risk of Type 2 Diabetes in Apparently Healthy Men. The American Journal of Medicine 122:4, 374-379
CrossRef1043
Katherine J Frachetti, Allison B Goldfine. (2009) Bariatric surgery for diabetes management. Current Opinion in Endocrinology, Diabetes and Obesity 16:2, 119-124
CrossRef1044
Sheela N. Magge, Nicolas Stettler, Abbas F. Jawad, Lorraine E. Levitt Katz. (2009) Increased Prevalence of Abnormal Glucose Tolerance among Obese Siblings of Children with Type 2 Diabetes. The Journal of Pediatrics 154:4, 562-566.e1
CrossRef1045
Laura E. Shay, Jennifer L. Shobert, Diane Seibert, Lauren E. Thomas. (2009) Adult weight management: Translating research and guidelines into practice. Journal of the American Academy of Nurse Practitioners 21:4, 197-206
CrossRef1046
M. Katherine Hoy, Barbara L. Winters, Rowan T. Chlebowski, Constantina Papoutsakis, Alice Shapiro, Michele P. Lubin, Cynthia A. Thomson, Mary B. Grosvenor, Trisha Copeland, Elyse Falk, Kristina Day, George L. Blackburn. (2009) Implementing a Low-Fat Eating Plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association 109:4, 688-696
CrossRef1047
David Jacobi, Marie-Aline Charles, Muriel Tafflet, Agnès Lommez, Jean-Michel Borys, Jean-Michel Oppert. (2009) Relationships of self-reported physical activity domains with accelerometry recordings in French adults. European Journal of Epidemiology 24:4, 171-179
CrossRef1048
Stephen Colagiuri, Daniel Davies. (2009) The value of early detection of type 2 diabetes. Current Opinion in Endocrinology, Diabetes and Obesity 16:2, 95-99
CrossRef1049
Yiduo Zhang, Timothy M. Dall, Sarah E. Mann, Yaozhu Chen, Jaana Martin, Victoria Moore, Alan Baldwin, Viviana A. Reidel, William W. Quick. (2009) The Economic Costs of Undiagnosed Diabetes. Population Health Management 12:2, 95-101
CrossRef1050
Joanne WY Chung, Louisa MY Chung, Bob Chen. (2009) The impact of lifestyle on the physical fitness of primary school children. Journal of Clinical Nursing 18:7, 1002-1009
CrossRef1051
Lucinda J. England, Patricia M. Dietz, Terry Njoroge, William M. Callaghan, Carol Bruce, Rebecca M. Buus, David F. Williamson. (2009) Preventing type 2 diabetes: public health implications for women with a history of gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 200:4, 365.e1-365.e8
CrossRef1052
Iwona Rudkowska. (2009) Functional foods for health: Focus on diabetes. Maturitas 62:3, 263-269
CrossRef1053
Susan Hazels Mitmesser. 2009. Cardiovascular Issues. , 397-413.
CrossRef1054
R. Villegas, X.O. Shu, G. Yang, C.E. Matthews, H. Li, H. Cai, Y. Gao, W. Zheng. (2009) Energy balance and type 2 diabetes: A report from the Shanghai Women's Health Study. Nutrition, Metabolism and Cardiovascular Diseases 19:3, 190-197
CrossRef1055
Alexis St. George, Adrian Bauman, Amanda Johnston, Geoffrey Farrell, Tien Chey, Jacob George. (2009) Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. Journal of Gastroenterology and Hepatology 24:3, 399-407
CrossRef1056
Giuseppe Derosa, Sibilla A. T. Salvadeo, Angela D’Angelo, Ilaria Ferrari, Roberto Mereu, Ilaria Palumbo, Pamela Maffioli, Sabrina Randazzo, Arrigo F. G. Cicero. (2009) Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial. Current Medical Research and Opinion 25:3, 607-615
CrossRef1057
A. Enrique Caballero. (2009) Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes. Journal of Diabetes and its Complications 23:2, 143-152
CrossRef1058
K. Chien, T. Cai, H. Hsu, T. Su, W. Chang, M. Chen, Y. Lee, F. B. Hu. (2009) A prediction model for type 2 diabetes risk among Chinese people. Diabetologia 52:3, 443-450
CrossRef1059
Cheryl Roumen, Ellen E Blaak, Eva Corpeleijn. (2009) Lifestyle intervention for prevention of diabetes: determinants of success for future implementation. Nutrition Reviews 67:3, 132-146
CrossRef1060
Anne Daly, Pam Michael, Elvira Q. Johnson, Carolyn C. Harrington, Stephanie Patrick, Tori Bender. (2009) Diabetes White Paper: Defining the Delivery of Nutrition Services in Medicare Medical Nutrition Therapy vs Medicare Diabetes Self-Management Training Programs. Journal of the American Dietetic Association 109:3, 528-539
CrossRef1061
Lauren Gellar, Tonja R. Nansel. (2009) High and Low Glycemic Index Mixed Meals and Blood Glucose in Youth with Type 2 Diabetes or Impaired Glucose Tolerance. The Journal of Pediatrics 154:3, 455-458
CrossRef1062
Sorin Ursoniu. (2009) Primordial prevention, developing countries and the epidemiological transition: thirty years later. Wiener klinische Wochenschrift 121:5-6, 168-172
CrossRef1063
Ann Albright, Nilka Ríos Burrows, Regina Jordan, Desmond E. Williams. (2009) The Kidney Disease Initiative and the Division of Diabetes Translation at the Centers for Disease Control and Prevention. American Journal of Kidney Diseases 53:3, S121-S125
CrossRef1064
G. Egger, J. Dixon. (2009) Should obesity be the main game? Or do we need an environmental makeover to combat the inflammatory and chronic disease epidemics?. Obesity Reviews 10:2, 237-249
CrossRef1065
Samantha M. Pfeifer, Sari Kives. (2009) Polycystic Ovary Syndrome in the Adolescent. Obstetrics and Gynecology Clinics of North America 36:1, 129-152
CrossRef1066
C. Herder, M. Peltonen, W. Koenig, K. Sütfels, J. Lindström, S. Martin, P. Ilanne-Parikka, J. G. Eriksson, S. Aunola, S. Keinänen-Kiukaanniemi, T. T. Valle, M. Uusitupa, H. Kolb, J. Tuomilehto, . (2009) Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 52:3, 433-442
CrossRef1067
Sun H. Kim, Fahim Abbasi, Cindy Lamendola, Gerald M. Reaven. (2009) Effect of moderate alcoholic beverage consumption on insulin sensitivity in insulin-resistant, nondiabetic individuals. Metabolism 58:3, 387-392
CrossRef1068
Claudia P. Neira, Margaret Hartig, Patricia A. Cowan, Pedro A. Velasquez-Mieyer. (2009) The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting. Journal of the American Academy of Nurse Practitioners 21:3, 173-178
CrossRef1069
Paul Haber. (2009) Medizinische Trainingstherapie – eine unterschätzte Komponente der Langzeittherapie chronischer Erkrankungen. Wiener klinische Wochenschrift 121:5-6, 165-167
CrossRef1070
Péter Apor. (2009) Fizikai edzés a cukorbetegség megelőzésében és kezelésében. Orvosi Hetilap 150:13, 579-587
CrossRef1071
Cesare R. Sirtori, Claudio Galli, James W. Anderson, Anna Arnoldi. (2009) Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins. Atherosclerosis 203:1, 8-17
CrossRef1072
J. J. Meier, B. Baller, B. A. Menge, B. Gallwitz, W. E. Schmidt, M. A. Nauck. (2009) Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?. Diabetes, Obesity and Metabolism 11:3, 213-222
CrossRef1073
Alison M. Hill, Penny M. Kris-Etherton. (2009) Contemporary strategies for weight loss and cardiovascular disease risk factor modification. Current Cardiovascular Risk Reports 3:2, 109-118
CrossRef1074
M. A. van Baak, A. Astrup. (2009) Consumption of sugars and body weight. Obesity Reviews 10, 9-23
CrossRef1075
Ayako Suzuki, Manal F Abdelmalek. (2009) Nonalcoholic fatty liver disease in women. Women's Health 5:2, 191-203
CrossRef1076
Yong Ma, Marinella Temprosa, Sarah Fowler, Ronald J. Prineas, Maria G. Montez, Janet Brown-Friday, Mary L. Carrion-Petersen, Tracy Whittington. (2009) Evaluating the Accuracy of an Aneroid Sphygmomanometer in a Clinical Trial Setting. American Journal of Hypertension 22:3, 263-266
CrossRef1077
Michael Lefevre, Leanne M. Redman, Leonie K. Heilbronn, Julie V. Smith, Corby K. Martin, Jennifer C. Rood, Frank L. Greenway, Donald A. Williamson, Steven R. Smith, Eric Ravussin. (2009) Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis 203:1, 206-213
CrossRef1078
M. Reimann, E. Bonifacio, M. Solimena, P.E.H. Schwarz, B. Ludwig, M. Hanefeld, S.R. Bornstein. (2009) An update on preventive and regenerative therapies in diabetes mellitus. Pharmacology & Therapeutics 121:3, 317-331
CrossRef1079
(2009) Prevention of diabetes*. Canadian Pharmacists Journal 142:sp1, S9-S9
CrossRef1080
Terry E. Jones, J.L. Basilio, P.M. Brophy, M.R. McCammon, R.C. Hickner. (2009) Long-term Exercise Training in Overweight Adolescents Improves Plasma Peptide YY and Resistin. Obesity
CrossRef1081
Katan, Martijn B., . (2009) Weight-Loss Diets for the Prevention and Treatment of Obesity. New England Journal of Medicine 360:9, 923-925
Full Text1082
Siobhan M. White, Edward McAuley, Paul A. Estabrooks, Kerry S. Courneya. (2009) Translating Physical Activity Interventions for Breast Cancer Survivors into Practice: An Evaluation of Randomized Controlled Trials. Annals of Behavioral Medicine 37:1, 10-19
CrossRef1083
T. Vogel, P.-H. Brechat, P.-M. Leprêtre, G. Kaltenbach, M. Berthel, J. Lonsdorfer. (2009) Health benefits of physical activity in older patients: a review. International Journal of Clinical Practice 63:2, 303-320
CrossRef1084
Andrew Krentz. (2009) Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications. Diabetes/Metabolism Research and Reviews 25:2, 112-126
CrossRef1085
Arya M. Sharma. (2009) Weighing in on blood pressure. Current Hypertension Reports 11:1, 10-11
CrossRef1086
G. Derosa, A. D’Angelo, E. Fogari, S. Salvadeo, A. Gravina, I. Ferrari, A. F. G. Cicero. (2009) Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin. Journal of Clinical Pharmacy and Therapeutics 34:1, 13-23
CrossRef1087
JOSEPH E. DONNELLY, STEVEN N. BLAIR, JOHN M. JAKICIC, MELINDA M. MANORE, JANET W. RANKIN, BRYAN K. SMITH. (2009) Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults. Medicine & Science in Sports & Exercise 41:2, 459-471
CrossRef1088
Dorothy Gohdes, Helen Amundson, Carrie S. Oser, Steven D. Helgerson, Todd S. Harwell. (2009) How are we diagnosing cardiometabolic risk in primary care settings?. Primary Care Diabetes 3:1, 29-35
CrossRef1089
A.R. Aro, P. Absetz. (2009) Guidance for professionals in health promotion: Keeping it simple–but not too simple. Psychology & Health 24:2, 125-129
CrossRef1090
Kevin C. Maki, Matthew S. Reeves, Michael L. Carson, Marvin P. Miller, Maciej Turowski, Tia M. Rains, Kerr Anderson, Yanni Papanikolaou, Donna M. Wilder. (2009) Dose–Response Characteristics of High-Viscosity Hydroxypropylmethylcellulose in Subjects at Risk for the Development of Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics 11:2, 119-125
CrossRef1091
Wen-Yuan Lin, Jeanine Albu. (2009) Clinical Case Report: Treatment of Type 2 Diabetes in an Obese Patient with Lifestyle Intervention and Pharmacotherapy. Obesity Management 5:2, 77-80
CrossRef1092
Daniel H. Bessesen. (2009) Book Review. Obesity Management 5:2, 85-87
CrossRef1093
Felipe González Castro, Gabriel Q. Shaibi, Edna Boehm-Smith. (2009) Ecodevelopmental contexts for preventing type 2 diabetes in Latino and other racial/ethnic minority populations. Journal of Behavioral Medicine 32:1, 89-105
CrossRef1094
L. V. Kallings, J. S. Johnson, R. M. Fisher, U. d. Faire, A. Stahle, E. Hemmingsson, M.-L. Hellenius. (2009) Beneficial effects of individualized physical activity on prescription on body composition and cardiometabolic risk factors: results from a randomized controlled trial. European Journal of Cardiovascular Prevention & Rehabilitation 16:1, 80-84
CrossRef1095
Liviu G. Danescu, Shiri Levy, Joseph Levy. (2009) Vitamin D and diabetes mellitus. Endocrine 35:1, 11-17
CrossRef1096
FRANCESCA AMATI, JOHN J. DUBÉ, MAJA STEFANOVIC-RACIC, FREDERICO G. TOLEDO, BRET H. GOODPASTER. (2009) Improvements in Insulin Sensitivity Are Blunted by Subclinical Hypothyroidism. Medicine & Science in Sports & Exercise 41:2, 265-269
CrossRef1097
Lillian F. Lien, Andrea M. Haqq, Michelle Arlotto, Cris A. Slentz, Michael J. Muehlbauer, Ross L. McMahon, James Rochon, Dianne Gallup, James R. Bain, Olga Ilkayeva, Brett R. Wenner, Robert D Stevens, David S. Millington, Deborah M Muoio, Mark D. Butler, Christopher B. Newgard, Laura P. Svetkey. (2009) The STEDMAN Project: Biophysical, Biochemical and Metabolic Effects of a Behavioral Weight Loss Intervention during Weight Loss, Maintenance, and Regain. OMICS: A Journal of Integrative Biology 13:1, 21-35
CrossRef1098
Nelia P. Steyn, Estelle V. Lambert, Hanani Tabana. (2009) Nutrition interventions for the prevention of type 2 diabetes. Proceedings of the Nutrition Society 68:01, 55
CrossRef1099
Alice Malpass, Rob Andrews, Katrina M. Turner. (2009) Patients with Type 2 Diabetes experiences of making multiple lifestyle changes: A qualitative study. Patient Education and Counseling 74:2, 258-263
CrossRef1100
Anne M. Wolf, Mir S. Siadaty, Jayne Q. Crowther, Jerry L. Nadler, Douglas L. Wagner, Stephen L. Cavalieri, Kurtis S. Elward, Viktor E. Bovbjerg. (2009) Impact of Lifestyle Intervention on Lost Productivity and Disability: Improving Control With Activity and Nutrition. Journal of Occupational and Environmental Medicine 51:2, 139-145
CrossRef1101
Nancy A Allen, Cynthia S Jacelon, Stuart R Chipkin. (2009) Feasibility and acceptability of continuous glucose monitoring and accelerometer technology in exercising individuals with type 2 diabetes. Journal of Clinical Nursing 18:3, 373-383
CrossRef1102
(2009) Position of the American Dietetic Association: Weight Management. Journal of the American Dietetic Association 109:2, 330-346
CrossRef1103
Subak, Leslee L., Wing, Rena, West, Delia Smith, Franklin, Frank, Vittinghoff, Eric, Creasman, Jennifer M., Richter, Holly E., Myers, Deborah, Burgio, Kathryn L., Gorin, Amy A., Macer, Judith, Kusek, John W., Grady, Deborah, . (2009) Weight Loss to Treat Urinary Incontinence in Overweight and Obese Women. New England Journal of Medicine 360:5, 481-490
Full Text1104
Laurie-ann M. Hellsten, W. Todd Rogers. (2009) Development and Preliminary Validation of the Time Management for Exercise Scale. Measurement in Physical Education and Exercise Science 13:1, 13-33
CrossRef1105
D DELUIS, R ALLER, O IZAOLA, M SAGRADO, R CONDE. (2009) Influence of G308A Promoter Variant of Tumor Necrosis Factor-α Gene on Insulin Resistance and Weight Loss Secondary to Two Hypocaloric Diets: A Randomized Clinical Trial. Archives of Medical Research 40:1, 36-41
CrossRef1106
J. M. Meyer, S. M. Stahl. (2009) The metabolic syndrome and schizophrenia. Acta Psychiatrica Scandinavica 119:1, 4-14
CrossRef1107
Mara Malacarne, Giorgio Gobbi, Paolo Pizzinelli, Alessandro Lesma, Alberto Castelli, Daniela Lucini, Massimo Pagani. (2009) A Point-to-Point Simple Telehealth Application for Cardiovascular Prevention: The ESINO LARIO Experience. Cardiovascular Prevention at Point of Care. Telemedicine and e-Health 15:1, 80-86
CrossRef1108
SR Mehta, AS Kashyap, S Das. (2009) Diabetes mellitus in India: The modern scourge. Medical Journal Armed Forces India 65:1, 50-54
CrossRef1109
Rashid M. Ansari. (2009) Effect of Physical Activity and Obesity on Type 2 Diabetes in a Middle-Aged Population. Journal of Environmental and Public Health 2009, 1-5
CrossRef1110
D. M. Nathan, J. B. Buse, M. B. Davidson, E. Ferrannini, R. R. Holman, R. Sherwin, B. Zinman. (2009) Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 52:1, 17-30
CrossRef1111
Véronique Provencher, Janet Polivy, Maxine Gallander Wintre, Michael W. Pratt, S. Mark Pancer, Shelly Birnie-Lefcovitch, Gerald R. Adams. (2009) Who gains or who loses weight? Psychosocial factors among first-year university students. Physiology & Behavior 96:1, 135-141
CrossRef1112
Judith Aponte. (2009) Diabetes-Related Risk Factors Across Hispanic Subgroups in the Hispanic Health and Nutritional Examination Survey (1982-1984). Public Health Nursing 26:1, 23-38
CrossRef1113
Sang Youl Rhee, Young Seol Kim. (2009) Double Diabetes. Korean Diabetes Journal 33:1, 1
CrossRef1114
Masayo Kawano, Naoko Shono, Toru Yoshimura, Miyuki Yamaguchi, Tsutomu Hirano, Akitaka Hisatomi. (2009) Improved Cardio-Respiratory Fitness Correlates with Changes in the Number and Size of Small Dense LDL: Randomized Controlled Trial with Exercise Training and Dietary Instruction. Internal Medicine 48:1, 25-32
CrossRef1115
Linda A. Barbour. 2009. Diabetes in Pregnancy. , 47-64.
CrossRef1116
Chisato Mori, Emiko Todaka. (2009) Establishment of sustainable health science for future generations: from a hundred years ago to a hundred years in the future. Environmental Health and Preventive Medicine 14:1, 1-6
CrossRef1117
Dianne Berryman, Marie Gill, Jonathan Pietsch, Hannah Halloran. (2009) Consulting consumers to develop marketing and recruitment strategies for a diabetes prevention program. Australian Journal of Primary Health 15:2, 173
CrossRef1118
Noël C. Barengo, Dana Misiņa, Lauma Zariņa, Jānis Kloviņš, Dita Ozola, Andra Dērveniece, Linda Tarāsova, Valdis Pīrāgs. (2009) Glucose Metabolism Disorders and Risk Factors of Type 2 Diabetes in 45-74-Years-old Population in Rīga, Latvia. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 63:4, 141-146
CrossRef1119
Molly A. Martin, Catherine D. Catrambone, Romina A. Kee, Arthur T. Evans, Lisa K. Sharp, Christopher Lyttle, Cheryl Rucker-Whitaker, Kevin B. Weiss, John Jay Shannon. (2009) Improving asthma self-efficacy: Developing and testing a pilot community-based asthma intervention for African American adults. Journal of Allergy and Clinical Immunology 123:1, 153-159.e3
CrossRef1120
James E. Sharman, Johannes B. Prins. (2009) Strengthening the Case for Global Risk Assessment of Patients With High Blood Pressure. American Journal of Hypertension 22:1, 9-9
CrossRef1121
Hee-Jung Ahn, Boo-Kyung Koo, Ji-Yeon Jung, Hwi-Ryun Kwon, Hyun-Jin Kim, Kang-Seo Park, Kyung-Ah Han, Kyung-Wan Min. (2009) Bowl-Based Meal Plan versus Food Exchange-Based Meal Plan for Dietary Intake Control in Korean Type 2 Diabetic Patients. Korean Diabetes Journal 33:2, 155
CrossRef1122
E. J. M. Feskens. 2009. Nutrition and the metabolic syndrome in the elderly. , 349-373.
CrossRef1123
R. LOOMBA, G. LUTCHMAN, D. E. KLEINER, M. RICKS, J. J. FELD, B. B. BORG, A. MODI, P. NAGABHYRU, A. E. SUMNER, T. J. LIANG, J. H. HOOFNAGLE. (2009) Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 29:2, 172-182
CrossRef1124
Ronit Endevelt, Orna Baron-Epel, Tomas Karpati, Anthony David Heymann. (2009) Does low socioeconomic status affect use of nutritional services by pre-diabetes patients?. International Journal of Health Care Quality Assurance 22:2, 157-167
CrossRef1125
Hiroaki Kawano, Hirofumi Soejima, Hiromi Fujii, Shigeki Nakayama, Isao Katayama, Kouzou Irisa, Tohru Marubayashi, Shuichi Koshi, Ikuro Koba, Yasuhiro Nagayoshi, Yasuaki Tanaka, Hiroshige Yamabe, Hisao Ogawa. (2009) Prevalence of Changes in Undiagnosed Glucose Intolerance According to Age and Gender in Japanese Middle-Aged Working People. Circulation Journal 73:6, 1062-1066
CrossRef1126
Hisami Yamanaka-Okumura, Masae Sakuma, Sugako Kimura, Tomoko Koda, Megumi Kubota, Machiko Harada. (2009) The Japanese Journal of Nutrition and Dietetics 67:6, 344-349
CrossRef1127
Raj Vuppalanchi, Naga Chalasani. (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 49:1, 306-317
CrossRef1128
Lai Ming Yung, Ismail Laher, Xiaoqiang Yao, Zhen Yu Chen, Yu Huang, Fung Ping Leung. (2009) Exercise, Vascular Wall and Cardiovascular Diseases. Sports Medicine 39:1, 45-63
CrossRef1129
M B Katan, M V Boekschoten, W E Connor, R P Mensink, J Seidell, B Vessby, W Willett. (2009) Which are the greatest recent discoveries and the greatest future challenges in nutrition?. European Journal of Clinical Nutrition 63:1, 2-10
CrossRef1130
Armagan Tugrul, Sibel Guldiken, Betul Ugur-Altun, Ender Arikan. (2009) An Evaluation of Glucose Tolerance in Essential Hypertension. Yonsei Medical Journal 50:2, 195
CrossRef1131
Richard S. Legro. (2009) Polycystic ovary syndrome and cardiovascular disease risk. Current Cardiovascular Risk Reports 3:1, 65-70
CrossRef1132
H. N. Yassine, C. M. Marchetti, R. K. Krishnan, T. R. Vrobel, F. Gonzalez, J. P. Kirwan. (2009) Effects of Exercise and Caloric Restriction on Insulin Resistance and Cardiometabolic Risk Factors in Older Obese Adults--A Randomized Clinical Trial. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 64A:1, 90-95
CrossRef1133
Elaine C. Rush, Michelle B. Cumin, Lela Migriauli, Lynnette R. Ferguson, Lindsay D. Plank. (2009) One Year Sustainability of Risk Factor Change from a 9-Week Workplace Intervention. Journal of Environmental and Public Health 2009, 1-7
CrossRef1134
A HODGE, A JENKINS, D ENGLISH, K ODEA, G GILES. (2009) NMR-determined lipoprotein subclass profile predicts type 2 diabetes
CrossRef1135
Naohito Tanabe, Kimie Saito, Yukio Yamada, Tetsuya Takasawa, Nao Seki, Hiroshi Suzuki. (2009) Risk Assessment by Post-Challenge Plasma Glucose, Insulin Response Ratio, and Other Indices of Insulin Resistance and/or Secretion for Predicting the Development of Type 2 Diabetes. Internal Medicine 48:6, 401-409
CrossRef1136
Marissa Grotzke, Robert E. Jones. 2009. Diabetes Mellitus. , 9-16.
CrossRef1137
Andrea Bersamin, Krista D Hanni, Marilyn A Winkleby. (2009) Predictors of trying to lose weight among overweight and obese Mexican-Americans: a signal detection analysis. Public Health Nutrition 12:01, 64
CrossRef1138
Boyd Swinburn. (2009) Obesity Prevention in Children and Adolescents. Child and Adolescent Psychiatric Clinics of North America 18:1, 209-223
CrossRef1139
Melanie Jay, Jennifer Adams, Sharon J. Herring, Colleen Gillespie, Tavinder Ark, Henry Feldman, Vicky Jones, Sondra Zabar, David Stevens, Adina Kalet. (2009) A randomized trial of a brief multimedia intervention to improve comprehension of food labels. Preventive Medicine 48:1, 25-31
CrossRef1140
Melinda R. Stolley, Marian L. Fitzgibbon, Linda Schiffer, Lisa K. Sharp, Vicky Singh, Linda Van Horn, Alan Dyer. (2009) Obesity Reduction Black Intervention Trial (ORBIT): Six-month Results. Obesity 17:1, 100-106
CrossRef1141
Bruna Guida, Nunzia Ruggiero Perrino, Roberta Laccetti, Rossella Trio, Annamaria Nastasi, Domenica Pesola, Ciro Maiello, Claudio Marra, Luca Salvatore De Santo, Maurizio Cotrufo. (2009) Role of dietary intervention and nutritional follow-up in heart transplant recipients. Clinical Transplantation 23:1, 101-107
CrossRef1142
Danielle Symons Downs, Mark Feinberg, Marianne M. Hillemeier, Carol S. Weisman, Gary A. Chase, Cynthia H. Chuang, Roxanne Parrott, Lori A. Francis. (2009) Design of the Central Pennsylvania Women’s Health Study (CePAWHS) Strong Healthy Women Intervention: Improving Preconceptional Health. Maternal and Child Health Journal 13:1, 18-28
CrossRef1143
Selma Feldman Witchel, Tony M. Plant. 2009. PubertyGonadarche and Adrenarche. , 395-431.
CrossRef1144
A. M. Sheehy, D. B. Coursin, R. A. Gabbay. (2009) Back to Wilson and Jungner: 10 Good Reasons to Screen for Type 2 Diabetes Mellitus. Mayo Clinic Proceedings 84:1, 38-42
CrossRef1145
Ellen W. Seely, Steven Grinspoon. 2009. Patient-Oriented ResearchClinical Pathophysiology and Clinical Therapeutics. , 3-12.
CrossRef1146
S. Krishnan, L. Rosenberg, J. R. Palmer. (2008) Physical Activity and Television Watching in Relation to Risk of Type 2 Diabetes: The Black Women's Health Study. American Journal of Epidemiology 169:4, 428-434
CrossRef1147
Ruchi Mathur, Carolyn J. Alexander, Jacqueline Yano, Bradley Trivax, Ricardo Azziz. (2008) Use of metformin in polycystic ovary syndrome. American Journal of Obstetrics and Gynecology 199:6, 596-609
CrossRef1148
D Simmons, E Rush, N Crook, . (2008) Development and piloting of a community health worker-based intervention for the prevention of diabetes among New Zealand Maori in Te Wai o Rona: Diabetes Prevention Strategy. Public Health Nutrition 11:12, 1318
CrossRef1149
Katherine Esposito, Miryam Ciotola, Maria Ida Maiorino, Dario Giugliano. (2008) Lifestyle approach for type 2 diabetes and metabolic syndrome. Current Atherosclerosis Reports 10:6, 523-528
CrossRef1150
Jason J. Diehl, Haemi Choi. (2008) Exercise: the Data on its Role in Health, Mental Health, Disease Prevention, and Productivity. Primary Care: Clinics in Office Practice 35:4, 803-816
CrossRef1151
Jeff Unger, Cynthia Moriarty. (2008) Preventing Type 2 Diabetes. Primary Care: Clinics in Office Practice 35:4, 645-662
CrossRef1152
Adrian J. Cameron, Edward J. Boyko, Richard A. Sicree, Paul Z. Zimmet, Stefan Söderberg, K. George M.M. Alberti, Jaakko Tuomilehto, Pierrot Chitson, Jonathan E. Shaw. (2008) Central Obesity as a Precursor to the Metabolic Syndrome in the AusDiab Study and Mauritius. Obesity 16:12, 2707-2716
CrossRef1153
Nicholas J. Wareham, Elizabeth H. Young, Ruth J.F. Loos. (2008) Epidemiological Study Designs to Investigate Gene–Behavior Interactions in the Context of Human Obesity. Obesity 16, S66-S71
CrossRef1154
D. Sánchez Fuentes, M. Budiño Sánchez. (2008) Síndrome metabólico. Medicine - Programa de Formación Médica Continuada Acreditado 10:23, 1527-1533
CrossRef1155
Brian R. Smith, Phil Schauer, Ninh T. Nguyen. (2008) Surgical Approaches to the Treatment of Obesity: Bariatric Surgery. Endocrinology & Metabolism Clinics of North America 37:4, 943-964
CrossRef1156
Dong-Chul Seo, Jaesin Sa. (2008) A meta-analysis of psycho-behavioral obesity interventions among US multiethnic and minority adults. Preventive Medicine 47:6, 573-582
CrossRef1157
Denise G. Simons-Morton. (2008) The Glycemia-Cardiovascular Disease Hypothesis. Clinical and Translational Science 1:3, 185-186
CrossRef1158
Alison M. Hill, Penny M. Kris-Etherton. (2008) Contemporary strategies for weight loss and cardiovascular disease risk factor modification. Current Atherosclerosis Reports 10:6, 486-496
CrossRef1159
Neil J. Stone. (2008) Clinical Trials Report. Current Atherosclerosis Reports 10:6, 457-459
CrossRef1160
Hirohide Yokokawa, Aya Goto, Yoko Abe, Sonoko Suzuki, Seiji Yasumura. (2008) Lifestyle characteristics and 3-year total mortality of Japanese with self-reported diabetes. Health & Social Care in the Community 16:6, 614-620
CrossRef1161
Anne L. Dunlop, Brian W. Jack, Joseph N. Bottalico, Michael C. Lu, Andra James, Cynthia S. Shellhaas, Lynne Haygood-Kane Hallstrom, Benjamin D. Solomon, W. Gregory Feero, M. Kathryn Menard, Mona R. Prasad. (2008) The clinical content of preconception care: women with chronic medical conditions. American Journal of Obstetrics and Gynecology 199:6, S310-S327
CrossRef1162
Christopher S. Vaccari, Syed T. Rahman, Qamar A. Khan, Faiz A. Cheema, Bobby V. Khan. (2008) Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Levels of Inflammatory Markers in Response to Exercise-Induced Stress: Studies in the Metabolic Syndrome. Journal of the CardioMetabolic Syndrome 3:1, 12-17
CrossRef1163
George A. Bray. (2008) Medications for Weight Reduction. Endocrinology & Metabolism Clinics of North America 37:4, 923-942
CrossRef1164
Paul A. Estabrooks, Edwin B. Fisher, Laura L. Hayman. (2008) What is Needed to Reverse the Trends in Childhood Obesity? A Call to Action. Annals of Behavioral Medicine 36:3, 209-216
CrossRef1165
Brent Van Dorsten, Emily M. Lindley. (2008) Cognitive and Behavioral Approaches in the Treatment of Obesity. Endocrinology & Metabolism Clinics of North America 37:4, 905-922
CrossRef1166
P. W. Franks, K. A. Jablonski, L. M. Delahanty, J. B. McAteer, S. E. Kahn, W. C. Knowler, J. C. Florez, . (2008) Assessing gene–treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia 51:12, 2214-2223
CrossRef1167
Arne Astrup, Sten Madsbad, Leif Breum, Thomas J Jensen, Jens Peter Kroustrup, Thomas Meinert Larsen. (2008) Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. The Lancet 372:9653, 1906-1913
CrossRef1168
Marianne M. Hillemeier, Danielle Symons Downs, Mark E. Feinberg, Carol S. Weisman, Cynthia H. Chuang, Roxanne Parrott, Diana Velott, Lori A. Francis, Sara A. Baker, Anne-Marie Dyer. (2008) Improving Women's Preconceptional HealthFindings from a Randomized Trial of the Strong Healthy Women Intervention in the Central Pennsylvania Women's Health Study. Women's Health Issues 18:6, S87-S96
CrossRef1169
Shinichi Kuriyama, Taichi Shimazu, Atsushi Hozawa, Shigeo Kure, Naoyuki Kurokawa, Masako Kakizaki, Toshimasa Sone, Kaori Matsuda-Ohmori, Naoki Nakaya, Hiroshi Satoh, Ichiro Tsuji. (2008) No effect of the Trp64Arg variant of the β3-adrenergic receptor gene on weight loss by diet and exercise intervention among Japanese adults. Metabolism 57:11, 1570-1575
CrossRef1170
Marcel C. Adriaanse, Jos W.R. Twisk, Jacqueline M. Dekker, Annemieke M.W. Spijkerman, Giel Nijpels, Robert J. Heine, Frank J. Snoek. (2008) Perceptions of risk in adults with a low or high risk profile of developing type 2 diabetes; a cross-sectional population-based study. Patient Education and Counseling 73:2, 307-312
CrossRef1171
Jonathan M Amiel, Christina V Mangurian, Rohan Ganguli, John W Newcomer. (2008) Addressing cardiometabolic risk during treatment with antipsychotic medications. Current Opinion in Psychiatry 21:6, 613-618
CrossRef1172
Jonathan T. Tan, Luor Shyuan M. Tan, Kee Seng Chia, Suok Kai Chew, E. Shyong Tai. (2008) A family history of type 2 diabetes is associated with glucose intolerance and obesity-related traits with evidence of excess maternal transmission for obesity-related traits in a South East Asian population. Diabetes Research and Clinical Practice 82:2, 268-275
CrossRef1173
Stanley Schwartz. (2008) Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide. Current Medical Research and Opinion 24:11, 3009-3022
CrossRef1174
Jean-Michel Halimi, Fabrice Bonnet, Céline Lange, Beverley Balkau, Jean Tichet, Michel Marre. (2008) Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. Journal of Hypertension 26:11, 2198-2206
CrossRef1175
Thomas Yates, Melanie Davies, Trish Gorely, Fiona Bull, Kamlesh Khunti. (2008) Rationale, design and baseline data from the Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: A randomized controlled trial. Patient Education and Counseling 73:2, 264-271
CrossRef1176
S. E. Kahn, D. B. Carr, M. V. Faulenbach, K. M. Utzschneider. (2008) An examination of β-cell function measures and their potential use for estimating β-cell mass. Diabetes, Obesity and Metabolism 10, 63-76
CrossRef1177
Matthew R. Smith. (2008) Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors. Current Prostate Reports 6:4, 149-154
CrossRef1178
Adam Reppert, Bruce F. Steiner, K. Chapman-Novakofski. (2008) Prevalence of Metabolic Syndrome and Associated Risk Factors in Illinois. American Journal of Health Promotion 23:2, 130-138
CrossRef1179
S. Rössner, M. Hammarstrand, E. Hemmingsson, M. Neovius, K. Johansson. (2008) Long-term weight loss and weight-loss maintenance strategies. Obesity Reviews 9:6, 624-630
CrossRef1180
Jane Faith Kapustin. (2008) Postpartum management for gestational diabetes mellitus: Policy and practice implications. Journal of the American Academy of Nurse Practitioners 20:11, 547-554
CrossRef1181
Stefano Balducci, Silvano Zanuso, Massimo Massarini, Gerardo Corigliano, Antonio Nicolucci, Serena Missori, Stefano Cavallo, Patrizia Cardelli, Elena Alessi, Giuseppe Pugliese, Francesco Fallucca. (2008) The Italian Diabetes and Exercise Study (IDES): Design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases 18:9, 585-595
CrossRef1182
G. Nijpels, W. Boorsma, J. M. Dekker, P. J. Kostense, L. M. Bouter, R. J. Heine. (2008) A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI). Diabetes/Metabolism Research and Reviews 24:8, 611-616
CrossRef1183
Jonathan R. Treadwell, Fang Sun, Karen Schoelles. (2008) Systematic Review and Meta-Analysis of Bariatric Surgery for Pediatric Obesity. Annals of Surgery 248:5, 763-776
CrossRef1184
Jackie L. Buell, Doug Calland, Fiona Hanks, Bruce Johnston, Benjamin Pester, Robert Sweeney, Robert Thorne. (2008) Presence of Metabolic Syndrome in Football Linemen. Journal of Athletic Training 43:6, 608-616
CrossRef1185
Carmine Zoccali, Elvira Puntorieri. (2008) Type-2 diabetes and endothelial dysfunction: exploring the road to disease in the reverse direction. Journal of Hypertension 26:11, 2096-2100
CrossRef1186
(2008) Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome. Fertility and Sterility 90:5, S69-S73
CrossRef1187
A.E. Nieuwenhuis-Ruifrok, W.K.H. Kuchenbecker, A. Hoek, P. Middleton, R.J. Norman. (2008) Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis. Human Reproduction Update 15:1, 57-68
CrossRef1188
Hussein Naji Yassine, Craig Stump. 2008. Cardiometabolic Syndrome, Diabetes and Oxidative Stress. , 91-102.
CrossRef1189
L. J. Tamariz, J. H. Young, J. S. Pankow, H.-C. Yeh, M. I. Schmidt, B. Astor, F. L. Brancati. (2008) Blood Viscosity and Hematocrit as Risk Factors for Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology 168:10, 1153-1160
CrossRef1190
K Y Wolin, G A Colditz. (2008) Can weight loss prevent cancer?. British Journal of Cancer 99:7, 995-999
CrossRef1191
George Bakris, Michael Böhm, Gilles Dagenais, Hans-Christoph Diener, Toshiro Fujita, Philip Gorelick, Sverre Erik Kjeldsen, Markku Laakso, Giuseppe Mancia, Bertram Pitt, Arya Sharma, Peter Sleight, Koon Teo, Thomas Unger, Michael Weber, Bryan Williams, Faiez Zannad. (2008) Cardiovascular protection for all individuals at high risk: evidence-based best practice. Clinical Research in Cardiology 97:10, 713-725
CrossRef1192
E M Venditti, G A Bray, M L Carrion-Petersen, L M Delahanty, S L Edelstein, R F Hamman, M A Hoskin, W C Knowler, Y Ma.. (2008) First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. International Journal of Obesity 32:10, 1537-1544
CrossRef1193
F.W.F. Hanna, J.R. Peters, J. Harlow, P.W. Jones. (2008) Gestational diabetes screening and glycaemic management; National survey on behalf of the Association of British Clinical Diabetologists. QJM 101:10, 777-784
CrossRef1194
M. Toshihiro, K. Saito, S. Takikawa, N. Takebe, T. Onoda, J. Satoh. (2008) Psychosocial factors are independent risk factors for the development of Type 2 diabetes in Japanese workers with impaired fasting glucose and/or impaired glucose tolerance 1. Diabetic Medicine 25:10, 1211-1217
CrossRef1195
Arlan L Rosenbloom, Janet H Silverstein, Shin Amemiya, Phil Zeitler, Georgeanna J Klingensmith. (2008) Type 2 diabetes mellitus in the child and adolescent. Pediatric Diabetes 9:5, 512-526
CrossRef1196
M.Á. Gómez Marcos, L. García Ortiz. (2008) Manejo general y extrahospitalario del paciente con diabetes. Valoración de la sintomatología. Procesos intercurrentes. Medicine - Programa de Formación Médica Continuada Acreditado 10:17, 1138-1148
CrossRef1197
Ronald T. Ackermann, Emily A. Finch, Edward Brizendine, Honghong Zhou, David G. Marrero. (2008) Translating the Diabetes Prevention Program into the Community. American Journal of Preventive Medicine 35:4, 357-363
CrossRef1198
Brent M. Egan, Stevo Julius. (2008) Prehypertension: Risk stratification and management considerations. Current Hypertension Reports 10:5, 359-366
CrossRef1199
Osama Hamdy, Catherine Carver. (2008) The why WAIT program: Improving clinical outcomes through weight management in type 2 diabetes. Current Diabetes Reports 8:5, 413-420
CrossRef1200
O Thomas, L Thabane, J Douketis, R Chu, A O Westfall, D B Allison. (2008) Industry funding and the reporting quality of large long-term weight loss trials. International Journal of Obesity 32:10, 1531-1536
CrossRef1201
J. Herráez García, A.C. Antolí Royo, A.J. Plata Izquierdo, Á. Romero Alegría. (2008) Tratamiento de la diabetes. Criterios de control. Objetivos terapéuticos. Medidas generales. Factores dietéticos. Medicine - Programa de Formación Médica Continuada Acreditado 10:18, 1184-1187
CrossRef1202
D.A. de Luis, R. Aller, O. Izaola, M. Gonzalez Sagrado, R. Conde. (2008) Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary to two hypocaloric diets: A randomized clinical trial. Diabetes Research and Clinical Practice 82:1, 113-118
CrossRef1203
Patricia M. Dietz, Kimberly K. Vesco, William M. Callaghan, Donald J. Bachman, F Carol Bruce, Cynthia J. Berg, Lucinda J. England, Mark C. Hornbrook. (2008) Postpartum Screening for Diabetes After a Gestational Diabetes Mellitus–Affected Pregnancy. Obstetrics & Gynecology 112:4, 868-874
CrossRef1204
J. Terry Saunders, Joyce Green Pastors. (2008) Practical tips on lifestyle management of type 2 diabetes for the busy clinician. Current Diabetes Reports 8:5, 353-360
CrossRef1205
Robert M. Califf, Mitradev Boolell, Steven M. Haffner, M. Angelyn Bethel, John McMurray, Anil Duggal, Rury R. Holman. (2008) Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. American Heart Journal 156:4, 623-632
CrossRef1206
Carley R. Benton, David C. Wright, Arend Bonen. (2008) PGC-1α-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. Applied Physiology, Nutrition, and Metabolism 33:5, 843-862
CrossRef1207
M. Tiburcy, W.-H. Zimmermann. (2008) Therapie des Diabetes mellitus Typ 2 und kardiovaskuläre Komplikationen. Der Kardiologe 2:5, 417-429
CrossRef1208
Rhonda Bentley-Lewis, Sue Levkoff, Alison Stuebe, Ellen W Seely. (2008) Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus. Nature Clinical Practice Endocrinology & Metabolism 4:10, 552-558
CrossRef1209
Amy D. Otto, David O. Garcia, John M. Jakicic. (2008) Lifestyle intervention strategies to prevent and control type 2 diabetes. Current Diabetes Reports 8:5, 407-412
CrossRef1210
Joel M. Schectman, John B. Schorling, John D. Voss. (2008) Appointment Adherence and Disparities in Outcomes Among Patients with Diabetes. Journal of General Internal Medicine 23:10, 1685-1687
CrossRef1211
C. Lloret-Linares, J. R. Greenfield, S. Czernichow. (2008) Effect of weight-reducing agents on glycaemic parameters and progression to Type 2 diabetes: a review. Diabetic Medicine 25:10, 1142-1150
CrossRef1212
Jacob George, Elizabeth Denney-Wilson, Anthony D Okely, Louise L Hardy, Robert Aitken. (2008) The population distributions, upper normal limits and correlations between liver tests among Australian adolescents. Journal of Paediatrics and Child Health 44:10, 579-585
CrossRef1213
A. Bakhai. (2008) Adipokines--targeting a root cause of cardiometabolic risk. QJM 101:10, 767-776
CrossRef1214
David J. Yankura, Molly B. Conroy, Rachel Hess, Kelley K. Pettee, Lewis H. Kuller, Andrea M. Kriska. (2008) Weight Regain and Health-related Quality of Life in Postmenopausal Women. Obesity 16:10, 2259-2265
CrossRef1215
J. Sobesky. (2008) Schlaganfallprävention jenseits der Apotheke. Der Nervenarzt 79:10, 1156-1163
CrossRef1216
Lillian F Lien, John R Guyton. (2008) Metabolic syndrome. Dermatologic Therapy 21:5, 362-375
CrossRef1217
Najwa Somani, Shannon Harrison, Wilma F Bergfeld. (2008) The clinical evaluation of hirsutism. Dermatologic Therapy 21:5, 376-391
CrossRef1218
Kerstyn C. Zalesin, Barry A. Franklin, Wendy M. Miller, Eric D. Peterson, Peter A. McCullough. (2008) Impact of Obesity on Cardiovascular Disease. Endocrinology & Metabolism Clinics of North America 37:3, 663-684
CrossRef1219
Beth E. Cohen, A. Ann Chang, Deborah Grady, Alka M. Kanaya. (2008) Restorative Yoga in Adults with Metabolic Syndrome: A Randomized, Controlled Pilot Trial. Metabolic Syndrome and Related Disorders 6:3, 223-229
CrossRef1220
M. W. Hanif, G. Valsamakis, A. Dixon, A. Boutsiadis, A. F. Jones, A. H. Barnett, S. Kumar. (2008) Detection of impaired glucose tolerance and undiagnosed type 2 diabetes in UK South Asians: an effective screening strategy. Diabetes, Obesity and Metabolism 10:9, 755-762
CrossRef1221
William T. Cefalu. (2008) Diabetic dyslipidemia and the metabolic syndrome. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2:3, 208-222
CrossRef1222
S. Martin. (2008) Blutglukoseselbstkontrolle zum Selbstmanagement bei Typ-2-Diabetes. Der Diabetologe 4:6, 457-466
CrossRef1223
J Pendlebury, RIG Holt. (2008) Supporting the lifestyle modification and treatment of type 2 diabetes for people with severe mental illness. European Diabetes Nursing 5:2, 58-63
CrossRef1224
Louis Monnier, Claude Colette. (2008) La glycémie postprandiale : du normal au pathologique
CrossRef1225
Miguel Ángel Martínez-González, Silvia Carlos, Jokin de Irala. (2008) Vacuna contra el virus del papiloma humano: razones para el optimismo y razones para la prudencia. Medicina Clínica 131:7, 256-263
CrossRef1226
Chih-Wen Pai, Dee W. Edington. (2008) Association Between Behavioral Intention and Actual Change for Physical Activity, Smoking, and Body Weight Among an Employed Population. Journal of Occupational and Environmental Medicine 50:9, 1077-1083
CrossRef1227
Panupong Jiamsripong, Martina Mookadam, Mohsen S. Alharthi, Bijoy K. Khandheria, Farouk Mookadam. (2008) The Metabolic Syndrome and Cardiovascular Disease: Part 2. Preventive Cardiology 11:4, 223-229
CrossRef1228
Ada Cuevas, Alfredo Molina, Attilio Rigotti, Juan Francisco Miquel, Guillermo Marshall, Soledad Reyes, Flavio Nervi. (2008) Trends in Obesity and Diabetes Prevalence in a Chilean Urban Population: 1993–2001. Metabolic Syndrome and Related Disorders 6:3, 219-222
CrossRef1229
Ramachandran Ambady, Snehalatha Chamukuttan. (2008) Early diagnosis and prevention of diabetes in developing countries. Reviews in Endocrine and Metabolic Disorders 9:3, 193-201
CrossRef1230
A. Tuthill, M. J. McKenna, D. O’Shea, T. J. McKenna. (2008) Weight changes in type 2 diabetes and the impact of gender. Diabetes, Obesity and Metabolism 10:9, 726-732
CrossRef1231
S.K. Singh, Amit Rastogi. (2008) Gestational diabetes mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2:3, 227-234
CrossRef1232
M Walker, Mk Jayapaul, L Walker. (2008) Type 2 diabetes in families and diabetes prevention. European Diabetes Nursing 5:2, 52-56
CrossRef1233
Patricio Lopez-Jaramillo. (2008) Defining the research priorities to fight the burden of cardiovascular diseases in Latin America. Journal of Hypertension 26:9, 1886-1889
CrossRef1234
Suzanne G Madden, Susan J Loeb, Carol A Smith. (2008) An integrative literature review of lifestyle interventions for the prevention of type II diabetes mellitus. Journal of Clinical Nursing 17:17, 2243-2256
CrossRef1235
Emily Jane Gallagher, Derek LeRoith, Eddy Karnieli. (2008) The Metabolic Syndrome—from Insulin Resistance to Obesity and Diabetes. Endocrinology & Metabolism Clinics of North America 37:3, 559-579
CrossRef1236
Sharon Chih, Brendan M. McQuillan, Joey Kaye, John P. Beilby, Joseph Hung. (2008) Abnormal glucose regulation in an Australian acute coronary syndrome population: A prospective study. Diabetes Research and Clinical Practice 81:3, 303-309
CrossRef1237
D. Preiss, N. Sattar, L. Harborne, J. Norman, R. Fleming. (2008) The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. International Journal of Clinical Practice 62:9, 1337-1343
CrossRef1238
Pedro A Velásquez-Mieyer, Claudia P Neira. (2008) Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus. Expert Opinion on Pharmacotherapy 9:13, 2377-2382
CrossRef1239
Xiaolin Wei, Jan Barnsley, David Zakus, Rhonda Cockerill, Richard Glazier, Xiaoming Sun. (2008) Assessing continuity of care in a community diabetes program: Initial questionnaire development and validation. Journal of Clinical Epidemiology 61:9, 925-931
CrossRef1240
Robert W Schrier, Yolanda E Bogaert. (2008) Stemming the obesity–diabetes epidemic: lifestyle changes and therapeutics. Nature Clinical Practice Nephrology 4:9, 486-487
CrossRef1241
Jean-Pierre Després, Benoit J. Arsenault, Mélanie Côté, Amélie Cartier, Isabelle Lemieux. (2008) Abdominal obesity: The cholesterol of the 21st century?. Canadian Journal of Cardiology 24, 7D-12D
CrossRef1242
Mahdi Malik, Sawsan Abdel Razig. (2008) The Prevalence of the Metabolic Syndrome among the Multiethnic Population of the United Arab Emirates: A Report of a National Survey. Metabolic Syndrome and Related Disorders 6:3, 177-186
CrossRef1243
N. Freemantle, J. Holmes, A. Hockey, S. Kumar. (2008) How strong is the association between abdominal obesity and the incidence of type 2 diabetes?. International Journal of Clinical Practice 62:9, 1391-1396
CrossRef1244
T. T. L. Pang, P. Narendran. (2008) Addressing insulin resistance in Type 1 diabetes. Diabetic Medicine 25:9, 1015-1024
CrossRef1245
Aaron K.F. Wong, Matlooba A. ALZadjali, Anna-Maria J. Choy, Chim C. Lang. (2008) Insulin Resistance: A Potential New Target for Therapy in Patients with Heart Failure. Cardiovascular Therapeutics 26:3, 203-213
CrossRef1246
Ichiro Kato, Takeshi Oya, Hikari Suzuki, Kumi Takasawa, Andi M. Ichsan, Shinji Nakada, Yoko Ishii, Yutaka Shimada, Masakiyo Sasahara, Kazuyuki Tobe, Shin Takasawa, Hiroshi Okamoto, Koichi Hiraga. (2008) A novel model of insulin-dependent diabetes with renal and retinal lesions by transgenic expression of CaMKIIα (Thr286Asp) in pancreatic β-cells. Diabetes/Metabolism Research and Reviews 24:6, 486-497
CrossRef1247
A.N. Schüring, K. Oelmeier, N. Schulte, P. Stute, L. Kiesel. (2008) Konsensusgerechte Therapie des PCOS. Gynäkologische Endokrinologie 6:3, 185-194
CrossRef1248
Pablo Tebas. (2008) Insulin Resistance and Diabetes Mellitus Associated With Antiretroviral Use in HIV-Infected Patients: Pathogenesis, Prevention, and Treatment Options. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:Supplement 2, S86-S92
CrossRef1249
A. J. Cameron, D. J. Magliano, P. Z. Zimmet, T. A. Welborn, S. Colagiuri, A. M. Tonkin, J. E. Shaw. (2008) The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. Journal of Internal Medicine 264:2, 177-186
CrossRef1250
Susan J. Appel, Mary Annette Wright, Alethea N. Hill, Fernando Ovalle. (2008) Uncovering Imperative Interventions in Prediabetes and Type 2 Diabetes. The Nurse Practitioner 33:8, 20-26
CrossRef1251
Y Fukino, A Ikeda, K Maruyama, N Aoki, T Okubo, H Iso. (2008) Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. European Journal of Clinical Nutrition 62:8, 953-960
CrossRef1252
Deanna M Minich, Jeffrey S Bland. (2008) Dietary management of the metabolic syndrome beyond macronutrients. Nutrition Reviews 66:8, 429-444
CrossRef1253
Carol J. Homko. (2008) Postpartum diabetes screening for women with gestational diabetes: Are we missing an opportunity for prevention?. Current Diabetes Reports 8:4, 277-278
CrossRef1254
M. Tyrberg, A. Melander, M. Lvestam-Adrian, U. Lindblad. (2008) Retinopathy in subjects with impaired fasting glucose: the NANSY-Eye baseline report. Diabetes, Obesity and Metabolism 10:8, 646-651
CrossRef1255
Mark O. Goodarzi, Ricardo Azziz. (2008) Metformin Use in Polycystic Ovary Syndrome: Metabolic Benefits and Diabetes Prevention. The American Journal of Medicine 121:8, e9
CrossRef1256
Meena Khandelwal. (2008) GDM: Postpartum management to reduce long-term risks. Current Diabetes Reports 8:4, 287-293
CrossRef1257
Stephen Colagiuri, Knut Borch-Johnsen, Nicholas J. Wareham. (2008) Back to the future—Do IGT and IFG have value as clinical entities?. Diabetes Research and Clinical Practice 81:2, 131-133
CrossRef1258
Patricia L. Mabry, Deborah H. Olster, Glen D. Morgan, David B. Abrams. (2008) Interdisciplinarity and Systems Science to Improve Population Health. American Journal of Preventive Medicine 35:2, S211-S224
CrossRef1259
Stephan Herpertz. (2008) Behandlung der Adipositas bei Diabetes mellitus. Psychosomatik und Konsiliarpsychiatrie 2:3, 145-150
CrossRef1260
Osama Hamdy, Ann Goebel-Fabbri, Catherine Carver, Gillian Arathuzik, Jacqueline Shahar, Roberta Capelson, Joan Beaton, Stacey O’Donnell, Nuha Elsayed, Joanna Mitri, Voula Mentzelopoulos, Martin J. Abrahamson. (2008) Why WAIT Program: A Novel Model for Diabetes Weight Management in Routine Clinical Practice. Obesity Management 4:4, 176-183
CrossRef1261
A. S. Wierzbicki. (2008) Shielding the population from the metabolic syndrome? There is one born every minute. International Journal of Clinical Practice 62:8, 1132-1134
CrossRef1262
Bikash Sharma, David C Henderson. (2008) Sibutramine: current status as an anti-obesity drug and its future perspectives. Expert Opinion on Pharmacotherapy 9:12, 2161-2173
CrossRef1263
Jack F. Hollis, Christina M. Gullion, Victor J. Stevens, Phillip J. Brantley, Lawrence J. Appel, Jamy D. Ard, Catherine M. Champagne, Arlene Dalcin, Thomas P. Erlinger, Kristine Funk, Daniel Laferriere, Pao-Hwa Lin, Catherine M. Loria, Carmen Samuel-Hodge, William M. Vollmer, Laura P. Svetkey. (2008) Weight Loss During the Intensive Intervention Phase of the Weight-Loss Maintenance Trial. American Journal of Preventive Medicine 35:2, 118-126
CrossRef1264
K K Steinberg, W H Dietz. (2008) Workshop on estimating the health burden of overweight and obesity. International Journal of Obesity 32, S1-S3
CrossRef1265
Jee-Fu Huang, Ming-Lung Yu, Chia-Yen Dai, Ming-Yen Hsieh, Shang-Jyh Hwang, Pi-Jung Hsiao, Li-Po Lee, Zu-Yau Lin, Shinn-Chern Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Shyi-Jang Shin, Wen-Yu Chang, Wan-Long Chuang. (2008) Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection. The American Journal of Gastroenterology 103:8, 1933-1940
CrossRef1266
Michael J. Blaha, Sandeep Bansal, Rosanne Rouf, Sherita H. Golden, Roger S. Blumenthal, Andrew P. DeFilippis. (2008) A Practical “ABCDE” Approach to the Metabolic Syndrome. Mayo Clinic Proceedings 83:8, 932-943
CrossRef1267
M. J. Blaha, S. Bansal, R. Rouf, S. H. Golden, R. S. Blumenthal, A. P. DeFilippis. (2008) A Practical 'ABCDE' Approach to the Metabolic Syndrome. Mayo Clinic Proceedings 83:8, 932-943
CrossRef1268
Christoph Handschin, Bruce M. Spiegelman. (2008) The role of exercise and PGC1α in inflammation and chronic disease. Nature 454:7203, 463-469
CrossRef1269
Lucie Nield, Carolyn D Summerbell, Lee Hooper, Vicki Whittaker, Helen Moore, Lucie Nield. 2008. Dietary advice for the prevention of type 2 diabetes mellitus in adults. .
CrossRef1270
Leonardo J Orozco, Ana Maria Buchleitner, Gabriel Gimenez-Perez, Marta Roqué i Figuls, Bernd Richter, Didac Mauricio, Didac Mauricio. 2008. Exercise or exercise and diet for preventing type 2 diabetes mellitus. .
CrossRef1271
Jaana Karjalainen, Markku Peltonen, Mauno Vanhala, Eeva Korpi-Hyövälti, Hannu Puolijoki, Juha Saltevo, Heikki Oksa, Timo Saaristo, Jaakko Tuomilehto, Urho M. Kujala. (2008) Leisure time physical activity in individuals with screen-detected type 2 diabetes compared to those with known type 2 diabetes. Diabetes Research and Clinical Practice 81:1, 110-116
CrossRef1272
Charles J. Glueck, Naila Goldenberg, Luann Sieve, Ping Wang. (2008) An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet. Metabolism 57:7, 954-960
CrossRef1273
S Franks. (2008) Polycystic ovary syndrome in adolescents. International Journal of Obesity 32:7, 1035-1041
CrossRef1274
Åsa Hörnsten, Hans Stenlund, Berit Lundman, Herbert Sandström. (2008) Improvements in HbA1c remain after 5 years – a follow up of an educational intervention focusing on patients’ personal understandings of type 2 diabetes. Diabetes Research and Clinical Practice 81:1, 50-55
CrossRef1275
M. Florentin, E. N. Liberopoulos, M. S. Elisaf. (2008) Sibutramine-associated adverse effects: a practical guide for its safe use. Obesity Reviews 9:4, 378-387
CrossRef1276
M Devers, M Fisher. (2008) Glycaemic control and metabolic risk: getting the extra mile from diabetes control. Practical Diabetes International 25:6, 233-236
CrossRef1277
Jacquelin V. Deatcher. (2008) Prediabetes. AJN, American Journal of Nursing 108:7, 77-79
CrossRef1278
A. E. Durham, D. I. Rendle, J. R. Newton. (2008) The effect of metformin on measurements of insulin sensitivity and β cell response in 18 horses and ponies with insulin resistance. Equine Veterinary Journal 40:5, 493-500
CrossRef1279
CARL J. CASPERSEN, JANET E. FULTON. (2008) Epidemiology of Walking and Type 2 Diabetes. Medicine & Science in Sports & Exercise 40:Supplement, S519-S528
CrossRef1280
M. Jecht. (2008) Wie aktive Intervention dauerhaft effektiv bleibt. Der Diabetologe 4:5, 376-377
CrossRef1281
Arya M Sharma. (2008) The value of current interventions for obesity. Nature Clinical Practice Cardiovascular Medicine 5, S3-S9
CrossRef1282
A. Hamann, J. Tafel. (2008) Nutzen und Risiko der medikamentösen Adipositastherapie. Der Diabetologe 4:4, 266-271
CrossRef1283
Neil J. Stone. (2008) Practical management of patients with hypertension and metabolic risk factors: Using lifestyle to reduce risk. Current Cardiovascular Risk Reports 2:4, 262-267
CrossRef1284
N. Hermanns, B. Kulzer, M. Krichbaum. (2008) Problemspezifische Patientenschulung. Der Diabetologe 4:5, 361-367
CrossRef1285
Paul A. Estabrooks, Renae L. Smith-Ray. (2008) Piloting a behavioral intervention delivered through interactive voice response telephone messages to promote weight loss in a pre-diabetic population. Patient Education and Counseling 72:1, 34-41
CrossRef1286
R. E. Lamb, B. J. Goldstein. (2008) Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. International Journal of Clinical Practice 62:7, 1087-1095
CrossRef1287
Jennifer S. Brach, Andrea M. Kriska, Nancy W. Glynn, Anne B. Newman. (2008) Physical activity and the older adult: Measurement, benefits, and risks. Current Cardiovascular Risk Reports 2:4, 305-310
CrossRef1288
K. Rahme. (2008) Impaired glucose tolerance and the practical implications from a clinical perspective. International Journal of Clinical Practice 62:7, 988-989
CrossRef1289
Kuei‐Yu Chien, Ku‐Fu Hsu, Hsin‐I Lo, Ryh‐Nan Pan, Chia‐Hua Kuo, Fu‐An Chen, Mei‐Chich Hsu. (2008) Effects of swimming on the pharmacokinetics and glucose tolerance of metformin in insulin‐resistant rats. Biopharmaceutics & Drug Disposition 29:5, 300-307
CrossRef1290
I-MIN LEE, DAVID M. BUCHNER. (2008) The Importance of Walking to Public Health. Medicine & Science in Sports & Exercise 40:Supplement, S512-S518
CrossRef1291
Hoon Lee, Hak C. Jang, Hae K. Park, Boyd E. Metzger, Nam H. Cho. (2008) Prevalence of type 2 diabetes among women with a previous history of gestational diabetes mellitus. Diabetes Research and Clinical Practice 81:1, 124-129
CrossRef1292
Itziar Zazpe, Ana Sanchez-Tainta, Ramon Estruch, Rosa María Lamuela-Raventos, Helmut Schröder, Jordi Salas-Salvado, Dolores Corella, Miquel Fiol, Enrique Gomez-Gracia, Fernando Aros, Emilio Ros, Valentina Ruíz-Gutierrez, Pablo Iglesias, Manuel Conde-Herrera, Miguel Angel Martinez-Gonzalez. (2008) A Large Randomized Individual and Group Intervention Conducted by Registered Dietitians Increased Adherence to Mediterranean-Type Diets: The PREDIMED Study. Journal of the American Dietetic Association 108:7, 1134-1144
CrossRef1293
Jill P Crandall, William C Knowler, Steven E Kahn, David Marrero, Jose C Florez, George A Bray, Steven M Haffner, Mary Hoskin, David M Nathan. (2008) The prevention of type 2 diabetes. Nature Clinical Practice Endocrinology & Metabolism 4:7, 382-393
CrossRef1294
D. P. Macfarlane, K. R. Paterson, M. Fisher. (2008) Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes. Diabetes, Obesity and Metabolism 10:7, 533-544
CrossRef1295
Kim M. Huffman, Cris A. Slentz, Johanna L. Johnson, Gregory P. Samsa, Brian D. Duscha, Charles J. Tanner, Brian H. Annex, Joseph A. Houmard, William E. Kraus. (2008) Impact of hormone replacement therapy on exercise training–induced improvements in insulin action in sedentary overweight adults. Metabolism 57:7, 888-895
CrossRef1296
S. A. Smith, N. D. Shah, S. C. Bryant, T. J. H. Christianson, S. S. Bjornsen, P. D. Giesler, K. Krause, P. J. Erwin, V. M. Montori, . (2008) Chronic Care Model and Shared Care in Diabetes: Randomized Trial of an Electronic Decision Support System. Mayo Clinic Proceedings 83:7, 747-757
CrossRef1297
Michele Mietus-Snyder, Ronald M. Krauss. (2008) Lipid metabolism in children and adolescents: Impact on vascular biology. Journal of Clinical Lipidology 2:3, 127-137
CrossRef1298
Cristina Bianchi, Giuseppe Penno, Giuseppe Daniele, Luca Benzi, Stefano Prato, Roberto Miccoli. (2008) Optimizing management of metabolic syndrome to reduce risk: focus on life-style. Internal and Emergency Medicine 3:2, 87-98
CrossRef1299
A. Brunani, A. Caumo, S. Graci, G. Castagna, G. Viberti, A. Liuzzi. (2008) Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients. Diabetes, Obesity and Metabolism 10:6, 460-467
CrossRef1300
Guenther Boden. (2008) Increased insulin resistance in young adults born with very low birth weight. Current Diabetes Reports 8:3, 231-232
CrossRef1301
Andrea Botomino, Rudolf Bruppacher, Stephan Krähenbühl, Kurt E. Hersberger. (2008) Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies. Pharmacy World & Science 30:3, 222-226
CrossRef1302
Anne K. Sebert Kuhlmann, Patricia M. Dietz, Christine Galavotti, Lucinda J. England. (2008) Weight-Management Interventions for Pregnant or Postpartum Women. American Journal of Preventive Medicine 34:6, 523-528
CrossRef1303
Delia S. West, T. Elaine Prewitt, Zoran Bursac, Holly C. Felix. (2008) Weight Loss of Black, White, and Hispanic Men and Women in the Diabetes Prevention Program. Obesity 16:6, 1413-1420
CrossRef1304
Leonid Yatskar, Elizabeth Holper, Sameer Bansilal, Arthur Schwartzbard, Manuel Lombardero, Krishnan Ramanathan, Frederick Feit, Edward Fisher, David Faxon, Judith S. Hochman, Michael E. Farkouh. (2008) Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease. Atherosclerosis 198:2, 389-395
CrossRef1305
Wei-Min Chen, Michael R. Erdos, Anne U. Jackson, Richa Saxena, Serena Sanna, Kristi D. Silver, Nicholas J. Timpson, Torben Hansen, Marco Orrù, Maria Grazia Piras, Lori L. Bonnycastle, Cristen J. Willer, Valeriya Lyssenko, Haiqing Shen, Johanna Kuusisto, Shah Ebrahim, Natascia Sestu, William L. Duren, Maria Cristina Spada, Heather M. Stringham, Laura J. Scott, Nazario Olla, Amy J. Swift, Samer Najjar, Braxton D. Mitchell, Debbie A. Lawlor, George Davey Smith, Yoav Ben-Shlomo, Gitte Andersen, Knut Borch-Johnsen, Torben Jørgensen, Jouko Saramies, Timo T. Valle, Thomas A. Buchanan, Alan R. Shuldiner, Edward Lakatta, Richard N. Bergman, Manuela Uda, Jaakko Tuomilehto, Oluf Pedersen, Antonio Cao, Leif Groop, Karen L. Mohlke, Markku Laakso, David Schlessinger, Francis S. Collins, David Altshuler, Gonçalo R. Abecasis, Michael Boehnke, Angelo Scuteri, Richard M. Watanabe. (2008) Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. Journal of Clinical Investigation
CrossRef1306
G. M. Nicholls, A. M. Dissanayake, W. Hazell. (2008) Notification of random hyperglycaemia to general practitioners by an emergency medicine team: impact of a simple intervention plan. Diabetic Medicine 25:6, 751-754
CrossRef1307
Catherine Kim, Laura N. McEwen, Aruna V. Sarma, John D. Piette, William H. Herman. (2008) Stress Urinary Incontinence in Women with a History of Gestational Diabetes Mellitus. Journal of Women's Health 17:5, 783-792
CrossRef1308
Markolf Hanefeld, Frank Schaper, Carsta Koehler. (2008) Effect of Acarbose on Vascular Disease in Patients with Abnormal Glucose Tolerance. Cardiovascular Drugs and Therapy 22:3, 225-231
CrossRef1309
Carlo Maria Rotella, Laura Pala. (2008) Time to insulin in type-2 diabetes: high hurdles or Santiago way?. Acta Diabetologica 45:2, 67-74
CrossRef1310
Thomas C. Keyserling, Carmen D. Samuel Hodge, Stephanie B. Jilcott, Larry F. Johnston, Beverly A. Garcia, Ziya Gizlice, Myron D. Gross, Carla E. Saviñon, Shrikant I. Bangdiwala, Julie C. Will, Rosanne P. Farris, Stewart Trost, Alice S. Ammerman. (2008) Randomized trial of a clinic-based, community-supported, lifestyle intervention to improve physical activity and diet: The North Carolina enhanced WISEWOMAN project. Preventive Medicine 46:6, 499-510
CrossRef1311
David B. Allison (chair), Morgan Downey (co-chair), Richard L. Atkinson, Charles J. Billington, George A. Bray, Robert H. Eckel, Eric A. Finkelstein, Michael D. Jensen, Angelo Tremblay. (2008) Obesity as a Disease: A White Paper on Evidence and Arguments Commissioned by the Council of The Obesity Society. Obesity 16:6, 1161-1177
CrossRef1312
Abby C. King, David F. Ahn, Audie A. Atienza, Helena C. Kraemer. (2008) Exploring Refinements in Targeted Behavioral Medicine Intervention to Advance Public Health. Annals of Behavioral Medicine 35:3, 251-260
CrossRef1313
M. Rahman, R. K Simmons, A.-H. Harding, N. J Wareham, S. J Griffin. (2008) A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study. Family Practice 25:3, 191-196
CrossRef1314
Gregory A. Nichols, Teresa A. Hillier, Jonathan B. Brown. (2008) Normal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis. The American Journal of Medicine 121:6, 519-524
CrossRef1315
J BRUN, S BORDENAVE, J MERCIER, A JAUSSENT, M PICOT, C PREFAUT. (2008) Cost-sparing effect of twice-weekly targeted endurance training in type 2 diabetics: A one-year controlled randomized trial. Diabetes & Metabolism 34:3, 258-265
CrossRef1316
Jan Balzer, Tienush Rassaf, Christian Heiss, Petra Kleinbongard, Thomas Lauer, Marc Merx, Nicole Heussen, Heidrun B. Gross, Carl L. Keen, Hagen Schroeter, Malte Kelm. (2008) Sustained Benefits in Vascular Function Through Flavanol-Containing Cocoa in Medicated Diabetic Patients. Journal of the American College of Cardiology 51:22, 2141-2149
CrossRef1317
Kelly H. Webber, Deborah F. Tate, Lisa M. Quintiliani. (2008) Motivational Interviewing in Internet Groups: A Pilot Study for Weight Loss. Journal of the American Dietetic Association 108:6, 1029-1032
CrossRef1318
M WEBER, K NARAYAN. (2008) Preventing type 2 diabetes: Genes or lifestyle?. Primary Care Diabetes 2:2, 65-66
CrossRef1319
S Alhassan, S Kim, A Bersamin, A C King, C D Gardner. (2008) Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study. International Journal of Obesity 32:6, 985-991
CrossRef1320
Nurgül Fitzgerald, Grace Damio, Sofia Segura-Pérez, Rafael Pérez-Escamilla. (2008) Nutrition Knowledge, Food Label Use, and Food Intake Patterns among Latinas with and without Type 2 Diabetes. Journal of the American Dietetic Association 108:6, 960-967
CrossRef1321
Asim Ahmed Elnour, James C. McElnay. (2008) Antenatal oral glucose-tolerance test values and pregnancy outcomes. International Journal of Pharmacy Practice 16:3, 189-197
CrossRef1322
Shauna M. Downs, Dru Marshall, Carmina Ng, Noreen D. Willows. (2008) Central adiposity and associated lifestyle factors in Cree children. Applied Physiology, Nutrition, and Metabolism 33:3, 476-482
CrossRef1323
S BORDENAVE, F BRANDOU, J MANETTA, C FEDOU, J MERCIER, J BRUN. (2008) Effects of acute exercise on insulin sensitivity, glucose effectiveness and disposition index in type 2 diabetic patients. Diabetes & Metabolism 34:3, 250-257
CrossRef1324
Stephen B. Thomas, Sandra Crouse Quinn. (2008) Poverty and Elimination of Urban Health Disparities. Annals of the New York Academy of Sciences 1136:1, 111-125
CrossRef1325
T. McLaughlin, P. Schweitzer, S. Carter, C.-G. Yen, C. Lamendola, F. Abbasi, G. Reaven. (2008) Persistence of improvement in insulin sensitivity following a dietary weight loss programme. Diabetes, Obesity and Metabolism 0:0, 080512004419299-???
CrossRef1326
D WILLIAMS, S DUNSIGER, J CICCOLO, B LEWIS, A ALBRECHT, B MARCUS. (2008) Acute affective response to a moderate-intensity exercise stimulus predicts physical activity participation 6 and 12 months later. Psychology of Sport and Exercise 9:3, 231-245
CrossRef1327
R C Colley, A P Hills, T M O'Moore-Sullivan, I J Hickman, J B Prins, N M Byrne. (2008) Variability in adherence to an unsupervised exercise prescription in obese women. International Journal of Obesity 32:5, 837-844
CrossRef1328
Matthew R. Smith. (2008) Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors. Current Urology Reports 9:3, 197-202
CrossRef1329
David C. Ziemer, Paul Kolm, Jovonne K. Foster, William S. Weintraub, Viola Vaccarino, Mary K. Rhee, Rincy M. Varughese, Circe W. Tsui, David D. Koch, Jennifer G. Twombly, K. M. Venkat Narayan, Lawrence S. Phillips. (2008) Random Plasma Glucose in Serendipitous Screening for Glucose Intolerance: Screening for Impaired Glucose Tolerance Study 2. Journal of General Internal Medicine 23:5, 528-535
CrossRef1330
SA Amiel. (2008) Brainstorming in diabetes. Practical Diabetes International 25:4, 158-162
CrossRef1331
C. Roumen, E. Corpeleijn, E. J. M. Feskens, M. Mensink, W. H. M. Saris, E. E. Blaak. (2008) Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study. Diabetic Medicine 25:5, 597-605
CrossRef1332
S. F. E. Praet, E. S. J. Rooij, A. Wijtvliet, L. J. M. Boonman-de Winter, Th. Enneking, H. Kuipers, C. D. A. Stehouwer, L. J. C. Loon. (2008) Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial. Diabetologia 51:5, 736-746
CrossRef1333
José Alejandro Luchsinger. (2008) Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease. European Journal of Pharmacology 585:1, 119-129
CrossRef1334
Andrea Dunaif. (2008) Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal. Nature Clinical Practice Endocrinology & Metabolism 4:5, 272-283
CrossRef1335
Kathy Keenan Isoldi, Louis J. Aronne. (2008) The Challenge of Treating Obesity: The Endocannabinoid System as a Potential Target. Journal of the American Dietetic Association 108:5, 823-831
CrossRef1336
Sergio Huerta, Serag Dredar, Elizabeth Hayden, Ali A. Siddiqui, Thomas Anthony, Massimo Asolati, J. Esteban Varela, Edward H. Livingston. (2008) Preoperative Weight Loss Decreases the Operative Time of Gastric Bypass at a Veterans Administration Hospital. Obesity Surgery 18:5, 508-512
CrossRef1337
Jean-Claude Tardif, John JV McMurray, Eric Klug, Robert Small, Jennifer Schumi, Jasmine Choi, Jim Cooper, Robert Scott, Eldrin F Lewis, Philippe L L'Allier, Marc A Pfeffer. (2008) Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. The Lancet 371:9626, 1761-1768
CrossRef1338
Chun-Hsin Chen, Chih-Chiang Chiu, Ming-Chyi Huang, Tzu-Hua Wu, Hui-Ching Liu, Mong-Liang Lu. (2008) Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:4, 925-931
CrossRef1339
Gary B. Wilkerson, Nicholas F. Boer, Christine B. Smith, Gregory W. Heath. (2008) Health-Related Factors Associated With the Healthcare Costs of Office Workers. Journal of Occupational and Environmental Medicine 50:5, 593-601
CrossRef1340
K. Færch, A. Vaag, J. J. Holst, C. Glümer, O. Pedersen, K. Borch-Johnsen. (2008) Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51:5, 853-861
CrossRef1341
Irene S. Hoffmann, Anna B. Alfieri, Luigi X. Cubeddu. (2008) Salt-Resistant and Salt-Sensitive Phenotypes Determine the Sensitivity of Blood Pressure to Weight Loss in Overweight/Obese Patients. The Journal of Clinical Hypertension 10:5, 355-361
CrossRef1342
Guangwei Li, Ping Zhang, Jinping Wang, Edward W Gregg, Wenying Yang, Qiuhong Gong, Hui Li, Hongliang Li, Yayun Jiang, Yali An, Ying Shuai, Bo Zhang, Jingling Zhang, Theodore J Thompson, Robert B Gerzoff, Gojka Roglic, Yinghua Hu, Peter H Bennett. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. The Lancet 371:9626, 1783-1789
CrossRef1343
Jaana Lindström, Matti Uusitupa. (2008) Lifestyle intervention, diabetes, and cardiovascular disease. The Lancet 371:9626, 1731-1733
CrossRef1344
Christopher V. Almario, Teresa Ecker, Leslie A. Moroz, Lynne Bucovetsky, Vincenzo Berghella, Jason K. Baxter. (2008) Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. American Journal of Obstetrics and Gynecology 198:5, 528.e1-528.e5
CrossRef1345
Frances Burke, Philippe Szapary. 2008. Dyslipidemia, Hypertension and Metabolic Syndrome. , 133-159.
CrossRef1346
Darwin Deen, Katherine Margo. 2008. Nutrition and the Primary Care Clinician. , 1-13.
CrossRef1347
Marion J Franz, Richard Wender. 2008. Diabetes, Pre-diabetes and Hypoglycemia. , 161-177.
CrossRef1348
Sonia Caprio. (2008) Treatment of impaired glucose tolerance in childhood. Nature Clinical Practice Endocrinology & Metabolism
CrossRef1349
David B. Buller, W. Gill Woodall, Donald E. Zimmerman, Michael D. Slater, Jerianne Heimendinger, Emily Waters, Joan M. Hines, Randall Starling, Barbara Hau, Patricia Burris-Woodall, Glenna Sue Davis, Laura Saba, Gary R. Cutter. (2008) Randomized Trial on the 5 a Day, the Rio Grande Way Website, A Web-based Program to Improve Fruit and Vegetable Consumption in Rural Communities. Journal of Health Communication 13:3, 230-249
CrossRef1350
Diane O. Tyler, Sharon D. Horner. (2008) Family-centered collaborative negotiation: A model for facilitating behavior change in primary care. Journal of the American Academy of Nurse Practitioners 20:4, 194-203
CrossRef1351
Rena R. Wing, Becky Marquez. (2008) Behavioral aspects of weight loss in type 2 diabetes. Current Diabetes Reports 8:2, 126-131
CrossRef1352
Charlotte Hayes, Andrea Kriska. (2008) Role of Physical Activity in Diabetes Management and Prevention. Journal of the American Dietetic Association 108:4, S19-S23
CrossRef1353
Ann Albright. (2008) What Is Public Health Practice Telling Us about Diabetes?. Journal of the American Dietetic Association 108:4, S12-S18
CrossRef1354
Isabela Romao, Jesse Roth. (2008) Genetic and Environmental Interactions in Obesity and Type 2 Diabetes. Journal of the American Dietetic Association 108:4, S24-S28
CrossRef1355
Ray M. Merrill, Penny Taylor, Steven G. Aldana. (2008) Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression. Nutrition 24:4, 314-321
CrossRef1356
W. Shehab Eldin, M. Emara, A. Shoker. (2008) Prediabetes: a must to recognise disease state. International Journal of Clinical Practice 62:4, 642-648
CrossRef1357
Kelly J. Hunt, Deborah L. Conway. (2008) Who returns for postpartum glucose screening following gestational diabetes mellitus?. American Journal of Obstetrics and Gynecology 198:4, 404.e1-404.e6
CrossRef1358
Antony D. Karelis, Marie-Ève Lavoie, Virginie Messier, Diane Mignault, Dominique Garrel, Denis Prud’homme, Rémi Rabasa-Lhoret. (2008) Relationship between the metabolic syndrome and physical activity energy expenditure: a MONET study. Applied Physiology, Nutrition, and Metabolism 33:2, 309-314
CrossRef1359
Anna MG Cali, Sonia Caprio. (2008) Prediabetes and type 2 diabetes in youth: an emerging epidemic disease?. Current Opinion in Endocrinology, Diabetes and Obesity 15:2, 123-127
CrossRef1360
Elizabeth J. Mayer-Davis. (2008) Type 2 Diabetes in Youth: Epidemiology and Current Research toward Prevention and Treatment. Journal of the American Dietetic Association 108:4, S45-S51
CrossRef1361
Paul Muntner, Jonathan Winston, Jaime Uribarri, Devin Mann, Caroline S. Fox. (2008) Overweight, Obesity, and Elevated Serum Cystatin C Levels in Adults in the United States. The American Journal of Medicine 121:4, 341-348
CrossRef1362
Linda M. Delahanty, David M. Nathan. (2008) Implications of the Diabetes Prevention Program and Look AHEAD Clinical Trials for Lifestyle Interventions. Journal of the American Dietetic Association 108:4, S66-S72
CrossRef1363
Jennifer M Perkins, Stephen N Davis. (2008) The renin–angiotensin–aldosterone system: a pivotal role in insulin sensitivity and glycemic control. Current Opinion in Endocrinology, Diabetes and Obesity 15:2, 147-152
CrossRef1364
Giuseppe Seghieri, Federica Tesi, Roberto Anichini, Alessandra De Bellis, Gianna Fabbri, Raffaella Malagoli, Flavia Franconi. (2008) Gender modulates the relationship between body weight and plasma glucose in overweight or obese subjects. Diabetes Research and Clinical Practice 80:1, 134-138
CrossRef1365
S.S. Rasmussen, C. Glümer, A. Sandbaek, T. Lauritzen, B. Carstensen, K. Borch-Johnsen. (2008) Short-term reproducibility of impaired fasting glycaemia, impaired glucose tolerance and diabetes. Diabetes Research and Clinical Practice 80:1, 146-152
CrossRef1366
Roslyn B. Mannon. (2008) Therapeutic management of posttransplant diabetes mellitus. Transplantation Reviews 22:2, 116-124
CrossRef1367
D SARTORELLI, L FRANCO, M CARDOSO. (2008) High intake of fruits and vegetables predicts weight loss in Brazilian overweight adults. Nutrition Research 28:4, 233-238
CrossRef1368
David L. Katz, Kerem Shuval, Beth P. Comerford, Zubaida Faridi, Valentine Y. Njike. (2008) Impact of an educational intervention on internal medicine residents’ physical activity counselling: the Pressure System Model. Journal of Evaluation in Clinical Practice 14:2, 294-299
CrossRef1369
J. C. Florez, K. A. Jablonski, J. McAteer, M. S. Sandhu, N. J. Wareham, I. Barroso, P. W. Franks, D. Altshuler, W. C. Knowler, . (2008) Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia 51:3, 451-457
CrossRef1370
Angela L. Brown. (2008) Obesity and the Metabolic Syndrome in African American Women. Journal of the CardioMetabolic Syndrome 3:2, 126-128
CrossRef1371
Katja S.C. Röckl, Carol A. Witczak, Laurie J. Goodyear. (2008) Signaling mechanisms in skeletal muscle: Acute responses and chronic adaptations to exercise. IUBMB Life 60:3, 145-153
CrossRef1372
Emilio A Francischetti, Bruno MJ Celoria, Aloisio Francischetti, Virginia A Genelhu. (2008) Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan. Expert Review of Cardiovascular Therapy 6:3, 289-303
CrossRef1373
Janice L. Thompson, Peg Allen, Deborah L. Helitzer, Clifford Qualls, Ayn N. Whyte, Venita K. Wolfe, Carla J. Herman. (2008) Reducing Diabetes Risk in American Indian Women. American Journal of Preventive Medicine 34:3, 192-201
CrossRef1374
Jason M. Hollander, Jeffrey I. Mechanick. (2008) Complementary and Alternative Medicine and the Management of the Metabolic Syndrome. Journal of the American Dietetic Association 108:3, 495-509
CrossRef1375
J.M. Weiss, D. Hadžiomerović, R. Kreienberg. (2008) Syndrom der polyzystischen Ovarien (PCOS). Der Gynäkologe 41:3, 179-188
CrossRef1376
Bonnie J Brehm, David A D'Alessio. (2008) Weight loss and metabolic benefits with diets of varying fat and carbohydrate content: separating the wheat from the chaff. Nature Clinical Practice Endocrinology & Metabolism 4:3, 140-146
CrossRef1377
G. Stennis Watson, Suzanne Craft. (2008) Insulin Resistance Alzheimer's Disease: Pathophysiology and Treatment. Progress in Neurotherapeutics and Neuropsychopharmacology 3:01,
CrossRef1378
Jeannet Lauenborg, Elisabeth R. Mathiesen, Lars Mølsted-Pedersen, Peter Damm. 2008. Diabetes mellitus and the metabolic syndrome after gestational diabetes. , 379-384.
CrossRef1379
Deborah Vincent, Marylyn M. McEwen, Alice Pasvogel. (2008) The Validity and Reliability of a Spanish Version of the Summary of Diabetes Self-Care Activities Questionnaire. Nursing Research 57:2, 101-106
CrossRef1380
(2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertility and Sterility 89:3, 505-522
CrossRef1381
E J Boyko, E L M Barr, P Z Zimmet, J E Shaw. (2008) Two-hour glucose predicts the development of hypertension over 5 years: the AusDiab study. Journal of Human Hypertension 22:3, 168-176
CrossRef1382
M Skamagas, TL Breen, D LeRoith. (2008) Update on diabetes mellitus: prevention, treatment, and association with oral diseases. Oral Diseases 14:2, 105-114
CrossRef1383
Boyd E. Metzger, Yoo Lee Kim. 2008. Detection and diagnostic strategies for gestational diabetes mellitus. , 156-164.
CrossRef1384
B COSTA. (2008) Efectividad en la prevención de la diabetes tipo 2. Un aterrizaje forzoso en la realidad. Medicina Clínica 130:8, 295-297
CrossRef1385
Sudha Ganne, Nathaniel Winer. (2008) Obesity and vascular compliance. Current Cardiovascular Risk Reports 2:2, 120-125
CrossRef1386
A Elisabeth Hak, Hyon K Choi. (2008) Lifestyle and gout. Current Opinion in Rheumatology 20:2, 179-186
CrossRef1387
Joseph Tibaldi. (2008) Preserving insulin secretion in Type 2 diabetes mellitus. Expert Review of Endocrinology & Metabolism 3:2, 147-159
CrossRef1388
F. Nothwehr, L. Snetselaar, H. Wu. (2008) Age group differences in diet and physical activity-related behaviors among rural men and women. The Journal of Nutrition Health and Aging 12:3, 169-174
CrossRef1389
M. McQuigg, J.E. Brown, J. Broom, R.A. Laws, J.P.D. Reckless, P.A. Noble, S. Kumar, E.L. McCombie, M.E.J. Lean, F.G. Lyons, G.S. Frost, M.F. Quinn, J.H. Barth, S.M. Haynes, N. Finer, D.W. Haslam, H.M. Ross, D.J. Hole, S. Radziwonik. (2008) The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change. Obesity Research & Clinical Practice 2:1, 15-27
CrossRef1390
Nanette K. Wenger. (2008) Preventing Cardiovascular Disease in Women: An Update. Clinical Cardiology 31:3, 109-113
CrossRef1391
Judith J. Prochaska, Bonnie Spring, Claudio R. Nigg. (2008) Multiple health behavior change research: An introduction and overview. Preventive Medicine 46:3, 181-188
CrossRef1392
Sergio Valdés, Patricia Botas, Elías Delgado, Francisco Álvarez, Francisco Diaz Cadórniga. (2008) Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study. Metabolism 57:3, 399-403
CrossRef1393
A SANCHEZRODRIGUEZ, M SANCHEZLEDESMA. (2008) El internista y la diabetes mellitus. Revista Clínica Española 208:3, 115-117
CrossRef1394
Arne Astrup, Jørn Dyerberg, Matthew Selleck, Steen Stender. (2008) Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obesity Reviews 9:s1, 48-52
CrossRef1395
M. L. Cugnetto, P. G. Saab, M. M. Llabre, R. Goldberg, J. R. McCalla, N. Schneiderman. (2008) Lifestyle Factors, Body Mass Index, and Lipid Profile in Adolescents. Journal of Pediatric Psychology 33:7, 761-771
CrossRef1396
Shelley R. Salpeter, Nicholas S. Buckley, Justin A. Kahn, Edwin E. Salpeter. (2008) Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus. The American Journal of Medicine 121:2, 149-157.e2
CrossRef1397
John A. Farmer. (2008) Diabetic dyslipidemia and atherosclerosis: Evidence from clinical trials. Current Diabetes Reports 8:1, 71-77
CrossRef1398
Tisha Joy, Robert A. Hegele. (2008) Is raising HDL a futile strategy for atheroprotection?. Nature Reviews Drug Discovery 7:2, 143-155
CrossRef1399
Daniel Antonio de Luis, Manuel Gonzalez Sagrado, Rosa Conde, Rocio Aller, Olatz Izaola. (2008) Changes of ghrelin and leptin in response to hypocaloric diet in obese patients. Nutrition 24:2, 162-166
CrossRef1400
Naveen Uli, Sumana Sundararajan, Leona Cuttler. (2008) Treatment of childhood obesity. Current Opinion in Endocrinology, Diabetes and Obesity 15:1, 37-47
CrossRef1401
Brandon M Nathan, Antoinette Moran. (2008) Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Current Opinion in Endocrinology, Diabetes and Obesity 15:1, 21-29
CrossRef1402
Monique A. Ford, Thomas G. Allison, Amir Lerman. (2008) New approaches to the concept of primary prevention of atherosclerosis. Current Treatment Options in Cardiovascular Medicine 10:1, 73-82
CrossRef1403
Amytis Towfighi, Bruce Ovbiagele. (2008) Metabolic syndrome and stroke. Current Diabetes Reports 8:1, 37-41
CrossRef1404
S. S. Rasmussen, C. Glümer, A. Sandbaek, T. Lauritzen, K. Borch-Johnsen. (2008) Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia 51:2, 249-257
CrossRef1405
Silvio Garattini, Vittorio Bertele’. (2008) Do we learn the right things from clinical trials?. European Journal of Clinical Pharmacology 64:2, 115-125
CrossRef1406
Barry Braun, Pamela Eze, Brooke R. Stephens, Todd A. Hagobian, Carrie G. Sharoff, Stuart R. Chipkin, Benjamin Goldstein. (2008) Impact of metformin on peak aerobic capacity. Applied Physiology, Nutrition, and Metabolism 33:1, 61-67
CrossRef1407
Patrice Flore, Véronique-A Bricout, Debbie van Biesen, Michel Guinot, François Laporte, Jean-Louis Pépin, Yves Eberhard, Anne Favre-Juvin, Bernard Wuyam, Peter van de Vliet, Patrice Faure. (2008) Oxidative stress and metabolism at rest and during exercise in persons with Down syndrome. European Journal of Cardiovascular Prevention & Rehabilitation 15:1, 35-42
CrossRef1408
G. Zhao, E. S. Ford, C. Li, A. H. Mokdad. (2008) Compliance with physical activity recommendations in US adults with diabetes. Diabetic Medicine 25:2, 221-227
CrossRef1409
Giorgio Sesti, Francesco Andreozzi, Riccardo C. Bonadonna, Giancarlo De Mattia, Frida Leonetti, Livio Luzi, Maria Adelaide Marini, Andrea Natali, Roberto Vettor, Enzo Bonora, . (2008) Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database.. Diabetes/Metabolism Research and Reviews 24:2, 130-136
CrossRef1410
Maria Werner, Anke Tönjes, Michael Stumvoll, Joachim Thiery, Jürgen Kratzsch. (2008) Assay-dependent variability of serum insulin levels during oral glucose tolerance test: influence on reference intervals for insulin and on cut-off values for insulin sensitivity indices. Clinical Chemistry and Laboratory Medicine 46:2, 240-246
CrossRef1411
S. M. Beard, L. McCrink, T. K. Le, A. Garcia-Cebrian, B. Monz, R. A. Malik. (2008) Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK*. Current Medical Research and Opinion 24:2, 385-399
CrossRef1412
M Kolehmainen, T Salopuro, U S Schwab, J Kekäläinen, P Kallio, D E Laaksonen, L Pulkkinen, V I Lindi, K Sivenius, U Mager, N Siitonen, L Niskanen, H Gylling, R Rauramaa, M Uusitupa. (2008) Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. International Journal of Obesity 32:2, 292-303
CrossRef1413
Gabriel Gregoratos, Gordon Leung. 2008. Diabetes Mellitus and Cardiovascular Disease in the Elderly. , 179-214.
CrossRef1414
Jeffrey Cardenas, Mark A. Frye, Susan L. Marusak, Eric M. Levander, Jason W. Chirichigno, Stryder Lewis, Shoshanna Nakelsky, Sun Hwang, Jim Mintz, Lori L. Altshuler. (2008) Modal subcomponents of metabolic syndrome in patients with bipolar disorder. Journal of Affective Disorders 106:1-2, 91-97
CrossRef1415
Markolf Hanefeld, Frank Schaper. (2008) Acarbose: oral antidiabetes drug with additional cardiovascular benefits. Expert Review of Cardiovascular Therapy 6:2, 153-163
CrossRef1416
Wai Ping Alicia Chan, Aaron Leonid Sverdlov, John David Horowitz. (2008) Management of the metabolic syndrome in cardiovascular disease. Current Treatment Options in Cardiovascular Medicine 10:1, 27-38
CrossRef1417
Andrew J. Krentz. (2008) Management of type 2 diabetes in the obese patient: current concerns and emerging therapies. Current Medical Research and Opinion 24:2, 401-417
CrossRef1418
Jamy D. Ard, Shiriki Kumanyika, Victor J. Stevens, William M. Vollmer, Carmen Samuel-Hodge, Betty Kennedy, Debra Gayles, Lawrence J. Appel, Phillip J. Brantley, Catherine Champagne, Jeanne Charleston, Laura P. Svetkey. (2008) Effect of Group Racial Composition on Weight Loss in African Americans. Obesity 16:2, 306-310
CrossRef1419
Kurt Laederach-Hofmann, Nadine Messerli-Burgy, Katharina Meyer. (2008) Long-term effects of non-surgical therapy for obesity on cardiovascular risk management: a weighted empirical review. Journal of Public Health 16:1, 21-29
CrossRef1420
Gabriel Q. Shaibi, Michael I. Goran. (2008) Examining Metabolic Syndrome Definitions in Overweight Hispanic Youth: A Focus on Insulin Resistance. The Journal of Pediatrics 152:2, 171-176
CrossRef1421
Stefano Bellentani, Riccardo Dalle Grave, Alessandro Suppini, Giulio Marchesini. (2008) Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology 47:2, 746-754
CrossRef1422
Lorna S. Aucott. (2008) Influences of weight loss on long-term diabetes outcomes. Proceedings of the Nutrition Society 67:01, 54-59
CrossRef1423
Ming-Yen Heish, Chia-Yen Dai, Jee-Fu Huang, Li-Po Lee, Nai-Jen Hou, Wan-Long Chuang, Ming-Lung Yu. (2008) Revisit of Oral Glucose Tolerance Test: A Must for Diagnosis of Type 2 Diabetes in Patients With Chronic Hepatitis C. The American Journal of Gastroenterology 103:2, 487-488
CrossRef1424
Nestler, John E., . (2008) Metformin for the Treatment of the Polycystic Ovary Syndrome. New England Journal of Medicine 358:1, 47-54
Full Text1425
Alejandro de la Sierra. (2008) The Clinical Significance of Metabolic Syndrome in Hypertension: Metabolic Syndrome Increases Cardiovascular Risk. High Blood Pressure & Cardiovascular Prevention 15:2, 53-57
CrossRef1426
Young Sil Eom, Sun Mee Yang, Pyung Chun Oh, Jung Hyun Lee, Ki Young Lee, Yeun Sun Kim, Sihoon Lee, Jung Soo Im, Jun Yim, Dae Kyu Oh, Moon Su Nam, Ie Byung Park. (2008) Association of Educational Level and Socioeconomic Status with Glucose Metabolism. Korean Diabetes Journal 32:4, 377
CrossRef1427
Joan Sargeant, Michel Valli, Suzanne Ferrier, Heather MacLeod. (2008) Lifestyle counseling in primary care: opportunities and challenges for changing practice. Medical Teacher 30:2, 185-191
CrossRef1428
Doo-Man Kim. (2008) The Prevention of Type 2 Diabetes Mellitus. Journal of the Korean Medical Association 51:9, 818
CrossRef1429
Carol R. Horowitz, Judith Z. Goldfinger, Sara E. Muller, Romina S. Pulichino, Thomas L. Vance, Guedy Arniella, Kristie J. Lancaster. (2008) A model for using community-based participatory research to address the diabetes epidemic in east harlem. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75:1, 13-21
CrossRef1430
Lucia Briatore, Barbara Salani, Gabriella Andraghetti, Cristina Danovaro, Elsa Sferrazzo, Nicola Scopinaro, Gian F Adami, Davide Maggi, Renzo Cordera. (2008) Restoration of Acute Insulin Response in T2DM Subjects 1 Month After Biliopancreatic Diversion. Obesity 16:1, 77-81
CrossRef1431
Prakash Deedwania, Sundararajan Srikanth. (2008) Diabetes and vascular disease. Expert Review of Cardiovascular Therapy 6:1, 127-138
CrossRef1432
So Hun Kim, Wan Sub Shim, Eun A Kim, Eun Joo Kim, Seung Hee Lee, Seong Bin Hong, Yong Seong Kim, Shin Goo Park, Jong Whan Lim, Hun-Jae Lee, Moonsuk Nam. (2008) The Effect of Lowering the Threshold for Diagnosis of Impaired Fasting Glucose. Yonsei Medical Journal 49:2, 217
CrossRef1433
Robert A. Wild. (2008) Pioglitazone and metformin for increased small low-density lipoprotein in polycystic ovary syndrome: Counterpoint. American Journal of Obstetrics and Gynecology 198:1, 4-6
CrossRef1434
Nichola J. Davis, Hillel W. Cohen, Judith Wylie-Rosett, Daniel Stein. (2008) Serum Potassium Changes with Initiating Low-Carbohydrate Compared to a Low-Fat Weight Loss Diet in Type 2 Diabetes. Southern Medical Journal 101:1, 46-49
CrossRef1435
Patrick Mathieu, Philippe Pibarot, Éric Larose, Paul Poirier, André Marette, Jean-Pierre Després. (2008) Visceral obesity and the heart. The International Journal of Biochemistry & Cell Biology 40:5, 821-836
CrossRef1436
Ramachandran S. Vasan. (2008) What is an Abnormal Blood Glucose Level?. JACC: Cardiovascular Imaging 1:1, 46-48
CrossRef1437
S. Glund, A. Krook. (2008) Role of interleukin-6 signalling in glucose and lipid metabolism. Acta Physiologica 192:1, 37-48
CrossRef1438
(2008) CrossRef Listing of Deleted DOIs. CrossRef Listing of Deleted DOIs
CrossRef1439
Naveed Sattar. (2008) Inflammation, insulin resistance, and cardiovascular disease: Cause or correlate?. Current Cardiovascular Risk Reports 2:1, 53-59
CrossRef1440
Melbourne F. Hovell, Mary M. Mulvihill, Michael J. Buono, Sandy Liles, Debra H. Schade, Tabitha A. Washington, Ruth Manzano, James F. Sallis. (2008) Culturally Tailored Aerobic Exercise Intervention for Low-income Latinas. American Journal of Health Promotion 22:3, 155-163
CrossRef1441
Romina Marone, Vladimir Cmiljanovic, Bernd Giese, Matthias P. Wymann. (2008) Targeting phosphoinositide 3-kinase—Moving towards therapy. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1784:1, 159-185
CrossRef1442
Bertram L. Kasiske, Ajay K. Israni. 2008. Cardiovascular Complications after Renal Transplantation. , 469-491.
CrossRef1443
Chang-Hae Park, Hyuk Ga, Jong-Han Leem, Seung-Min Kwak, Hwan-Cheol Kim, Ji-Ho Choi. (2008) The Effect of Smoking Status upon Occurrence of Impaired Fasting Glucose or Type 2 Diabetes in Korean Men. Journal of Preventive Medicine and Public Health 41:4, 249
CrossRef1444
A Gordon Smith, J Robinson Singleton. (2008) Impaired Glucose Tolerance and Neuropathy. The Neurologist 14:1, 23-29
CrossRef1445
Arnold Vang, Pramil N. Singh, Jerry W. Lee, Ella H. Haddad, Charles H. Brinegar. (2008) Meats, Processed Meats, Obesity, Weight Gain and Occurrence of Diabetes among Adults: Findings from Adventist Health Studies. Annals of Nutrition and Metabolism 52:2, 96-104
CrossRef1446
M.J. Amiot, D. Lairon. 2008. Fruit and vegetables, cardiovascular disease, diabetes and obesity. , 95-118.
CrossRef1447
Erik Ingelsson. (2008) Associations of insulin resistance and type 2 diabetes to heart failure: Epidemiology, potential mechanisms, and clinical perspectives. Current Cardiovascular Risk Reports 2:1, 60-65
CrossRef1448
Junko Fujio, Akifumi Kushiyama, Hideyuki Sakoda, Midori Fujishiro, Takehide Ogihara, Yasushi Fukushima, Motonobu Anai, Nanao Horike, Hideaki Kamata, Yasunobu Uchijima, Hiroki Kurihara, Tomoichiro Asano. (2008) Regulation of gut-derived resistin-like molecule β expression by nutrients. Diabetes Research and Clinical Practice 79:1, 2-10
CrossRef1449
Ronald M. Witteles, Michael B. Fowler. (2008) Insulin-Resistant Cardiomyopathy. Journal of the American College of Cardiology 51:2, 93-102
CrossRef1450
D.A. de Luis, R. Aller, O. Izaola, M. Gonzalez Sagrado, R. Conde. (2008) Influence of Lys656Asn Polymorphism of Leptin Receptor Gene on Leptin Response Secondary to Two Hypocaloric Diets: A Randomized Clinical Trial. Annals of Nutrition and Metabolism 52:3, 209-214
CrossRef1451
K Kapur, T Dunning. (2008) Global nutritional recommendations: a combination of evidence and food availability?. Practical Diabetes International 25:1, 19-26
CrossRef1452
Sophie E. Yeo, Robert H. Coker. (2008) Aerobic exercise training versus the aetiology of insulin resistance. European Journal of Sport Science 8:1, 3-14
CrossRef1453
S PHUMIPAMORN, J PONGWECHARAK, S SOORAPAN, S PATTHARACHAYAKUL. (2008) Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes
CrossRef1454
Tae Sun Park, Hong-Sun Baek, Ji-Hyun Park. (2008) General Principles for Diabetes Mellitus Management. Journal of the Korean Medical Association 51:9, 806
CrossRef1455
David Arterburn, Emily O Westbrook, Cheryl J Wiese, Evette J Ludman, David C Grossman, Paul A Fishman, Eric A Finkelstein, Robert W Jeffery, Adam Drewnowski. (2008) Insurance Coverage and Incentives for Weight Loss Among Adults With Metabolic Syndrome. Obesity 16:1, 70-76
CrossRef1456
Derek T. Smith, Mandolyn Jade Vendela, R. Todd Bartee, Lucas J. Carr. (2008) Body Mass Index in Rural First Grade Schoolchildren: Progressive Increase in Boys. The Journal of Rural Health 24:1, 40-48
CrossRef1457
Jason M.R. Gill, Ashley R. Cooper. (2008) Physical Activity and Prevention of Type 2 Diabetes Mellitus. Sports Medicine 38:10, 807-824
CrossRef1458
Mercedes R. Carnethon, Lynette L. Craft. (2008) Autonomic Regulation of the Association between Exercise and Diabetes. Exercise and Sport Sciences Reviews 36:1, 12-18
CrossRef1459
A. Hamann. (2008) Pharmakotherapie der Adipositas. Der Internist 49:1, 106-113
CrossRef1460
Enzo Bonora. (2008) Protection of pancreatic beta-cells: Is it feasible?. Nutrition, Metabolism and Cardiovascular Diseases 18:1, 74-83
CrossRef1461
Howard Leventhal, John Weinman, Elaine A. Leventhal, L. Alison Phillips. (2008) Health Psychology: The Search for Pathways between Behavior and Health. Annual Review of Psychology 59:1, 477-505
CrossRef1462
ROBERT H. LUSTIG, RAM WEISS. 2008. Disorders of Energy Balance. , 788-838.
CrossRef1463
Sebastio Perrini, Anna Leonardini, Luigi Laviola, Francesco Giorgino. (2008) Biological specificity of visceral adipose tissue and therapeutic intervention. Archives Of Physiology And Biochemistry 114:4, 277-286
CrossRef1464
Luigi X Cubeddu, Anna B Alfieri, Irene S Hoffmann. (2008) Lowering the Threshold for Defining Microalbuminuria: Effects of a Lifestyle–metformin Intervention in Obese “Normoalbuminuric” Non-diabetic Subjects. American Journal of Hypertension 21:1, 105-110
CrossRef1465
A Golay. (2008) Metformin and body weight. International Journal of Obesity 32:1, 61-72
CrossRef1466
Cathy E Lloyd, Anthony H Barnett. (2008) Physical activity and risk of diabetes. The Lancet 371:9606, 5-7
CrossRef1467
Thomas Wolever, Janet Vogt. 2007. The Metabolic Syndrome and Type 2 Diabetes Mellitus. .
CrossRef1468
R M van Dam, J C Seidell. (2007) Carbohydrate intake and obesity. European Journal of Clinical Nutrition 61, S75-S99
CrossRef1469
Anna Peeters, Paul E. OʼBrien, Cheryl Laurie, Margaret Anderson, Rory Wolfe, David Flum, Robert J. MacInnis, Dallas R. English, John Dixon. (2007) Substantial Intentional Weight Loss and Mortality in the Severely Obese. Annals of Surgery 246:6, 1028-1033
CrossRef1470
Jean-Louis Chiasson. (2007) Prevention of Type 2 diabetes: fact or fiction?. Expert Opinion on Pharmacotherapy 8:18, 3147-3158
CrossRef1471
Apostolos Tsapas, Efthymia Vlachaki, Athanasios Christoforidis, Maria Sarigianni, Eleni Bekiari, Vassilis Perifanis, Vassilis Tsapas, Konstantinos Paletas, Miranda Athanassiou-Metaxa. (2007) Insulin sensitivity assessment with euglycemic insulin clamp in adult β-thalassaemia major patients. European Journal of Haematology 79:6, 526-530
CrossRef1472
Lisa M. Neff, Louis J. Aronne. (2007) Pharmacotherapy for obesity. Current Atherosclerosis Reports 9:6, 454-462
CrossRef1473
Paolo Pozzilli, Chiara Guglielmi, Ekaterina Pronina, Elena Petraikina. (2007) Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths. Pediatric Diabetes 8:s9, 88-95
CrossRef1474
BOYD E. METZGER. (2007) Long-term Outcomes in Mothers Diagnosed With Gestational Diabetes Mellitus and Their Offspring. Clinical Obstetrics and Gynecology 50:4, 972-979
CrossRef1475
S. Smith, D. Yeomans, C. J. P. Bushe, C. Eriksson, T. Harrison, R. Holmes, L. Mynors-Wallis, H. Oatway, G. Sullivan. (2007) A well-being programme in severe mental illness. Baseline findings in a UK cohort. International Journal of Clinical Practice 61:12, 1971-1978
CrossRef1476
Matthew J Watt, Gregory R Steinberg. (2007) Pathways involved in lipid-induced insulin resistance in obesity. Future Lipidology 2:6, 659-667
CrossRef1477
K. G. M. M. Alberti, C. J. Bailey, L. Blonde, A. M. Felton, P. Zimmet, . (2007) Partnering with governments and other institutions: driving change in diabetes care. International Journal of Clinical Practice 61, 38-46
CrossRef1478
Julia M. Bottomley, Frank D. Raymond. (2007) Pharmaco-economic issues for diabetes therapy. Best Practice & Research Clinical Endocrinology & Metabolism 21:4, 657-685
CrossRef1479
Francine R Kaufman, Jonathan Shaw. (2007) Type 2 diabetes in youth: rates, antecedents, treatment, problems and prevention. Pediatric Diabetes 8:s9, 4-6
CrossRef1480
Craig A. Johnston, Chermaine Tyler, John P. Foreyt. (2007) Behavioral management of obesity. Current Atherosclerosis Reports 9:6, 448-453
CrossRef1481
J UNGER. (2007) Diagnosis and Management of Type 2 Diabetes and Prediabetes. Primary Care: Clinics in Office Practice 34:4, 731-759
CrossRef1482
Thomas A Gaziano, Gauden Galea, K Srinath Reddy. (2007) Scaling up interventions for chronic disease prevention: the evidence. The Lancet 370:9603, 1939-1946
CrossRef1483
Barbara Gross, Bart Staels. (2007) PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 21:4, 687-710
CrossRef1484
Louis J. Aronne, W. Virgil Brown, Kathy Keenan Isoldi. (2007) Cardiovascular disease in obesity: A review of related risk factors and risk-reduction strategies. Journal of Clinical Lipidology 1:6, 575-582
CrossRef1485
Melissa M. Ahern, Michael Hendryx. (2007) Avoidable Hospitalizations for Diabetes: Comorbidity Risks. Disease Management 10:6, 347-355
CrossRef1486
David M Maahs, Stephen R Daniels. (2007) A Pediatric Perspective: Adult problems in kids, new challenges in pediatric diabetes. Pediatric Diabetes 8:6, 349-351
CrossRef1487
Kathryn A Taubert, Nathaniel G Clark, Robert A Smith. (2007) Patient-centered prevention strategies for cardiovascular disease, cancer and diabetes. Nature Clinical Practice Cardiovascular Medicine 4:12, 656-666
CrossRef1488
S. Del Prato, E. Horton, R. Nesto, . (2007) We have the evidence, we need to act to improve diabetes care. International Journal of Clinical Practice 61, 9-15
CrossRef1489
S. Matthaei, N. Munro, B. Zinman, . (2007) Raising diabetes awareness in the public domain. International Journal of Clinical Practice 61, 31-37
CrossRef1490
Ram Weiss. (2007) Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth. Pediatric Diabetes 8:s9, 70-75
CrossRef1491
S. A. Anderssen, S. Carroll, P. Urdal, I. Holme. (2007) Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study. Scandinavian Journal of Medicine & Science in Sports 17:6, 687-695
CrossRef1492
Neville G. Suskin, George Heigenhauser, Rizwan Afzal, Diane Finegood, Hertzel C. Gerstein, Robert S. McKelvie. (2007) The effects of exercise training on insulin resistance in patients with coronary artery disease. European Journal of Cardiovascular Prevention & Rehabilitation 14:6, 803-808
CrossRef1493
J Mann. (2007) Dietary carbohydrate: relationship to cardiovascular disease and disorders of carbohydrate metabolism. European Journal of Clinical Nutrition 61, S100-S111
CrossRef1494
V ZAMUDIO. (2007) Lifestyle Interventions. Primary Care: Clinics in Office Practice 34:4, 683-711
CrossRef1495
Katherine Esposito, Antonio Ceriello, Dario Giugliano. (2007) Diet and the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 5:4, 291-296
CrossRef1496
L. Miles. (2007) Physical activity and health. Nutrition Bulletin 32:4, 314-363
CrossRef1497
D.A. de Luis, M. Gonzalez Sagrado, R. Aller, O. Izaola, R. Conde. (2007) Influence of the Trp64Arg polymorphism in the beta 3 adrenoreceptor gene on insulin resistance, adipocytokine response, and weight loss secondary to lifestyle modification in obese patients. European Journal of Internal Medicine 18:8, 587-592
CrossRef1498
Rhonda M. Cooper-DeHoff,, Carl J. Pepine,. (2007) Metabolic Syndrome and Cardiovascular Disease: Challenges and Opportunities. Clinical Cardiology 30:12, 593-597
CrossRef1499
Walter Futterweit. (2007) Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment. Primary Care: Clinics in Office Practice 34:4, 761-789
CrossRef1500
Heather A. Haugen, Zung V. Tran, Holly R. Wyatt, Mary J. Barry, James O. Hill. (2007) Using Telehealth to Increase Participation in Weight Maintenance Programs**. Obesity 15:12, 3067-3077
CrossRef1501
Hertzel C. Gerstein, Pasqualina Santaguida, Parminder Raina, Katherine M. Morrison, Cynthia Balion, Dereck Hunt, Hossein Yazdi, Lynda Booker. (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Research and Clinical Practice 78:3, 305-312
CrossRef1502
H. M. Devlin, J. Desai, G. S. Holzman, D. T. Gilbertson. (2007) Trends and Disparities Among Diabetes-Complicated Births in Minnesota, 1993-2003. American Journal of Public Health 98:1, 59-62
CrossRef1503
Erin J Keely, Janine C Malcolm, Stasia Hadjiyannakis, Isabelle Gaboury, Gigi Lough, Margaret L Lawson. (2007) Prevalence of metabolic markers of insulin resistance in offspring of gestational diabetes pregnancies. Pediatric Diabetes 0:0, 071127170524005-???
CrossRef1504
Simona Bo, Giovannino Ciccone, Carla Baldi, Lorenzo Benini, Ferruccio Dusio, Giuseppe Forastiere, Claudio Lucia, Claudio Nuti, Marilena Durazzo, Maurizio Cassader, Luigi Gentile, Gianfranco Pagano. (2007) Effectiveness of a Lifestyle Intervention on Metabolic Syndrome. A Randomized Controlled Trial. Journal of General Internal Medicine 22:12, 1695-1703
CrossRef1505
Darren E.R. Warburton, Peter T. Katzmarzyk, Ryan E. Rhodes, Roy J. Shephard. (2007) Evidence-informed physical activity guidelines for Canadian adultsThis article is part of a supplement entitled Advancing physical activity measurement and guidelines in Canada: a scientific review and evidence-based foundation for the future of Canadian physical activity guidelines co-published by Applied Physiology, Nutrition, and Metabolism and the Canadian Journal of Public Health . It may be cited as Appl. Physiol. Nutr. Metab. 32(Suppl. 2E) or as Can. J. Public Health 98(Suppl. 2).. Applied Physiology, Nutrition, and Metabolism 32:S2E, S16-S68
CrossRef1506
T. J. Wilkin. (2007) Comment on: Gale EAM (2007) To boldly go—or to go too boldly? The accelerator hypothesis revisited. Diabetologia 50:1571–1575—a reply to the editor. Diabetologia 50:12, 2604-2606
CrossRef1507
P. W. Franks, K. A. Jablonski, L. Delahanty, R. L. Hanson, S. E. Kahn, D. Altshuler, W. C. Knowler, J. C. Florez, . (2007) The Pro12Ala variant at the peroxisome proliferator-activated receptor γ gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 50:12, 2451-2460
CrossRef1508
H-E. Johansson, M. Öhrvall, A. Haenni, M. Sundbom, B. Edén Engström, F. A. Karlsson, B. Zethelius. (2007) Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretion. Diabetic Medicine 24:11, 1213-1220
CrossRef1509
Paul Kuo, Christopher K. Rayner, Michael Horowitz. (2007) Gastric Emptying, Diabetes, and Aging. Clinics in Geriatric Medicine 23:4, 785-808
CrossRef1510
Takeki Suzuki, Shunichi Homma. (2007) Treatment of Hypertension and Other Cardiovascular Risk Factors in Patients with Metabolic Syndrome. Medical Clinics of North America 91:6, 1211-1223
CrossRef1511
W F Coutinho. (2007) The obese older female patient: CV risk and the SCOUT study. International Journal of Obesity 31, S26-S30
CrossRef1512
M. E. Wallymahmed, C. Morgan, G. V. Gill, I. A. MacFarlane. (2007) Aerobic fitness and hand grip strength in Type 1 diabetes: relationship to glycaemic control and body composition. Diabetic Medicine 24:11, 1296-1299
CrossRef1513
Edward W. Gregg, Yiling J. Cheng, K.M. Venkat Narayan, Theodore J. Thompson, David F. Williamson. (2007) The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Preventive Medicine 45:5, 348-352
CrossRef1514
M. Nieuwdorp, E. S. G. Stroes, J. J. P. Kastelein, . (2007) Normalization of metabolic syndrome using fenofibrate, metformin or their combination. Diabetes, Obesity and Metabolism 9:6, 869-878
CrossRef1515
Y. Claire Wang, Graham A. Colditz, Karen M. Kuntz. (2007) Forecasting the Obesity Epidemic in the Aging U.S. Population**. Obesity 15:11, 2855-2865
CrossRef1516
Traci Tupper, Geetha Gopalakrishnan. (2007) Prevention of Diabetes Development in Those with the Metabolic Syndrome. Medical Clinics of North America 91:6, 1091-1105
CrossRef1517
Stephen A. Brietzke. (2007) Controversy in Diagnosis and Management of the Metabolic Syndrome. Medical Clinics of North America 91:6, 1041-1061
CrossRef1518
Vivian Vu, Michael C. Riddell, Gary Sweeney. (2007) Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise. Diabetes/Metabolism Research and Reviews 23:8, 600-611
CrossRef1519
T Danne, D Becker. (2007) Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes. Acta Paediatrica 96:11, 1560-1570
CrossRef1520
C Cheyette. (2007) Weight No More: a randomised controlled trial for people with type 2 diabetes on insulin therapy. Practical Diabetes International 24:9, 450-456
CrossRef1521
Marion Kimball Slack. (2007) Using Standard Studies to Interpret the Scores from Scales for Assessing the Internal Validity of Randomized Controlled Trials. Hospital Pharmacy 42:11, 1027-1036
CrossRef1522
Donald A. Smith. (2007) Treatment of the Dyslipidemia of Insulin Resistance. Medical Clinics of North America 91:6, 1185-1210
CrossRef1523
George A. Bray. (2007) Medical Therapy for Obesity—Current Status and Future Hopes. Medical Clinics of North America 91:6, 1225-1253
CrossRef1524
Andrew J. Krentz, Geraldine Clough, Christopher D. Byrne. (2007) Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes, Obesity and Metabolism 9:6, 781-791
CrossRef1525
Sebastian M Schmid, Manfred Hallschmid, Bernd Schultes. (2007) Sleep loss, obesity and diabetes: a fatal connection?. Expert Review of Endocrinology & Metabolism 2:6, 713-715
CrossRef1526
D Ryan. (2007) Obesity in women: a life cycle of medical risk. International Journal of Obesity 31, S3-S7
CrossRef1527
Alan C. Moses. (2007) Commentary: Will It Take Harry Potter to Solve Diabetes? Divining the Future of Diabetes Care. Journal of Periodontology 78:11, 2077-2080
CrossRef1528
Junzeng Zhang, Christa Tiller, Jingkai Shen, Can Wang, Gabrielle S. Girouard, Dorothy Dennis, Colin J. Barrow, Mingsan Miao, H. Stephen Ewart. (2007) Antidiabetic properties of polysaccharide- and polyphenolic-enriched fractions from the brown seaweed Ascophyllum nodosum This article is one of a selection of papers published in this special issue (part 2 of 2) on the Safety and Efficacy of Natural Health Products.. Canadian Journal of Physiology and Pharmacology 85:11, 1116-1123
CrossRef1529
Sherry Pagoto, Jamie S. Bodenlos, Lyle Kantor, Mitchell Gitkind, Carol Curtin, Yunsheng Ma. (2007) Association of Major Depression and Binge Eating Disorder with Weight Loss in a Clinical Setting. Obesity 15:11, 2557-2559
CrossRef1530
E. Windler, B.C. Zyriax, H. Boeing. (2007) Unterschätzte Effekte der Ernährung auf die koronare Herzkrankheit. Der Internist 48:11, 1309-1312
CrossRef1531
ROGER A. FIELDING, JEFFREY KATULA, MICHAEL E. MILLER, KARI ABBOTT-PILLOLA, ALEXANDER JORDAN, NANCY W. GLYNN, BRETT GOODPASTER, MICHAEL P. WALKUP, ABBY C. KING, W. JACK REJESKI. (2007) Activity Adherence and Physical Function in Older Adults with Functional Limitations. Medicine & Science in Sports & Exercise 39:11, 1997-2004
CrossRef1532
A. J. Green, D. D. Bazata, K. M. Fox, S. Grandy, . (2007) Health-related behaviours of people with diabetes and those with cardiometabolic risk factors: results from SHIELD. International Journal of Clinical Practice 61:11, 1791-1797
CrossRef1533
B BAUDUCEAU, E VACHEY, H MAYAUDON, P BURNAT, O DUPUY, C GARCIA, F CEPPA, L BORDIER. (2007) Should we have more definitions of metabolic syndrome or simply take waist measurement?. Diabetes & Metabolism 33:5, 333-339
CrossRef1534
J A Batsis, R E Nieto-Martinez, F Lopez-Jimenez. (2007) Metabolic Syndrome: From Global Epidemiology to Individualized Medicine. Clinical Pharmacology & Therapeutics 82:5, 509-524
CrossRef1535
Jeng-Yueh Hsiao, Chiao-Ling Wang, Pi-Jung Hsia, Ming-Chia Hsieh, Shih-Chieh Hsin, Kun-Der Lin, Shyi-Jang Shin. (2007) Decreased Insulin Secretion and Insulin Sensitivity Are Associated With Liver Function in Subjects With Fasting Glucose Between 100 and 109 mg/dL in Taiwanese Population. Pancreas 35:4, 343-347
CrossRef1536
M. Indira Paharia, Larina Kase. 2007. Obesity. , 81-103.
CrossRef1537
M. Indira Paharia. 2007. Chronic Disease Prevention. , 53-80.
CrossRef1538
G NICHOLS, C KORO, N KOLATKAR. (2007) The epidemiology of congestive heart failure in hyperglycemia below the threshold for diabetes: A critical review
CrossRef1539
J.C. Trussell, Richard S. Legro. (2007) Erectile dysfunction: does insulin resistance play a part?. Fertility and Sterility 88:4, 771-778
CrossRef1540
Rachel Dankner, Muhammad A. Abdul-Ghani, Yariv Gerber, Angela Chetrit, Julio Wainstein, Itamar Raz. (2007) Predicting the 20-year diabetes incidence rate. Diabetes/Metabolism Research and Reviews 23:7, 551-558
CrossRef1541
William T. Donahoo, James O. Hill. (2007) What Will It Take to Get Reimbursement for Treating Obesity?. Obesity Management 3:5, 193-195
CrossRef1542
E. Fossum, G. W. Gleim, S. E. Kjeldsen, J. R. Kizer, S. Julius, R. B. Devereux, W. E. Brady, D. A. Hille, P. A. Lyle, B. Dahlöf. (2007) The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study. Journal of Internal Medicine 262:4, 439-448
CrossRef1543
ME Wallymahmed, C Morgan, GV Gill, IA MacFarlane. (2007) Does hypoglycaemic avoidance behaviour contribute to increased HbA1c levels in physically active people with type 1 diabetes?. Practical Diabetes International 24:8, 418-421
CrossRef1544
Sharon D. Jackson. (2007) The TODAY study. Current Diabetes Reports 7:5, 379-380
CrossRef1545
Rona L. Levy, Emily A. Finch, Michael D. Crowell, Nicholas J. Talley, Robert W. Jeffery. (2007) Behavioral Intervention for the Treatment of Obesity: Strategies and Effectiveness Data. The American Journal of Gastroenterology 102:10, 2314-2321
CrossRef1546
C. L. Hart, D. A. Lawlor, G. D. Smith. (2007) Authors? response. Diabetic Medicine 24:10, 1172-1173
CrossRef1547
John M. Boltri, J. Paul Seale, Ike S. Okosun, Andrew Ouzts, Monica Cornelius, Monique Davis-Smith. (2007) The effects of a patient-based risk assessment prompt on diabetes screening. Diabetes Research and Clinical Practice 78:1, 102-107
CrossRef1548
Anthony L. McCall. (2007) Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers. Current Diabetes Reports 7:5, 329-332
CrossRef1549
X CLEANTHOUS, M NOAKES, J KEOGH, P MOHR, P CLIFTON. (2007) Weight loss maintenance in women 3 years after following a 12-week structured weight loss program. Obesity Research & Clinical Practice 1:3, 195-211
CrossRef1550
Rhonda Bentley-Lewis, Katherine Koruda, Ellen W Seely. (2007) The metabolic syndrome in women. Nature Clinical Practice Endocrinology & Metabolism 3:10, 696-704
CrossRef1551
Martha M. Funnell. (2007) Insulin detemir: A new option for the treatment of diabetes. Journal of the American Academy of Nurse Practitioners 19:10, 508-515
CrossRef1552
Brent Dorsten. (2007) The use of motivational interviewing in weight loss. Current Diabetes Reports 7:5, 386-390
CrossRef1553
N. Gupta, N.H. Al-Huniti, P. Veng-Pedersen. (2007) Individualized pharmacokinetic risk assessment for development of diabetes in high risk population. Diabetes Research and Clinical Practice 78:1, 93-101
CrossRef1554
M. N. Weedon. (2007) The importance of TCF7L2. Diabetic Medicine 24:10, 1062-1066
CrossRef1555
Marion J. Franz, Jeffrey J. VanWormer, A. Lauren Crain, Jackie L. Boucher, Trina Histon, William Caplan, Jill D. Bowman, Nicolas P. Pronk. (2007) Weight-Loss Outcomes: A Systematic Review and Meta-Analysis of Weight-Loss Clinical Trials with a Minimum 1-Year Follow-Up. Journal of the American Dietetic Association 107:10, 1755-1767
CrossRef1556
Peter E. H. Schwarz, Jiang Li, Jaana Lindström, Antje Bergmann, Ulrike Gruhl, Timo Saaristo, Jaakko Tuomilehto. (2007) How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?. Current Diabetes Reports 7:5, 353-362
CrossRef1557
R. K. Simmons, S. J. Griffin, N. J. Wareham. (2007) Researching how to realize the potential of diabetes prevention. Diabetic Medicine 24:10, 1055-1057
CrossRef1558
František Duška, Petr Tůma, Pavel Mokrejš, Aleš Kuběna, Michal Anděl. (2007) Analysis of factors influencing nitrogen balance during acute starvation in obese subject with and without type 2 diabetes. Clinical Nutrition 26:5, 552-558
CrossRef1559
Ariane Godbout, Jean-Louis Chiasson. (2007) Who should benefit from the use of alpha-glucosidase inhibitors?. Current Diabetes Reports 7:5, 333-339
CrossRef1560
S. Mayor. (2007) International Diabetes Federation consensus on prevention of type 2 diabetes. International Journal of Clinical Practice 61:10, 1773-1775
CrossRef1561
Isabelle Lemieux, Paul Poirier, Jean Bergeron, Natalie Alméras, Benoît Lamarche, Bernard Cantin, Gilles R. Dagenais, Jean-Pierre Després. (2007) Hypertriglyceridemic waist: A useful screening phenotype in preventive cardiology?. Canadian Journal of Cardiology 23, 23B-31B
CrossRef1562
(2007) Diagnóstico y tratamiento del riesgo cardiometabólico. Medicina Clínica 129:15, 588-596
CrossRef1563
Talat Waseem, Kris M. Mogensen, David B. Lautz, Malcolm K. Robinson. (2007) Pathophysiology of Obesity: Why Surgery Remains the Most Effective Treatment. Obesity Surgery 17:10, 1389-1398
CrossRef1564
Stefano Del Prato, Cristina Bianchi, Piero Marchetti. (2007) ß-cell function and anti-diabetic pharmacotherapy. Diabetes/Metabolism Research and Reviews 23:7, 518-527
CrossRef1565
R. E. Glasgow, E. B. Fisher, D. Haire-Joshu, M. G. Goldstein. (2007) National Institutes of Health Science Agenda: A Public Health Perspective. American Journal of Public Health 97:11, 1936-1938
CrossRef1566
Peter E. H. Schwarz, Ulrike Gruhl, Stefan R. Bornstein, Rüdiger Landgraf, Michael Hall, Jaakko Tuomilehto. (2007) Development and Implementation of A European Guideline and Training Standards for Diabetes Prevention-The IMAGE project. Journal of Public Health 15:5, 353-360
CrossRef1567
Brunzell, John D., . (2007) Hypertriglyceridemia. New England Journal of Medicine 357:10, 1009-1017
Full Text1568
G SRIDHAR, K MADHU, S VEENA, R MADHAVI, B SANGEETHA, A RANI. (2007) Living with diabetes: Indian experience. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 1:3, 181-187
CrossRef1569
M FORTIER, S SWEET, T OSULLIVAN, G WILLIAMS. (2007) A self-determination process model of physical activity adoption in the context of a randomized controlled trial. Psychology of Sport and Exercise 8:5, 741-757
CrossRef1570
G. Mathur, B. Noronha, E. Rodrigues, G. Davis. (2007) The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus. Diabetes, Obesity and Metabolism 9:5, 617-629
CrossRef1571
(2007) Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007. Revista Española de Cardiología 60:9, 968.e1-968.e94
CrossRef1572
T. Reinehr. (2007) Diabetes mellitus Typ 2 bei Kindern. Der Diabetologe 3:5, 364-371
CrossRef1573
&NA;. (2007) FULL TEXT Chapter 1: Introduction. European Journal of Cardiovascular Prevention & Rehabilitation 14:Supplement 2, S2-S113
CrossRef1574
M. Girke. (2007) Patient-Arzt-Beziehung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 50:9, 1128-1132
CrossRef1575
Helena J. Teede, Samantha K. Hutchison, Sophia Zoungas. (2007) The management of insulin resistance in polycystic ovary syndrome. Trends in Endocrinology & Metabolism 18:7, 273-279
CrossRef1576
Marie Russell, Giovanni de Simone, Helaine E. Resnick, Barbara V. Howard. (2007) The Metabolic Syndrome in American Indians: The Strong Heart Study. Journal of the CardioMetabolic Syndrome 2:4, 283-287
CrossRef1577
James Plumb, Rickie Brawer, Nancy Brisbon. (2007) The interplay of obesity and asthma. Current Allergy and Asthma Reports 7:5, 385-389
CrossRef1578
Guido Lastra-Gonzalez, Camila Manrique-Acevedo, Guido Lastra-Lastra. (2007) Central obesity and the cardiometabolic syndrome in Hispanics. Therapy 4:5, 609-621
CrossRef1579
Thomas Yates, Kamlesh Khunti, Melanie Davis. (2007) Prevention of diabetes: A reality in primary care?. Primary Care Diabetes 1:3, 119-121
CrossRef1580
José I. Botella-Carretero, Francisco Álvarez-Blasco, M. Ángeles Martinez-García, Manuel Luque-Ramírez, José L. San Millán, Héctor F. Escobar-Morreale. (2007) The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event. Obesity Surgery 17:9, 1199-1208
CrossRef1581
Vivencio Barrios, Carlos Escobar, Alberto Calderon. (2007) Candesartan: from left ventricular hypertrophy to heart failure, a global approach. Expert Review of Cardiovascular Therapy 5:5, 825-834
CrossRef1582
Jing Chen, Raymond R Townsend. (2007) Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome. Expert Opinion on Pharmacotherapy 8:13, 2001-2009
CrossRef1583
Debra M. Palmer, Brenda Luther. (2007) Screening for Metabolic Syndrome. Orthopaedic Nursing 26:5, 293-295
CrossRef1584
D Banerjee, A Misra. (2007) Does using ethnic specific criteria improve the usefulness of the term metabolic syndrome? controversies and suggestions. International Journal of Obesity 31:9, 1340-1349
CrossRef1585
Harald Sourij, Thomas C Wascher. (2007) Pioglitazone in the management of Type 2 diabetes and beyond. Therapy 4:5, 517-533
CrossRef1586
Alex Doyle, Purnami DeSilva, David Koduah, Jagdeep Birdi, Mazen Sabah, Richard King. (2007) An insight into undiagnosed impaired glucose regulation. Primary Care Diabetes 1:3, 155-158
CrossRef1587
S. Del Prato, C. Bianchi, R. Miccoli, G. Penno. (2007) Pharmacological intervention in prediabetes: considering the risks and benefits. Diabetes, Obesity and Metabolism 9:s1, 17-22
CrossRef1588
Y. Hayashino, S. Fukuhara, Y. Suzukamo, T. Okamura, T. Tanaka, H. Ueshima. (2007) Normal fasting plasma glucose levels and type 2 diabetes: the high-risk and population strategy for occupational health promotion (HIPOP-CHP) study. Acta Diabetologica 44:3, 164-166
CrossRef1589
J KARAKAYA, D AKSOY, A HARMANCI, E KARAAGAOGLU, A GURLEK. (2007) Predictive ability of fasting plasma glucose for a diabetic 2-h postload glucose value in oral glucose tolerance test: spectrum effect. Journal of Diabetes and its Complications 21:5, 300-305
CrossRef1590
Ann M. Rodden, Vanessa A. Diaz, Arch G. Mainous, Richelle J. Koopman, Mark E. Geesey. (2007) Insulin Resistance in Adolescents. The Journal of Pediatrics 151:3, 275-279
CrossRef1591
Andrew P. Yu, Eric Q. Wu, Howard G. Birnbaum, Srinivas Emani, Madeleine Fay, Gerhardt Pohl, Matthew Wintle, Elaine Yang, Alan Oglesby. (2007) Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data. Current Medical Research and Opinion 23:9, 2157-2169
CrossRef1592
Alejandra Larrañaga, Ricardo García-Mayor. (2007) Tratamiento psicológico de la obesidad. Medicina Clínica 129:10, 387-391
CrossRef1593
J. P. H. Wilding. (2007) The importance of free fatty acids in the development of Type
2 diabetes. Diabetic Medicine 24:9, 934-945
CrossRef1594
Anthony S. Wierzbicki. (2007) Primary and secondary prevention in obesity. International Journal of Clinical Practice 61:9, 1431-1434
CrossRef1595
Andrea T. Kozak, Cheryl Rucker-Whitaker, Sanjib Basu, Carlos F. Mendes de Leon, James E. Calvin, Kathleen L. Grady, DeJuran Richardson, Lynda H. Powell. (2007) Elements of Nonpharmacologic Interventions That Prevent Progression of Heart Failure: A Meta-Analysis. Congestive Heart Failure 13:5, 280-287
CrossRef1596
Daniel Antonio de Luis, Rocío Aller, Olazt Izaola, Manuel González Sagrado, Rosa Conde, Enrique Romero. (2007) Influencia del polimorfismo G308A del factor de necrosis tumoral alfa en la resistencia a la insulina en pacientes obesos tras la pérdida de peso. Medicina Clínica 129:11, 401-404
CrossRef1597
L Romayne Kurukulasuriya, James R Sowers. (2007) The obesity pandemic. Therapy 4:5, 497-500
CrossRef1598
Melissa A. Kalarchian, Nichole N. Beagle, Anita P. Courcoulas. (2007) Behavioral Weight Control Following Bariatric Surgery. Bariatric Nursing and Surgical Patient Care 2:3, 189-192
CrossRef1599
Y SATO, M NAGASAKI, M KUBOTA, T UNO, N NAKAI. (2007) Clinical aspects of physical exercise for diabetes/metabolic syndrome. Diabetes Research and Clinical Practice 77:3, S87-S91
CrossRef1600
J. Rosenstock. (2007) Reflecting on Type 2 Diabetes Prevention: More Questions than Answers!. Diabetes, Obesity and Metabolism 9:s1, 3-11
CrossRef1601
Anoop Misra, Lokesh Khurana. (2007) The rosiglitazone riddle: DREAMs and nightmares. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 1:3, 193-195
CrossRef1602
Anil S Modak. (2007) Stable isotope breath tests in clinical medicine: a review. Journal of Breath Research 1:1, 014003
CrossRef1603
D. Hadžiomerović, R. Kreienberg, J.M. Weiss. (2007) Syndrom der polyzystischen Ovarien (PCOS) – Diagnostik und Therapie. Der Gynäkologe 40:9, 713-724
CrossRef1604
David Siegel, Arthur L.M. Swislocki. (2007) Effects of Antihypertensives on Glucose Metabolism. Metabolic Syndrome and Related Disorders 5:3, 211-219
CrossRef1605
K. G. M. M. Alberti. (2007) Screening and diagnosis of prediabetes: where are we headed?. Diabetes, Obesity and Metabolism 9:s1, 12-16
CrossRef1606
F. Hadaegh, H. Harati, A. Ghasemi, M. Tohidi, A. Zabetian, Y. Mehrabi, F. Azizi. (2007) Using common clinical data improves the prediction of abnormal glucose tolerance by the new criteria of impaired fasting glucose: Tehran lipid and glucose study. Diabetes Research and Clinical Practice 77:3, 459-464
CrossRef1607
Deanna L. Kelly, Douglas L. Boggs, Robert R. Conley. (2007) Reaching for Wellness in Schizophrenia. Psychiatric Clinics of North America 30:3, 453-479
CrossRef1608
Hans-Georg Joost. 2007. Personalized Prevention of Type 2 Diabetes. , 61-74.
CrossRef1609
Bray, George A., . (2007) The Missing Link — Lose Weight, Live Longer. New England Journal of Medicine 357:8, 818-820
Full Text1610
S. Lindeberg, T. Jönsson, Y. Granfeldt, E. Borgstrand, J. Soffman, K. Sjöström, B. Ahrén. (2007) A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia 50:9, 1795-1807
CrossRef1611
M. Teran-Garcia, T. Rankinen, T. Rice, A. S. Leon, D. C. Rao, J. S. Skinner, C. Bouchard. (2007) Variations in the four and a half LIM domains 1 gene (FHL1) are associated with fasting insulin and insulin sensitivity responses to regular exercise. Diabetologia 50:9, 1858-1866
CrossRef1612
B.-C. Zyriax, H. Boeing, E. Windler. (2007) Chancen der Ernährung in der Prävention koronarer Herzkrankheit bei Frauen. Der Kardiologe 1:2, 114-119
CrossRef1613
Shawna L. Mercer, Barbara J. DeVinney, Lawrence J. Fine, Lawrence W. Green, Denise Dougherty. (2007) Study Designs for Effectiveness and Translation Research. American Journal of Preventive Medicine 33:2, 139-154.e2
CrossRef1614
A. F. Kirk, J. Barnett, N. Mutrie. (2007) Physical activity consultation for people with Type
CrossRef1615
Jeffrey L. Anderson, Cynthia D. Adams, Elliott M. Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin, A. Michael Lincoff, Eric D. Peterson, Pierre Theroux, Nanette Kass Wenger, R. Scott Wright, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Jonathan L. Halperin, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2007) ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology 50:7, e1-e157
CrossRef1616
Joanne Gallivan, Rachel Greenberg, Carolyn Leontos. (2007) Role of Food and Nutrition Professionals in Stemming the Diabetes Epidemic. Journal of the American Dietetic Association 107:8, 1394-1397
CrossRef1617
M. Bartnik, A. Norhammar, L. Rydén. (2007) Hyperglycaemia and cardiovascular disease. Journal of Internal Medicine 262:2, 145-156
CrossRef1618
N CHEUNG, B SMITH, H HENRIKSEN, L TAPSELL, M MCLEAN, A BAUMAN. (2007) A group-based healthy lifestyle program for women with previous gestational diabetes. Diabetes Research and Clinical Practice 77:2, 333-334
CrossRef1619
Nicholas J. Wareham. (2007) Epidemiological studies of physical activity and diabetes risk, and implications for diabetes preventionThis paper was originally part of the Symposium “Exercise, insulin sensitivity and diabetes—what’s new?”, which appeared in the June issue of Appl. Physiol. Nutr. Metab.. Applied Physiology, Nutrition, and Metabolism 32:4, 778-782
CrossRef1620
Anne M. Wolf, Mir Siadaty, Beverly Yaeger, Mark R. Conaway, Jayne Q. Crowther, Jerry L. Nadler, Viktor E. Bovbjerg. (2007) Effects of Lifestyle Intervention on Health Care Costs: Improving Control with Activity and Nutrition (ICAN). Journal of the American Dietetic Association 107:8, 1365-1373
CrossRef1621
S Härmä-Rodriquez. (2007) Prevention of type 2 diabetes: the Finnish experience. European Diabetes Nursing 4:3, 119-123
CrossRef1622
A. Tschoner, J. Engl, M. Laimer, S. Kaser, M. Rettenbacher, W. W. Fleischhacker, J. R. Patsch, C. F. Ebenbichler. (2007) Metabolic side effects of antipsychotic medication. International Journal of Clinical Practice 61:8, 1356-1370
CrossRef1623
Najmeddine Echahidi, Philippe Pibarot, Jean-Pierre Després, Jean-Marc Daigle, Dania Mohty, Pierre Voisine, Richard Baillot, Patrick Mathieu. (2007) Metabolic Syndrome Increases Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting Surgery. Journal of the American College of Cardiology 50:9, 843-851
CrossRef1624
Xavier Pi-Sunyer, Louis Aronne, George Bray. (2007) Weight Gain Induced by Psychotropic Drugs. Obesity Management 3:4, 165-169
CrossRef1625
Robert W Schrier, Raymond O Estacio, Philip S Mehler, William R Hiatt. (2007) Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nature Clinical Practice Nephrology 3:8, 428-438
CrossRef1626
Ricardo Vasconcellos Bruno, Márcio Augusto Pinto de Ávila, Fernanda Baleeiro Neves, Antonio Egidio Nardi, Clícia Márcia Santos Crespo, Antonio Tavares Carneiro Sobrinho. (2007) Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference. Fertility and Sterility 88:2, 510-512
CrossRef1627
R. K. Simmons, A-H. Harding, N. J. Wareham, S. J. Griffin, . (2007) Do simple questions about diet and physical activity help to identify those at risk of Type 2 diabetes?. Diabetic Medicine 24:8, 830-835
CrossRef1628
E. Bonora. (2007) Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight. International Journal of Clinical Practice 61, 19-28
CrossRef1629
Judith Wylie-Rosett, Ann A. Albright, Caroline Apovian, Nathaniel G. Clark, Linda Delahanty, Marion J. Franz, Byron Hoogwerf, Karmeen Kulkarni, Alice H. Lichtenstein, Elizabeth Mayer-Davis, Arshag D. Mooradian, Madelyn Wheeler. (2007) 2006-2007 American Diabetes Association Nutrition Recommendations: Issues for Practice Translation. Journal of the American Dietetic Association 107:8, 1296-1304
CrossRef1630
Robert J Norman, Didier Dewailly, Richard S Legro, Theresa E Hickey. (2007) Polycystic ovary syndrome. The Lancet 370:9588, 685-697
CrossRef1631
David Heber. 2007. Obesity, Nutrigenomics, Metabolic Syndrome, and Type 2 Diabetes. , 107-121.
CrossRef1632
Neil Stone, Jennifer Berliner. 2007. The Metabolic Syndrome Defined. , 3-14.
CrossRef1633
Paresh Dandona, Ajay Chaudhuri, Priya Mohanty, Husam Ghanim. 2007. The Metabolic Syndrome. , 15-31.
CrossRef1634
Hussein M. Dashti, Thazhumpal C. Mathew, Mousa Khadada, Mahdi Al-Mousawi, Husain Talib, Sami K. Asfar, Abdulla I. Behbahani, Naji S. Al-Zaid. (2007) Beneficial effects of ketogenic diet in obese diabetic subjects. Molecular and Cellular Biochemistry 302:1-2, 249-256
CrossRef1635
Lucie Nield, Helen Moore, Lee Hooper, Kennedy Cruickshank, Avni Vyas, Vicki Whittaker, Carolyn D Summerbell, Lucie Nield. 2007. Dietary advice for treatment of type 2 diabetes mellitus in adults. .
CrossRef1636
Suzanne J Grant, Alan Bensoussan, Dennis Chang, Hosen Kiat, Nerida L Klupp, Jian Ping Liu, Suzanne J Grant. 2007. Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose. .
CrossRef1637
H. B. Holt, S. H. Wild, N. Wareham, U. Ekelund, M. Umpleby, F. Shojaee-Moradie, R. I. G. Holt, D. I. Phillips, C. D. Byrne. (2007) Differential effects of fatness, fitness and physical activity energy expenditure on whole-body, liver and fat insulin sensitivity. Diabetologia 50:8, 1698-1706
CrossRef1638
Luigi Fernando Meneghini. (2007) Impact of bariatric surgery on type 2 diabetes. Cell Biochemistry and Biophysics 48:2-3, 97-102
CrossRef1639
Mark A. Deeg, Sindhu Jacob, Jianzhao Shen, David G. Marrero. (2007) Primary care physician treatment of low HDL: Rational approach or Pandora’s Box?. Journal of Clinical Lipidology 1:3, 198-202
CrossRef1640
Cynthia A. Stuenkel. (2007) Isoflavones and cardiovascular risk in postmenopausal women. Menopause 14:4, 606-608
CrossRef1641
Arne Astrup, Frank L. Greenway, Walter Ling, Lisa Pedicone, Jean Lachowicz, Catherine D. Strader, Rudolf Kwan. (2007) Randomized Controlled Trials of the D1/D5 Antagonist Ecopipam for Weight Loss in Obese Subjects*. Obesity 15:7, 1717-1731
CrossRef1642
James K. Liao. (2007) Clinical trials report. Current Atherosclerosis Reports 9:4, 255-257
CrossRef1643
Syed Shah, Muhammad Iqbal, Jocelyne Karam, Moro Salifu, Samy I. McFarlane. (2007) Oxidative Stress, Glucose Metabolism, and the Prevention of Type 2 Diabetes: Pathophysiological Insights. Antioxidants & Redox Signaling 9:7, 911-929
CrossRef1644
Shivakumar Chitturi, Geoffrey C Farrell. (2007) Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health. Journal of Gastroenterology and Hepatology 22:7, 967-969
CrossRef1645
P. H. Evans, C. Greaves, R. Winder, J. Fearn-Smith, J. L. Campbell. (2007) Development of an educational ?toolkit? for health professionals and their patients with prediabetes: The WAKEUP study (Ways of Addressing Knowledge Education and Understanding in Pre-diabetes). Diabetic Medicine 24:7, 770-777
CrossRef1646
Zafar H Israili, Badi??a Lyoussi, Rafael Hern??ndez-Hern??ndez, Manuel Velasco. (2007) Metabolic Syndrome: Treatment of Hypertensive Patients. American Journal of Therapeutics 14:4, 386-402
CrossRef1647
Glenn A. Gaesser. (2007) Does physical activity reduce the risk of cardiovascular disease in overweight and obese individuals?. Current Cardiovascular Risk Reports 1:3, 221-227
CrossRef1648
Sung Hee Choi, Zheng Shan Zhao, Yong Jik Lee, Soo Kyung Kim, Dae Jung Kim, Chul Woo Ahn, Sung Kil Lim, Hyun Chul Lee, Bong Soo Cha. (2007) The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats. Diabetes/Metabolism Research and Reviews 23:5, 411-418
CrossRef1649
Luisa Zanolla, Corrado Vassanelli. (2007) Reducing diabetes incidence through the inhibition of the renin–angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?. Journal of Cardiovascular Medicine 8:7, 473-482
CrossRef1650
S. Schäfer, K. Kantartzis, J. Machann, C. Venter, A. Niess, F. Schick, F. Machicao, H.-U. Häring, A. Fritsche, N. Stefan. (2007) Lifestyle intervention in individuals with normal versus impaired glucose tolerance. European Journal of Clinical Investigation 37:7, 535-543
CrossRef1651
A. Fritsche, C. Thamer, N. Stefan, H.-U. Häring. (2007) Gen-Umwelt-Interaktion in Pathogenese und Prävention des Diabetes mellitus Typ 2. Der Internist 48:7, 669-675
CrossRef1652
G GRASSI, F QUARTITREVANO, G SERAVALLE, R DELLORO. (2007) Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases 17:6, 473-481
CrossRef1653
Birna Bjarnason-Wehrens, Klaus Held, Eike Hoberg, Marthin Karoff, Bernhard Rauch. (2007) Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha). Clinical Research in Cardiology Supplements 2:3, 1-54
CrossRef1654
Markku Laakso. (2007) Challenges in studies of the genetic basis of Type 2 diabetes. Expert Review of Endocrinology & Metabolism 2:4, 451-459
CrossRef1655
C. S. Blaum, N. A. West, M. N. Haan. (2007) Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans?. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 62:7, 766-773
CrossRef1656
N. Burns, F. M. Finucane, M. Hatunic, M. Gilman, M. Murphy, D. Gasparro, A. Mari, A. Gastaldelli, J. J. Nolan. (2007) Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 50:7, 1500-1508
CrossRef1657
N. D. Cohen, J. E. Shaw. (2007) Diabetes: advances in treatment. Internal Medicine Journal 37:6, 383-388
CrossRef1658
A HUSSAIN, B CLAUSSEN, A RAMACHANDRAN, R WILLIAMS. (2007) Prevention of type 2 diabetes: A review. Diabetes Research and Clinical Practice 76:3, 317-326
CrossRef1659
JC Will, O Khavjou, EA Finkelstein, RK Loo, KY Gregory-Mercado. (2007) One-year changes in glucose and heart disease risk factors among participants in the WISEWOMAN programme. European Diabetes Nursing 4:2, 57-63
CrossRef1660
P VARDI, K SHAHAFALKALAI, E SPRECHER, I KOREN, Z ZADIK, M SABBAH, O MINUCHIN, A LERNER, L SLEZAK, M ABDULGHANI. (2007) Components of the metabolic syndrome (MTS), hyperinsulinemia, and insulin resistance in obese Israeli children and adolescents. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 1:2, 97-103
CrossRef1661
E. Standl. (2007) The importance of β-cell management in type 2 diabetes. International Journal of Clinical Practice 61, 10-19
CrossRef1662
Martha J. Price, Patricia H. Parkerton. (2007) Care Delivery Challenges for Nursing. AJN, American Journal of Nursing 107:Supplement, 60-64
CrossRef1663
Amal Farag, Jocelyne Karam, John Nicasio, Samy I. McFarlane. (2007) Prevention of type 2 diabetes: An update. Current Diabetes Reports 7:3, 200-207
CrossRef1664
James L. Early, Caroline M. Apovian, Louis J. Aronne, Madelyn H. Fernstrom, Arthur Frank, Frank L. Greenway, David Heber, Robert F. Kushner, Kristine M. Cwik, Julia K. Walch, Ann C. Hewkin, Vicky Blakesley. (2007) Sibutramine Plus Meal Replacement Therapy for Body Weight Loss and Maintenance in Obese Patients*. Obesity 15:6, 1464-1472
CrossRef1665
Peter Y. Liu, Ian D. Caterson, Ronald R. Grunstein, David J. Handelsman. (2007) Androgens, Obesity, and Sleep-Disordered Breathing in Men. Endocrinology & Metabolism Clinics of North America 36:2, 349-363
CrossRef1666
Joseph N. Bottalico. (2007) Recurrent Gestational Diabetes: Risk Factors, Diagnosis, Management, and Implications. Seminars in Perinatology 31:3, 176-184
CrossRef1667
J ASCASO. (2007) Diabetes mellitus y riesgo cardiovascular. Recomendaciones del grupo de trabajo Diabetes mellitus y enfermedad cardiovascular de la Sociedad Española de Diabetes 2006. Clínica e Investigación en Arteriosclerosis 19:3, 147-152
CrossRef1668
S. Wiegand. (2007) Die Therapie des Typ-2-Diabetes-mellitus. Monatsschrift Kinderheilkunde 155:S02, M19-M28
CrossRef1669
Ondøřej Šeda, Lucie Šedová. (2007) Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and Type 2 diabetes. Pharmacogenomics 8:6, 587-596
CrossRef1670
Brian L. Mealey, Gloria L. Ocampo. (2007) Diabetes mellitus and periodontal disease. Periodontology 2000 44:1, 127-153
CrossRef1671
Gemma Carreras-González, Jordi Ordóñez-Llanos. (2007) Adolescencia, actividad física y factores metabólicos de riesgo cardiovascular. Revista Española de Cardiología 60:6, 565-568
CrossRef1672
Keith H. Bachman. (2007) Obesity, Weight Management, and Health Care Costs: A Primer. Disease Management 10:3, 129-137
CrossRef1673
Gil Yosipovitch, Amy DeVore, Aerlyn Dawn. (2007) Obesity and the skin: Skin physiology and skin manifestations of obesity. Journal of the American Academy of Dermatology 56:6, 901-916
CrossRef1674
Kelley K. Pettee, Beth M. Larouere, Andrea M. Kriska, B. Delia Johnson, Trevor J. Orchard, Bret H. Goodpaster, Molly B. Conroy, Rachel H. Mackey, Darcy A. Underwood, Lewis H. Kuller. (2007) Associations Among Walking Performance, Physical Activity, and Subclinical Cardiovascular Disease. Preventive Cardiology 10:3, 134-140
CrossRef1675
F BUSSE, V DENTI, M STUMVOLL. (2007) Awareness of pathophysiological concepts of type 2 diabetes—A survey in 847 physicians. Diabetes Research and Clinical Practice 76:3, 445-448
CrossRef1676
Beate G. Brouwer, Frank L.J. Visseren, Ronald P. Stolk, Yolanda van der Graaf. (2007) Abdominal Fat and Risk of Coronary Heart Disease in Patients with Peripheral Arterial Disease*. Obesity 15:6, 1623-1630
CrossRef1677
Claudio Maffeis, Marta Castellani. (2007) Physical activity: An effective way to control weight in children?. Nutrition, Metabolism and Cardiovascular Diseases 17:5, 394-408
CrossRef1678
Kelly J. Hunt, Kelly L. Schuller. (2007) The Increasing Prevalence of Diabetes in Pregnancy. Obstetrics and Gynecology Clinics of North America 34:2, 173-199
CrossRef1679
Oded Langer. (2007) Oral Anti-Hyperglycemic Agents for the Management of Gestational Diabetes Mellitus. Obstetrics and Gynecology Clinics of North America 34:2, 255-274
CrossRef1680
Siri L. Kjos. (2007) After Pregnancy Complicated by Diabetes: Postpartum Care and Education. Obstetrics and Gynecology Clinics of North America 34:2, 335-349
CrossRef1681
Suzanne McDermott, Robert Moran, Tan Platt, Srikanth Dasari. (2007) Prevalence of Diabetes in Persons with Disabilities in Primary Care. Journal of Developmental and Physical Disabilities 19:3, 263-271
CrossRef1682
2007. Food and Nutrition Guidance. , 303-350.
CrossRef1683
2007. Prevalence of Diet-Related Chronic Diseases. , 119-157.
CrossRef1684
(2007) Treatment of Infertility in the Polycystic Ovary Syndrome. New England Journal of Medicine 356:19, 1999-2001
Full Text1685
M. R. Carnethon. (2007) Can we out-run the diabetes epidemic?. Diabetologia 50:6, 1113-1115
CrossRef1686
T. Yates, K. Khunti, F. Bull, T. Gorely, M. J. Davies. (2007) The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia 50:6, 1116-1126
CrossRef1687
Elena Serrano, Jennifer Leiferman, Sarah Dauber. (2007) Self-efficacy and health behaviors toward the prevention of diabetes among high risk individuals living in appalachia. Journal of Community Health 32:2, 121-133
CrossRef1688
Elizabeth M. Venditti. (2007) Efficacy of lifestyle behavior change programs in diabetes. Current Diabetes Reports 7:2, 123-127
CrossRef1689
P. E. H. Schwarz, U. Gruhl, J. Schulze, S. R. Bornstein, R. Landgraf, H. Hauner. (2007) Prävention des Diabetes mellitus. Ernährung - Wissenschaft und Praxis 1:3, 108-115
CrossRef1690
Jesús Millán. (2007) Tratamiento de la dislipemia en pacientes con síndrome metabólico o con diabetes mellitus. Medicina Clínica 128:20, 786-794
CrossRef1691
Timothy D. Lavis, William M. Scelza, William L. Bockenek. (2007) Cardiovascular Health and Fitness in Persons with Spinal Cord Injury. Physical Medicine and Rehabilitation Clinics of North America 18:2, 317-331
CrossRef1692
Pablo Tebas. (2007) Interventions for body habitus changes associated with HIV infection and its treatment. Current HIV/AIDS Reports 4:2, 86-92
CrossRef1693
K. G. M. M. Alberti, P. Zimmet, J. Shaw. (2007) International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabetic Medicine 24:5, 451-463
CrossRef1694
Elena T. Carbone, Milagros C. Rosal, M. Idalí Torres, Karin V. Goins, Odilia I. Bermudez. (2007) Diabetes self-management: Perspectives of Latino patients and their health care providers. Patient Education and Counseling 66:2, 202-210
CrossRef1695
S. Wiegand. (2007) Diabetes mellitus Typ 2 bei Kindern und Jugendlichen. Ernährung - Wissenschaft und Praxis 1:3, 124-131
CrossRef1696
S W Ryder. (2007) Innovation and Improvement in the Treatment of Obesity and Diabetes. Clinical Pharmacology & Therapeutics 81:5, 615-619
CrossRef1697
B COSTA, F BARRIO, B BOLIBAR, C CASTELL. (2007) Prevención primaria de la diabetes tipo 2 en Cataluña mediante la intervención sobre el estilo de vida en personas de alto riesgo
CrossRef1698
N CHATURVEDI. (2007) The burden of diabetes and its complications: Trends and implications for intervention. Diabetes Research and Clinical Practice 76:3, S3-S12
CrossRef1699
Cristina Bianchi, Giuseppe Penno, Fabiola Romero, Stefano Del Prato, Roberto Miccoli. (2007) Treating the metabolic syndrome. Expert Review of Cardiovascular Therapy 5:3, 491-506
CrossRef1700
Howard Leventhal, Tamara J. Musumeci, Richard J. Contrada. (2007) Current issues and new directions in Psychology and Health : Theory, translation, and evidence-based practice. Psychology & Health 22:4, 381-386
CrossRef1701
Nadia A. Khan, Brenda Hemmelgarn, Raj Padwal, Pierre Larochelle, Jeff L. Mahon, Richard Z. Lewanczuk, Finlay A. McAlister, Simon W. Rabkin, Michael D Hill, Ross D. Feldman, Ernesto L. Schiffrin, Norman R.C. Campbell, Alexander G. Logan, Malcolm Arnold, Gordon Moe, Tavis S. Campbell, Alain Milot, James A. Stone, Charlotte Jones, Lawrence A. Leiter, Richard I. Ogilvie, Robert J. Herman, Pavel Hamet, George Fodor, George Carruthers, Bruce Culleton, Kevin D. Burns, Marcel Ruzicka, Jacques deChamplain, George Pylypchuk, Norm Gledhill, Robert Petrella, Jean-Martin Boulanger, Luc Trudeau, Robert A. Hegele, Vincent Woo, Phil McFarlane, Rhian M. Touyz, Sheldon W. Tobe. (2007) The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy. Canadian Journal of Cardiology 23:7, 539-550
CrossRef1702
L R Jones, C I Wilson, T A Wadden. (2007) Lifestyle Modification in the Treatment of Obesity: An Educational Challenge and Opportunity. Clinical Pharmacology & Therapeutics 81:5, 776-779
CrossRef1703
S.A. Ritchie, J.M.C. Connell. (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutrition, Metabolism and Cardiovascular Diseases 17:4, 319-326
CrossRef1704
(2007) Guías de práctica clínica sobre diabetes, prediabetes y enfermedades cardiovasculares: versión resumida. Revista Española de Cardiología 60:5, 525.e1-525.e64
CrossRef1705
Cynthia L. Ogden, Susan Z. Yanovski, Margaret D. Carroll, Katherine M. Flegal. (2007) The Epidemiology of Obesity. Gastroenterology 132:6, 2087-2102
CrossRef1706
Jana Vrbikova, Katerina Dvorakova, Tereza Grimmichova, Martin Hill, Sona Stanicka, David Cibula, Bela Bendlova, Luboslav Starka, Karel Vondra. (2007) Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome. Clinical Chemistry and Laboratory Medicine 45:5, 639-644
CrossRef1707
Thomas A. Wadden, Meghan L. Butryn, Christopher Wilson. (2007) Lifestyle Modification for the Management of Obesity. Gastroenterology 132:6, 2226-2238
CrossRef1708
Eran Ben-Arye, Adva Lear, Doron Hermoni, Ruth Stashefsky Margalit. (2007) Promoting Lifestyle Self-Awareness among the Medical Team by the Use of an Integrated Teaching Approach: A Primary Care Experience. The Journal of Alternative and Complementary Medicine 13:4, 461-470
CrossRef1709
G. Benker, M. Epe, H.M. Schulte, M. Ludwig. (2007) Metabolische und endokrinologische Ursachen von Blutungsstörungen. Gynäkologische Endokrinologie 5:2, 80-86
CrossRef1710
Joy C. Bunt, Jonathan Krakoff, Emilio Ortega, William C. Knowler, Clifton Bogardus. (2007) Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations. Diabetes/Metabolism Research and Reviews 23:4, 304-310
CrossRef1711
A. Icks, W. Rathmann, B. Haastert, A. Gandjour, R. Holle, J. John, G. Giani, . (2007) Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a ‘real world’ routine healthcare setting: model based on the KORA Survey 2000. Diabetic Medicine 24:5, 473-480
CrossRef1712
George A. Bray, Donna H. Ryan. (2007) Drug Treatment of the Overweight Patient. Gastroenterology 132:6, 2239-2252
CrossRef1713
Sudhesh Kumar. (2007) Cardiometabolic risk factors and their treatment in patients with Type 2 diabetes. Expert Review of Endocrinology & Metabolism 2:3, 331-339
CrossRef1714
Nanette K. Wenger. (2007) Clinical guidelines for cardiovascular disease prevention: Should they differ by gender?. Current Cardiovascular Risk Reports 1:2, 148-152
CrossRef1715
Hyon K. Choi, Earl S. Ford. (2007) Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia. The American Journal of Medicine 120:5, 442-447
CrossRef1716
S Robinson, A Dornhorst, . (2007) ABCD position statement on screening for gestational diabetes mellitus. Practical Diabetes International 24:4, 192-195
CrossRef1717
Marc L. Reitman, Eric E. Schadt. (2007) Pharmacogenetics of metformin response: a step in the path toward personalized medicine. Journal of Clinical Investigation 117:5, 1226-1229
CrossRef1718
Ian W. Campbell, Segundo Mariz. (2007) β-Cell preservation with thiazolidinediones. Diabetes Research and Clinical Practice 76:2, 163-176
CrossRef1719
Angela Marinilli Pinto, Jessica Gokee-LaRose, Rena R Wing. (2007) Behavioral approaches to weight control: a review of current research. Women's Health 3:3, 341-353
CrossRef1720
I S Hoffmann, A B Alfieri, L X Cubeddu. (2007) Effects of lifestyle changes and metformin on salt sensitivity and nitric oxide metabolism in obese salt-sensitive Hispanics. Journal of Human Hypertension
CrossRef1721
LJ Orozco, D Mauricio, G Gimenez-Perez, M Roque, Leonardo J Orozco. 2007. Exercise or exercise and diet for preventing type 2 diabetes mellitus. .
CrossRef1722
James H. Ting, David H. Wallis. (2007) Medical Management of the Athlete: Evaluation and Treatment of Important Issues in Sports Medicine. Clinics in Podiatric Medicine and Surgery 24:2, 127-158
CrossRef1723
Thomas Haak, Steven Edelman, Claudia Walter, Brigitte Lecointre, Gerry Spollett. (2007) Comparison of usability and patient preference for the new disposable insulin device solostar versus flexpen, lilly disposable pen, and a prototype pen: an open-label study. Clinical Therapeutics 29:4, 650-660
CrossRef1724
A Enrique Caballero. (2007) Type 2 diabetes in the Hispanic or Latino population: challenges and opportunities. Current Opinion in Endocrinology, Diabetes and Obesity 14:2, 151-157
CrossRef1725
C. M. Bennett, M. Guo, S. C. Dharmage. (2007) HbA 1c as a screening tool for detection of Type 2 diabetes: a systematic review. Diabetic Medicine 24:4, 333-343
CrossRef1726
John A. Farmer. (2007) Diabetic dyslipidemia and atherosclerosis: Evidence from clinical trials. Current Atherosclerosis Reports 9:2, 162-168
CrossRef1727
Tessa G Lebinger. (2007) Metformin and polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes and Obesity 14:2, 132-140
CrossRef1728
Cheryl L. Rock, Bilge Pakiz, Shirley W. Flatt, Elizabeth L. Quintana. (2007) Randomized Trial of a Multifaceted Commercial Weight Loss Program*. Obesity 15:4, 939-949
CrossRef1729
Gretchen A Piatt, Janice C Zgibor. (2007) Novel approaches to diabetes care: a population perspective. Current Opinion in Endocrinology, Diabetes and Obesity 14:2, 158-165
CrossRef1730
A.-C. Santos, S. Ebrahim, H. Barros. (2007) Alcohol intake, smoking, sleeping hours, physical activity and the metabolic syndrome. Preventive Medicine 44:4, 328-334
CrossRef1731
Tamae Shimazaki, Takashi Kadowaki, Yoshiharu Ohyama, Kazuhiko Ohe, Kiyoshi Kubota. (2007) Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Translational Research 149:4, 196-204
CrossRef1732
Claresa Levetan. (2007) Oral antidiabetic agents in type 2 diabetes. Current Medical Research and Opinion 23:4, 945-952
CrossRef1733
Anne Merete Boas Soja, Ann-Dorthe Olsen Zwisler, Marianne Frederiksen, Thomas Melchior, Eva Hommel, Christian Torp-Pedersen, Mette Madsen. (2007) Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance—the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study. American Heart Journal 153:4, 621-628
CrossRef1734
M. N. Cook, C. J. Girman, P. P. Stein, C. M. Alexander. (2007) Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care. Diabetic Medicine 24:4, 350-358
CrossRef1735
Keng Ee Choo, Kim Bee Lau, Wendy A. Davis, Peng Hong Chew, Alicia J. Jenkins, Timothy M.E. Davis. (2007) Cardiovascular risk factors in pre-pubertal Malays: Effects of diabetic parentage. Diabetes Research and Clinical Practice 76:1, 119-125
CrossRef1736
Francesco Corrado, Rosario D’Anna, Maria L. Cannata, Desirée Cannizzaro, Francesco Caputo, Emanuela Raffone, Antonino Di Benedetto. (2007) Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance. American Journal of Obstetrics and Gynecology 196:4, 339.e1-339.e5
CrossRef1737
M. Thiele, H.-M. Reuter. (2007) Metabolisch-vaskuläres Syndrom – ein gesundheitspolitisches Problem. Der Diabetologe 3:2, 126-133
CrossRef1738
Sheridan Henness. (2007) Pharmacological interventions in the prevention of type 2 diabetes. Current Opinion in Endocrinology, Diabetes and Obesity 14:2, 166-169
CrossRef1739
P LECOMTE, S VOL, E CACES, C BORN, C CHABROLLE, G LASFARGUES, J HALIMI, J TICHET. (2007) Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose. Diabetes & Metabolism 33:2, 140-147
CrossRef1740
STAVROS A. KAVOURAS, DEMOSTHENES B. PANAGIOTAKOS, CHRISTOS PITSAVOS, CHRISTINA CHRYSOHOOU, COSTAS A. ANASTASIOU, YANNIS LENTZAS, CHRISTODOULOS STEFANADIS. (2007) Physical Activity, Obesity Status, and Glycemic Control. Medicine & Science in Sports & Exercise 39:4, 606-611
CrossRef1741
S. Jessani, K. Gangopadhyay, J. V. Patel, G. Y. H. Lip, T. Millane. (2007) Should oral glucose tolerance testing be mandatory following acute myocardial infarction?. International Journal of Clinical Practice 61:4, 680-683
CrossRef1742
A. DeNayer, M. DeHert, A. Scheen, L. VanGaal, J. Peuskens. (2007) Troubles métaboliques associés aux antipsychotiques atypiques : consensus belge sur la conduite à tenir. L'Encéphale 33:2, 197-202
CrossRef1743
Giuseppe Derosa, Arrigo F.G. Cicero, Angela D'Angelo, Elena Fogari, Sibilla Salvadeo, Alessia Gravina, Ilaria Ferrari, Raffaella Fassi, Roberto Fogari. (2007) Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: A sequential, randomized, double-blind clinical trial. Clinical Therapeutics 29:4, 602-610
CrossRef1744
P. Zimmer, M. Halle. (2007) Bewegungsanpassung in der Prävention des Diabetes mellitus Typ 2. Der Diabetologe 3:2, 113-119
CrossRef1745
Allison B Goldfine. (2007) Changing horizons: approaches to diabetes care, current and future. Current Opinion in Endocrinology, Diabetes and Obesity 14:2, 95-97
CrossRef1746
Karen V. Smirnakis, Alicia Plati, Myles Wolf, Ravi Thadhani, Jeffrey L. Ecker. (2007) Predicting gestational diabetes: choosing the optimal early serum marker. American Journal of Obstetrics and Gynecology 196:4, 410.e1-410.e7
CrossRef1747
A. Kohl, A.F.H. Pfeiffer. (2007) Primärprävention. Der Diabetologe 3:2, 120-125
CrossRef1748
Russell E. Glasgow, Karen M. Emmons. (2007) How Can We Increase Translation of Research into Practice? Types of Evidence Needed. Annual Review of Public Health 28:1, 413-433
CrossRef1749
(2007) Current issues and new direction in Psychology and Health : Advancing the science of behavior change. Psychology & Health 22:3, 249-253
CrossRef1750
Julien Lamontagne, Pellegrino Masiello, Mariannick Marcil, Viviane Delghingaro-Augusto, Yan Burelle, Marc Prentki, Christopher James Nolan. (2007) Circulating lipids are lowered but pancreatic islet lipid metabolism and insulin secretion are unaltered in exercise-trained female rats. Applied Physiology, Nutrition, and Metabolism 32:2, 241-248
CrossRef1751
Robert M. Kaplan, Michael Ong. (2007) Rationale and Public Health Implications of Changing CHD Risk Factor Definitions. Annual Review of Public Health 28:1, 321-44
CrossRef1752
K. Reinli, B. Guggenbühl. (2007) Diabetesprimärprävention. Der Diabetologe 3:2, 105-112
CrossRef1753
R Chudleigh, J Beaverstock, S Davis, D Hullin, Pms Evans, Md Page. (2007) Missed opportunities for diagnosis of diabetes. Practical Diabetes International 24:3, 138-141
CrossRef1754
P.E.H. Schwarz, U. Gruhl, R. Hoffmann, S.R. Bornstein, J. Schulze, R. Landgraf. (2007) Primärprävention des Diabetes mellitus. Der Diabetologe 3:2, 86-95
CrossRef1755
(2007) Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatric Diabetes 8:2, 74-87
CrossRef1756
YACINE AGGOUN. (2007) Obesity, Metabolic Syndrome, and Cardiovascular Disease. Pediatric Research PAP,
CrossRef1757
Subhashini Yaturu, Sushil Jain. 2007. Obesity and Type 2 Diabetes. , 139-154.
CrossRef1758
Frank Greenway, Alok Gupta. 2007. Safety of Obesity Drugs. , 199-217.
CrossRef1759
R. Boushel, E. Gnaiger, P. Schjerling, M. Skovbro, R. Kraunsøe, F. Dela. (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50:4, 790-796
CrossRef1760
Fabrice M. A. C. Martens, Frank L. J. Visseren. (2007) The operative risk factors in the metabolic syndrome: Is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity?. Current Diabetes Reports 7:1, 74-81
CrossRef1761
David A. Booth, Gareth J. Treharne, George D. Kitas, Sudhesh Kumar. (2007) Avoidance of unhealthy fattening: A longstanding proposal. Appetite 48:2, 129-134
CrossRef1762
Onno E. Janßen, K. Mann, R. Erbel. (2007) Das Herz bei endokrinen Erkrankungen. Der Internist 48:3, 246-254
CrossRef1763
Sudha Ganne, Surender Arora, Jocelyne Karam, Samy I McFarlane. (2007) Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach. Expert Review of Cardiovascular Therapy 5:2, 201-211
CrossRef1764
Ning Cheung, Tien Y. Wong. (2007) Obesity and Eye Diseases. Survey of Ophthalmology 52:2, 180-195
CrossRef1765
Torben Østergård, Niels Jessen, Ole Schmitz, Lawrence J. Mandarino. (2007) The effect of exercise, training, and inactivity on insulin sensitivity in diabetics and their relatives: what is new?. Applied Physiology, Nutrition, and Metabolism 32:3, 541-548
CrossRef1766
Carolyn L. Blue. (2007) Does the Theory of Planned Behavior Identify Diabetes-Related Cognitions for Intention to Be Physically Active and Eat a Healthy Diet?. Public Health Nursing 24:2, 141-150
CrossRef1767
Risa M. Hoffman, Judith S. Currier. (2007) Management of Antiretroviral Treatment–Related Complications. Infectious Disease Clinics of North America 21:1, 103-132
CrossRef1768
Yoshiko Adachi, Chifumi Sato, Koji Yamatsu, Sakurako Ito, Kyo Adachi, Toshiko Yamagami. (2007) A randomized controlled trial on the long-term effects of a 1-month behavioral weight control program assisted by computer tailored advice. Behaviour Research and Therapy 45:3, 459-470
CrossRef1769
F. Xavier Pi-Sunyer. (2007) How Effective Are Lifestyle Changes in the Prevention of Type 2 Diabetes Mellitus?. Nutrition Reviews 65:3, 101-110
CrossRef1770
KATHLEEN M. HOEGER. (2007) Obesity and Lifestyle Management in Polycystic Ovary Syndrome. Clinical Obstetrics and Gynecology 50:1, 277-294
CrossRef1771
William J. McCarthy, Antronette K. Yancey, Gail G. Harrison, Joanne Leslie, Judith M. Siegel. (2007) Fighting cancer with fitness: Dietary outcomes of a randomized, controlled lifestyle change intervention in healthy African–American women. Preventive Medicine 44:3, 246-253
CrossRef1772
Raul Artal, Rosemary B. Catanzaro, Jeffrey A. Gavard, Dorothea J. Mostello, Joann C. Friganza. (2007) A lifestyle intervention of weight-gain restriction: diet and exercise in obese women with gestational diabetes mellitus. Applied Physiology, Nutrition, and Metabolism 32:3, 596-601
CrossRef1773
Paolo Pozzilli, Raffaella Buzzetti. (2007) A new expression of diabetes: double diabetes. Trends in Endocrinology & Metabolism 18:2, 52-57
CrossRef1774
Graham A. Colditz. (2007) From epidemiology to cancer prevention: implications for the 21st Century. Cancer Causes & Control 18:2, 117-123
CrossRef1775
Alison Kirk, Pierpaolo De Feo. (2007) Strategies to enhance compliance to physical activity for patients with insulin resistance. Applied Physiology, Nutrition, and Metabolism 32:3, 549-556
CrossRef1776
L. G. Kraemer de Aguiar, C. M. Laflor, L. Bahia, N. R. Villela, N. Wiernsperger, D. A. Bottino, E. Bouskela. (2007) Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome. Diabetic Medicine 24:3, 272-279
CrossRef1777
Glenn A. Gaesser. (2007) Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome. Current Diabetes Reports 7:1, 14-19
CrossRef1778
Erin M Fekete, Michael H Antoni, Neil Schneiderman. (2007) Psychosocial and behavioral interventions for chronic medical conditions. Current Opinion in Psychiatry 20:2, 152-157
CrossRef1779
L. Villa-Caballero, A.A. Nava-Ocampo, A.C. Frati-Munari, S.M. Rodríguez de León, A.R. Becerra–Pérez, R.M. Ceja, M.G. Campos-Lara, H.A. Ponce-Monter. (2007) Hemodynamic and oxidative stress profile after exercise in type 2 diabetes. Diabetes Research and Clinical Practice 75:3, 285-291
CrossRef1780
G Y H Lip, A H Barnett, A Bradbury, F P Cappuccio, P S Gill, E Hughes, C Imray, K Jolly, K Patel. (2007) Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. Journal of Human Hypertension 21:3, 183-211
CrossRef1781
P. Kopelman. (2007) Health risks associated with overweight and obesity. Obesity Reviews 8:s1, 13-17
CrossRef1782
Jun Li, Yong Jin, Ting-Yu Wang, Xiong-Wen Lü, Yuan-Hai Li. (2007) Relative bioavailability and bioequivalence of metforphin hydrochloride extended-released and immediate-released tablets in healthy Chinese volunteers. European Journal of Drug Metabolism and Pharmacokinetics 32:1, 21-28
CrossRef1783
R. Retnakaran, P. W. Connelly, G. Maguire, M. Sermer, B. Zinman, A. J. G. Hanley. (2007) Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes. Diabetic Medicine 24:3, 245-252
CrossRef1784
(2007) Programmes et actions de prévention au plan international. Obésité 2:1, 53-64
CrossRef1785
Andrea J. Cussons, Bronwyn G. A. Stuckey, Gerald F. Watts. (2007) Metabolic syndrome and cardiometabolic risk in PCOS. Current Diabetes Reports 7:1, 66-73
CrossRef1786
Gang Hu, Timo A. Lakka, Tuomas O. Kilpeläinen, Jaakko Tuomilehto. (2007) Epidemiological studies of exercise in diabetes prevention. Applied Physiology, Nutrition, and Metabolism 32:3, 583-595
CrossRef1787
Wim Derave, Ann Mertens, Erik Muls, Karel Pardaens, Peter Hespel. (2007) Effects of Post-absorptive and Postprandial Exercise on Glucoregulation in Metabolic Syndrome*. Obesity 15:3, 704-711
CrossRef1788
J. P. H. Wilding. (2007) Treatment strategies for obesity. Obesity Reviews 8:s1, 137-144
CrossRef1789
P. T. Katzmarzyk, C. L. Craig, L. Gauvin. (2007) Adiposity, physical fitness and incident diabetes: the physical activity longitudinal study. Diabetologia 50:3, 538-544
CrossRef1790
J.M. González-Clemente, O. Carro, I. Gallach, J. Vioque, A. Humanes, C. Sauret, M. Abella, G. Giménez-Pérez, D. Mauricio. (2007) Increased cholesterol intake in women with gestational diabetes mellitus. Diabetes & Metabolism 33:1, 25-29
CrossRef1791
F LAMISSE. (2007) Le diabète de type 2 des enfants et des adolescents. Cahiers de Nutrition et de Diététique 42:1, 25-30
CrossRef1792
Claus Thamer, Juergen Machann, Norbert Stefan, Michael Haap, Silke Schäfer, Sonja Brenner, Konstantin Kantartzis, Claus Claussen, Fritz Schick, Hans Haring, Andreas Fritsche. (2007) High Visceral Fat Mass and High Liver Fat Are Associated with Resistance to Lifestyle Intervention*. Obesity 15:2, 531-538
CrossRef1793
Colin Berry, Jean-Claude Tardif, Martial G. Bourassa. (2007) Coronary Heart Disease in Patients With Diabetes. Journal of the American College of Cardiology 49:6, 631-642
CrossRef1794
Roja Motaghedi, Sahil Gujral, Sunil Sinha, Cristina Sison, Svetlana Ten, Noel K. Maclaren. (2007) Insulin-Like Growth Factor Binding Protein-1 to Screen for Insulin Resistance in Children. Diabetes Technology & Therapeutics 9:1, 43-51
CrossRef1795
(2007) References. American Journal of Kidney Diseases 49:2, S160-S179
CrossRef1796
Lydia Sebba Souza Mariosa, Fernando Flexa Ribeiro-Filho, Artur Beltrame Ribeiro, Maria Teresa Zanella. (2007) Diagnosing Abnormal Glucose Tolerance in Hypertensive Women: Are We Making the Best Choice?. Journal of the CardioMetabolic Syndrome 2:2, 98-103
CrossRef1797
Karl G. Hofbauer, Janet R. Nicholson, Olivier Boss. (2007) The Obesity Epidemic: Current and Future Pharmacological Treatments. Annual Review of Pharmacology and Toxicology 47:1, 565-592
CrossRef1798
Laura D. Hoeman. (2007) The Obese Teen. AJN, American Journal of Nursing 107:2, 40-48
CrossRef1799
Camilla Skov-Jensen, Mette Skovbro, Anne Flint, Jørn Wulff Helge, Flemming Dela. (2007) Contraction-mediated glucose uptake is increased in men with impaired glucose tolerance. Applied Physiology, Nutrition, and Metabolism 32:1, 115-124
CrossRef1800
Tore Christiansen, Jens M. Bruun, Erik L. Madsen, Bjørn Richelsen. (2007) Weight Loss Maintenance in Severely Obese Adults after an Intensive Lifestyle Intervention: 2- to 4-Year Follow-Up*. Obesity 15:2, 413-420
CrossRef1801
(2007) The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabetic Medicine 24:2, 137-144
CrossRef1802
Tracy L. Setji, Ann J. Brown. (2007) Polycystic Ovary Syndrome: Diagnosis and Treatment. The American Journal of Medicine 120:2, 128-132
CrossRef1803
Susan J. Appel, Jennifer M. Bannon. (2007) Hazardous Waist: How Body Shape Puts Health at Risk. Nursing for Women's Health 11:1, 44-53
CrossRef1804
Torsten Lauritzen, Knut Borch-Johnsen, Annelli Sandbæk. (2007) Is prevention of Type-2 diabetes feasible and efficient in primary care?. Primary Care Diabetes 1:1, 5-11
CrossRef1805
Michelle Lee, Louis J. Aronne. (2007) Weight Management for Type 2 Diabetes Mellitus: Global Cardiovascular Risk Reduction. The American Journal of Cardiology 99:4, 68-79
CrossRef1806
Thomas J. Biuso, Susan Butterworth, Ariel Linden. (2007) A Conceptual Framework for Targeting Prediabetes with Lifestyle, Clinical, And Behavioral Management Interventions. Disease Management 10:1, 6-15
CrossRef1807
C E Finley, C E Barlow, F L Greenway, C L Rock, B J Rolls, S N Blair. (2007) Retention rates and weight loss in a commercial weight loss program. International Journal of Obesity 31:2, 292-298
CrossRef1808
R. Bilous. (2007) Editorial. Diabetic Medicine 24:2, 107-109
CrossRef1809
Timo A. Lakka, David E. Laaksonen. (2007) Physical activity in prevention and treatment of the metabolic syndrome. Applied Physiology, Nutrition, and Metabolism 32:1, 76-88
CrossRef1810
Florence Conus, Rémi Rabasa-Lhoret, François Péronnet. (2007) Characteristics of metabolically obese normal-weight (MONW) subjects. Applied Physiology, Nutrition, and Metabolism 32:1, 4-12
CrossRef1811
A.J. Scheen. (2007) Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?. Diabetes & Metabolism 33:1, 3-12
CrossRef1812
J.D.G. Fearn-Smith, P.H. Evans, G. Harding, J.L. Campbell. (2007) Attitudes of GPs to the diagnosis and management of impaired glucose tolerance: The practitioners’ attitudes to hyperglycaemia (PAtH) questionnaire. Primary Care Diabetes 1:1, 35-41
CrossRef1813
G. Derosa, A. D'Angelo, P. D. Ragonesi, L. Ciccarelli, M. N. Piccinni, F. Pricolo, S. A. T. Salvadeo, L. Montagna, A. Gravina, I. Ferrari, S. Paniga, A. F. G. Cicero. (2007) Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin. Internal Medicine Journal 37:2, 79-86
CrossRef1814
A.F.H. Pfeiffer, A. Kohl. (2007) Komplexe diätetische und Pharmakotherapie beim metabolischen Syndrom. Der Internist 48:2, 164-172
CrossRef1815
Abdurrahman Kadayifci, Raphael B. Merriman, Nathan M. Bass. (2007) Medical Treatment of Non-alcoholic Steatohepatitis. Clinics in Liver Disease 11:1, 119-140
CrossRef1816
TATSUHIKO URAKAMI, SHIGEO MORIMOTO, YOSHIKAZU NITADORI, KENSUKE HARADA, MISAO OWADA, TERUO KITAGAWA. (2007) Urine Glucose Screening Program at Schools in Japan to Detect Children with Diabetes and Its Outcome-Incidence and Clinical Characteristics of Childhood Type 2 Diabetes in Japan. Pediatric Research 61:2, 141-145
CrossRef1817
Eriko Shikata, Rei Yamamoto, Hiroshi Takane, Chiaki Shigemasa, Tadasu Ikeda, Kenji Otsubo, Ichiro Ieiri. (2007) Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin. Journal of Human Genetics 52:2, 117-122
CrossRef1818
Peter Weyrich, Norbert Stefan, Hans-Ulrich Häring, Markku Laakso, Andreas Fritsche. (2007) Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes. Journal of Molecular Medicine 85:2, 107-117
CrossRef1819
Michael F Costello, Bhushan Shrestha, John Eden, Neil Johnson, Lisa J Moran, Michael F Costello. 2007. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. .
CrossRef1820
S. S. Rasmussen, C. Glümer, A. Sandbaek, T. Lauritzen, K. Borch-Johnsen. (2007) Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark. Diabetologia 50:2, 293-297
CrossRef1821
Gary Wittert, Ian Caterson, Nick Finer. (2007) The clinical effectiveness of weight loss drugs. Obesity Research & Clinical Practice 1:1, 1-5
CrossRef1822
Céline Gaudel, Paul A. Grimaldi. (2007) Metabolic Functions of Peroxisome Proliferator-Activated Receptor β/δ in Skeletal Muscle. PPAR Research 2007, 1-6
CrossRef1823
J BOLTRI, I OKOSUN, Y DAVISSMITH, J SEALE, P ROMAN, B TOBIN. (2007) A simple nurse-based prompt increases screening and prevention counseling for diabetes
CrossRef1824
Giuseppe DEROSA, Elena FOGARI, Arrigo F. G. CICERO, Angela D'ANGELO, Leonardina CICCARELLI, Mario N. PICCINNI, Fabio PRICOLO, Sibilla A. T. SALVADEO, Alessia GRAVINA, Ilaria FERRARI, Roberto FOGARI. (2007) Blood Pressure Control and Inflammatory Markers in Type 2 Diabetic Patients Treated with Pioglitazone or Rosiglitazone and Metformin. Hypertension Research 30:5, 387-394
CrossRef1825
(2007) Traitement médicamenteux du diabète de type 2recommandation de bonne pratique. Diabetes & Metabolism 33:1, S26-S105
CrossRef1826
Setsuko TOMIOKA, Hiroyasu OGATA, Yoshifumi TAMURA, Tomoaki SHIMIZU, Hirotaka WATADA, Yoshio FUJITANI, Ryuzo KAWAMORI, Takahisa HIROSE. (2007) Clinical Characteristics Influencing the Effectiveness of Metformin on Japanese Type 2 Diabetes Receiving Sulfonylureas. Endocrine Journal 54:2, 247-253
CrossRef1827
J-F Fu, L Liang, C-C Zou, F Hong, C-L Wang, X-M Wang, Z-Y Zhao. (2007) Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. International Journal of Obesity 31:1, 15-22
CrossRef1828
A Secchiutti, C Fagour, C Perlemoine, H Gin, J Durrieu, V Rigalleau. (2007) Air displacement plethysmography can detect moderate changes in body composition. European Journal of Clinical Nutrition 61:1, 25-29
CrossRef1829
Chang-Yu Pan, Harald Landen. (2007) Post-Marketing Surveillance of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus and Subjects with Impaired Glucose Tolerance in China. Clinical Drug Investigation 27:6, 397-405
CrossRef1830
Francine Grodstein. (2007) Cardiovascular risk factors and cognitive function. Alzheimer s and Dementia 3:2, S16
CrossRef1831
Stephen Cook. 2007. Metabolic Syndrome. , 371-372.
CrossRef1832
Celia Aradillas-Garcia, Juan M. Malacara, Ma. Eugenia Garay-Sevilla, Juan M. Guízar, Nicolás Camacho, Esperanza Cruz-Mendoza, Leticia Quemada, Juan Francisco Hernández Sierra. (2007) Prediabetes in Rural and Urban Children in 3 States in Mexico. Journal of the CardioMetabolic Syndrome 2:1, 35-39
CrossRef1833
Ann M. Swartz, Scott J. Strath, Nora E. Miller, Susan E. Cashin, Linda J. Cieslik. (2007) Glucose Control and Walking in a Multiethnic Sample of Older Adults. Gerontology 53:6, 454-461
CrossRef1834
Antonio Gil-Núñez. (2007) The Metabolic Syndrome and Cerebrovascular Disease: Suspicion and Evidence. Cerebrovascular Diseases 24:1, 64-75
CrossRef1835
C. L. Hart, D. J. Hole, D. A. Lawlor, G. Davey Smith. (2007) How many cases of Type 2 diabetes mellitus are due to being overweight in middle age? Evidence from the Midspan prospective cohort studies using mention of diabetes mellitus on hospital discharge or death records. Diabetic Medicine 24:1, 73-80
CrossRef1836
John Q. Trojanowski, M. Kathryn Jedrziewski, Virginia M.-Y. Lee. (2007) Physical activity and cognitive health. Alzheimer s and Dementia 3:2, 98
CrossRef1837
Kerry B. Goralski, Christopher J. Sinal. (2007) Type 2 diabetes and cardiovascular disease: getting to the fat of the matterThis paper is one of a selection of papers published in this Special Issue, entitled Young Investigators' Forum.. Canadian Journal of Physiology and Pharmacology 85:1, 113-132
CrossRef1838
Simona Moscatiello, Rita Manini, Giulio Marchesini. (2007) Diabetes and liver disease: An ominous association. Nutrition, Metabolism and Cardiovascular Diseases 17:1, 63-70
CrossRef1839
Mark Gurnell. (2007) ‘Striking the Right Balance’ in Targeting PPARγ in the Metabolic Syndrome: Novel Insights from Human Genetic Studies. PPAR Research 2007, 1-14
CrossRef1840
T. Berentzen, L. Petersen, O. Pedersen, E. Black, A. Astrup, T. I. A. Sørensen. (2007) Long-term effects of leisure time physical activity on risk of insulin resistance and impaired glucose tolerance, allowing for body weight history, in Danish men. Diabetic Medicine 24:1, 63-72
CrossRef1841
Michal Armoni, Chava Harel, Eddy Karnieli. (2007) Transcriptional regulation of the GLUT4 gene: from PPAR-γ and FOXO1 to FFA and inflammation. Trends in Endocrinology and Metabolism 18:3, 100
CrossRef1842
Kathleen Mulligan, Yang Yang, David A Wininger, Susan L Koletar, Robert A Parker, Beverly L Alston-Smith, Jeffrey T Schouten, Roger A Fielding, Michael T Basar, Steven Grinspoon. (2007) Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. AIDS 21:1, 47-57
CrossRef1843
Tae Seo Sohn, Jung Min Lee, Sang Ah Chang, Kyung Ah Han, Hyun Shik Son, Hyo Jeong Kim, Chul Woo Ahn, Yeon Ah Sung, Kyung Wan Min, Sei Hyun Baik, Jae Myeong Yu, Sung Woo Park. (2007) The Appropriate Distance and Duration of Walking for Exercise in Patients with Type 2 Diabetes Mellitus. The Journal of Korean Diabetes Association 31:2, 157
CrossRef1844
Aaron Vinik. (2007) Advancing Therapy in Type 2 Diabetes Mellitus with Early, Comprehensive Progression from Oral Agents to Insulin Therapy. Clinical Therapeutics 29:6, 1236-1253
CrossRef1845
Aaron Vinik. (2007) Too Many Notes: Up and Down the Scales of Diabetes Therapy. Clinical Therapeutics 29:6, 1227-1235
CrossRef1846
Cris A. Slentz, Joseph A. Houmard, William E. Kraus. (2007) Modest Exercise Prevents the Progressive Disease Associated with Physical Inactivity. Exercise and Sport Sciences Reviews18-23
CrossRef1847
Nicola Joss, Christine E. Staatz, Alison H. Thomson, Alan G. Jardine. (2007) Predictors of new onset diabetes after renal transplantation. Clinical Transplantation 21:1, 136-143
CrossRef1848
E. Mollet. (2007) Attività fisica, diabete ed altri fattori di rischio cardiovascolare. EMC - AKOS - Trattato di Medicina 9:1, 1-6
CrossRef1849
Aleksandra Nikolic, Dejan Nikolic, Violeta Stanimirovic. (2007) The metabolic syndrome X or insulin resistance syndrome. Vojnosanitetski pregled 64:1, 45-51
CrossRef1850
Anthony N. Fabricatore. (2007) Behavior Therapy and Cognitive-Behavioral Therapy of Obesity: Is There a Difference?. Journal of the American Dietetic Association 107:1, 92-99
CrossRef1851
Anthony S. Wierzbicki, Emmanuel S. Ganotakis, Dimitri P. Mikhailidis. (2007) Shape of the Nations survey and attitudes to cardiometabolic risk. Current Medical Research and Opinion 23:1, 25-28
CrossRef1852
Nathan D Wong. (2007) Metabolic Syndrome. American Journal of Cardiovascular Drugs 7:4, 259-272
CrossRef1853
Sue Baic, Janice L. Thompson. (2007) Prevent It. ACSM's Health & Fitness Journal 11:1, 15-20
CrossRef1854
Akira Babazono, Chihoko Kame, Reiko Ishihara, Eiji Yamamoto, Alan L Hillman. (2007) Patient-Motivated Prevention of Lifestyle-Related Disease in Japan. Disease Management & Health Outcomes 15:2, 119-126
CrossRef1855
Tomoko Nakagami, Makoto Tominaga, Rimei Nishimura, Makoto Daimon, Toshihide Oizumi, Nobuo Yoshiike, Naoko Tajima. (2007) Combined Use of Fasting Plasma Glucose and Glycated Hemoglobin A1c in a Stepwise Fashion to Detect Undiagnosed Diabetes Mellitus. The Tohoku Journal of Experimental Medicine 213:1, 25-32
CrossRef1856
Pilar Mazón-Ramos, Vicente Bertomeu-Martínez, José L. Palma-Gámiz, Juan Quiles-Granado, José Guindo-Soldevilla, José R. González-Juanatey. (2007) Tratamiento global del riesgo cardiovascular en el paciente hipertenso. Revista Española de Cardiología 60, 79-91
CrossRef1857
Mira Vukovic, Mirjana Lapcevic, Nevena Kalezic, Branislav Gvozdenovic. (2007) The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2. Srpski arhiv za celokupno lekarstvo 135:7-8, 447-452
CrossRef1858
Biljana Beleslin, Jasmina Ciric, Milos Zarkovic, Zorana Penezic, Svetlana Vujovic, Bozo Trbojevic, Milka Drezgic. (2007) The effects of three-week fasting diet on blood pressure, lipid profile and glucoregulation in extremely obese patients. Srpski arhiv za celokupno lekarstvo 135:7-8, 440-446
CrossRef1859
D. M. Nathan, . (2006) Response to comments on: Nathan DM, Buse JB, Davidson MB et al. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721. Diabetologia 50:1, 231-233
CrossRef1860
A. C. M. Thiebaut, A. Schatzkin, R. Ballard-Barbash, V. Kipnis. (2006) Dietary Fat and Breast Cancer: Contributions From a Survival Trial. JNCI Journal of the National Cancer Institute 98:24, 1753-1755
CrossRef1861
Rena Wing, Angela Marinilli Pinto, Heather Niemeier. 2006. Maintenance. , 177-196.
CrossRef1862
Louis Aronne, Marie Thearle. 2006. Pharmacologic Therapy for Obesity and Overweight in Adults and Adolescents. , 97-122.
CrossRef1863
Nathan, David M., . (2006) Thiazolidinediones for Initial Treatment of Type 2 Diabetes?. New England Journal of Medicine 355:23, 2477-2480
Full Text1864
S.M. Arponen, C. Suárez Fernández. (2006) Aspectos actuales y perspectiva de futuro del tratamiento del síndrome metabólico. Medicine - Programa de Formación Médica Continuada Acreditado 9:69, 4429-4435
CrossRef1865
Y CHOI, Y CHO, C PARK, H JANG, K PARK, S KIM, H LEE. (2006) Rapidly increasing diabetes-related mortality with socio-environmental changes in South Korea during the last two decades. Diabetes Research and Clinical Practice 74:3, 295-300
CrossRef1866
Michael Bottorff. (2006) Role of the Pharmacist. Pharmacotherapy 26:12part2, 227S-232S
CrossRef1867
Christian Herder, Stephan Martin, Kerstin Kempf, Bettina Rose, Hubert Kolb. (2006) The DREAM trial. The Lancet 368:9552, 2049
CrossRef1868
Michelle A. Russell, Maureen G. Phipps, Courtney L. Olson, H Gilbert Welch, Marshall W. Carpenter. (2006) Rates of Postpartum Glucose Testing After Gestational Diabetes Mellitus. Obstetrics & Gynecology 108:6, 1456-1462
CrossRef1869
P L Zock. (2006) Do favourable effects of increasing unsaturated fat intake on cardiovascular disease risk outweigh the potential adverse effect on body weight?. International Journal of Obesity 30, S10-S15
CrossRef1870
Kenneth L Jones. (2006) The dilemma of the metabolic syndrome in children and adolescents: disease or distraction?. Pediatric Diabetes 7:6, 311-321
CrossRef1871
Anastassios G. Pittas, Susan B. Roberts, Sai Krupa Das, Cheryl H. Gilhooly, Edward Saltzman, Julie Golden, Paul C. Stark, Andrew S. Greenberg. (2006) The Effects of the Dietary Glycemic Load on Type 2 Diabetes Risk Factors during Weight Loss*. Obesity 14:12, 2200-2209
CrossRef1872
Stasia S. Reynolds, Lisa R. Yanek, Dhananjay Vaidya, Samia Mora, Taryn F. Moy, Christopher D. Saudek, Lewis C. Becker, Diane M. Becker. (2006) Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease. Diabetes Research and Clinical Practice 74:3, 267-273
CrossRef1873
K. Lange. (2006) Förderung der eigenverantwortlichen Therapie bei Typ-2-Diabetes. Der Diabetologe 2:6, 484-492
CrossRef1874
Andrew J. Krentz. (2006) Prevention of Cardiovascular Complications of the Metabolic Syndrome: Focus on Pharmacotherapy. Metabolic Syndrome and Related Disorders 4:4, 328-341
CrossRef1875
Brian K. Smith, Jeana Frost, Meltem Albayrak, Rajneesh Sudhakar. (2006) Facilitating narrative medical discussions of type 1 diabetes with computer visualizations and photography. Patient Education and Counseling 64:1-3, 313-321
CrossRef1876
P DEFEO, C DILORETO, A RANCHELLI, C FATONE, M MICCIO, G GAMBELUNGHE, P LUCIDI. (2006) Alternative indicators of metabolic control. Diabetes Research and Clinical Practice 74, S72-S76
CrossRef1877
A. S. WIERZBICKI. (2006) Rimonabant: endocannabinoid inhibition for the metabolic syndrome. International Journal of Clinical Practice 60:12, 1697-1706
CrossRef1878
S. A. Harding, R. Anscombe, M. Weatherall, S. Prasad, N. Lever, J. Krebs. (2006) Abnormal glucose metabolism and features of the metabolic syndrome are common in patients presenting for elective cardiac catheterization. Internal Medicine Journal 36:12, 759-764
CrossRef1879
Gang Hu, Timo A. Lakka, Hanna-Maaria Lakka, Jaakko Tuomilehto. (2006) Lifestyle Management in the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 4:4, 270-286
CrossRef1880
Alan Brennan, Roberta Ara, Raimund Sterz, Bernd Matiba, Rito Bergemann. (2006) Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany. The European Journal of Health Economics 7:4, 276-284
CrossRef1881
E GHANASSIA, J BRUN, C FEDOU, E RAYNAUD, J MERCIER. (2006) Substrate oxidation during exercise: type 2 diabetes is associated with a decrease in lipid oxidation and an earlier shift towards carbohydrate utilization. Diabetes & Metabolism 32:6, 604-610
CrossRef1882
Ken Fujioka. (2006) Metabolic Syndrome Treatment Strategies. Pharmacotherapy 26:12part2, 222S-226S
CrossRef1883
Kay-Tee Khaw, Nicholas Wareham. (2006) Glycated hemoglobin as a marker of cardiovascular risk. Current Opinion in Lipidology 17:6, 637-643
CrossRef1884
A Astrup. (2006) Carbohydrates as macronutrients in relation to protein and fat for body weight control. International Journal of Obesity 30, S4-S9
CrossRef1885
John E. Gerich. (2006) Glycemic Control in the Metabolic Syndrome and Implications in Preventing Cardiovascular Disease. Metabolic Syndrome and Related Disorders 4:4, 315-327
CrossRef1886
L. W. Johnson, R. S. Weinstock. (2006) The Metabolic Syndrome: Concepts and Controversy. Mayo Clinic Proceedings 81:12, 1615-1620
CrossRef1887
K. K. Yeo, B. C. Tai, D. Heng, J. M. J. Lee, S. Ma, K. Hughes, S. K. Chew, K. S. Chia, E. S. Tai. (2006) Ethnicity modifies the association between diabetes mellitus and ischaemic heart disease in Chinese, Malays and Asian Indians living in Singapore. Diabetologia 49:12, 2866-2873
CrossRef1888
E JEANBAPTISTE, P LARCO, N CHARLESLARCO, C VILGRAIN, D SIMON, R CHARLES. (2006) Glucose intolerance and other cardiovascular risk factors in Haiti (PREDIAH). Diabetes & Metabolism 32:5, 443-451
CrossRef1889
J. W. Stephens, R. Williams. (2006) Time to stop talking about screening for diabetes?. Diabetic Medicine 23:11, 1163-1164
CrossRef1890
Karol Watson. (2006) Surgical risk in patients with metabolic syndrome: Focus on lipids and hypertension. Current Cardiology Reports 8:6, 433-438
CrossRef1891
S. C. M. van Esch, M. C. Cornel, F. J. Snoek. (2006) Type
CrossRef1892
André J Scheen, Nick Finer, Priscilla Hollander, Michael D Jensen, Luc F Van Gaal. (2006) Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. The Lancet 368:9548, 1660-1672
CrossRef1893
Greg Schimmack, Ralph A. DeFronzo, Nicolas Musi. (2006) AMP-activated protein kinase: role in metabolism and therapeutic implications. Diabetes, Obesity and Metabolism 8:6, 591-602
CrossRef1894
Kun-Ho Yoon, Jin-Hee Lee, Ji-Won Kim, Jae Hyoung Cho, Yoon-Hee Choi, Seung-Hyun Ko, Paul Zimmet, Ho-Young Son. (2006) Epidemic obesity and type 2 diabetes in Asia. The Lancet 368:9548, 1681-1688
CrossRef1895
Ronald B Goldberg. (2006) Lifestyle interventions to prevent type 2 diabetes. The Lancet 368:9548, 1634-1636
CrossRef1896
Lawrence Blonde, Judith Dempster, Joanne M. Gallivan, Elizabeth Warren-Boulton. (2006) Reducing cardiovascular disease risk in patients with diabetes: A message from the National Diabetes Education Program. Journal of the American Academy of Nurse Practitioners 18:11, 524-533
CrossRef1897
Mauricio Avendano, JP Mackenbach. (2006) Blood glucose levels: facing a global crisis. The Lancet 368:9548, 1631-1632
CrossRef1898
Anna Wredenberg, Christoph Freyer, Marie E. Sandström, Abram Katz, Rolf Wibom, Håkan Westerblad, Nils-Göran Larsson. (2006) Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochemical and Biophysical Research Communications 350:1, 202-207
CrossRef1899
(2006) Relationship of Body Size and Shape to the Development of Diabetes in the Diabetes Prevention Program*. Obesity 14:11, 2107-2117
CrossRef1900
Kayoko Tahara, Ayumi Yonemoto, Yuji Yoshiyama, Toshiya Nakamura, Masaaki Aizawa, Yoshikuni Fujita, Takashi Nishikawa. (2006) Determination of antihyperglycemic biguanides in serum and urine using an ion-pair solid-phase extraction technique followed by HPLC-UV on a pentafluorophenylpropyl column and on an octadecyl column. Biomedical Chromatography 20:11, 1200-1205
CrossRef1901
Earl S Ford, Chaoyang Li. (2006) Physical activity or fitness and the metabolic syndrome. Expert Review of Cardiovascular Therapy 4:6, 897-915
CrossRef1902
Andrew J. M. Boulton. (2006) Treatment of prediabetic neuropathy. Current Diabetes Reports 6:6, 415-416
CrossRef1903
Tina Berentzen, Thorkild I.A. Sørensen. (2006) Effects of Intended Weight Loss on Morbidity and Mortality: Possible Explanations of Controversial Results. Nutrition Reviews 64:11, 502-507
CrossRef1904
Torben Østergård, Birgit Nyholm, Troels K. Hansen, Lars M. Rasmussen, Jørgen Ingerslev, Keld E. Sørensen, Hans E. Bøtker, Bengt Saltin, Ole Schmitz. (2006) Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training. Metabolism 55:11, 1508-1515
CrossRef1905
Jaana Lindström, Pirjo Ilanne-Parikka, Markku Peltonen, Sirkka Aunola, Johan G Eriksson, Katri Hemiö, Helena Hämäläinen, Pirjo Härkönen, Sirkka Keinänen-Kiukaanniemi, Mauri Laakso, Anne Louheranta, Marjo Mannelin, Merja Paturi, Jouko Sundvall, Timo T Valle, Matti Uusitupa, Jaakko Tuomilehto. (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. The Lancet 368:9548, 1673-1679
CrossRef1906
Floris A Van de Laar, Peter LBJ Lucassen, Reinier P Akkermans, Eloy H Van de Lisdonk, Wim JC De Grauw, Floris A Van de Laar. 2006. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. .
CrossRef1907
The DREAM Trial Investigators. (2006) Effect of Ramipril on the Incidence of Diabetes. New England Journal of Medicine 355:15, 1551-1562
Full Text1908
Wing, Rena R., Tate, Deborah F., Gorin, Amy A., Raynor, Hollie A., Fava, Joseph L., . (2006) A Self-Regulation Program for Maintenance of Weight Loss. New England Journal of Medicine 355:15, 1563-1571
Full Text1909
Ingelfinger, Julie R., Solomon, Caren G., . (2006) Angiotensin-Converting–Enzyme Inhibitors for Impaired Glucose Tolerance — Is There Still Hope?. New England Journal of Medicine 355:15, 1608-1610
Full Text1910
M. Möhlig, A. Flöter, J. Spranger, M. O. Weickert, T. Schill, H. W. Schlösser, G. Brabant, A. F. H. Pfeiffer, J. Selbig, C. Schöfl. (2006) Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling. Diabetologia 49:11, 2572-2579
CrossRef1911
José A. Fornos, N. Floro Andrés, J. Carlos Andrés, M. Mercedes Guerra, Beatriz Egea. (2006) A Pharmacotherapy Follow-Up Program in Patients with Type-2 Diabetes in Community Pharmacies in Spain. Pharmacy World & Science 28:2, 65-72
CrossRef1912
Anne Merete Boas Soja, Ann-Dorthe Olsen Zwisler, Thomas Melchior, Eva Hommel, Christian Torp-Pedersen, Mette Madsen. (2006) Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study. European Journal of Cardiovascular Prevention & Rehabilitation 13:5, 784-790
CrossRef1913
Adam Gilden Tsai, David A. Asch, Thomas A. Wadden. (2006) Insurance Coverage for Obesity Treatment. Journal of the American Dietetic Association 106:10, 1651-1655
CrossRef1914
Anthony S. Wierzbicki. (2006) Low HDL-cholesterol: common and under-treated, but which drug to use?. International Journal of Clinical Practice 60:10, 1149-1153
CrossRef1915
William H. Theodore, Susan S. Spencer, Samuel Wiebe, John T. Langfitt, Amza Ali, Patricia O. Shafer, Anne T. Berg, Barbara G. Vickrey. (2006) Epilepsy in North America: A Report Prepared under the Auspices of the Global Campaign against Epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia 47:10, 1700-1722
CrossRef1916
S Ash, M Reeves, J Bauer, T Dover, A Vivanti, C Leong, T O'Moore Sullivan, S Capra. (2006) A randomised control trial comparing lifestyle groups, individual counselling and written information in the management of weight and health outcomes over 12 months. International Journal of Obesity 30:10, 1557-1564
CrossRef1917
Steven H Horowitz. (2006) Recent clinical advances in diabetic polyneuropathy. Current Opinion in Anaesthesiology 19:5, 573-578
CrossRef1918
Jaakko Tuomilehto, Nicholas Wareham. (2006) Glucose lowering and diabetes prevention: are they the same?. The Lancet 368:9543, 1218-1219
CrossRef1919
Tamara S Hannon, Fida Bacha, So Jung Lee, Janine Janosky, Silva A Arslanian. (2006) Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatric Diabetes 7:5, 260-266
CrossRef1920
Ronald Goldberg. 2006. Type 2 Diabetes. , 187-254.
CrossRef1921
H.-G. Joost. (2006) Nutrigenomik. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 49:10, 1011-1019
CrossRef1922
Herman Blomeier, Neil J Stone. 2006. Obesity and Lifestyle Modification. , 63-78.
CrossRef1923
Charles Reasner. 2006. The Metabolic Syndrome: Identification and Management of the Patient at High Risk for Cardiovascular Disease. , 409-440.
CrossRef1924
Mattias Ekstedt, Lennart E. Franzén, Ulrik L. Mathiesen, Lars Thorelius, Marika Holmqvist, Göran Bodemar, Stergios Kechagias. (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:4, 865-873
CrossRef1925
Paul Araiza, Hilary Hewes, Carrie Gashetewa, Chantal A. Vella, Mark R. Burge. (2006) Efficacy of a pedometer-based physical activity program on parameters of diabetes control in type 2 diabetes mellitus. Metabolism 55:10, 1382-1387
CrossRef1926
Daniel A Duprez, Daniel J Wilson. 2006. Arterial Hypertension. , 19-62.
CrossRef1927
Alton Hart, Lesley Tinker, Deborah J. Bowen, Gary Longton, Shirley A.A. Beresford. (2006) Correlates of Fat Intake Behaviors in Participants in the Eating for a Healthy Life Study. Journal of the American Dietetic Association 106:10, 1605-1613
CrossRef1928
Kerstyn C. Zalesin, Peter A. McCullough. (2006) Bariatric Surgery for Morbid Obesity: Risks and Benefits in Chronic Kidney Disease Patients. Advances in Chronic Kidney Disease 13:4, 403-417
CrossRef1929
J D Krebs, L M Browning, N K McLean, J L Rothwell, G D Mishra, C S Moore, S A Jebb. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. International Journal of Obesity 30:10, 1535-1544
CrossRef1930
LAURA S. GERSON, BARRY BRAUN. (2006) Effect of High Cardiorespiratory Fitness and High Body Fat on Insulin Resistance. Medicine & Science in Sports & Exercise 38:10, 1709-1715
CrossRef1931
Paul W. Franks, Ruth J. F. Loos. (2006) PGC-1?? Gene and Physical Activity in Type 2 Diabetes Mellitus. Exercise and Sport Sciences Reviews 34:4, 171-175
CrossRef1932
Vivian A. Fonseca. (2006) Review Paper
CrossRef1933
J Lord, R Thomas, B Fox, U Acharya, T Wilkin. (2006) The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG: An International Journal of Obstetrics & Gynaecology 113:10, 1203-1209
CrossRef1934
(2006) The Influence of Age on the Effects of Lifestyle Modification and Metformin in Prevention of Diabetes. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:10, 1075-1081
CrossRef1935
D DELUISROMAN, R DELAFUENTE, M SAGRADO, O IZAOLA, R VICENTE. (2006) Leptin Receptor Lys656Asn Polymorphism Is Associated with Decreased Leptin Response and Weight Loss Secondary to a Lifestyle Modification in Obese Patients. Archives of Medical Research 37:7, 854-859
CrossRef1936
Dominic S. Ng. 2006. Insulin Resistance, Diabetes and its Complications. .
CrossRef1937
(2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. The Lancet 368:9541, 1096-1105
CrossRef1938
B. Zinman, S. B. Harris, H. C. Gerstein, T. K. Young, J. M. Raboud, J. Neuman, A. J. G. Hanley. (2006) Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial. Diabetes, Obesity and Metabolism 8:5, 531-537
CrossRef1939
(2006) Abdominelle Adipositas und das Endocannabinoid-System. Clinical Research in Cardiology Supplements 1:1, 74-78
CrossRef1940
A. Wirth. (2006) Metabolisches Syndrom und kardiovaskuläre Komplikationen. Clinical Research in Cardiology Supplements 1:1, 55-67
CrossRef1941
James W. Carson, Francis J. Keefe, Glenn Affleck, Meredith E. Rumble, David S. Caldwell, Pat M. Beaupre, Susmita Kashikar-Zuck, Marlene Sandstrom, James N. Weisberg. (2006) A Comparison of Conventional Pain Coping Skills Training and Pain Coping Skills Training With a Maintenance Training Component: A Daily Diary Analysis of Short- and Long-Term Treatment Effects. The Journal of Pain 7:9, 615-625
CrossRef1942
Sachin Jadhav, William Ferrell, Ian A. Greer, John R. Petrie, Stuart M. Cobbe, Naveed Sattar. (2006) Effects of Metformin on Microvascular Function and Exercise Tolerance in Women With Angina and Normal Coronary Arteries. Journal of the American College of Cardiology 48:5, 956-963
CrossRef1943
K P Truesdale, J Stevens, C E Lewis, P J Schreiner, C M Loria, J Cai. (2006) Changes in risk factors for cardiovascular disease by baseline weight status in young adults who maintain or gain weight over 15 years: the CARDIA study. International Journal of Obesity 30:9, 1397-1407
CrossRef1944
Marc S. Rendell, Lois Jovanovic. (2006) Targeting postprandial hyperglycemia. Metabolism 55:9, 1263-1281
CrossRef1945
K. Borodulin, J. Tuomilehto, M. Peltonen, T. A. Lakka, J. Sundvall, P. Jousilahti. (2006) Association of leisure time physical activity and abdominal obesity with fasting serum insulin and 2-h postchallenge plasma glucose levels. Diabetic Medicine 23:9, 1025-1028
CrossRef1946
Marie-Hélène Pesant, Jean-Patrice Baillargeon. (2006) Comparing rosiglitazone with ethinylestradiol/cyproterone acetate in the treatment of polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology 1:1, 81-92
CrossRef1947
Juliet M. Mancino. (2006) Orlistat: Current issues for patients with type 2 diabetes. Current Diabetes Reports 6:5, 389-394
CrossRef1948
J.I. Mann. (2006) Nutrition Recommendations for the Treatment and Prevention of Type 2 Diabetes and the Metabolic Syndrome: An Evidenced-Based Review. Nutrition Reviews 64:9, 422-427
CrossRef1949
GF Watts, DC Chan, EMM Ooi, PJ Nestel, LJ Beilin, PHR Barrett. (2006) FISH OILS, PHYTOSTEROLS AND WEIGHT LOSS IN THE REGULATION OF LIPOPROTEIN TRANSPORT IN THE METABOLIC SYNDROME: LESSONS FROM STABLE ISOTOPE TRACER STUDIES. Clinical and Experimental Pharmacology and Physiology 33:9, 877-882
CrossRef1950
Ruth McPherson, Jiri Frohlich, George Fodor, Jacques Genest. (2006) Canadian Cardiovascular Society position statement – Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Canadian Journal of Cardiology 22:11, 913-927
CrossRef1951
Patrick H. Dessein, Barry I. Joffe. (2006) Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis & Rheumatism 54:9, 2765-2775
CrossRef1952
Michelle D. Owens, Edith C. Kieffer, Farah M. Chowdhury. (2006) Preconception Care and Women with or at Risk for Diabetes: Implications for Community Intervention. Maternal and Child Health Journal 10:S1, 137-141
CrossRef1953
M. NORBERG, J. W. ERIKSSON, B. LINDAHL, C. ANDERSSON, O. ROLANDSSON, H. STENLUND, L. WEINEHALL. (2006) A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. Journal of Internal Medicine 260:3, 263-271
CrossRef1954
Preethi Srikanthan, Stanley Korenman, Susan Davis. (2006) Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?. Endocrinology & Metabolism Clinics of North America 35:3, 611-631
CrossRef1955
Valéria Lamounier-Zepter, Monika Ehrhart-Bornstein, Stefan R. Bornstein. (2006) Insulin resistance in hypertension and cardiovascular disease. Best Practice & Research Clinical Endocrinology & Metabolism 20:3, 355-367
CrossRef1956
K. A. NASER, A. GRUBER, G. A. THOMSON. (2006) The emerging pandemic of obesity and diabetes: are we doing enough to prevent a disaster?. International Journal of Clinical Practice 60:9, 1093-1097
CrossRef1957
N. Fine Olivarius, A. H. Andreasen, V. Siersma, B. Richelsen, H. Beck-Nielsen. (2006) Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus. Diabetologia 49:9, 2058-2067
CrossRef1958
Ak Viswanath, O Pereira, S Philip, KC Mchardy. (2006) Diagnosing diabetes mellitus: contemporary use of the oral glucose tolerance test in a regional diabetes centre. Practical Diabetes International 23:7, 287-290
CrossRef1959
Kenneth L McCall, Deeatra Craddock, Krystal Edwards. (2006) Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers on the Rate of New-Onset Diabetes Mellitus: A Review and Pooled Analysis. Pharmacotherapy 26:9, 1297-1306
CrossRef1960
P. E. Heldgaard, S. J. Griffin. (2006) Routinely collected general practice data aids identification of people with hyperglycaemia and metabolic syndrome. Diabetic Medicine 23:9, 996-1002
CrossRef1961
Martin C. Gulliford, Judith Charlton, Radoslav Latinovic. (2006) Predictive validity of different definitions of hypertension for type 2 diabetes. Diabetes/Metabolism Research and Reviews 22:5, 361-366
CrossRef1962
Tamara Darsow, David Kendall, David Maggs. (2006) Is the metabolic syndrome a real clinical entity and should it receive drug treatment?. Current Diabetes Reports 6:5, 357-364
CrossRef1963
David Virsaladze. (2006) Wide Clinical Implementation of Insulin Resistance Syndrome?. Metabolic Syndrome and Related Disorders 4:3, 165-171
CrossRef1964
Graydon S. Meneilly. (2006) Diabetes in the Elderly. Medical Clinics of North America 90:5, 909-923
CrossRef1965
Kathleen V Fitch, Ellen J Anderson, Jane L Hubbard, Sara J Carpenter, William R Waddell, Angela M Caliendo, Steven K Grinspoon. (2006) Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome. AIDS 20:14, 1843-1850
CrossRef1966
Massimo Massi-Benedetti. (2006) Changing targets in the treatment of type 2 diabetes. Current Medical Research and Opinion 22:s2, S5-S13
CrossRef1967
O. E. Johansen, K. I. Birkeland, E. Brustad, E. Aaser, A. K. Lindahl, R. Midha, T. Ueland, P. Aukrust, L. Gullestad. (2006) Undiagnosed dysglycaemia and inflammation in cardiovascular disease. European Journal of Clinical Investigation 36:8, 544-551
CrossRef1968
Bart Staels. (2006) Metformin and pioglitazone: effectively treating insulin resistance. Current Medical Research and Opinion 22:s2, S27-S37
CrossRef1969
Patrick Mathieu, Philippe Pibarot, Jean-Pierre Despres. (2006) Metabolic syndrome: the danger signal in atherosclerosis. Vascular Health and Risk Management 2:3, 285-302
CrossRef1970
A. W. K. Tso, P. C. Sham, N. M. S. Wat, A. Xu, B. M. Y. Cheung, R. Rong, C. H. Y. Fong, J. Y. Xu, K. K. Y. Cheng, E. D. Janus, K. S. L. Lam. (2006) Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study. Diabetologia 49:8, 1806-1815
CrossRef1971
So Hun Kim, Suk Jeong Lee, Eun Seok Kang, Shinae Kang, Kyu Yeon Hur, Hyun Joo Lee, Chul Woo Ahn, Bong Soo Cha, Ji Soo Yoo, Hyun Chul Lee. (2006) Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism 55:8, 1053-1059
CrossRef1972
Kathy Love-Osborne, Nancy Butler, Dexiang Gao, Phil Zeitler. (2006) Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes. Pediatric Diabetes 7:4, 205-210
CrossRef1973
David M. Webb, Matthew Wintle, James K. Malone. (2006) Exenatide effects on glucose metabolism and metabolic disorders common to overweight and obese patients with type 2 diabetes. Drug Development Research 67:8, 666-676
CrossRef1974
D A Davis, D M Pellowski, D A Davis, W T Donahoo. (2006) Acute and 1-month effect of small-volume suction lipectomy on insulin sensitivity and cardiovascular risk. International Journal of Obesity 30:8, 1217-1222
CrossRef1975
G. Derosa, A. D'Angelo, P. D. Ragonesi, L. Ciccarelli, M. N. Piccinni, F. Pricolo, S. A. T. Salvadeo, L. Montagna, A. Gravina, I. Ferrari, S. Paniga, A. F. G. Cicero. (2006) Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome. Journal of Clinical Pharmacy and Therapeutics 31:4, 375-383
CrossRef1976
Adam Gilden Tsai, Thomas A. Wadden. (2006) The Evolution of Very-Low-Calorie Diets: An Update and Meta-analysis*. Obesity 14:8, 1283-1293
CrossRef1977
Catherine A. Sarkisian, Sara M. Shunkwiler, Iris Aguilar, Alison A. Moore. (2006) Ethnic Differences in Expectations for Aging Among Older Adults. Journal of the American Geriatrics Society 54:8, 1277-1282
CrossRef1978
C-S KUO, D. PEI, C-Y YAO, M-C HSIEH, S-W KUO. (2006) Effect of orlistat in overweight poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study. International Journal of Clinical Practice 60:8, 906-910
CrossRef1979
D. M. Nathan, J. B. Buse, M. B. Davidson, R. J. Heine, R. R. Holman, R. Sherwin, B. Zinman. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 49:8, 1711-1721
CrossRef1980
I. Mühlhauser, J. Kasper, G. Meyer, . (2006) Understanding of diabetes prevention studies: questionnaire survey of professionals in diabetes care. Diabetologia 49:8, 1742-1746
CrossRef1981
R. Colagiuri, S. Colagiuri, D. Yach, S. Pramming. (2006) The Answer to Diabetes Prevention: Science, Surgery, Service Delivery, or Social Policy?. American Journal of Public Health 96:9, 1562-1569
CrossRef1982
C. Kim, B. P. Tabaei, R. Burke, L. N. McEwen, R. W. Lash, S. L. Johnson, K. L. Schwartz, S. J. Bernstein, W. H. Herman. (2006) Missed Opportunities for Type 2 Diabetes Mellitus Screening Among Women With a History of Gestational Diabetes Mellitus. American Journal of Public Health 96:9, 1643-1648
CrossRef1983
Florez, Jose C., Jablonski, Kathleen A., Bayley, Nick, Pollin, Toni I., de Bakker, Paul I.W., Shuldiner, Alan R., Knowler, William C., Nathan, David M., Altshuler, David, . (2006) TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program. New England Journal of Medicine 355:3, 241-250
Full Text1984
Rijk O.B. Gans. (2006) The Metabolic Syndrome, Depression, and Cardiovascular Disease: Interrelated Conditions that Share Pathophysiologic Mechanisms. Medical Clinics of North America 90:4, 573-591
CrossRef1985
GABRIEL Q. SHAIBI, MARTHA L. CRUZ, GEOFF D. C. BALL, MARC J. WEIGENSBERG, GEORGE J. SALEM, NOE C. CRESPO, MICHAEL I. GORAN. (2006) Effects of Resistance Training on Insulin Sensitivity in Overweight Latino Adolescent Males. Medicine & Science in Sports & Exercise 38:7, 1208-1215
CrossRef1986
Michael L. Lydic, Margaret McNurlan, Shirley Bembo, Lina Mitchell, Eugene Komaroff, Marie Gelato. (2006) Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome. Fertility and Sterility 86:1, 243-246
CrossRef1987
Faryle Nothwehr, Linda Snetselaar, Jingzhen Yang, Haotong Wu. (2006) Stage of Change for Healthful Eating and Use of Behavioral Strategies. Journal of the American Dietetic Association 106:7, 1035-1041
CrossRef1988
Prabhakaran Balagopal. (2006) Obesity-Related Cardiovascular Risk in Children and the Role of Lifestyle Changes. Journal of the CardioMetabolic Syndrome 1:4, 269-276
CrossRef1989
Michaela Diamant, Maarten E. Tushuizen. (2006) The metabolic syndrome and endothelial dysfunction: Common highway to type 2 diabetes and CVD?. Current Diabetes Reports 6:4, 279-286
CrossRef1990
Agnieszka Behn, Ehud Ur. (2006) The obesity epidemic and its cardiovascular consequences. Current Opinion in Cardiology 21:4, 353-360
CrossRef1991
Joel G. Ray. (2006) Metabolic syndrome and higher risk of maternal placental syndromes and cardiovascular disease. Drug Development Research 67:7, 607-611
CrossRef1992
David K. Murdock, Karen J. Olson, Ryan M. Juza, Bryan L. Hendricks. (2006) Effect of Body Mass Index on Insulin Resistance and Lipids in Prepubertal and Postpubertal Children: SCHOOL Observations. Journal of the CardioMetabolic Syndrome 1:4, 242-247
CrossRef1993
J Lord, R Thomas, B Fox, U Acharya, T Wilkin. (2006) The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome-a randomised, double-blind, placebo-controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology 113:7, 817-824
CrossRef1994
Johannes B. Ruige, Ilse L. Mertens, Ellen Bartholomeeusen, Eveline Dirinck, Ele Ferrannini, Luc F. Van Gaal. (2006) Fasting-based Estimates of Insulin Sensitivity in Overweight and Obesity: A Critical Appraisal*. Obesity 14:7, 1250-1256
CrossRef1995
John E. Gerich, Hans J. Woerle. (2006) Clinical significance of postprandial hyperglycemia. Drug Development Research 67:7, 587-590
CrossRef1996
B. J. GOLDSTEIN. (2006) Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?. International Journal of Clinical Practice 60:7, 873-883
CrossRef1997
Mala Puri, Joseph T. Flynn. (2006) Management of Hypertension in Children and Adolescents With the Metabolic Syndrome. Journal of the CardioMetabolic Syndrome 1:4, 259-268
CrossRef1998
Irina Chazova, Vladimir A. Almazov, Evgeny Shlyakhto. (2006) Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin. Diabetes, Obesity and Metabolism 8:4, 456-465
CrossRef1999
J. Radziuk, S. Pye. (2006) Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?. Diabetologia 49:7, 1619-1628
CrossRef2000
Lenore J. Launer. (2006) Prevention of AD: the Which, When, and on Whom?. Alzheimer Disease & Associated Disorders 20:Supplement 2, S75-S78
CrossRef2001
M R Skilton, D S Celermajer. (2006) Endothelial dysfunction and arterial abnormalities in childhood obesity. International Journal of Obesity 30:7, 1041-1049
CrossRef2002
Gunnar Kaati, Lars-Olov Bygren, Monica Vester, AnnBrith Karlsson, Michael Sjöström. (2006) Outcomes of comprehensive lifestyle modification in inpatient setting. Patient Education and Counseling 62:1, 95-103
CrossRef2003
R. G. Josse, A. J. Mcguire, G. B. Saal. (2006) A review of the economic evidence for acarbose in the prevention of diabetes and cardiovascular events in individuals with impaired glucose tolerance. International Journal of Clinical Practice 60:7, 847-855
CrossRef2004
C. Tissa Kappagoda, Amy Ma, Douglas A. Cort, Linda Paumer, Debbie Lucus, Jill Burns, Ezra Amsterdam. (2006) Cardiac event rate in a lifestyle modification program for patients with chronic coronary artery disease. Clinical Cardiology 29:7, 317-321
CrossRef2005
Sverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, Gordon T McInnes, Tsushung Hua, Michael A Weber, Antonio Coca, Steffan Ekman, Xavier Girerd, Kenneth Jamerson, Pierre Larochelle, Thomas M MacDonald, Roland E Schmieder, M Anthony Schork, Pelle Stolt, Reuven Viskoper, Jiri Widimský, Alberto Zanchetti. (2006) Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial. Journal of Hypertension 24:7, 1405-1412
CrossRef2006
A RAMACHANDRAN, C SNEHALATHA, B MUKESH, M SIMON, C KUMAR, V VIJAY. (2006) Persistent impaired glucose tolerance has similar rate of risk factors as for diabetes—Results of Indian Diabetes Prevention Programme (IDPP). Diabetes Research and Clinical Practice 73:1, 100-103
CrossRef2007
Miriam Promintzer, Michael Krebs. (2006) Effects of dietary protein on glucose homeostasis. Current Opinion in Clinical Nutrition and Metabolic Care 9:4, 463-468
CrossRef2008
P RUTKOWSKI, A KLASSEN, K SEBEKOVA, U BAHNER, A HEIDLAND. (2006) Renal Disease in Obesity: The Need for Greater Attention. Journal of Renal Nutrition 16:3, 216-223
CrossRef2009
André Scheen. 2006. Diabetes, Obesity, and Metabolic Syndrome. , 1-30.
CrossRef2010
Kurt E. Hersberger, Andrea Botomino, Maxime Mancini, Rudolf Bruppacher. (2006) Sequential screening for diabetes—evaluation of a campaign in Swiss community pharmacies. Pharmacy World and Science 28:3, 171-179
CrossRef2011
Anne E Sumner. (2006) The health consequences in African–Americans of each component of the metabolic syndrome. Future Lipidology 1:3, 283-289
CrossRef2012
Gary W. Small, Daniel H. S. Silverman, Prabha Siddarth, Linda M. Ercoli, Karen J. Miller, Helen Lavretsky, Benjamin C. Wright, Susan Y. Bookheimer, Jorge R. Barrio, Michael E. Phelps. (2006) Effects of a 14-Day Healthy Longevity Lifestyle Program on Cognition and Brain Function. American Journal of Geriatric Psychiatry 14:6, 538-545
CrossRef2013
James F. Clapp. (2006) Effects of Diet and Exercise on Insulin Resistance during Pregnancy. Metabolic Syndrome and Related Disorders 4:2, 84-90
CrossRef2014
Lionel S. Lim, Darryl S. Chutka. (2006) Preventive medicine beyond 65. Geriatrics and Gerontology International 6:2, 73-81
CrossRef2015
Julia Warren-Ulanch, Silva Arslanian. (2006) Treatment of PCOS in adolescence. Best Practice & Research Clinical Endocrinology & Metabolism 20:2, 311-330
CrossRef2016
Natalia Vukshich Oster, Verna Welch, Laura Schild, Julie A. Gazmararian, Kimberly Rask, Claire Spettell. (2006) Differences in Self-Management Behaviors and Use of Preventive Services among Diabetes Management Enrollees by Race and Ethnicity. Disease Management 9:3, 167-175
CrossRef2017
S. P. Wallace. (2006) EVIDENCE-BASED POLICY AND PRACTICE: PROSPECTS AND PERILS. The Gerontologist 46:3, 409-413
CrossRef2018
S BONINGUILLAUME, F HERRMANN, D BOILLAT, I SZANTO, J MICHEL, F ROHNERJEANRENAUD, U VISCHER. (2006) Insulinemia and leptinemia or of undernutrition in geriatric patients: markers of the metabolic syndrome or of undernutrition?. Diabetes & Metabolism 32:3, 236-243
CrossRef2019
John P. Thyfault, R. Scott Rector, Robert C. Noland. (2006) Metabolic Inflexibility in Skeletal Muscle: A Prelude to the Cardiometabolic Syndrome?. Journal of the CardioMetabolic Syndrome 1:3, 184-189
CrossRef2020
Kathleen M. Hoeger. (2006) Role of lifestyle modification in the management of polycystic ovary syndrome. Best Practice & Research Clinical Endocrinology & Metabolism 20:2, 293-310
CrossRef2021
F. Xavier Pi-Sunyer. (2006) Use of Lifestyle Changes Treatment Plans and Drug Therapy in Controlling Cardiovascular and Metabolic Risk Factors. Obesity 14:6s, 135S-142S
CrossRef2022
Edward Kwok-Ho Hui, Laurence Z. Rubenstein. (2006) Promoting Physical Activity and Exercise in Older Adults. Journal of the American Medical Directors Association 7:5, 310-314
CrossRef2023
Matthew J. Gurka, Anne M. Wolf, Mark R. Conaway, Jayne Q. Crowther, Jerry L. Nadler, Viktor E. Bovbjerg. (2006) Lifestyle Intervention in Obese Patients with Type 2 Diabetes: Impact of the Patient’s Educational Background*. Obesity 14:6, 1085-1092
CrossRef2024
Susmeeta T. Sharma, John E. Nestler. (2006) Prevention of diabetes and cardiovascular disease in women with PCOS: Treatment with insulin sensitizers. Best Practice & Research Clinical Endocrinology & Metabolism 20:2, 245-260
CrossRef2025
Lawrence A. Leiter. (2006) Can thiazolidinediones delay disease progression in type 2 diabetes?. Current Medical Research and Opinion 22:6, 1193-1201
CrossRef2026
Sung Hee Um, David D'Alessio, George Thomas. (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metabolism 3:6, 393-402
CrossRef2027
Thomas Songer, Judith Glazner, Laura P Coombs, Leona Cuttler, Mary Daniel, Silvia Estrada, Georgeanna Klingensmith, Andrea Kriska, Lori Laffel, Ping Zhang. (2006) Examining the economic costs related to lifestyle and pharmacological interventions in youth with Type 2 diabetes. Expert Review of Pharmacoeconomics & Outcomes Research 6:3, 315-324
CrossRef2028
Shih-Pei Chang, Yu-Hsuan Chen, Weng-Cheng Chang, I-Min Liu, Juei-Tang Cheng. (2006) Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats. Life Sciences 79:3, 240-246
CrossRef2029
M Dumortier, J F Brun, J Mercier. (2006) Response to Fogelholm. International Journal of Obesity 30:6, 1022-1023
CrossRef2030
ANDREA M. KRISKA, SHARON L. EDELSTEIN, RICHARD F. HAMMAN, AMY OTTO, GEORGE A. BRAY, ELIZABETH J. MAYER-DAVIS, RENA R. WING, EDWARD S. HORTON, STEVEN M. HAFFNER, JUDITH G. REGENSTEINER. (2006) Physical Activity in Individuals at Risk for Diabetes. Medicine & Science in Sports & Exercise 38:5, 826-832
CrossRef2031
A. Wirth. (2006) Medikamentöse Therapie der Adipositas. Der Diabetologe 2:3, 233-242
CrossRef2032
(2006) The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It*. Obesity 14:5, 737-752
CrossRef2033
Nadia A. Khan, Finlay A. McAlister, Simon W. Rabkin, Raj Padwal, Ross D. Feldman, Norman R.C. Campbell, Lawrence A. Leiter, Richard Z. Lewanczuk, Ernesto L. Schiffrin, Michael D. Hill, Malcolm Arnold, Gordon Moe, Tavis S. Campbell, Carol Herbert, Alain Milot, James A. Stone, Ellen Burgess, B. Hemmelgarn, Charlotte Jones, Pierre Larochelle, Richard I. Ogilvie, Robyn Houlden, Robert J. Herman, Pavel Hamet, George Fodor, George Carruthers, Bruce Culleton, Jacques deChamplain, George Pylypchuk, Alexander G. Logan, Norm Gledhill, Robert Petrella, Sheldon Tobe, Rhian M. Touyz. (2006) The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II – Therapy. Canadian Journal of Cardiology 22:7, 583-593
CrossRef2034
Jerrilynn D. Burrowes. (2006) Metabolic Syndrome. Nutrition Today 41:3, 131-137
CrossRef2035
Anne-Helen Harding, Simon J. Griffin, Nicholas J. Wareham. (2006) Population impact of strategies for identifying groups at high risk of type 2 diabetes. Preventive Medicine 42:5, 364-368
CrossRef2036
, N. G. Forouhi, B. Balkau, K. Borch-Johnsen, J. Dekker, C. Glumer, Q. Qiao, A. Spijkerman, R. Stolk, A. Tabac, N. J. Wareham. (2006) The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia 49:5, 822-827
CrossRef2037
G PARTIDAHERNANDEZ, F ARREOLA, B FENTON, M CABEZA, R ROMANRAMOS, M REVILLAMONSALVE. (2006) Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomedecine & Pharmacotherapy 60:4, 161-168
CrossRef2038
K. G. M. M. Alberti, P. Zimmet, J. Shaw. (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine 23:5, 469-480
CrossRef2039
J Robinson Singleton, A Gordon Smith. (2006) Therapy Insight: neurological complications of prediabetes. Nature Clinical Practice Neurology 2:5, 276-282
CrossRef2040
Stuart T Haines, Dawn C Fuke, Dan Lender, Philip T Rodgers, Suzanne K Sysko. (2006) Evaluating and Treating Cardiometabolic Risk Factors: A Case Discussion. Pharmacotherapy 26:5part2, 32S-41S
CrossRef2041
Philip T Rodgers, Dawn C Fuke. (2006) New and Emerging Strategies for Reducing Cardiometabolic Risk Factors. Pharmacotherapy 26:5part2, 13S-31S
CrossRef2042
R. K. Simmons, A.-H. Harding, R. W. Jakes, A. Welch, N. J. Wareham, S. J. Griffin. (2006) How much might achievement of diabetes prevention behaviour goals reduce the incidence of diabetes if implemented at the population level?. Diabetologia 49:5, 905-911
CrossRef2043
Mary Ann Banerji, Robyn B. Stewart. (2006) A public health approach to the diabetes epidemic: New York city’s diabetes registry. Current Diabetes Reports 6:3, 169-171
CrossRef2044
José F. Cara, Rochelle L. Chaiken. (2006) Type 2 diabetes and the metabolic syndrome in children and adolescents. Current Diabetes Reports 6:3, 241-250
CrossRef2045
Stuart T Haines. (2006) Introduction: Addressing Cardiometabolic Risk. Pharmacotherapy 26:5part2, 1S-2S
CrossRef2046
David Eddy. (2006) Bringing Health Economic Modeling to the 21st Century. Value in Health 9:3, 168-178
CrossRef2047
Curtis Triplitt, Ralph A DeFronzo. (2006) Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitus. Expert Review of Endocrinology & Metabolism 1:3, 329-341
CrossRef2048
J OLDROYD, N UNWIN, M WHITE, J MATHERS, K ALBERTI. (2006) Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Research and Clinical Practice 72:2, 117-127
CrossRef2049
J. Lindström, M. Peltonen, J. G. Eriksson, A. Louheranta, M. Fogelholm, M. Uusitupa, J. Tuomilehto. (2006) High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 49:5, 912-920
CrossRef2050
Harold E. Lebovitz. (2006) Insulin resistance - a common link between type 2 diabetes and cardiovascular disease. Diabetes, Obesity and Metabolism 8:3, 237-249
CrossRef2051
Michael Roden. (2006) Diabetes mellitus. Wiener klinische Wochenschrift Education 1:1, 19-30
CrossRef2052
A. Gruber, K. Nasser, R. Smith, J. C. Sharma, G. A. Thomson. (2006) Diabetes prevention: is there more to it than lifestyle changes?. International Journal of Clinical Practice 60:5, 590-594
CrossRef2053
Samy I. McFarlane, Tanja Rundek, John Nicasio, Mrunalini Deshmukh, James R. Sowers. (2006) The dream trial and the prospect of diabetes prevention. Current Diabetes Reports 6:3, 205-206
CrossRef2054
W. A. Cutchie, N. W. Cheung, D. Simmons. (2006) Comparison of international and New Zealand guidelines for the care of pregnant women with diabetes. Diabetic Medicine 23:5, 460-468
CrossRef2055
Yi-Jen Hung, Shih-Hua Lin, Dee Pei, Shi-Wen Kuo, Chang-Hsun Hsieh, Chih-Tsueng He, Chien Hsing Lee, Sandra Chyi Fan, Wayne Huey-Herng Sheu. (2006) Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein. Metabolism 55:4, 439-444
CrossRef2056
Annette K. Low, Marshall J. Bouldin, Caryl D. Sumrall, Fleetwood V. Loustalot, Kelly K. Land. (2006) A Clinician???s Approach to Medical Management of Obesity. The American Journal of the Medical Sciences 331:4, 175-182
CrossRef2057
R LLANESDETORRES. (2006) Prediabetes en atención primaria: diagnóstico... ¿y tratamiento?. Atención Primaria 37:7, 400-406
CrossRef2058
J-P Després, I Lemieux, N Alméras. (2006) Contribution of CB1 blockade to the management of high-risk abdominal obesity. International Journal of Obesity 30, S44-S52
CrossRef2059
Hanno Pijl, Johannes A Romijn. (2006) Obesity, dopamine and the metabolic syndrome: potential of dopaminergic agents in the control of metabolism. Current Opinion in Endocrinology & Diabetes 13:2, 179-184
CrossRef2060
Charles J. Glueck, John A. Morrison, Lisa Aronson Friedman, Naila Goldenberg, Davis M. Stroop, Ping Wang. (2006) Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism 55:4, 508-514
CrossRef2061
Miles Fisher. (2006) Cardiometabolic disease: the new challenge?. Practical Diabetes International 23:3, 95-97
CrossRef2062
Judith McDevitt, JoEllen Wilbur. (2006) Exercise and People with Serious, Persistent Mental Illness. AJN, American Journal of Nursing 106:4, 50-54
CrossRef2063
Tamara S Hannon, Silva A Arslanian. (2006) Obesity and type 2 diabetes mellitus in adolescents: what is new?. Current Opinion in Endocrinology & Diabetes 13:2, 111-118
CrossRef2064
Anthony N. Fabricatore, Thomas A. Wadden. (2006) Obesity. Annual Review of Clinical Psychology 2:1, 357-377
CrossRef2065
Scott M. Grundy. (2006) Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nature Reviews Drug Discovery 5:4, 295-309
CrossRef2066
Cynthia Cheng, Harvey Kushner, Bonita E. Falkner. (2006) The utility of fasting glucose for detection of prediabetes. Metabolism 55:4, 434-438
CrossRef2067
J MANN, D TIPENELEACH, H PAHAU, N JOSEPH, S ABEL, K MCAULEY, K COPPELL, C BOOKER, S WILLIAMS. (2006) Insulin resistance and impaired glucose metabolism in a predominantly Maori community
CrossRef2068
Kaberi Dasgupta, Steven A. Grover, Deborah Da Costa, Ilka Lowensteyn, Jean-François Yale, Elham Rahme. (2006) Impact of modified glucose target and exercise interventions on vascular risk factors. Diabetes Research and Clinical Practice 72:1, 53-60
CrossRef2069
Trudi Deakin. (2006) Patient-centred weight loss programmes. Practical Diabetes International 23:3, 100-100
CrossRef2070
Jaan E. Sidorov, Karen Fitzner. (2006) Obesity Disease Management Opportunities and Barriers*. Obesity 14:4, 645-649
CrossRef2071
J BRIMBLECOMBE, D MACKERRAS, J GARNGGULKPUY, E MAYPILAMA, L BUNDHALA, R DHURRKAY, J FITZ, L MAPLEBROWN, T SHEMESH, K ROWLEY. (2006) Leanness and type 2 diabetes in a population of indigenous Australians. Diabetes Research and Clinical Practice 72:1, 93-99
CrossRef2072
Michelle Asp, Li-Fen Liu, Angela Collene, Martha Belury, Celeste Koster, Aparna Purushotham, Angela Wendel, Gayle Shrode. 2006. Is There a Role for Conjugated Linoleic Acid to Aid in the Prevention of Type 2 Diabetes?. , 263-273.
CrossRef2073
Lynda J. GILLEN, Linda C. TAPSELL. (2006) Development of food groupings to guide dietary advice for people with diabetes. Nutrition <html_ent glyph="@amp;" ascii="&"/> Dietetics 63:1, 36-47
CrossRef2074
Nazario Melchionda, Gabriele Forlani, Lucia La Rovere, Paola Argnani, Fausto Trevisani, Donato Zocchi, Giandomenico Savorani, Anna Covezzoli, Marisa De Rosa, Giulio Marchesini. (2006) Disease Management of the Metabolic Syndrome in a Community: Study Design and Process Analysis on Baseline Data. Metabolic Syndrome and Related Disorders 4:1, 7-16
CrossRef2075
M Petersen, M A Taylor, W H M Saris, C Verdich, S Toubro, I Macdonald, S Rössner, V Stich, B Guy-Grand, D Langin, J A Martinez, O Pedersen, C Holst, T I A Sørensen, A Astrup. (2006) Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high- versus low-fat content. International Journal of Obesity 30:3, 552-560
CrossRef2076
Marie Clark. (2006) ‘The long and winding road…’. Practical Diabetes International 23:2, 69-74
CrossRef2077
Juan Liu, T. Kue Young, Bernard Zinman, Stewart B. Harris, Philip W. Connelly, Anthony J.G. Hanley. (2006) Lifestyle Variables, Non-traditional Cardiovascular Risk Factors, and the Metabolic Syndrome in an Aboriginal Canadian Population*. Obesity 14:3, 500-508
CrossRef2078
Shari S. Bassuk, Jo Ann E. Manson. 2006. Overview of the Obesity Epidemic and Its Relationship to Cardiovascular Disease. , 1-32.
CrossRef2079
Leslie-Faith Morritt Taub. (2006) Concordance of provider recommendations with American Diabetes Association's Guidelines. Journal of the American Academy of Nurse Practitioners 18:3, 124-133
CrossRef2080
George L. Blackburn, Daniel B. Jones. (2006) Effective surgical treatment of diabetes for the obese patient. Current Diabetes Reports 6:2, 85-87
CrossRef2081
David F. Blackburn, Thomas W. Wilson. (2006) Antihypertensive medications and blood sugar: Theories and implications. Canadian Journal of Cardiology 22:3, 229-233
CrossRef2082
Scott M. Grundy. (2006) Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds. Journal of the American College of Cardiology 47:6, 1093-1100
CrossRef2083
Greeshma K. Shetty, Christos S. Mantzoros. 2006. Insulin Resistance, Obesity, Body Fat Distribution, and Risk of Cardiovascular Disease. , 51-74.
CrossRef2084
Mikael Fogelholm, Bente Stallknecht, Marleen Van Baak. (2006) ECSS position statement: Exercise and obesity. European Journal of Sport Science 6:1, 15-24
CrossRef2085
Giulio Marchesini, Rebecca Marzocchi, Riccardo Dalle Grave. (2006) Outcome research in obesity: lessons from the QUOVADIS study. Drug Development Research 67:3, 260-270
CrossRef2086
E M Östman, A H Frid, L C Groop, I M E Björck. (2006) A dietary exchange of common bread for tailored bread of low glycaemic index and rich in dietary fibre improved insulin economy in young women with impaired glucose tolerance. European Journal of Clinical Nutrition 60:3, 334-341
CrossRef2087
Abby G. Ershow, Rebecca B. Costello. (2006) Dietary guidance in heart failure: a perspective on needs for prevention and management. Heart Failure Reviews 11:1, 7-12
CrossRef2088
G. Derosa, A. V. Gaddi, M. N. Piccinni, S. Salvadeo, L. Ciccarelli, E. Fogari, M. Ghelfi, I. Ferrari, A. F. G. Cicero. (2006) Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. Diabetes, Obesity and Metabolism 8:2, 197-205
CrossRef2089
Lalita Khaodhiar, Karen C McCowen, George L Blackburn. 2006. Risk Assessment and Treatment Standards of Obesity and Overweight in Relation to Cardiovascular Disease. , 225-256.
CrossRef2090
Rena R Wing, Douglas A Raynor. 2006. Lifestyle Modification in the Obese Patient with Cardiovascular Disease. , 301-322.
CrossRef2091
N. P. Hays, R. D. Starling, D. H. Sullivan, J. D. Fluckey, R. H. Coker, R. H. Williams, W. J. Evans. (2006) Effects of an Ad Libitum, High Carbohydrate Diet and Aerobic Exercise Training on Insulin Action and Muscle Metabolism in Older Men and Women. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:3, 299-304
CrossRef2092
Teresa Caulin-Glaser, James M Falko. (2006) Effects of cardiac rehabilitation on lipoprotein abnormalities in patients with Type 2 diabetes mellitus and metabolic syndrome. Future Lipidology 1:1, 65-73
CrossRef2093
Ryan E. Rhodes, Chris M. Blanchard, Deborah Hunt Matheson. (2006) A multicomponent model of the theory of planned behaviour. British Journal of Health Psychology 11:1, 119-137
CrossRef2094
A. Ramachandran, C. Snehalatha, S. Mary, B. Mukesh, A. D. Bhaskar, V. Vijay, . (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:2, 289-297
CrossRef2095
Victor Wong, Laura Stavar, Linda Szeto, Kristine Uffelman, Chao-Hung Wang, I George Fantus, Gary F. Lewis. (2006) Atorvastatin induces insulin sensitization in Zucker lean and fatty rats. Atherosclerosis 184:2, 348-355
CrossRef2096
David C.W. Lau, Hongyun Yan, Bikramjit Dhillon. (2006) Metabolic syndrome: A marker of patients at high cardiovascular risk. Canadian Journal of Cardiology 22, 85B-90B
CrossRef2097
M. Lankisch, R. Füth, D. Schotes, B. Rose, H. Lapp, W. Rathmann, B. Haastert, H. Gülker, W. A. Scherbaum, Stephan Martin. (2006) High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clinical Research in Cardiology 95:2, 80-87
CrossRef2098
Felicia Hill-Briggs, Tiffany L. Gary, Hsin-Chieh Yeh, Marian Batts-Turner, Neil R. Powe, Christopher D. Saudek, Frederick L. Brancati. (2006) Association of Social Problem Solving With Glycemic Control in a Sample of Urban African Americans With Type 2 Diabetes. Journal of Behavioral Medicine 29:1, 69-78
CrossRef2099
Geoffrey C. Farrell, Claire Z. Larter. (2006) Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 43:S1, S99-S112
CrossRef2100
L CHEN, M LIN, Z CHEN, S HWANG, S TSAI, S CHIOU. (2006) Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese. Diabetes Research and Clinical Practice 71:2, 170-176
CrossRef2101
Agnes E. Coutinho, Sergiu Fediuc, Jonathan E. Campbell, Michael C. Riddell. (2006) Metabolic effects of voluntary wheel running in young and old Syrian golden hamsters. Physiology & Behavior 87:2, 360-367
CrossRef2102
, M. Peyrot, R. R. Rubin, T. Lauritzen, S. E. Skovlund, F. J. Snoek, D. R. Matthews, R. Landgraf. (2006) Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study. Diabetologia 49:2, 279-288
CrossRef2103
An Jeffery, BS Metcalf, J Hosking, Ld Voss, Tj Wilkin. (2006) Obesity-linked insulin resistance in children — an emerging problem. European Diabetes Nursing 3:1, 41-45
CrossRef2104
W. Dallas Hall, Laurence O. Watkins, Jackson T. Wright, Nanette K. Wenger, Shiriki K. Kumanyika, James R. Gavin, Keith C. Ferdinand, Karol Watson, Luther T. Clark, John M. Flack, James W. Reed, Ella W. Horton, Elijah Saunders. (2006) The Metabolic Syndrome: Recognition and Management. Disease Management 9:1, 16-33
CrossRef2105
V. Lee Grotz. (2006) A Look at Food Industry Responses to the Rising Prevalence of Overweight. Nutrition Reviews 64, S48-S52
CrossRef2106
Antonio M. Gotto, George L. Blackburn, George E. Dailey, Alan J. Garber, Scott M. Grundy, Burton E. Sobel, Matthew R. Weir. (2006) The metabolic syndrome: a call to action. Coronary Artery Disease 17:1, 77-80
CrossRef2107
Danielle E. Lane. (2006) Polycystic Ovary Syndrome and Its Differential Diagnosis. Obstetrical & Gynecological Survey 61:2, 125-135
CrossRef2108
Judith Wylie-Rosett, William H Herman, Ronald B Goldberg. (2006) Lifestyle intervention to prevent diabetes: intensive AND cost effective. Current Opinion in Lipidology 17:1, 37-44
CrossRef2109
Judith K. Ockene. (2006) Fulfilling our assignment to improve the health of all: Good Science just isn’t enough. Annals of Behavioral Medicine 31:1, 14-20
CrossRef2110
Kitt Falk Petersen, Gerald I. Shulman. (2006) New Insights into the Pathogenesis of Insulin Resistance in Humans Using Magnetic Resonance Spectroscopy. Obesity 14:2S, 34S-40S
CrossRef2111
B. K. Pedersen, B. Saltin. (2006) Evidence for prescribing exercise as therapy in chronic disease. Scandinavian Journal of Medicine and Science in Sports 16:S1, 3-63
CrossRef2112
N FOROUHI. (2006) Epidemiology of diabetes. Medicine 34:2, 57-60
CrossRef2113
MC Riddell, KE Iscoe. (2006) Physical activity, sport, and pediatric diabetes. Pediatric Diabetes 7:1, 60-70
CrossRef2114
H. Hauner. (2006) Evidenzbasierte Therapie der Adipositas. Der Internist 47:2, 159-170
CrossRef2115
V Rimbert, C Montaurier, M Bedu, Y Boirie, B Morio. (2006) Behavioral and physiological regulation of body fatness: a cross-sectional study in elderly men. International Journal of Obesity 30:2, 322-330
CrossRef2116
Shiriki Kumanyika. (2006) Nutrition and Chronic Disease Prevention: Priorities for US Minority Groups. Nutrition Reviews 64, S9-S14
CrossRef2117
Kevin A. Deans, Naveed Sattar. (2006) "Anti-Inflammatory" Drugs and Their Effects on Type 2 Diabetes. Diabetes Technology & Therapeutics 8:1, 18-27
CrossRef2118
Alexandra Hauber, Edwin A. M. Gale. (2006) The market in diabetes. Diabetologia 49:2, 247-252
CrossRef2119
V PASCUALFUSTER. (2006) Nuevos conceptos en el tratamiento dietético del síndrome metabólico. Revista Clínica Española 206:2, 100-102
CrossRef2120
A. P. Jones. (2006) Understanding Diabetes Population Dynamics Through Simulation Modeling and Experimentation. American Journal of Public Health 96:3, 488-494
CrossRef2121
Cathy Nonas, Bantwal Suresh Baliga, Zachary Bloomgarden. 2006. Medical Nutrition Therapy For Patients With Type-2 Diabetes. , 81-104.
CrossRef2122
Robert Kushner, Julie Roth. 2006. Nutritional Strategies for Patients with Obesity and the Metabolic Syndrome. , 55-80.
CrossRef2123
Marilyn Valentine, Elliot Rayfield. 2006. Pathophysiology and Clinical Management of Diabetes and Prediabetes. , 15-44.
CrossRef2124
Jeffrey Mechanick, Elise Brett, Philip Rabito. 2006. Exercise, Nutrition, and Diabetes. , 297-311.
CrossRef2125
Donald Hensrud. 2006. Preventive Nutritional Strategies in Diabetic and Prediabetic Patients. , 45-54.
CrossRef2126
Marlene Schwartz, Ingrid Kohlstadt, Arline Salbe. 2006. Childhood Obesity. , 253-269.
CrossRef2127
R.M. van Dam. (2006) Coffee and type 2 diabetes: From beans to beta-cells. Nutrition, Metabolism and Cardiovascular Diseases 16:1, 69-77
CrossRef2128
(2006) Indian Health Service guidelines for care of adults with prediabetes and/or the metabolic syndrome in clinical settings
CrossRef2129
T FRITZ, P WANDELL, H ABERG, P ENGFELDT. (2006) Walking for exercise—does three times per week influence risk factors in type 2 diabetes?. Diabetes Research and Clinical Practice 71:1, 21-27
CrossRef2130
Wael A. AlJaroudi, John L. Petersen. (2006) Obesity, diabetes, and associated risk factors. Current Treatment Options in Cardiovascular Medicine 8:1, 67-78
CrossRef2131
Verna L Welch, Natalia Vukshich Oster, Julie A Gazmararian, Kimberly Rask, Laura Schild, Charles Cutler, Claire Spettell, Michael Reardon. (2006) Impact of a Diabetes Disease Management Program by Race and Ethnicity. Disease Management & Health Outcomes 14:4, 245-252
CrossRef2132
Jonathan A. Waitman, Louis J. Aronne. 2006. Medical Management of Uncomplicated Obesity. , 355-368.
CrossRef2133
Chidum Ezenwaka, Risha Kalloo, Nkechi Offiah, Juergen Eckel. (2006) Development of impaired glucose tolerance and diabetes in follow-up offspring of Caribbean patients with type 2 diabetes: Analysis of 5-year follow-up study. Archives Of Physiology And Biochemistry 112:3, 158-165
CrossRef2134
Duc Son Nguyen Trung Le, Kaoru Kusama, Shigeru Yamamoto. (2006) A Community-based Picture of Type 2 Diabetes Mellitus in Vietnam. Journal of Atherosclerosis and Thrombosis 13:1, 16-20
CrossRef2135
Alain Duclos, Lawrence M Flechner, Charles Faiman, Stuart M Flechner. (2006) Post-Transplant Diabetes Mellitus. Drugs & Aging 23:10, 781-793
CrossRef2136
D.A. de Luis, R. Aller, O. Izaola, M. Gonzalez Sagrado, R. Conde. (2006) Influence of <i>ALA54THR</i> Polymorphism of Fatty Acid Binding Protein 2 on Lifestyle Modification Response in Obese Subjects. Annals of Nutrition and Metabolism 50:4, 354-360
CrossRef2137
D. I. Shaw, W. L. Hall, C. M. Williams. 2006. Dietary fatty acids, insulin resistance and diabetes. , 25-48.
CrossRef2138
Deborah L. Burnet, Lorrie D. Elliott, Michael T. Quinn, Andrea J. Plaut, Mindy A. Schwartz, Marshall H. Chin. (2006) Preventing Diabetes in the Clinical Setting. Journal of General Internal Medicine 21:1, 84-93
CrossRef2139
S. R. Stannard, N. A. Johnson. (2006) Energy well spent fighting the diabetes epidemic. Diabetes/Metabolism Research and Reviews 22:1, 11-19
CrossRef2140
Jin Soon Hwang. (2006) Type 2 diabetes mellitus and metabolic syndrome. Korean Journal of Pediatrics 49:7, 710
CrossRef2141
Keith C. Ferdinand. (2006) Hypertension and the Cardiometabolic Syndrome?Is It the Blood Pressure Lowering or the Blood Pressure Medication That Is Important?. Journal of the CardioMetabolic Syndrome 1:1, 72-73
CrossRef2142
Kyung Wan Min, Sung Woo Park. (2006) Physical Activity and Type 2 Diabetes Mellitus. The Journal of Korean Diabetes Association 30:1, 1
CrossRef2143
Lisa J Moran, Grant Brinkworth, Manny Noakes, Robert J Norman. (2006) Effects of lifestyle modification in polycystic ovarian syndrome. Reproductive BioMedicine Online 12:5, 569-578
CrossRef2144
Lionel H Opie, Patrick J Commerford, Bernard J Gersh. (2006) Controversies in stable coronary artery disease. The Lancet 367:9504, 69-78
CrossRef2145
Phyllis A. Dennery. (2006) Introduction to serial review on the role of oxidative stress in diabetes mellitus. Free Radical Biology and Medicine 40:1, 1-2
CrossRef2146
Nicola Abate, Manisha Chandalia. (2006) Should all patients with metabolic syndrome be treated with statins?. Current Diabetes Reports 6:1, 72-76
CrossRef2147
Sherwyn Schwartz. (2006) Is There a Rationale for Insulin Therapy in Pre-Diabetic Individuals?. Treatments in Endocrinology 5:6, 385-393
CrossRef2148
Norman M Kaplan, Lionel H Opie. (2006) Controversies in hypertension. The Lancet 367:9505, 168-176
CrossRef2149
Donna H. Ryan. 2006. Pharmacologic Agents in the Treatment of Obesity. , 261-288.
CrossRef2150
Richard A. Bermudes, Anna Guerdjikova. 2006. Metabolic Syndrome: Overview and Relationship with Psychiatric Disorders. , 165-188.
CrossRef2151
Satoru Kodama, Shu Miao, Nobuhiro Yamada, Hirohito Sone. (2006) Exercise Training for Ameliorating Cardiovascular Risk Factors-focusing on Exercise Intensity and Amount. International Journal of Sport and Health Science 4, 325-338
CrossRef2152
Arthur V Everitt, Sarah N Hilmer, Jennie C Brand-Miller, Hamish A Jamieson, A Stewart Truswell, Anita P Sharma, Rebecca S Mason, Brian J Morris, David G Le Couteur. (2006) Dietary approaches that delay age-related diseases. Clinical Interventions in Aging 1:1, 11-31
CrossRef2153
DONNA A. WIRSHING, REBECCA A. SMITH, ZACHARY D. ERICKSON, SHIRLEY J. MENA, WILLIAM C. WIRSHING. (2006) A Wellness Class for Inpatients with Psychotic Disorders. Journal of Psychiatric Practice 12:1, 24-29
CrossRef2154
Edwin A. M. Gale. (2006) Troglitazone: the lesson that nobody learned?. Diabetologia 49:1, 1-6
CrossRef2155
David Aguilar, Scott D Solomon. (2006) ACE Inhibitors and Angiotensin Receptor Antagonists and the Incidence of New-Onset Diabetes Mellitus. Drugs 66:9, 1169-1177
CrossRef2156
Barry A Franklin. (2006) Walking: The Undervalued Prescription. Preventive Cardiology 9:1, 56-59
CrossRef2157
Patricia E. Case, Melinda M. Manore, Janice L. Thompson. (2006) Stemming the Tide. ACSM's Health & Fitness Journal 10:1, 7-13
CrossRef2158
Glen E. Duncan. (2006) Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome. Current Diabetes Reports 6:1, 29-35
CrossRef2159
N CHEUNG, D HELMINK. (2006) Gestational diabetesThe significance of persistent fasting hyperglycemia for the subsequent development of diabetes mellitus. Journal of Diabetes and its Complications 20:1, 21-25
CrossRef2160
Michele Colombo, Mogens Kruhoeffer, Soeren Gregersen, Andreas Agger, PerBendix Jeppesen, Torben Oerntoft, Kjeld Hermansen. (2006) Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis. Metabolism 55:1, 43-52
CrossRef2161
Rahul Pannala, Mark Kidd, Irvin M. Modlin. (2006) Surgery for Obesity: Panacea or Pandora’s Box?. Digestive Surgery 23:1-2, 1-11
CrossRef2162
Camila M. Manrique, Guido Lastra, John Palmer, Craig S. Stump, James R. Sowers. (2006) Hypertension?A Treatable Component of the Cardiometabolic Syndrome: Challenges for the Primary Care Physician. The Journal of Clinical Hypertension 8:s1, 12-20
CrossRef2163
Pablo Stiefel, María L. Miranda, Ovidio Muñiz, José Villar. (2006) Respuesta de los autores. Medicina Clínica 126:3, 117
CrossRef2164
Patrick G. O'Malley, Courtney Kowalczyk, Jody Bindeman, Allen J. Taylor. (2006) The Impact of Cardiovascular Risk Factor Case Management on the Metabolic Syndrome in a Primary Prevention Population: Results From a Randomized Controlled Trial. Journal of the CardioMetabolic Syndrome 1:1, 6-12
CrossRef2165
2006. Biguanides. , 506-515.
CrossRef2166
Berhart Hasbum, Jose T Real, Carlos S??nchez, Maria A Priego, Juan D??az, Angeles Viguer, Marisa Basanta, Jose Mart??nez-Valls, Julio Mar??n, Rafael Carmena, Juan F Ascaso. (2006) Effects of a Controlled Program of Moderate Physical Exercise on Insulin Sensitivity in Nonobese, Nondiabetic Subjects. Clinical Journal of Sport Medicine 16:1, 46-50
CrossRef2167
Leonie van Passel, Hiba Arif, Lawrence J Hirsch. (2006) Topiramate for the treatment of epilepsy and other nervous system disorders. Expert Review of Neurotherapeutics 6:1, 19-31
CrossRef2168
Carole B. Rudra, Michelle A. Williams, I-Min Lee, Raymond S. Miller, Tanya K. Sorensen. (2006) Perceived Exertion in Physical Activity and Risk of Gestational Diabetes Mellitus. Epidemiology 17:1, 31-37
CrossRef2169
Susan L. McElroy, Renu Kotwal. 2006. Behavioral Weight Management of Obese Patients with Mental Disorders. , 235-260.
CrossRef2170
H Tanaka, Y Shiohira, Y Uezu, A Higa, K Iseki. (2006) Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney International 69:2, 369-374
CrossRef2171
M. Loebe, K. Ramasubbu, D. J. Hamilton. (2006) Diabetes und Herztransplantation. Clinical Research in Cardiology 95:S1, i48-i53
CrossRef2172
Anne McTiernan. 2005. Physical Activity Intervention Studies in Humans. , 199-207.
CrossRef2173
Gail G. Harrison, Marjorie Kagawa-Singer, Susan B. Foerster, Henry Lee, Loan Pham Kim, Tu-Uyen Nguyen, Allyn Fernandez-Ami, Valerie Quinn, Dileep G. Bal. (2005) Seizing the moment. Cancer 104:S12, 2962-2968
CrossRef2174
Laura Lewis Frank. 2005. Exercise and Insulin Resistance. , 131-155.
CrossRef2175
C Cugnet, C Thivolet. (2005) Classification of diabetes in young adults: New concepts for an old disease. Diabetes & Metabolism 31:6, 595-598
CrossRef2176
Christopher B. Ruser, Lisa Sanders, Gina R. Brescia, Meredith Talbot, Karl Hartman, Kathleen Vivieros, Dawn M. Bravata. (2005) BRIEF REPORT: Identification and Management of Overweight and Obesity by Internal Medicine Residents. Journal of General Internal Medicine 20:12, 1139-1141
CrossRef2177
Meguid El Nahas. (2005) The global challenge of chronic kidney disease. Kidney International 68:6, 2918-2929
CrossRef2178
Robert Menuet, Carl J. Lavie, Richard V. Milani. (2005) Importance and Management of Dyslipidemia in the Metabolic Syndrome. The American Journal of the Medical Sciences 330:6, 295-302
CrossRef2179
Mary Hoskin, Shandiin Begay, Paula Bolin, Jeanette Hermes, Louise E. Ingraham, Tina Killean, Julie Nelson, Carol Percy, Nancy Scurlock, Leigh Shovestull, Christine Tomchee. (2005) Providing Lifestyle Interventions in Native American Communities. Obesity Management 1:6, 251-255
CrossRef2180
J. Tréton. (2005) A new challenge for diabetologists and geriatricians!. Diabetes & Metabolism 31, 5S9-5S12
CrossRef2181
Vivian A. Fonseca, Christina Bratcher, Tina Thethi. (2005) Pharmacological Treatment of the Insulin Resistance Syndrome in People Without Diabetes. Metabolic Syndrome and Related Disorders 3:4, 260-266
CrossRef2182
B SCHAAN, V PORTAL, M DEUGARTE, A DIAS, D HATEM. (2005) Emerging risk factors and early atherosclerosis indices in subjects with impaired glucose tolerance. Diabetes & Metabolism 31:6, 581-587
CrossRef2183
Gerald M. Devins, David C. Mendelssohn, Paul E. Barré, Kenneth Taub, Yitzchak M. Binik. (2005) Predialysis Psychoeducational Intervention Extends Survival in CKD: A 20-Year Follow-Up. American Journal of Kidney Diseases 46:6, 1088-1098
CrossRef2184
T. Lohmann. (2005) Führung des Diabetes mellitus bei Angiopathien. Zeitschrift für Kardiologie 94:S4, iv28-iv30
CrossRef2185
Kristi Reynolds, Jiang He. (2005) Epidemiology of the Metabolic Syndrome. The American Journal of the Medical Sciences 330:6, 273-279
CrossRef2186
Vivian A. Fonseca, Christina Bratcher, Tina Thethi. (2005) Pharmacological Treatment of the Insulin Resistance Syndrome in People Without Diabetes. Metabolic Syndrome and Related Disorders 3:4, 332-338
CrossRef2187
H BREKKE, P JANSSON, R LENNER. (2005) Long-term (1- and 2-year) effects of lifestyle intervention in type 2 diabetes relatives. Diabetes Research and Clinical Practice 70:3, 225-234
CrossRef2188
Karen V. Smirnakis, Lisa Chasan-Taber, Myles Wolf, Glenn Markenson, Jeffrey L. Ecker, Ravi Thadhani. (2005) Postpartum Diabetes Screening in Women With a History of Gestational Diabetes. Obstetrics & Gynecology 106:6, 1297-1303
CrossRef2189
OLIVER SCHNELL. (2005) The Links between Diabetes and Cardiovascular Disease. Journal of Interventional Cardiology 18:6, 413-416
CrossRef2190
Rubin Zhang, Jie Liao, Stephen Morse, Shawn Donelon, Efrain Reisin. (2005) Kidney Disease and the Metabolic Syndrome. The American Journal of the Medical Sciences 330:6, 319-325
CrossRef2191
Saad Hafidh, Neelavathi Senkottaiyan, Daniel Villarreal, Martin A. Alpert. (2005) Management of the Metabolic Syndrome. The American Journal of the Medical Sciences 330:6, 343-351
CrossRef2192
Veronica K. Jamnik, Norman Gledhill, Rhian M. Touyz, Norman R.C. Campbell, Alexander G. Logan, Raj Padwal, Rob Petrella. (2005) Lifestyle Modifications to Prevent and Manage Hypertension for Exercise Physiologists and Fitness Professionals. Canadian Journal of Applied Physiology 30:6, 754-761
CrossRef2193
Hilde Hendrickx, Bruce S. McEwen, Frans van der Ouderaa. (2005) Metabolism, mood and cognition in aging: The importance of lifestyle and dietary intervention. Neurobiology of Aging 26:1, 1-5
CrossRef2194
P Valensi, EH Schwarz, M Hall, AM Felton, A Maldonato, C Mathieu. (2005) Pre-diabetes essential action: a European perspective. Diabetes & Metabolism 31:6, 606-620
CrossRef2195
Mark R. Cobain, John P. Foreyt. (2005) Designing “lifestyle interventions” with the brain in mind. Neurobiology of Aging 26:1, 85-87
CrossRef2196
Paul Zimmet, K. George M.M. Alberti, Manuel Serrano Ríos. (2005) Una nueva definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: fundamento y resultados. Revista Española de Cardiología 58:12, 1371-1376
CrossRef2197
M. M. Agarwal, G. S. Dhatt, J. Punnose, G. Koster. (2005) Gestational diabetes: dilemma caused by multiple international diagnostic criteria. Diabetic Medicine 22:12, 1731-1736
CrossRef2198
Birgitta Trolle, Finn Friis Lauszus. (2005) Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 84:12, 1192-1196
CrossRef2199
Janne Sallinen, Mikael Fogelholm, Arto Pakarinen, Tuula Juvonen, Jeff S. Volek, William J. Kraemer, Markku Alen, Keijo Häkkinen. (2005) Effects of Strength Training and Nutritional Counseling on Metabolic Health Indicators in Aging Women. Canadian Journal of Applied Physiology 30:6, 690-707
CrossRef2200
Brent A. Neuschwander-Tetri. (2005) Nonalcoholic Steatohepatitis and the Metabolic Syndrome. The American Journal of the Medical Sciences 330:6, 326-335
CrossRef2201
Michele Colombo, Soeren Gregersen, Mogens Kruhoeffer, Andreas Agger, Jianzhong Xiao, Per Bendix Jeppesen, Torben Orntoft, Thorkil Ploug, Henrik Galbo, Kjeld Hermansen. (2005) Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis. Metabolism 54:12, 1571-1581
CrossRef2202
Sonia Caprio, Barbara Gower. 2005. Puberty, Insulin Resistance, and Type 2 Diabetes. , 175-196.
CrossRef2203
Lillian Lien, Mark Feinglos. 2005. Management of Obesity-Associated Type 2 Diabetes. , 205-225.
CrossRef2204
Samuel Dagogo-Jack. 2005. Management of Type 2 Diabetes in Underrepresented Minorities in the U.S.. , 227-247.
CrossRef2205
Fateh Entabi, Michael Watkins. 2005. Oxidative Stress and Vascular Complications of Diabetes Mellitus. , 361-379.
CrossRef2206
William Kraus, Cris Slentz. 2005. Metabolic Syndrome. , 57-78.
CrossRef2207
Jarol Boan. 2005. Nonsurgical Management of Obesity. , 99-109.
CrossRef2208
Connie Bales, Jama L.Purser. 2005. Achieving a Healthy Body Weight. , 43-56.
CrossRef2209
Michael Freemark. 2005. Type 2 Diabetes in Childhood. , 177-204.
CrossRef2210
Wadden, Thomas A., Berkowitz, Robert I., Womble, Leslie G., Sarwer, David B., Phelan, Suzanne, Cato, Robert K., Hesson, Louise A., Osei, Suzette Y., Kaplan, Rosalind, Stunkard, Albert J., . (2005) Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity. New England Journal of Medicine 353:20, 2111-2120
Full Text2211
Yanovski, Susan Z., . (2005) Pharmacotherapy for Obesity — Promise and Uncertainty. New England Journal of Medicine 353:20, 2187-2189
Full Text2212
D. B. Panagiotakos, C. Pitsavos, C. Chrysohoou, C. Stefanadis. (2005) The epidemiology of Type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabetic Medicine 22:11, 1581-1588
CrossRef2213
S. Del Prato, A-M Felton, N. Munro, R. Nesto, P. Zimmet, B. Zinman. (2005) Improving glucose management: Ten steps to get more patients with type 2 diabetes to glycaemic goal. International Journal of Clinical Practice 59:11, 1345-1355
CrossRef2214
Simona Bo, Luigi Gentile, Giovannino Ciccone, Carla Baldi, Lorenzo Benini, Ferruccio Dusio, Claudio Lucia, Giuseppe Forastiere, Claudio Nuti, Maurizio Cassader, Gian Franco Pagano. (2005) The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes/Metabolism Research and Reviews 21:6, 515-524
CrossRef2215
William E. Connor, P. Barton Duell, Sonja L. Connor. (2005) Benefits and hazards of dietary carbohydrate. Current Atherosclerosis Reports 7:6, 428-434
CrossRef2216
Jeanette S. Brown. (2005) Urinary Incontinence: An Important and Underrecognized Complication of Type 2 Diabetes Mellitus. Journal of the American Geriatrics Society 53:11, 2028-2029
CrossRef2217
Mark O. Goodarzi, Michael Bryer-Ash. (2005) Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes, Obesity and Metabolism 7:6, 654-665
CrossRef2218
Helena J Teede, C Meyer, RJ Norman. (2005) Insulin-sensitisers in the treatment of polycystic ovary syndrome. Expert Opinion on Pharmacotherapy 6:14, 2419-2427
CrossRef2219
(2005) Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age?. Diabetic Medicine 22:11, 1476-1481
CrossRef2220
P. E. H. Schwarz, J. Schwarz, S. R. Bornstein, J. Schulze. (2005) Prevention of type 2 diabetes: what challenges do we have to address?. Journal of Public Health 13:6, 303-308
CrossRef2221
David C. Nieman. (2005) You Asked For It. ACSM's Health & Fitness Journal 9:6, 6-7
CrossRef2222
E. N. Liberopoulos, D. P. Mikhailidis, M. S. Elisaf. (2005) Diagnosis and management of the metabolic syndrome in obesity. Obesity Reviews 6:4, 283-296
CrossRef2223
CAROLINE R. RICHARDSON, SABRINA A. AVRIPAS, DAVID L. NEAL, SHEILA M. MARCUS. (2005) Increasing Lifestyle Physical Activity in Patients with Depression or Other Serious Mental Illness. Journal of Psychiatric Practice 11:6, 379-388
CrossRef2224
M. Krebs, M. Roden. (2005) Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes, Obesity and Metabolism 7:6, 621-632
CrossRef2225
Susan Simmons Holcomb. (2005) Selection of antihypertensive agents in patients at risk for diabetes. Current Hypertension Reports 7:6, 461-465
CrossRef2226
Gladys Velarde, Bradford C. Berk. (2005) Role of hypertension in the metabolic syndrome: Who is affected?. Current Hypertension Reports 7:6, 418-426
CrossRef2227
D KILMER, N WRIGHT, S AITKENS. (2005) Impact of a Home-Based Activity and Dietary Intervention in People With Slowly Progressive Neuromuscular Diseases. Archives of Physical Medicine and Rehabilitation 86:11, 2150-2156
CrossRef2228
Karen L. Lifford, Gary C. Curhan, Frank B. Hu, Robert L. Barbieri, Francine Grodstein. (2005) Type 2 Diabetes Mellitus and Risk of Developing Urinary Incontinence. Journal of the American Geriatrics Society 53:11, 1851-1857
CrossRef2229
G. MARCHESINI, S. NATALE, R. MANINI, F. AGOSTINI. (2005) Review article: the treatment of fatty liver disease associated with the metabolic syndrome. Alimentary Pharmacology and Therapeutics 22:s2, 37-39
CrossRef2230
S. Fourlanos, F. Dotta, C. J. Greenbaum, J. P. Palmer, O. Rolandsson, P. G. Colman, L. C. Harrison. (2005) Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:11, 2206-2212
CrossRef2231
Frank B. Hu. (2005) The Role of Diet and Lifestyle Modifications in the Statin Era. Journal of the American Dietetic Association 105:11, 1718-1721
CrossRef2232
M. Burger, F. Tiemann. (2005) Diabetes mellitus in Deutschland. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 48:11, 1242-1249
CrossRef2233
C. J. Bailey, S. Del Prato, D. Eddy, B. Zinman. (2005) Earlier intervention in type 2 diabetes: The case for achieving early and sustained glycaemic control. International Journal of Clinical Practice 59:11, 1309-1316
CrossRef2234
Daniel E. Rosenberg, Serge A. Jabbour, Barry J. Goldstein. (2005) Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabetes, Obesity and Metabolism 7:6, 642-653
CrossRef2235
M. Venojarvi, R. Puhke, H. Hamalainen, J. Marniemi, M. Rastas, H. Rusko, P. Nuutila, O. Hanninen, S. Aunola. (2005) Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention. Diabetes, Obesity and Metabolism 7:6, 745-754
CrossRef2236
M Costello, B Shrestha, J Eden, P Sjoblom, N Johnson, Michael Costello. 2005. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne, and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. .
CrossRef2237
Tirosh, Amir, Shai, Iris, Tekes-Manova, Dorit, Israeli, Eran, Pereg, David, Shochat, Tzippora, Kochba, Ilan, Rudich, Assaf, . (2005) Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men. New England Journal of Medicine 353:14, 1454-1462
Full Text2238
S. Wiegand. (2005) Therapie des Diabetes mellitus Typ 2. Monatsschrift Kinderheilkunde 153:10, 936-944
CrossRef2239
Y. Dong, W. Gao, H. Nan, H. Yu, F. Li, W. Duan, Y. Wang, Bin Sun, R. Qian, J. Tuomilehto, Q. Qiao. (2005) Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabetic Medicine 22:10, 1427-1433
CrossRef2240
Thomas Bodenheimer. (2005) Helping Patients Improve Their Health-Related Behaviors: What System Changes Do We Need?. Disease Management 8:5, 319-330
CrossRef2241
David W Haslam, W Philip T James. (2005) Obesity. The Lancet 366:9492, 1197-1209
CrossRef2242
K. Silventoinen, J. Pankow, J. Lindstrom, P. Jousilahti, G. Hu, J. Tuomilehto. (2005) The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. European Journal of Cardiovascular Prevention & Rehabilitation 12:5, 451-458
CrossRef2243
N. Ferreira-Maldent, F. Maillot, J.-L. Guilmot. (2005) Le pied du diabétique : attention, danger !. Annales de Dermatologie et de Vénéréologie 132:10, 797-814
CrossRef2244
Roberta B. Ness, Carl A. Hubel. (2005) Risk for Coronary Artery Disease and Morbid Preeclampsia: A Commentary. Annals of Epidemiology 15:9, 726-733
CrossRef2245
Roger De Moraes, Giovanni Gioseffi, Nuno do Nascimento Lopes, Marilia Brito Gomes, Antonio Claudio Lucas Nobrega, Eduardo Tibirica. (2005) Exercise training protects the renal circulation against high glucose challenge. Fundamental and Clinical Pharmacology 19:5, 537-543
CrossRef2246
J D Douketis, C Macie, L Thabane, D F Williamson. (2005) Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. International Journal of Obesity 29:10, 1153-1167
CrossRef2247
W. S. Leslie, C. R. Hankey, L. McCombie, M. E. J. Lean. (2005) Weight management: a survey of current practice in secondary care NHS settings in 2004. Journal of Evaluation in Clinical Practice 11:5, 462-467
CrossRef2248
S. Eckert, D. Tschöpe. (2005) Glukosestoffwechsel. Zeitschrift für Kardiologie 94:S3, iii88-iii91
CrossRef2249
Thomas A. Arcury, Anne H. Skelly, Wilbert M. Gesler, Molly C. Dougherty. (2005) Diabetes Beliefs Among Low-income, White Residents of a Rural North Carolina Community. The Journal of Rural Health 21:4, 337-345
CrossRef2250
Paul Bray, Debra Thompson, Joan D. Wynn, Doyle M. Cummings, Lauren Whetstone. (2005) Confronting Disparities in Diabetes Care: The Clinical Effectiveness of Redesigning Care Management for Minority Patients in Rural Primary Care Practices. The Journal of Rural Health 21:4, 317-321
CrossRef2251
David A. Dorr, Adam Wilcox, Steven M. Donnelly, Laurie Burns, Paul D. Clayton. (2005) Impact of Generalist Care Managers on Patients with Diabetes. Health Services Research 40:5p1, 1400-1421
CrossRef2252
Kathryn Aston-Mourney, Joseph Proietto, Sofianos Andrikopoulos. (2005) Investigational agents that protect pancreatic islet β-cells from failure. Expert Opinion on Investigational Drugs 14:10, 1241-1250
CrossRef2253
Marc-Andre Cornier. (2005) Obesity and diabetes. Current Opinion in Internal Medicine 4:5, 535-541
CrossRef2254
Guido Lastra-Gonzalez, Camila Margarita Manrique, Gurushankar Govindarajan, Adam Whaley-Connell, James R Sowers. (2005) Insights into the emerging cardiometabolic prevention and management of diabetes mellitus. Expert Opinion on Pharmacotherapy 6:13, 2209-2221
CrossRef2255
Emilio Rodrigo, Celestino Pinera, Maria Angeles Cos, Blanca Sanchez, Juan Carlos Ruiz, Gema Fernandez-Fresnedo, Rosa Palomar, Julio Gonzalez-Cotorruelo, Carlos Gomez-Alamillo, Saturnino Sanz Castro, Angel Luis Martin Francisco, Manuel Arias. (2005) Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation. Transplant International 18:10, 1152-1157
CrossRef2256
W R Bruce, M Cirocco, A Giacca, Y-I Kim, N Marcon, S Minkin. (2005) A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation. British Journal of Cancer 93:6, 639-646
CrossRef2257
Rhoda H. Cobin. (2005) Polycystic Ovarian Syndrome and Insulin Resistance: Implications for Estrogen Use in Premenopausal and Postmenopausal Women. Metabolic Syndrome and Related Disorders 3:3, 259-269
CrossRef2258
B BAUDUCEAU, F BAIGTS, L BORDIER, P BURNAT, F CEPPA, V DUMENIL, O DUPUY, J LEBERRE, H MAYAUDON, S PAILLASSON. (2005) Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study). Diabetes & Metabolism 31:4, 353-359
CrossRef2259
Katriina T. Kukkonen-Harjula, Patrik T. Borg, Arja M. Nenonen, Mikael G. Fogelholm. (2005) Effects of a weight maintenance program with or without exercise on the metabolic syndrome: A randomized trial in obese men. Preventive Medicine 41:3-4, 784-790
CrossRef2260
M. Ludwig, M. Epe. (2005) Polyzystisches Ovarsyndrom. Gynäkologische Endokrinologie 3:3, 187-198
CrossRef2261
R. Kahn, J. Buse, E. Ferrannini, M. Stern. (2005) The metabolic syndrome: time for a critical appraisal. Diabetologia 48:9, 1684-1699
CrossRef2262
R. DALLE GRAVE, N. MELCHIONDA, S. CALUGI, E. CENTIS, A. TUFANO, G. FATATI, M. A. FUSCO, G. MARCHESINI. (2005) Continuous care in the treatment of obesity: an observational multicentre study. Journal of Internal Medicine 258:3, 265-273
CrossRef2263
M Hall. (2005) The European Union and diabetes. European Diabetes Nursing 2:2, 80-82
CrossRef2264
P. Valdivielso Felices, C. García Arias, M.A. Sánchez Chaparro, P. González Santos. (2005) Manejo terapéutico de la arteriosclerosis. Medicine - Programa de Formación Médica Continuada Acreditado 9:38, 2536-2541
CrossRef2265
Tina Costacou. (2005) Evaluation of epidemiologic evidence on the role of nutrition in the development of diabetes and its complications. Current Diabetes Reports 5:5, 366-373
CrossRef2266
Stig Eric Underbjerg Dyrskog, Per Bendix Jeppesen, Michele Colombo, Reziwanggu Abudula, Kjeld Hermansen. (2005) Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Metabolism 54:9, 1181-1188
CrossRef2267
A. F. G. Cicero, A. Dormi, S. Nascetti, M. P. Panourgia, E. Grandi, S. D'Addato, A. Gaddi. (2005) Relative role of major risk factors for Type 2 diabetes development in the historical cohort of the Brisighella Heart Study: an 8-year follow-up. Diabetic Medicine 22:9, 1263-1266
CrossRef2268
Sixten Borg, Ulf Persson, Knut Ödegaard, Göran Berglund, Jan-Åke Nilsson, Peter M. Nilsson. (2005) Obesity, Survival, and Hospital Costs—Findings from a Screening Project in Sweden. Value in Health 8:5, 562-571
CrossRef2269
Giuseppe Derosa, Arrigo F.G. Cicero, Antonio V. Gaddi, Leonardina Ciccarelli, Mario N. Piccinni, Sibilla Salvadeo, Fabio Pricolo, Elena Fogari, Morena Ghelfi, Ilaria Ferrari, Roberto Fogari. (2005) Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: A 12-month, double-blind, randomized clinical trial. Clinical Therapeutics 27:9, 1383-1391
CrossRef2270
Emily S. Loghmani. (2005) Nutrition therapy for overweight children and adolescents with Type 2 Diabetes. Current Diabetes Reports 5:5, 385-390
CrossRef2271
Leonard E. Egede, Samuel Dagogo-Jack. (2005) Epidemiology of Type 2 Diabetes: Focus on Ethnic Minorities. Medical Clinics of North America 89:5, 949-975
CrossRef2272
N Khaleghnezhad Tabari, Bagher Larijani. (2005) Report of the International Conference on Diabetes and Obesity. Therapy 2:5, 693-697
CrossRef2273
V. Mohan, K. Gokulakrishnan, R. Deepa, C. S. Shanthirani, M. Datta. (2005) Association of physical inactivity with components of metabolic syndrome and coronary artery disease-the Chennai Urban Population Study (CUPS no. 15). Diabetic Medicine 22:9, 1206-1211
CrossRef2274
Antonios H. Tzamaloukas, Glen H. Murata. (2005) Prevention of Nephropathy in Patients with type 2 Diabetes Mellitus. International Urology and Nephrology 37:3, 655-663
CrossRef2275
Kristina Orth-Gomér, Christian Albus, Nuri Bagés, Guy DeBacker, Hans-Christian Deter, Christoph Herrmann-Lingen, Brian Oldenburg, Susana Sans, Redford B Williams, Neil Schneiderman. (2005) Psychosocial considerations in the european guidelines for prevention of cardiovascular diseases in clinical practice: third joint task force. International Journal of Behavioral Medicine 12:3, 132-141
CrossRef2276
Madelyn L. Wheeler. (2005) Translation of successful diabetes-related lifestyle interventions from research to practice. Current Diabetes Reports 5:5, 363-365
CrossRef2277
P NOUSSITOU, D MONBARON, Y VIAL, R GAILLARD, J RUIZ. (2005) Gestational diabetes mellitus and the risk of metabolic syndrome: a population-based study in Lausanne, Switzerland. Diabetes & Metabolism 31:4, 361-369
CrossRef2278
Ram Weiss, Sonia Caprio. (2005) The metabolic consequences of childhood obesity. Best Practice & Research Clinical Endocrinology & Metabolism 19:3, 405-419
CrossRef2279
C. Wilson, S. Gilliland, T. Cullen, K. Moore, Y. Roubideaux, L. Valdez, W. Vanderwagen, K. Acton. (2005) Diabetes Outcomes in the Indian Health System During the Era of the Special Diabetes Program for Indians and the Government Performance and Results Act. American Journal of Public Health 95:9, 1518-1522
CrossRef2280
E. B. Fisher, C. A. Brownson, M. L. O'Toole, G. Shetty, V. V. Anwuri, R. E. Glasgow. (2005) Ecological Approaches to Self-Management: The Case of Diabetes. American Journal of Public Health 95:9, 1523-1535
CrossRef2281
J. Two Feathers, E. C. Kieffer, G. Palmisano, M. Anderson, B. Sinco, N. Janz, M. Heisler, M. Spencer, R. Guzman, J. Thompson, K. Wisdom, S. A. James. (2005) Racial and Ethnic Approaches to Community Health (REACH) Detroit Partnership: Improving Diabetes-Related Outcomes Among African American and Latino Adults. American Journal of Public Health 95:9, 1552-1560
CrossRef2282
Augustine Marchie, Azadeh Emam, Cyril Kendall, Julia Wong, David Jenkins, Russell de Souza. 2005. Synergy of Portfolio Diet Components and Drugs in Coronary Heart Disease. , 63-76.
CrossRef2283
Gerald M. Reaven. (2005) THE INSULIN RESISTANCE SYNDROME: Definition and Dietary Approaches to Treatment. Annual Review of Nutrition 25:1, 391-406
CrossRef2284
Ingela Melin, Brita Karlström, Lars Berglund, Manuela Zamfir, Stephan Rössner. (2005) Education and supervision of health care professionals to initiate, implement and improve management of obesity. Patient Education and Counseling 58:2, 127-136
CrossRef2285
Fidelma Dunne. (2005) Type 2 diabetes and pregnancy. Seminars in Fetal and Neonatal Medicine 10:4, 333-339
CrossRef2286
T. C. Crowe. (2005) Safety of low-carbohydrate diets. Obesity Reviews 6:3, 235-245
CrossRef2287
B. Gallwitz. (2005) Glucagon-Like Peptide-1 as a Treatment Option for Type 2 Diabetes and Its Role in Restoring Beta-Cell Mass. Diabetes Technology & Therapeutics 7:4, 651-657
CrossRef2288
Nefertiti Durant, Joanne Cox. (2005) Current treatment approaches to overweight in adolescents. Current Opinion in Pediatrics 17:4, 454-459
CrossRef2289
G. Hu, P. Jousilahti, M. Peltonen, J. Lindström, J. Tuomilehto. (2005) Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland. Diabetologia 48:8, 1477-1483
CrossRef2290
Judith Buttriss, Anne Nugent. (2005) Proceedings of the Nutrition Society 64:03, 345-347
CrossRef2291
Maria Bitsori, Anthony Kafatos. (2005) Dysmetabolic syndrome in childhood and adolescence. Acta Paediatrica 94:8, 995-1005
CrossRef2292
(2005) Clinical Case Report. Obesity Management 1:4, 163-165
CrossRef2293
G Hu, J Tuomilehto, K Silventoinen, N C Barengo, M Peltonen, P Jousilahti. (2005) The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. International Journal of Obesity 29:8, 894-902
CrossRef2294
Susan J. Appel. (2005) Calculating Insulin Resistance in the Primary Care Setting: Why Should We Worry about Insulin Levels in Euglycemic Patients?. Journal of the American Academy of Nurse Practitioners 17:8, 331-336
CrossRef2295
Vasilios G. Athyros, Dimitri P. Mikhailidis, Athanasios A. Papageorgiou, Triandafillos P. Didangelos, Athanasia Peletidou, Drosia Kleta, Asterios Karagiannis, Anna I. Kakafika, Konstantinos Tziomalos, Moses Elisaf. (2005) Targeting vascular risk in patients with metabolic syndrome but without diabetes. Metabolism 54:8, 1065-1074
CrossRef2296
Kate Marsh, Jennie Brand-Miller. (2005) The optimal diet for women with polycystic ovary syndrome?. British Journal of Nutrition 94:02, 154
CrossRef2297
Roberto Miccoli, Cristina Bianchi, Leonardo Odoguardi, Giuseppe Penno, Francesco Caricato, Maria Giovanna Giovannitti, Laura Pucci, Stefano Del Prato. (2005) Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutrition, Metabolism and Cardiovascular Diseases 15:4, 250-254
CrossRef2298
L. A. Leiter. (2005) beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes. Diabetic Medicine 22:8, 963-972
CrossRef2299
(2005) Empowering primary care to tackle the obesity epidemic: the Counterweight Programme. European Journal of Clinical Nutrition 59, S93-S101
CrossRef2300
Sheri L. Maddigan, Sumit R. Majumdar, Jeffrey A. Johnson. (2005) Understanding the complex associations between patient–provider relationships, self-care behaviours, and health-related quality of life in type 2 diabetes: A structural equation modeling approach. Quality of Life Research 14:6, 1489-1500
CrossRef2301
I. J. Perry, R. Villegas, A. Salim, A. Flynn. (2005) Clustering of protective factors for glucose intolerance and insulin resistance: a cross-sectional study. Diabetic Medicine 22:8, 1091-1097
CrossRef2302
E M H Mathus-Vliegen. (2005) Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study. European Journal of Clinical Nutrition 59, S31-S39
CrossRef2303
Antonio Saenz, Inmaculada Fernandez-Esteban, Angel Mataix, Monica Ausejo Segura, Marta Roqué i Figuls, David Moher, Antonio Saenz. 2005. Metformin monotherapy for type 2 diabetes mellitus. .
CrossRef2304
Hussam Abuissa, David S. H. Bell, James H. O’Keefe. (2005) Strategies to prevent type 2 diabetes. Current Medical Research and Opinion 21:7, 1107-1114
CrossRef2305
Angela M Taylor, Coleen A McNamara, Anne Hedelt, Cherie Chaney, Mary Lou Perry, Thomas M Miller III, Karen D Tyler, Anthony L McCall. (2005) Outcomes of a multidisciplinary team approach to cardiovascular risk reduction in patients with diabetes mellitus. Therapy 2:4, 587-595
CrossRef2306
Susan B. Racette, Edward P. Weiss, Robert C. Hickner, John O. Holloszy. (2005) Modest weight loss improves insulin action in obese African Americans. Metabolism 54:7, 960-965
CrossRef2307
Leslie Citrome, Lawrence Blonde, Cristina Damatarca. (2005) Metabolic Issues in Patients with Severe Mental Illness. Southern Medical Journal 98:7, 714-719
CrossRef2308
Katherine E Nori Janosz, Wendy M Miller, Jacqueline Odom, Martin Lillystone, Jose Yanez, Peter A McCullough. (2005) Optimal diabetes management during medical weight loss for cardiovascular risk reduction. Expert Review of Cardiovascular Therapy 3:4, 761-775
CrossRef2309
D. A. Smith, E. M. Ness, R. Herbert, C. B. Schechter, R. A. Phillips, J. A. Diamond, P. J. Landrigan. (2005) Abdominal diameter index: a more powerful anthropometric measure for prevalent coronary heart disease risk in adult males. Diabetes, Obesity and Metabolism 7:4, 370-380
CrossRef2310
B. Stribling, C. Blackler. (2005) Clinical networks in diabetes. Diabetic Medicine 22:s3, 13-16
CrossRef2311
Melania Manco, Geltrude Mingrone. (2005) Effects of weight loss and calorie restriction on carbohydrate metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 8:4, 431-439
CrossRef2312
Agnieszka Dobrzyn, James M. Ntambi. (2005) The role of stearoyl-CoA desaturase in the control of metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids 73:1, 35-41
CrossRef2313
J COSTAFONT, J GIL. (2005) Obesity and the incidence of chronic diseases in Spain: A seemingly unrelated probit approach. Economics & Human Biology 3:2, 188-214
CrossRef2314
Gary D. Foster, Angie P. Makris. (2005) Low-carbohydrate Diets in the Treatment of Obesity. Nutrition Today 40:4, 165-168
CrossRef2315
L SUBAK, E WHITCOMB, H SHEN, J SAXTON, E VITTINGHOFF, J BROWN. (2005) WEIGHT LOSS: A NOVEL AND EFFECTIVE TREATMENT FOR URINARY INCONTINENCE. The Journal of Urology 174:1, 190-195
CrossRef2316
Giacomo Levantesi, Alejandro Macchia, RosaMaria Marfisi, Maria G. Franzosi, Aldo P. Maggioni, Gian L. Nicolosi, Carlo Schweiger, Luigi Tavazzi, Gianni Tognoni, Franco Valagussa, Roberto Marchioli. (2005) Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction. Journal of the American College of Cardiology 46:2, 277-283
CrossRef2317
Stacy L. Strehlow, Jorge H. Mestman. (2005) Prevention of T2DM in women with a previous history of GDM. Current Diabetes Reports 5:4, 272-277
CrossRef2318
Lynda J. Gillen, Linda C. Tapsell, Craig S. Patch, Alice Owen, Marijka Batterham. (2005) Structured Dietary Advice Incorporating Walnuts Achieves Optimal Fat and Energy Balance in Patients with Type 2 Diabetes Mellitus. Journal of the American Dietetic Association 105:7, 1087-1096
CrossRef2319
Hong Kyu Lee. 2005. Mitochondria in Diabetes Mellitus. , 377-454.
CrossRef2320
R Huxley, A Ansary-Moghaddam, A Berrington de González, F Barzi, M Woodward. (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. British Journal of Cancer 92:11, 2076-2083
CrossRef2321
M. Krebs. (2005) Amino acid-dependent modulation of glucose metabolism in humans. European Journal of Clinical Investigation 35:6, 351-354
CrossRef2322
M. C. Thomas, M. K. Walker, J. R. Emberson, A. G. Thomson, D. A. Lawlor, S. Ebrahim, P. H. Whincup. (2005) Prevalence of undiagnosed Type 2 diabetes and impaired fasting glucose in older B ritish men and women. Diabetic Medicine 22:6, 789-793
CrossRef2323
Katharine Douaihy. (2005) Prediabetes & Atherosclerosis: What???s the Connection?. The Nurse Practitioner 30:6, 24-35
CrossRef2324
Cathy Nonas, Donna Ryan. (2005) Weight Loss as the Primary Treatment for Type 2 Diabetes. Obesity Management 1:3, 96-99
CrossRef2325
J ROBBINS, V VACCARINO, H ZHANG, S KASL. (2005) Socioeconomic status and diagnosed diabetes incidence. Diabetes Research and Clinical Practice 68:3, 230-236
CrossRef2326
Rebecca Parish, Kitt Falk Petersen. (2005) Mitochondrial dysfunction and type 2 diabetes. Current Diabetes Reports 5:3, 177-183
CrossRef2327
Jill A. Bennett, Nancy A. Perrin, Ginger Hanson, Diane Bennett, William Gaynor, Marna Flaherty-Robb, Carol Joseph, Susan Butterworth, Kathleen Potempa. (2005) Healthy aging demonstration project: Nurse coaching for behavior change in older adults. Research in Nursing & Health 28:3, 187-197
CrossRef2328
Stuart R Chipkin, Steven E Black, Barry Braun. (2005) The balance between exercise and diet: impact on insulin sensitivity. Current Opinion in Internal Medicine 4:3, 256-260
CrossRef2329
William O’Donohue, Michael A. Cucciare. (2005) Pathways to Medical Utilization. Journal of Clinical Psychology in Medical Settings 12:2, 185-197
CrossRef2330
Domenico Fedele. (2005) Therapy Insight: sexual and bladder dysfunction associated with diabetes mellitus. Nature Clinical Practice Urology 2:6, 282-290
CrossRef2331
Phillip Gorden, Carla Musso. (2005) The impact of evidence-based medicine on diabetes therapy. Current Diabetes Reports 5:3, 157-159
CrossRef2332
Fernando G. Cosio, Yogish Kudva, Marije van der Velde, Timothy S. Larson, Stephen C. Textor, Matthew D. Griffin, Mark D. Stegall. (2005) New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney International 67:6, 2415-2421
CrossRef2333
D BETTERIDGE. (2005) Long-term risk reduction: Who needs treatment?. Diabetes Research and Clinical Practice 68, S15-S22
CrossRef2334
Lev M. Berstein. (2005) Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer. Cancer Letters 224:2, 203-212
CrossRef2335
J TUOMILEHTO. (2005) Cardiovascular risk: Prevention and treatment of the metabolic syndrome. Diabetes Research and Clinical Practice 68, S28-S35
CrossRef2336
G JERMENDY. (2005) Can type 2 diabetes mellitus be considered preventable?. Diabetes Research and Clinical Practice 68, S73-S81
CrossRef2337
Ervin Szoke, John E. Gerich. (2005) Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Comprehensive Therapy 31:2, 106-112
CrossRef2338
Susan B. Moyers. (2005) Medications as Adjunct Therapy for Weight Loss: Approved and Off-Label Agents in Use. Journal of the American Dietetic Association 105:6, 948-959
CrossRef2339
Andrew J. Drexler, Richard W. Nesto, Martin J. Abrahamson, George Bakris, David Bell, John Brunzell, Paresh Dandona, Jaime Davidson, Vivian Fonseca, Michael Fowler, Robert Frye, Thomas Giles, Steven Haffner, Norman Hollenberg, Willa Hsueh, Ronald Law, Jorge Plutzky, Robert Ratner, Jane Reusch, Andrew Selwyn, James Sowers, Kathleen Wyne, Lawrence H. Young. (2005) Evaluating the Cardiovascular Effects of the Thiazolidinediones and Their Place in the Management of Type 2 Diabetes in Relation to the Metabolic Syndrome. Metabolic Syndrome and Related Disorders 3:2, 147-173
CrossRef2340
Johannes P. van Hooff, Maarten H. L. Christiaans, Elly M. van Duijnhoven. (2005) Tacrolimus and Posttransplant Diabetes Mellitus in Renal Transplantation. Transplantation 79:11, 1465-1469
CrossRef2341
Matti Uusitupa. (2005) Gene–diet interaction in relation to the prevention of obesity and type 2 diabetes: Evidence from the Finnish Diabetes Prevention Study. Nutrition, Metabolism and Cardiovascular Diseases 15:3, 225-233
CrossRef2342
I TKAC. (2005) Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Research and Clinical Practice 68, S2-S9
CrossRef2343
D Simmons, A McKenzie, S Eaton, N Cox, M A Khan, J Shaw, P Zimmet. (2005) Choice and availability of takeaway and restaurant food is not related to the prevalence of adult obesity in rural communities in Australia. International Journal of Obesity 29:6, 703-710
CrossRef2344
A. Enrique Caballero. (2005) Diabetes in the hispanic or latino population: Genes, environment, culture, and more. Current Diabetes Reports 5:3, 217-225
CrossRef2345
R. Williams. (2005) Medical and economic case for prevention of type 2 diabetes and cardiovascular disease. European Heart Journal Supplements 7:Suppl D, D14-D17
CrossRef2346
J. Tuomilehto, J. Lindstrom, Q. Qiao. (2005) Strategies for the prevention of type 2 diabetes and cardiovascular disease. European Heart Journal Supplements 7:Suppl D, D18-D22
CrossRef2347
C. J. Bailey. (2005) Overview of new and developing pharmacological treatments. European Heart Journal Supplements 7:Suppl D, D23-D26
CrossRef2348
Mary Ann Huang, Joel K. Greenson, Cewin Chao, Lilian Anderson, Debra Peterman, Jon Jacobson, Dawn Emick, Anna S. Lok, Hari S. Conjeevaram. (2005) One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Non-Alcoholic Steatohepatitis: A Pilot Study. The American Journal of Gastroenterology 100:5, 1072-1081
CrossRef2349
A. J. Karter, R. B. D'Agostino, E. J. Mayer-Davis, L. E. Wagenknecht, A. J. G. Hanley, R. F. Hamman, R. Bergman, M. F. Saad, S. M. Haffner, . (2005) Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes, Obesity and Metabolism 7:3, 230-238
CrossRef2350
Xavier Pi-Sunyer, P.M. Kris-Etherton. (2005) Improving Health Outcomes: Future Directions in the Field. Journal of the American Dietetic Association 105:5, 14-16
CrossRef2351
Stuart A Cook, Tim Aitman, Rossi P Naoumova. (2005) Therapy Insight: heart disease and the insulin-resistant patient. Nature Clinical Practice Cardiovascular Medicine 2:5, 252-260
CrossRef2352
Ian D. Caterson. (2005) Obesity in 2005 and in DOM. Diabetes, Obesity and Metabolism 7:3, 209-210
CrossRef2353
James O. Hill, Helen Thompson, Holly Wyatt. (2005) Weight Maintenance: What’s Missing?. Journal of the American Dietetic Association 105:5, 63-66
CrossRef2354
Karen M. Emmons, Colleen M. McBride, Elaine Puleo, Kathryn I. Pollak, Bess H. Marcus, Melissa Napolitano, Elizabeth Clipp, Jane Onken, Francis A. Farraye, Robert Fletcher. (2005) Prevalence and predictors of multiple behavioral risk factors for colon cancer. Preventive Medicine 40:5, 527-534
CrossRef2355
M. Vázquez Carrera. (2005) Receptores activados por proliferadores peroxisómicos tipo gamma en el síndrome metabólico: ¿amigos o enemigos?. Clínica e Investigación en Arteriosclerosis 17, 59-69
CrossRef2356
Giuseppe Derosa, Antonio V. Gaddi, Mario N. Piccinni, Leonardina Ciccarelli, Sibilla Salvadeo, Emmanouil Peros, Morena Ghelfi, Ilaria Ferrari, Arrigo F. G. Cicero. (2005) Antithrombotic Effects of Rosiglitazone-Metformin versus Glimepiride-Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. Pharmacotherapy 25:5, 637-645
CrossRef2357
Christina C. Wee, Roger B. Davis, Russell S. Phillips. (2005) Stage of Readiness to Control Weight and Adopt Weight Control Behaviors in Primary Care. Journal of General Internal Medicine 20:5, 410-415
CrossRef2358
Bruce S. Rabin. (2005) Stressor-induced alteration of health across the life span: There's more to it than immunology. Clinical and Applied Immunology Reviews 5:3, 207-224
CrossRef2359
A. V. Ciardullo. (2005) Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance: does it really work? If yes, is it a novelty?. Diabetic Medicine 22:5, 666-667
CrossRef2360
B. P. Tabaei, M. M. Engelgau, W. H. Herman. (2005) A multivariate logistic regression equation to screen for dysglycaemia: development and validation. Diabetic Medicine 22:5, 599-605
CrossRef2361
Ryan E. Rhodes, Ronald C. Plotnikoff. (2005) Can current physical activity act as a reasonable proxy measure of future physical activity? Evaluating cross-sectional and passive prospective designs with the use of social cognition models. Preventive Medicine 40:5, 547-555
CrossRef2362
Daniel Schneider, Judith Hsia. (2005) Coronary heart disease prevention in menopausal women. Expert Opinion on Pharmacotherapy 6:5, 695-705
CrossRef2363
Frank Vinicor. (2005) TIME FOR "DRILLING DOWN". Journal of General Internal Medicine 20:5, 483-484
CrossRef2364
Miguel A. Martínez-González, Jokin de Irala. (2005) Medicina preventiva y fracaso clamoroso de la salud pública: llegamos mal porque llegamos tarde. Medicina Clínica 124:17, 656-660
CrossRef2365
J. R. Lindsay, N. A. Duffy, A. M. McKillop, J. Ardill, F. P. M. O'Harte, P. R. Flatt, P. M. Bell. (2005) Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes. Diabetic Medicine 22:5, 654-657
CrossRef2366
Raymond A. Plodkowski, Jessica Krenkel. (2005) Combined Treatment for Obesity and the Metabolic Syndrome. Journal of the American Dietetic Association 105:5, 124-130
CrossRef2367
M. Maldonado, S. D'Amico, M. Otiniano, A. Balasubramanyam, L. Rodriguez, E. Cuevas. (2005) Predictors of glycaemic control in indigent patients presenting with diabetic ketoacidosis. Diabetes, Obesity and Metabolism 7:3, 282-289
CrossRef2368
J LEAHY. (2005) Pathogenesis of Type 2 Diabetes Mellitus. Archives of Medical Research 36:3, 197-209
CrossRef2369
J RULL, C AGUILARSALINAS, R ROJAS, J RIOSTORRES, F GOMEZPEREZ, G OLAIZ. (2005) Epidemiology of Type 2 Diabetes in Mexico. Archives of Medical Research 36:3, 188-196
CrossRef2370
D BOTERO, J WOLFSDORF. (2005) Diabetes Mellitus in Children and Adolescents. Archives of Medical Research 36:3, 281-290
CrossRef2371
D. L. Hurley, W. L. Isley. (2005) Getting There: Statin Plus Ezetimibe for Low-Density Lipoprotein Cholesterol Goals. Mayo Clinic Proceedings 80:5, 585-586
CrossRef2372
David L. Katz. (2005) COMPETING DIETARY CLAIMS FOR WEIGHT LOSS: Finding the Forest Through Truculent Trees. Annual Review of Public Health 26:1, 61-88
CrossRef2373
Matthias B. Schulze, Frank B. Hu. (2005) PRIMARY PREVENTION OF DIABETES: What Can Be Done and How Much Can Be Prevented?. Annual Review of Public Health 26:1, 445-467
CrossRef2374
Trudi A Deakin, Catherine E McShane, Janet E Cade, Rhys Williams, Aslak Steinsbekk. 2005. Group based training for self-management strategies in people with type 2 diabetes mellitus. .
CrossRef2375
Michael Stumvoll, Barry J Goldstein, Timon W van Haeften. (2005) Type 2 diabetes: principles of pathogenesis and therapy. The Lancet 365:9467, 1333-1346
CrossRef2376
J PEREIRACUNILL. (2005) Tratamiento farmacológico de la obesidad. Revista Clínica Española 205:4, 175-177
CrossRef2377
Ramesh L. Bijlani, Rama P. Vempati, Raj K. Yadav, Rooma Basu Ray, Vani Gupta, Ratna Sharma, Nalin Mehta, Sushil C. Mahapatra. (2005) A Brief but Comprehensive Lifestyle Education Program Based on Yoga Reduces Risk Factors for Cardiovascular Disease and Diabetes Mellitus. The Journal of Alternative and Complementary Medicine 11:2, 267-274
CrossRef2378
Robert H Eckel, Scott M Grundy, Paul Z Zimmet. (2005) The metabolic syndrome. The Lancet 365:9468, 1415-1428
CrossRef2379
H BREKKE, R LENNER, M TASKINEN, J MANSSON, T FUNAHASHI, Y MATSUZAWA, P JANSSON. (2005) Lifestyle modification improves risk factors in type 2 diabetes relatives. Diabetes Research and Clinical Practice 68:1, 18-28
CrossRef2380
Deborah J. Toobert, Lisa A. Strycker, Russell E. Glasgow, Manuel Barrera, Karyn Angell. (2005) Effects of the mediterranean lifestyle program on multiple risk behaviors and psychosocial outcomes among women at risk for heart disease. Annals of Behavioral Medicine 29:2, 128-137
CrossRef2381
Rebecca Pellicano, Peter G. Kerr, Robert C. Atkins. (2005) What have we learned from clinical trials on prevention?. Kidney International 67:s94, s101-s106
CrossRef2382
Ehrmann, David A., . (2005) Polycystic Ovary Syndrome. New England Journal of Medicine 352:12, 1223-1236
Full Text2383
Karen Lutfey, Jeremy Freese. (2005) Toward Some Fundamentals of Fundamental Causality: Socioeconomic Status and Health in the Routine Clinic Visit for Diabetes. American Journal of Sociology 110:5, 1326-1372
CrossRef2384
Alessia Fornoni, Leopoldo Raij. (2005) Metabolic syndrome and endothelial dysfunction. Current Hypertension Reports 7:2, 88-95
CrossRef2385
Allison M. Pritchett, John P. Foreyt, Douglas L. Mann. (2005) Treatment of the metabolic syndrome: The impact of lifestyle modification. Current Atherosclerosis Reports 7:2, 95-102
CrossRef2386
A. R. Chacra, J. A. Davidson, J. Diaz, M. Escalante-Pulido, L. E. Litwak, J. H. Mestman, L. More, R. M. Violante. (2005) An algorithm for the treatment of type 2 diabetes in Latin America. Diabetes, Obesity and Metabolism 7:2, 148-160
CrossRef2387
A DORNHORST. (2005) Diabetes in pregnancy. Women's Health Medicine 2:2, 8-12
CrossRef2388
Thomas A. Buchanan, Anny H. Xiang. (2005) Gestational diabetes mellitus. Journal of Clinical Investigation 115:3, 485-491
CrossRef2389
Ligia J. Dominguez, James R. Sowers. (2005) Metabolic syndrome therapy: Prevention of vascular injury by antidiabetic agents. Current Hypertension Reports 7:2, 110-116
CrossRef2390
Emiko Todaka, Kenichi Sakurai, Chisato Mori. (2005) An experimental trial to establish risk communication as a tool to decrease the risk by exposure to multiple chemicals for the future generations. Reproductive Medicine and Biology 4:1, 65-69
CrossRef2391
A. M. Aas, I. Bergstad, P. M. Thorsby, O. Johannesen, M. Solberg, K. I. Birkeland. (2005) An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study. Diabetic Medicine 22:3, 316-322
CrossRef2392
Peter M Nilsson. (2005) Diabetes and obesity: new data on mechanisms and intervention trials. Expert Review of Cardiovascular Therapy 3:2, 243-247
CrossRef2393
Marco Mensink. (2005) Lifestyle Intervention, Glucose Tolerance, and Risk of Developing Type 2 Diabetes Mellitus. Metabolic Syndrome and Related Disorders 3:1, 26-34
CrossRef2394
Carolyn L. Blue, David R. Black. (2005) Synthesis of Intervention Research to Modify Physical Activity and Dietary Behaviors. Research and Theory for Nursing Practice 19:1, 25-61
CrossRef2395
Fabrice Bonnet, Kate Irving, Jean-Louis Terra, Patrice Nony, François Berthezène, Philippe Moulin. (2005) Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. Journal of Hypertension 23:3, 611-617
CrossRef2396
K. Waki, M. Noda, S. Sasaki, Y. Matsumura, Y. Takahashi, A. Isogawa, Y. Ohashi, T. Kadowaki, S. Tsugane, . (2005) Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I. Diabetic Medicine 22:3, 323-331
CrossRef2397
Carl J. Lavie, Richard V. Milani. (2005) Cardiac Rehabilitation and Exercise Training Programs in Metabolic Syndrome and Diabetes. Journal of Cardiopulmonary Rehabilitation 25:2, 59-66
CrossRef2398
Arthur V. Everitt, George S. Roth, David G. Couteur, Sarah N. Hilmer. (2005) Caloric restriction versus drug therapy to delay the onset of aging diseases and extend life. AGE 27:1, 39-48
CrossRef2399
Gang Hu, Timo A. Lakka, Noël C. Barengo, Jaakko Tuomilehto. (2005) Physical Activity, Physical Fitness, and Risk of Type 2 Diabetes Mellitus. Metabolic Syndrome and Related Disorders 3:1, 35-44
CrossRef2400
Donald W. Richardson, Aaron I. Vinik. (2005) Metabolic Implications of Obesity: Before and After Gastric Bypass. Gastroenterology Clinics of North America 34:1, 9-24
CrossRef2401
Osama Hamdy. (2005) Lifestyle modification and endothelial function in obese subjects. Expert Review of Cardiovascular Therapy 3:2, 231-241
CrossRef2402
T WADDEN, C CRERAND, J BROCK. (2005) Behavioral Treatment of Obesity. Psychiatric Clinics of North America 28:1, 151-170
CrossRef2403
A TSAI, T WADDEN, L WOMBLE, K BYRNE. (2005) Commercial and Self-help Programs for Weight Control. Psychiatric Clinics of North America 28:1, 171-192
CrossRef2404
A MAKRIS, G FOSTER. (2005) Dietary Approaches to the Treatment of Obesity. Psychiatric Clinics of North America 28:1, 117-139
CrossRef2405
Sigal Eilat-Adar, Uri Goldbourt, Helaine E Resnick, Barbara V Howard. (2005) Intentional weight loss, blood lipids and coronary morbidity and mortality. Current Opinion in Lipidology 16:1, 5-9
CrossRef2406
Josefina Biarnés, José Manuel Fernández-Real, Miguel Fernández-Castañer, Maria del Mar García, Juan Soler, Wilfredo Ricart. (2005) Differential regulation of insulin action and tumor necrosis factor α system activity by metformin. Metabolism 54:2, 235-239
CrossRef2407
Ronald P Mensink. (2005) Metabolic and health effects of isomeric fatty acids. Current Opinion in Lipidology 16:1, 27-30
CrossRef2408
David E. Moller, Keith D. Kaufman. (2005) Metabolic Syndrome: A Clinical and Molecular Perspective. Annual Review of Medicine 56:1, 45-62
CrossRef2409
K KOSAKA, M NODA, T KUZUYA. (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Research and Clinical Practice 67:2, 152-162
CrossRef2410
Lyndel Costain, Helen Croker. (2005) Helping individuals to help themselves. Proceedings of the Nutrition Society 64:01, 89-96
CrossRef2411
James H Stein. (2005) Managing Cardiovascular Risk in Patients With HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 38:2, 115-123
CrossRef2412
Alfonse T. Masi, Jean C. Aldag, Johannes W.G. Jacobs. (2005) Rheumatoid Arthritis: Neuroendocrine Immune Integrated Physiopathogenetic Perspectives and Therapy. Rheumatic Disease Clinics of North America 31:1, 131-160
CrossRef2413
Peter G. Kopelman. (2005) Clinical treatment of obesity: are drugs and surgery the answer?. Proceedings of the Nutrition Society 64:01, 65-71
CrossRef2414
GENEVI??VE C. MAJOR, MARIE-??VE PICH??, JEAN BERGERON, S JOHN WEISNAGEL, ANDR?? NADEAU, SIMONE LEMIEUX. (2005) Energy Expenditure from Physical Activity and the Metabolic Risk Profile at Menopause. Medicine & Science in Sports & Exercise 37:2, 204-212
CrossRef2415
P. Betts, J. Mulligan, P. Ward, B. Smith, T. Wilkin. (2005) Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabetic Medicine 22:2, 144-151
CrossRef2416
Pablo F. Mora. (2005) Post-Transplantation Diabetes Mellitus. The American Journal of the Medical Sciences 329:2, 86-94
CrossRef2417
Susan L Norris, Xuanping Zhang, Alison Avenell, Edward Gregg, Christopher H Schmid, Joseph Lau, Susan L Norris. 2005. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. .
CrossRef2418
H Moore, CD Summerbell, L Hooper, V Ashton, P Kopelman, Helen Moore. 2005. Dietary advice for the prevention of type 2 diabetes mellitus in adults. .
CrossRef2419
Susan L Norris, Jinan Saadine, Farah M Chowdhury, Xuanping Zhang, Sanjat Kanjilal, Carol Mangione, Ralf Burhmann, Xuanping Zhang. 2005. Interventions to promote screening for diabetic retinopathy. .
CrossRef2420
Maren T. Scheuner. 2005. Approach to common chronic disorders of adulthood. .
CrossRef2421
Bernhard O. Boehm, Simone Claudi‐boehm. (2005) The Metabolic Syndrome. Scandinavian Journal of Clinical & Laboratory Investigation 65:s240, 3-13
CrossRef2422
Julia Wong, Shirley Wong, Swarna Weerasinghe, Lydia Makrides, Thelma Coward-Ince. (2005) Building community partnerships for diabetes primary prevention: lessons learned. Clinical Governance: An International Journal 10:1, 6-14
CrossRef2423
Baptist Gallwitz. (2005) Glucagon-Like Peptide-1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus. Treatments in Endocrinology 4:6, 361-370
CrossRef2424
Alfredo Halpern, Marcio C Mancini. (2005) Diabesity. Treatments in Endocrinology 4:2, 65-74
CrossRef2425
Jonathan Rappaport, Vivian Fonseca. (2005) Case-Based Study: From Prediabetes to Complications—Opportunities for Prevention. PLoS Medicine 2:2, e40
CrossRef2426
M. Noakes. 2005. Dietary fat and weight control. , 204-222.
CrossRef2427
L. Lissner. 2005. WEIGHT MANAGEMENT | Weight Cycling. , 421-427.
CrossRef2428
Margarite J Vale, Michael V Jelinek, James D Best. (2005) Impact of Coaching Patients on Coronary Risk Factors. Disease Management & Health Outcomes 13:4, 225-244
CrossRef2429
Jonathan A. Waitman, Louis J. Aronne. (2005) Pharmacotherapy of Obesity. Obesity Management 1:1, 15-19
CrossRef2430
A. T. Masi, J. C. Aldag. (2005) Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase?. Scandinavian Journal of Rheumatology 34:5, 342-352
CrossRef2431
Shigetaka Sugihara, Nozomu Sasaki, Hitoshi Kohno, Shin Amemiya, Toshiaki Tanaka, Nobuo Matsuura. (2005) Survey of Current Medical Treatments for Childhood-Onset Type 2 Diabetes Mellitus in Japan. Clinical Pediatric Endocrinology 14:2, 65-75
CrossRef2432
Yi-Jen Hung, Chang-Hsun Hsieh, Dee Pei, Shi-Wen Kuo, Jiunn-Tay Lee, Ling-Yi Wu, Chih-Tsueng He, Chien Hsing Lee, Sandra Chyi Fan, Wayne Huey-Herng Sheu. (2005) Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance. Clinical Endocrinology 62:1, 85-91
CrossRef2433
Itamar Raz, Roi Eldor, Simona Cernea, Eleazar Shafrir. (2005) Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes/Metabolism Research and Reviews 21:1, 3-14
CrossRef2434
Mark F. McCarty. (2005) AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome. Medical Hypotheses 64:6, 1211-1215
CrossRef2435
Caroline R Richardson, Beverley B Brown, Sharon Foley, Kathleen S Dial, Julie C Lowery. (2005) Feasibility of Adding Enhanced Pedometer Feedback to Nutritional Counseling for Weight Loss. Journal of Medical Internet Research 7:5, e56
CrossRef2436
J. Robinson Singleton, A. Gordon Smith, James Russell, Eva L. Feldman. (2005) Polyneuropathy with impaired glucose tolerance: Implications for diagnosis and therapy. Current Treatment Options in Neurology 7:1, 33-42
CrossRef2437
C. Meisinger, H. L
CrossRef2438
Scott A Paluska. (2005) An Overview of Hip Injuries in Running. Sports Medicine 35:11, 991-1014
CrossRef2439
Thorkild I.A. Sørensen, Aila Rissanen, Maarit Korkeila, Jaakko Kaprio. (2005) Intention to Lose Weight, Weight Changes, and 18-y Mortality in Overweight Individuals without Co-Morbidities. PLoS Medicine 2:6, e171
CrossRef2440
Yun-Jun Yang. (2005) Exercise in Diabetes Mellitus. Journal of the Korean Medical Association 48:9, 822
CrossRef2441
Kwan Woo Lee. (2005) The Importance of Lifestyle in the Prevention and Trearment of Diabetes. Journal of the Korean Medical Association 48:8, 703
CrossRef2442
Gerit‐Holger Schernthaner, Guntram Schernthaner. (2005) Insulin Resistance and Inflammation in the Early Phase of Type 2 Diabetes: Potential for Therapeutic Intervention. Scandinavian Journal of Clinical & Laboratory Investigation 65:s240, 30-40
CrossRef2443
B. Ahrén. 2005. GLUCOSE | Glucose Tolerance. , 405-412.
CrossRef2444
C. Ionescu-Tîrgovişte. (2005) Comment on: Godsland IF, Jeffs JAR, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157–1166. Diabetologia 48:1, 203-204
CrossRef2445
Peter Hertzman. (2005) The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden. PharmacoEconomics 23:10, 1007-1020
CrossRef2446
Maria Bitsori, Anthony Kafatos. (2005) Dysmetabolic syndrome in childhood and adolescence. Acta Paediatrica 94:8, 995
CrossRef2447
K. A. McAuley, C. M. Hopkins, K. J. Smith, R. T. McLay, S. M. Williams, R. W. Taylor, J. I. Mann. (2005) Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia 48:1, 8-16
CrossRef2448
Richard J Woodman, Gerard T Chew, Gerald F Watts. (2005) Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes Mellitus. Drugs 65:1, 31-74
CrossRef2449
Justin B. Lundbye, Paul D. Thompson. (2005) Statin use in the metabolic syndrome. Current Atherosclerosis Reports 7:1, 17-21
CrossRef2450
Andrew J Krentz, Clifford J Bailey. (2005) Oral Antidiabetic Agents. Drugs 65:3, 385-411
CrossRef2451
Craig S Stump, Suzanne E Clark, James R Sowers. (2005) Oxidative Stress in Insulin-Resistant Conditions. Treatments in Endocrinology 4:6, 343-351
CrossRef2452
A. De Nayer, M. De Hert, A. Scheen, L. Van Gaal, J Peuskens, on behalf of the Consensus Group, A. De Nayer, M. De Hert, A. Scheen, L. Van Gaal, J Peuskens, on behalf of the Consensus Group. (2005) Belgian consensus on metabolic problems associated with atypical antipsychotics. International Journal of Psychiatry in Clinical Practice 9:2, 130-137
CrossRef2453
Josep M. Argil
CrossRef2454
Hye Soon Park, Jee-Young Park, Hong-Jun Cho. (2005) Attitudes and Reported Practice for Obesity Management in Korea After Introduction of Anti-obesity Agents. Journal of Korean Medical Science 20:1, 1
CrossRef2455
Peter M. Rothwell. (2005) Prevention of Stroke in Patients with Diabetes mellitus and the Metabolic Syndrome. Cerebrovascular Diseases 20:1, 24-34
CrossRef2456
Lawrence Blonde. (2005) Current challenges in diabetes management. Clinical Cornerstone 7, S6-S17
CrossRef2457
Marie Thearle, Anne Marie B Brillantes. (2005) Unique characteristics of the geriatric diabetic population and the role for therapeutic strategies that enhance glucagon-like peptide-1 activity. Current Opinion in Clinical Nutrition and Metabolic Care 8:1, 9-16
CrossRef2458
Tom L. Broderick, Paul Poirier, Melissa Gillis. (2005) Exercise training restores abnormal myocardial glucose utilization and cardiac function in diabetes. Diabetes/Metabolism Research and Reviews 21:1, 44-50
CrossRef2459
Paul J. Hershberger, Jean M. Edwards, John R. Rudisill. (2005) Consultation to Help Individuals Cope With Lifestyle Modification.. Consulting Psychology Journal: Practice and Research 57:2, 133-141
CrossRef2460
H. Maeda, R. Yamamoto, K. Hirao, O. Tochikubo. (2005) Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes. Diabetes, Obesity and Metabolism 7:1, 40-46
CrossRef2461
Gwanpyo Koh, Jeong-taek Woo. (2005) Prevention of Metabolic Syndrome. Journal of the Korean Medical Association 48:12, 1188
CrossRef2462
Jean Kinsey. (2005) Will food safety jeopardize food security?. Agricultural Economics 32:s1, 149-158
CrossRef2463
G BIOLO, B CIOCCHI, M STULLE, A PICCOLI, S LORENZON, V DALMAS, R BARAZZONI, M ZANETTI, G GUARNIERI. (2005) Metabolic consequences of physical inactivity. Journal of Renal Nutrition 15:1, 49-53
CrossRef2464
Juergen M Weiss, Sascha Tauchert, Annika K Ludwig, K Diedrich. (2005) Treatment strategies in PCOS patients. Reproductive BioMedicine Online 10, 67-74
CrossRef2465
Sjöström, Lars, Lindroos, Anna-Karin, Peltonen, Markku, Torgerson, Jarl, Bouchard, Claude, Carlsson, Björn, Dahlgren, Sven, Larsson, Bo, Narbro, Kristina, Sjöström, Carl David, Sullivan, Marianne, Wedel, Hans, . (2004) Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. New England Journal of Medicine 351:26, 2683-2693
Full Text2466
Donna H Ryan, Tiffany M Stewart. (2004) Medical Management of Obesity in Women: Office-Based Approaches to Weight Management. Clinical Obstetrics and Gynecology 47:4, 914-927
CrossRef2467
S NAKANISHI, M OKUBO, M YONEDA, K JITSUIKI, K YAMANE, N KOHNO. (2004) A comparison between Japanese-Americans living in Hawaii and Los Angeles and native Japanese: the impact of lifestyle westernization on diabetes mellitus. Biomedecine & Pharmacotherapy 58:10, 571-577
CrossRef2468
J.I. Mann, I. De Leeuw, K. Hermansen, B. Karamanos, B. Karlström, N. Katsilambros, G. Riccardi, A.A. Rivellese, S. Rizkalla, G. Slama, M. Toeller, M. Uusitupa, B. Vessby. (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases 14:6, 373-394
CrossRef2469
Aaron L. Carrel, David T. Bernhardt. (2004) Exercise prescription for the prevention of obesity in adolescents. Current Sports Medicine Reports 3:6, 330-336
CrossRef2470
A Consoli, R Gomis, S Halimi, PD Home, H Mehnert, K Strojek, LF Van Gaal. (2004) Initiating oral glucose-lowering therapy with metformin in tyape 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications. Diabetes & Metabolism 30:6, 509-516
CrossRef2471
Y. Rodríguez, M. Giri, E. Feyen, A.B. Christophe. (2004) Effect of metformin vs. placebo treatment on serum fatty acids in non-diabetic obese insulin resistant individuals. Prostaglandins, Leukotrienes and Essential Fatty Acids 71:6, 391-397
CrossRef2472
R. Villegas, A. Salim, A. Flynn, I.J. Perry. (2004) Prudent diet and the risk of insulin resistance. Nutrition, Metabolism and Cardiovascular Diseases 14:6, 334-343
CrossRef2473
R. Stoeckli, U. Keller. (2004) Nutritional fats and the risk of type 2 diabetes and cancer. Physiology & Behavior 83:4, 611-615
CrossRef2474
Michael Charlton. (2004) Nonalcoholic fatty liver disease: A review of current understanding and future impact. Clinical Gastroenterology and Hepatology 2:12, 1048-1058
CrossRef2475
K PARK. (2004) Prevention of type 2 diabetes mellitus from the viewpoint of genetics. Diabetes Research and Clinical Practice 66, S33-S35
CrossRef2476
Sandeep Vijan, Rodney A. Hayward, Kenneth M. Langa. (2004) The Impact of Diabetes on Workforce Participation: Results from a National Household Sample. Health Services Research 39:6p1, 1653-1670
CrossRef2477
Neil Schneiderman. (2004) Psychosocial, Behavioral, and Biological Aspects of Chronic Diseases. Current Directions in Psychological Science 13:6, 247-251
CrossRef2478
Jeffrey W. Olin, James Jang, Michael R. Jaff, Joshua A. Beckman, Thom Rooke. (2004) The Top 12 Advances in Vascular Medicine. Journal of Endovascular Therapy 11:SupplementII, II-21-II-31
CrossRef2479
Shinichi Kuriyama, Atsushi Hozawa, Kaori Ohmori, Yoshinori Suzuki, Yoshikazu Nishino, Kazuki Fujita, Yoshitaka Tsubono, Ichiro Tsuji. (2004) Joint impact of health risks on health care charges: 7-year follow-up of National Health Insurance beneficiaries in Japan (the Ohsaki Study). Preventive Medicine 39:6, 1194-1199
CrossRef2480
Michael M. Engelgau, Stephen Colagiuri, Ambady Ramachandran, Knut Borch-Johnsen, K.M. Venkat Narayan. (2004) Prevention of Type 2 Diabetes: Issues and Strategies for Identifying Persons for Interventions. Diabetes Technology & Therapeutics 6:6, 874-882
CrossRef2481
Guillermo Burlando, Ramiro A S??nchez, Felipe H Ramos, Carl E Mogensen, Alberto Zanchetti. (2004) Latin American consensus on diabetes mellitus and hypertension. Journal of Hypertension 22:12, 2229-2241
CrossRef2482
Bret H Goodpaster, Donna Wolf. (2004) Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatric Diabetes 5:4, 219-226
CrossRef2483
J.I. Mann, G. Riccardi. (2004) Evidence-based European guidelines on diet and diabetes. Nutrition, Metabolism and Cardiovascular Diseases 14:6, 332-333
CrossRef2484
S SADIKOT. (2004) Comparing the ADA 1997 and the WHO 1999 criteria: Prevalence of Diabetes in India Study. Diabetes Research and Clinical Practice 66:3, 309-315
CrossRef2485
David Edelman, Maren K. Olsen, Tara K. Dudley, Amy C. Harris, Eugene Z. Oddone. (2004) Utility of Hemoglobin A1c in Predicting Diabetes Risk. Journal of General Internal Medicine 19:12, 1175-1180
CrossRef2486
AJ Scheen. (2004) Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Diabetes & Metabolism 30:6, 487-496
CrossRef2487
Lindsay E. Robinson, Terry E. Graham. (2004) Metabolic Syndrome, a Cardiovascular Disease Risk Factor: Role of Adipocytokines and Impact of Diet and Physical Activity. Canadian Journal of Applied Physiology 29:6, 808-829
CrossRef2488
L. Van Gaal, I. Mertens, D. Ballaux, H.J. Verkade. (2004) Modern, new pharmacotherapy for obesity. A gastrointestinal approach. Best Practice & Research Clinical Gastroenterology 18:6, 1049-1072
CrossRef2489
SL Archer, KJ Greenlund, R Valdez, ML Casper, S Rith-Najarian, JB Croft. (2004) Differences in food habits and cardiovascular disease risk factors among Native Americans with and without diabetes: the Inter-Tribal Heart Project. Public Health Nutrition 7:08,
CrossRef2490
Olga Vaccaro, Maria Masulli, Vincenzo Cuomo, Angela Albarosa Rivellese, Matti Uusitupa, Bengt Vessby, Kjeld Hermansen, Linda Tapsell, Gabriele Riccardi. (2004) Comparative evaluation of simple indices of insulin resistance. Metabolism 53:12, 1522-1526
CrossRef2491
Pedro R. Moreno, Valentin Fuster. (2004) New aspects in the pathogenesis of diabetic atherothrombosis. Journal of the American College of Cardiology 44:12, 2293-2300
CrossRef2492
F GALERNEAU, S INZUCCHI. (2004) Diabetes mellitus in pregnancy. Obstetrics and Gynecology Clinics of North America 31:4, 907-933
CrossRef2493
Ross L. Prentice. (2004) Chronic disease prevention: public health potential and research needs. Statistics in Medicine 23:22, 3409-3420
CrossRef2494
Hofman, Paul L., Regan, Fiona, Jackson, Wendy E., Jefferies, Craig, Knight, David B., Robinson, Elizabeth M., Cutfield, Wayne S., . (2004) Premature Birth and Later Insulin Resistance. New England Journal of Medicine 351:21, 2179-2186
Full Text2495
Cynthia V. Ferchak, Luigi F. Meneghini. (2004) Obesity, bariatric surgery and type 2 diabetes?a systematic review. Diabetes/Metabolism Research and Reviews 20:6, 438-445
CrossRef2496
Lisa L. Willett, Eric S. Albright. (2004) Achieving Glycemic Control in Type 2 Diabetes: A Practical Guide for Clinicians on Oral Hypoglycemics. Southern Medical Journal 97:11, 1088-1092
CrossRef2497
Eleni I. Boutati, Sotirios A. Raptis. (2004) Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice. Diabetes/Metabolism Research and Reviews 20:S2, S13-S23
CrossRef2498
Maeve Moran. (2004) The evolution of the nutritional management of diabetes. Proceedings of the Nutrition Society 63:04, 615-620
CrossRef2499
Ali A. Rizvi. (2004) Type 2 Diabetes: Epidemiologic Trends, Evolving Pathogenic Concepts, and Recent Changes in Therapeutic Approach. Southern Medical Journal 97:11, 1079-1087
CrossRef2500
Karin A. Mack, Lynda Anderson, Deborah Galuska, Diane Zablotsky, Deborah Holtzman, Indu Ahluwalia. (2004) Health and Sociodemographic Factors Associated with Body Weight and Weight Objectives for Women: 2000 Behavioral Risk Factor Surveillance System. Journal of Women's Health 13:9, 1019-1032
CrossRef2501
CAROLINE R. RICHARDSON, ANDREA M. KRISKA, PAULA M. LANTZ, RODNEY A. HAYWARD. (2004) Physical Activity and Mortality across Cardiovascular Disease Risk Groups. Medicine & Science in Sports & Exercise 36:11, 1923-1929
CrossRef2502
Jesse Roth, Xiaoling Qiang, Sharon Lee Marbán, Henry Redelt, Barbara C. Lowell. (2004) The Obesity Pandemic: Where Have We Been and Where Are We Going?. Obesity 12, 88S-101S
CrossRef2503
J. J. Caro, D. Getsios, I. Caro, W. S. Klittich, J. A. O'Brien. (2004) Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada. Diabetic Medicine 21:11, 1229-1236
CrossRef2504
L. A. Palinkas, P. P. Lee, E. Barrett-Connor. (2004) A prospective study of Type 2 diabetes and depressive symptoms in the elderly: The Rancho Bernardo Study. Diabetic Medicine 21:11, 1185-1191
CrossRef2505
Werner K. Waldhäusl. (2004) The metabolic syndrome and type 2 diabetes: What has gone wrong in type 2 diabetes care?. Current Diabetes Reports 4:6, 395-396
CrossRef2506
Adrienne Forman. (2004) The Second National Conference on Diabesity® in America. Nutrition Today 39:6, 245-253
CrossRef2507
J WANG. (2004) Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose. Diabetes Research and Clinical Practice 66:2, 183-191
CrossRef2508
LS Conwell, JA Batch. (2004) Oral glucose tolerance test in children and adolescents: Positives and pitfalls. Journal of Paediatrics and Child Health 40:11, 620-626
CrossRef2509
T STEER, S JEBB. (2004) Obesity: dietary treatment. Women's Health Medicine 1:1, 42-48
CrossRef2510
Jaime Guevara-Aguirre, Marco Guevara, Jeannette Saavedra, Marko Mihic, Pankaj Modi. (2004) Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study. Diabetes/Metabolism Research and Reviews 20:6, 472-478
CrossRef2511
Michael J. Wolk, C. Noel Bairey Merz, Paul D. Thompson. (2004) President's page: The promise of prevention: So, why aren't all cardiologists “preventive”?. Journal of the American College of Cardiology 44:10, 2082-2084
CrossRef2512
Julie V Smith, Leonie K Heilbronn, Eric Ravussin. (2004) Energy restriction and aging. Current Opinion in Clinical Nutrition and Metabolic Care 7:6, 615-622
CrossRef2513
X. Yu, S. McCorkle, M. Wang, Y. Lee, J. Li, A. K. Saha, R. H. Unger, N. B. Ruderman. (2004) Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia 47:11, 2012-2021
CrossRef2514
Cyril W. C. Kendall, David J. A. Jenkins. (2004) A Dietary portfolio: Maximal reduction of low-density lipoprotein cholesterol with diet. Current Atherosclerosis Reports 6:6, 492-498
CrossRef2515
Michael M. Bond, Scott W. Yates. (2004) Is the Future Bright for Diabetes?. Southern Medical Journal 97:11, 1027-1028
CrossRef2516
&NA;. (2004) Body Mass Index and Insulin Resistance. Obstetrics & Gynecology 104:Supplement, 5S-10S
CrossRef2517
Catherine L. Davis. (2004) Highlights of NIDDK's Translational Diabetes and Obesity Research Conference. Diabetes Technology & Therapeutics 6:5, 750-754
CrossRef2518
S. Caprio, R. Weiss. (2004) The metabolic phenotype of pre-diabetes in obese youth. Nutrition, Metabolism and Cardiovascular Diseases 14:5, 270-275
CrossRef2519
William H. Bestermann, Daniel T. Lackland, Jessica E. Riehle, Brent M. Egan. (2004) A Systematic Approach to Managing Hypertension and the Metabolic Syndrome in Primary Care. Southern Medical Journal 97:10, 932-938
CrossRef2520
Bulent O Yildiz. (2004) Recent advances in the treatment of polycystic ovary syndrome. Expert Opinion on Investigational Drugs 13:10, 1295-1305
CrossRef2521
Susan J. Appel, Joyce Newman Giger, Natalie A. Floyd. (2004) Dysmetabolic Syndrom. The Nurse Practitioner 29:10, 18-35
CrossRef2522
F. Civeira Murillo, E. Meriño-Ibarra, J. Mozota Duarte, J.A. Pinilla López-Oliva. (2004) Síndrome metabólico. Medicine - Programa de Formación Médica Continuada Acreditado 9:18, 1131-1139
CrossRef2523
S. Del Prato, P. Marchetti. (2004) Targeting Insulin Resistance and β-Cell Dysfunction: The Role of Thiazolidinediones. Diabetes Technology & Therapeutics 6:5, 719-731
CrossRef2524
M. S. Eberhardt, E. R. Pamuk. (2004) The Importance of Place of Residence: Examining Health in Rural and Nonrural Areas. American Journal of Public Health 94:10, 1682-1686
CrossRef2525
E. J. Mayer-Davis, A. M. D'Antonio, S. M. Smith, G. Kirkner, S. Levin Martin, D. Parra-Medina, R. Schultz. (2004) Pounds Off With Empowerment (POWER): A Clinical Trial of Weight Management Strategies for Black and White Adults With Diabetes Who Live in Medically Underserved Rural Communities. American Journal of Public Health 94:10, 1736-1742
CrossRef2526
I FRASER, G KOVACS. (2004) Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology 18:5, 813-823
CrossRef2527
Yki-Järvinen, Hannele, . (2004) Thiazolidinediones. New England Journal of Medicine 351:11, 1106-1118
Full Text2528
Antonios M Xydakis, Christie M Ballantyne. (2004) Management of metabolic syndrome: statins. Endocrinology & Metabolism Clinics of North America 33:3, 509-523
CrossRef2529
Judy Lau Carino, Lola Coke, Meg Gulanick. (2004) Using Motivational Interviewing to Reduce Diabetes Risk. Progress in Cardiovascular Nursing 19:4, 149-154
CrossRef2530
Yuriko Yoshida, Naotake Hashimoto, Yoshiharu Tokuyama, Hiroshi Kitagawa, Kazuo Takahashi, Kazuo Yagui, Azuma Kanatsuka, Hideaki Bujo, Mayumi Higurashi, Saori Miyazawa, Shouji Yoshida, Yasushi Saito. (2004) Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis. Metabolism 53:9, 1095-1100
CrossRef2531
(2004) Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 47:9, 1519-1527
CrossRef2532
Arne Astrup, Thomas Meinert Larsen, Angela Harper. (2004) Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss?. The Lancet 364:9437, 897-899
CrossRef2533
Yasameen A. Shakir, G??ran Samsioe, Christina Nerbrand, Jonas Lidfeldt. (2004) Combined hormone therapy in postmenopausal women with features of metabolic syndrome. Results from a population-based study of Swedish women: Women???s Health in the Lund Area study. Menopause 11:5, 549-555
CrossRef2534
Nancy L. Keim, Cynthia A. Blanton, Mary J. Kretsch. (2004) America’s obesity epidemic: Measuring physical activity to promote an active lifestyle. Journal of the American Dietetic Association 104:9, 1398-1409
CrossRef2535
A WAGNER, C KLEINPLATAT, D ARVEILER, M HAAN, J SCHLIENGER, C SIMON. (2004) Parent-child physical activity relationships in 12-year old French students do not depend on family socioeconomic status. Diabetes & Metabolism 30:4, 359-366
CrossRef2536
Marion J. Franz. (2004) Effectiveness of weight loss and maintenance interventions in women. Current Diabetes Reports 4:5, 387-393
CrossRef2537
Mizuho Tokudome, Masaru Nagasaki, Kiyoshi Shimaoka, Yuzo Sato. (2004) Effects of home-based combined resistance training and walking on metabolic profiles in elderly Japanese. Geriatrics and Gerontology International 4:3, 157-162
CrossRef2538
Parin Parikh, Rahul Garg, Andrew Atiemo, Chandrasekhar R. Vasamreddy, Vicki Chan, Roger S. Blumenthal. (2004) The Metabolic Syndrome: What to Treat, How to Treat, What Are the Goals?. The American Heart Hospital Journal 2:4, 191-197
CrossRef2539
M. Savage. (2004) Screening for glucose intolerance post myocardial infarction. Diabetic Medicine 21:s4, 12-13
CrossRef2540
R. L. Prentice, W. C. Willett, P. Greenwald, D. Alberts, L. Bernstein, N. F. Boyd, T. Byers, S. K. Clinton, G. Fraser, L. Freedman, D. Hunter, V. Kipnis, L. N. Kolonel, B. S. Kristal, A. Kristal, J. W. Lampe, A. McTiernan, J. Milner, R. E. Patterson, J. D. Potter, E. Riboli, A. Schatzkin, A. Yates, E. Yetley. (2004) Nutrition and Physical Activity and Chronic Disease Prevention: Research Strategies and Recommendations. JNCI Journal of the National Cancer Institute 96:17, 1276-1287
CrossRef2541
Paul Nestel. (2004) Nutritional aspects in the causation and management of the metabolic syndrome. Endocrinology & Metabolism Clinics of North America 33:3, 483-492
CrossRef2542
Kathleen L. Wyne. (2004) Management of Type 2 Diabetes Mellitus: Is It Time for a Paradigm Shift?. Metabolic Syndrome and Related Disorders 2:4, 251-262
CrossRef2543
J. Cabezas-Cerrato, J.M. Cabezas Agrícola. (2004) Tratamiento no farmacológico y farmacológico de la diabetes mellitus. Medicine - Programa de Formación Médica Continuada Acreditado 9:16, 1000-1007
CrossRef2544
Daniel Einhorn, Vanita R Aroda, Robert R Henry. (2004) Glitazones and the management of insulin resistance: what they do and how might they be used. Endocrinology & Metabolism Clinics of North America 33:3, 595-616
CrossRef2545
J.L. Herrera Pombo, O. Sánchez-Vilar. (2004) Diabetes mellitus tipo 2. Manifestaciones clínicas y seguimiento. Referencia a la medicina especializada. Medicine - Programa de Formación Médica Continuada Acreditado 9:16, 981-989
CrossRef2546
Robert S. Gaston, Giacomo Basadonna, Fernando G. Cosio, Connie L. Davis, Bertram L. Kasiske, Jennifer Larsen, Alan B. Leichtman, Francis L. Delmonico. (2004) Transplantation in the diabetic patient with advanced chronic kidney disease: A task force report. American Journal of Kidney Diseases 44:3, 529-542
CrossRef2547
Robert S Rosenson, Charles A Reasner. (2004) Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes. Current Opinion in Cardiology 19:5, 480-487
CrossRef2548
Neil J. Stone. (2004) Focus on lifestyle change and the metabolic syndrome. Endocrinology & Metabolism Clinics of North America 33:3, 493-508
CrossRef2549
James N. Roemmich, Emily Y. Liu, Alan D. Rogol, Leonard H. Epstein, Teresa Quattrin. (2004) Diminished Insulin Resistance with Weight Loss in Severely Overweight Youth. Metabolic Syndrome and Related Disorders 2:3, 160-168
CrossRef2550
T. A. Jacobson, C. C. Case, S. Roberts, A. Buckley, K. M. Murtaugh, J. C. Y. Sung, D. Gause, C. Varas, C. M. Ballantyne. (2004) Characteristics of US adults with the metabolic syndrome and therapeutic implications. Diabetes, Obesity and Metabolism 6:5, 353-362
CrossRef2551
Roderick E. Warren. (2004) The stepwise approach to the management of type 2 diabetes. Diabetes Research and Clinical Practice 65, S3-S8
CrossRef2552
Karen R. Segal. (2004) Type 2 Diabetes and Disease Management: Exploring the Connections. Disease Management 7:supplement 1, S-11-S-22
CrossRef2553
Marion J. Franz. (2004) Is weight loss the best lifestyle intervention for type 2 diabetes?. Current Diabetes Reports 4:5, 361-363
CrossRef2554
David L. Katz. (2004) Lifestyle and dietary modification for prevention of heart failure. Medical Clinics of North America 88:5, 1295-1320
CrossRef2555
C Sierra, Luis M Ruilope. (2004) Novel antihypertensive agents. Expert Opinion on Investigational Drugs 13:8, 987-998
CrossRef2556
Ehud Arbit. (2004) The Physiological Rationale for Oral Insulin Administration. Diabetes Technology & Therapeutics 6:4, 510-517
CrossRef2557
Hidekazu Arai, Akira Mizuno, Kaoru Matsuo, Makiko Fukaya, Hajime Sasaki, Hirofumi Arima, Motoi Matsuura, Yutaka Taketani, Toshio Doi, Eiji Takeda. (2004) Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion. Metabolism 53:8, 977-983
CrossRef2558
Martie Truschnig-Wilders, Bernhard O. Boehm, Winfried März. (2004) Laboratoriumsdiagnostik bei Diabetes mellitus/Laboratory diagnostics in patients with diabetes mellitus. LaboratoriumsMedizin 28:4, 334-345
CrossRef2559
Kathleen M Hoeger, Lynda Kochman, Nellie Wixom, Kimberly Craig, Richard K Miller, David S Guzick. (2004) A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: A pilot study. Fertility and Sterility 82:2, 421-429
CrossRef2560
SHUEI-LIONG LIN, YUNG-MING CHEN, WEN-CHIH CHIANG, TUN-JUN TSAI, WAN-YU CHEN. (2004) Review Article. Pentoxifylline: A potential therapy for chronic kidney disease. Nephrology 9:4, 198-204
CrossRef2561
Stuart JH Biddle, Trish Gorely, David J Stensel. (2004) Health-enhancing physical activity and sedentary behaviour in children and adolescents. Journal of Sports Sciences 22:8, 679-701
CrossRef2562
H YOKOYAMA, M EMOTO, S FUJIWARA, K MOTOYAMA, T MORIOKA, H KOYAMA, T SHOJI, M INABA, Y NISHIZAWA. (2004) Short-term aerobic exercise improves arterial stiffness in type 2 diabetes. Diabetes Research and Clinical Practice 65:2, 85-93
CrossRef2563
Charlotte Keller, Pernille Keller, Mercé Giralt, Juan Hidalgo, Bente Klarlund Pedersen. (2004) Exercise normalises overexpression of TNF-α in knockout mice. Biochemical and Biophysical Research Communications 321:1, 179-182
CrossRef2564
Susan J. Appel, Ellen D. Jones, Laurie Kennedy-Malone. (2004) Central Obesity and the Metabolic Syndrome: Implications for Primary Care Providers. Journal of the American Academy of Nurse Practitioners 16:8, 335-342
CrossRef2565
George A Bray. (2004) The epidemic of obesity and changes in food intake: the Fluoride Hypothesis. Physiology & Behavior 82:1, 115-121
CrossRef2566
F BONNET, M LAVILLE. (2004) Le syndrome métabolique : une entité à haut risque métabolique et cardiovasculaire. Cahiers de Nutrition et de Diététique 39:4, 285-289
CrossRef2567
Konstantinos Makrilakis, Demosthenes B. Panagiotakos, Christos Pitsavos, Christina Chrysohoou, Ioannis Ioannidis, Charilaos Dimosthenopoulos, Pavlos Toutouzas, Christodoulos Stefanadis, Nikolaos Katsilambros. (2004) The association between physical activity and the development of acute coronary syndromes in diabetic subjects (the CARDIO2000 II study). European Journal of Cardiovascular Prevention & Rehabilitation 11:4, 298-303
CrossRef2568
Andrew J Palmer, William J Valentine, Joshua A Ray. (2004) Cost-effectiveness studies of diabetes prevention in high-risk patients. Expert Review of Pharmacoeconomics & Outcomes Research 4:4, 393-402
CrossRef2569
JOHN A. HAWLEY, JOSEPH A. HOUMARD. (2004) Introduction???Preventing Insulin Resistance through Exercise: A Cellular Approach. Medicine & Science in Sports & Exercise 36:7, 1187-1190
CrossRef2570
G Terence Wilson, Tanya R Schlam. (2004) The transtheoretical model and motivational interviewing in the treatment of eating and weight disorders. Clinical Psychology Review 24:3, 361-378
CrossRef2571
John L Lin, Doris Armour. (2004) Selected medical management of the older rehabilitative patient. Archives of Physical Medicine and Rehabilitation 85, 76-82
CrossRef2572
G. A. Nichols, J. B. Brown. (2004) Functional status before and after diagnosis of Type 2 diabetes. Diabetic Medicine 21:7, 793-797
CrossRef2573
R. J. Durbin. (2004) Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance. Diabetes, Obesity and Metabolism 6:4, 280-285
CrossRef2574
(2004) SCREENING FOR DIABETES IN GENERAL PRACTICE. Preventive Cardiology 7:3, 142-143
CrossRef2575
Christine T. Tobin. (2004) 7 Basic Principles of Diabetes Care. Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional 22:7, 491-495
CrossRef2576
C. J. Bates, M. E. J. Lean, M. A. Mansoor, A. Prentice. (2004) Nutrient intakes; biochemical and risk indices associated with Type 2 diabetes and glycosylated haemoglobin, in the British National Diet and Nutrition Survey of people aged 65 years and over. Diabetic Medicine 21:7, 677-684
CrossRef2577
E. M. H. Mathus-Vliegen. (2004) Interventiestrategieën bij overgewicht. Bijblijven 20:9, 361-369
CrossRef2578
Allyson S. Gaylor, Michelle E. Condren. (2004) Type 2 Diabetes Mellitus in the Pediatric Population. Pharmacotherapy 24:7, 871-878
CrossRef2579
Katherine M. Flegal, Cynthia L. Ogden, Margaret D. Carroll. (2004) Prevalence and Trends in Overweight in Mexican-American Adults and Children. Nutrition Reviews 62, S144-S148
CrossRef2580
M. Parillo, G. Riccardi. (2004) Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. British Journal of Nutrition 92:01, 7
CrossRef2581
Kevin J Acheson. (2004) Carbohydrate and weight control: where do we stand?. Current Opinion in Clinical Nutrition and Metabolic Care 7:4, 485-492
CrossRef2582
Harold E Lebovitz. (2004) Oral antidiabetic agents: 2004. Medical Clinics of North America 88:4, 847-863
CrossRef2583
Victor J. Lawrence, Peter G. Kopelman. (2004) Medical consequences of obesity. Clinics in Dermatology 22:4, 296-302
CrossRef2584
N. Younis. (2004) The prevention of type 2 diabetes mellitus: recent advances. QJM 97:7, 451-455
CrossRef2585
Kelley, David E., . (2004) Thermodynamics, Liposuction, and Metabolism. New England Journal of Medicine 350:25, 2542-2544
Full Text2586
P. Koh-Banerjee. (2004) Changes in Body Weight and Body Fat Distribution as Risk Factors for Clinical Diabetes in US Men. American Journal of Epidemiology 159:12, 1150-1159
CrossRef2587
F Xavier Pi–Sunyer. 2004. Weight Loss and Metabolic Diseases. , 195-215.
CrossRef2588
Hans Hauner. 2004. Orlistat. , 219-244.
CrossRef2589
Paolo Suter. 2004. Weight Loss and Associated Diseases. , 173-193.
CrossRef2590
James Douketis, Arya Sharma, Tobias Pischon. 2004. Weight Loss and Cardiovascular Risk Factors. , 155-173.
CrossRef2591
Ulrich Keller. 2004. Appendix. , 465-465.
CrossRef2592
Ulrich Keller, Rolf Stöckli. 2004. Efficacy of Different Antiobesity Interventions. , 435-448.
CrossRef2593
Robin Whittemore, Gail D'Eramo Melkus, Margaret Grey. (2004) Applying the Social Ecological Theory to Type 2 Diabetes Prevention and Management. Journal of Community Health Nursing 21:2, 87-99
CrossRef2594
Gen Sarashina, Masaru Yamakoshi, Masayuki Noritake, Mamoru Takahashi, Masahiko Kure, Yoshiya Katsura, Hiroshi Shiomi, Isami Tsuboi, Shoji Kawazu, Fumio Yamagata, Makoto Tominaga, Takeshi Matsuoka. (2004) A study of urinary myo-inositol as a sensitive marker of glucose intolerance. Clinica Chimica Acta 344:1-2, 181-188
CrossRef2595
Andrea Natali, Ele Ferrannini. (2004) Hypertension, insulin resistance, and the metabolic syndrome. Endocrinology & Metabolism Clinics of North America 33:2, 417-429
CrossRef2596
Marie Clark. (2004) Is weight loss a realistic goal of treatment in type 2 diabetes?. Patient Education and Counseling 53:3, 277-283
CrossRef2597
(2004) Position of the American Dietetic Association and Dietitians of Canada: Nutrition and Women’s Health. Journal of the American Dietetic Association 104:6, 984-1001
CrossRef2598
Rosanne P. Farris, Dawn M. Haney, Diane O. Dunet. (2004) Expanding the Evidence for Health Promotion: Developing Best Practices for WISEWOMAN. Journal of Women's Health 13:5, 634-643
CrossRef2599
Jeffrey W Stephens, Steven J Hurel, Jacqueline A Cooper, Jayshree Acharya, George J Miller, Steve E Humphries. (2004) A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Molecular Genetics and Metabolism 82:2, 180-186
CrossRef2600
Julie P. Sutherland, Benjamin McKinley, Robert H. Eckel. (2004) The Metabolic Syndrome and Inflammation. Metabolic Syndrome and Related Disorders 2:2, 82-104
CrossRef2601
A. Dotevall, S. Johansson, L. Wilhelmsen, A. Rosengren. (2004) Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA*study. Diabetic Medicine 21:6, 615-622
CrossRef2602
(2004) A new evidence-based model for weight management in primary care: the Counterweight Programme. Journal of Human Nutrition and Dietetics 17:3, 191-208
CrossRef2603
S. M. A. Bennett, A. Agrawal, H. Elasha, M. Heise, N. P. Jones, M. Walker, J. P. H. Wilding. (2004) Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance. Diabetic Medicine 21:5, 415-422
CrossRef2604
Jean-Francois Louet, Cedric LeMay, Franck Mauvais-Jarvis. (2004) Antidiabetic actions of estrogen: Insight from human and genetic mouse models. Current Atherosclerosis Reports 6:3, 180-185
CrossRef2605
Jodi Godfrey. (2004) Toward Optimal Health: The Experts Discuss Advances in Diabetes Management in Women. Journal of Women's Health 13:4, 365-370
CrossRef2606
Jeanne H. Steppel, Edward S. Horton. (2004) Beta-cell failure in the pathogenesis of type 2 diabetes mellitus. Current Diabetes Reports 4:3, 169-175
CrossRef2607
M. J. Davies, J. R. Tringham, J. Troughton, K. K. Khunti. (2004) Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting. Diabetic Medicine 21:5, 403-414
CrossRef2608
M Gomyo. (2004) Effects of sex, age and BMI on screening tests for impaired glucose tolerance. Diabetes Research and Clinical Practice 64:2, 129-136
CrossRef2609
David JA Jenkins. (2004) Psychological, physiological, and drug interventions for type 2 diabetes. The Lancet 363:9421, 1569-1570
CrossRef2610
&NA;. (2004) Screening for Obesity in Adults: Recommendations and Rationale. AJN, American Journal of Nursing 104:5, 94-102
CrossRef2611
R��mi Rabasa-Lhoret, Jean-Louis Chiasson. 2004. ��-Glucosidase Inhibitors. .
CrossRef2612
Henrik Galbo, Erik A. Richter. 2004. Exercise. .
CrossRef2613
Qing Qiao, Desmond E. Williams, Giuseppina Imperatore, K.M. Venkat Narayan, Jaakko Tuomilehto. 2004. Epidemiology and Geography of Type 2 Diabetes Mellitus. .
CrossRef2614
Rury Holman. 2004. Should We Treat Impaired Glucose Tolerance and Impaired Fasting Glycemia?. .
CrossRef2615
James S. Forrester. (2004) Common ancestors: Chronic progressive diseases have the same pathogenesis. Clinical Cardiology 27:4, 186-190
CrossRef2616
CR Hankey, S Eley, WS Leslie, CM Hunter, MEJ Lean. (2004) Eating habits, beliefs, attitudes and knowledge among health professionals regarding the links between obesity, nutrition and health. Public Health Nutrition 7:02,
CrossRef2617
P. E. Heldgaard, N. de. F. Olivarius, C. Hindsberger, J. E. Henriksen. (2004) Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease. Diabetic Medicine 21:4, 363-370
CrossRef2618
David Maahs, Phil Zeitler. (2004) Type 2 diabetes in children: a growing epidemic. Current Opinion in Endocrinology & Diabetes 11:2, 60-64
CrossRef2619
SHIVAKUMAR CHITTURI, GEOFFREY C FARRELL, JACOB GEORGE. (2004) Non-alcoholic steatohepatitis in the Asia-Pacific region: Future shock?. Journal of Gastroenterology and Hepatology 19:4, 368-374
CrossRef2620
Andrea M. Kriska, Linda M. Delahanty, Kelley K. Pettee. (2004) Lifestyle intervention for the prevention of type 2 diabetes: Translation and future recommendations. Current Diabetes Reports 4:2, 113-118
CrossRef2621
Harold E. Lebovitz, Mary Ann Banerji. (2004) Treatment of insulin resistance in diabetes mellitus. European Journal of Pharmacology 490:1-3, 135-146
CrossRef2622
G. Marchesini, G. Forlani, F. Cerrelli, R. Manini, S. Natale, L. Baraldi, G. Ermini, G. Savorani, D. Zocchi, N. Melchionda. (2004) WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabetic Medicine 21:4, 383-387
CrossRef2623
H COMBE, S VOL, A THEVENOT, G LASFARGUES, E CACES, J TICHET, P LECOMTE. (2004) Comparison of men with impaired fasting glycaemia to controls and to diabetic subjects with fasting glycaemia from 7.0 to 7.7 mmol/l: clinical, nutritional and biological status. Diabetes & Metabolism 30:2, 167-174
CrossRef2624
Giulio Marchesini, Nazario Melchionda, Giovanni Apolone, Massimo Cuzzolaro, Edoardo Mannucci, Francesco Corica, Enzo Grossi. (2004) The metabolic syndrome in treatment-seeking obese persons. Metabolism 53:4, 435-440
CrossRef2625
Neil Ruderman, Marc Prentki. (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nature Reviews Drug Discovery 3:4, 340-351
CrossRef2626
Lawrence Blonde, George E. Dailey, Serge A. Jabbour, Charles A. Reasner, Donna J. Mills. (2004) Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study. Current Medical Research and Opinion 20:4, 565-572
CrossRef2627
B. Charbonnel, B. Bouhanick, C. Le Feuvre. (2004) Recommandations SFC/ALFEDIAM sur la prise en charge du patient diabétique vu par le cardiologue. Diabetes & Metabolism 30:2, 2S9-2S24
CrossRef2628
Shanti Serdy, Martin J. Abrahamson. (2004) Durability of Glycemic Control: A Feature of the Thiazolidinediones. Diabetes Technology & Therapeutics 6:2, 179-189
CrossRef2629
Ulrich Keller. (2004) Zukunftsperspektiven in der Therapie des Typ-2-Diabetes. Wiener Klinische Wochenschrift 116:7-8, 213-214
CrossRef2630
Sunder Mudaliar, Robert R. Henry. 2004. Thiazolidinediones as PPAR Agonists. .
CrossRef2631
Alan J. Garber. 2004. Metformin and Other Biguanides: Pharmacology and Therapeutic Usage. .
CrossRef2632
Assiamira Ferrara, Henry S. Kahn, Charles P. Quesenberry, Candice Riley, Monique M. Hedderson. (2004) An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000. Obstetrics & Gynecology 103:3, 526-533
CrossRef2633
Margriet Kruijshoop, Edith J.M. Feskens, Ellen E. Blaak, Tjerk W.A. de Bruin. (2004) Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population. Clinica Chimica Acta 341:1-2, 33-40
CrossRef2634
&NA;. (2004) Screening for Type 2 Diabetes Mellitus in Adults: Recommendations and Rationale. AJN, American Journal of Nursing 104:3, 83-90
CrossRef2635
Brian K. Irons, Timothy A. Mazzolini, Ronald Shane Greene. (2004) Delaying the Onset of Type 2 Diabetes Mellitus in Patients with Prediabetes. Pharmacotherapy 24:3, 362-371
CrossRef2636
Arati Wagh, Neil J Stone. (2004) Treatment of metabolic syndrome. Expert Review of Cardiovascular Therapy 2:2, 213-228
CrossRef2637
Lori Mosca, Lawrence J Appel, Emelia J Benjamin, Kathy Berra, Nisha Chandra-Strobos, Rosalind P Fabunmi, Deborah Grady, Constance K Haan, Sharonne N Hayes, Debra R Judelson, Nora L Keenan, Patrick McBride, Suzanne Oparil, Pamela Ouyang, Mehmet C Oz, Michael E Mendelsohn, Richard C Pasternak, Vivian W Pinn, Rose Marie Robertson, Karin Schenck-Gustafsson, Cathy A Sila, Sidney C Smith, George Sopko, Anne L Taylor, Brian W Walsh, Nanette K Wenger, Christine L Williams. (2004) Evidence-based guidelines for cardiovascular disease prevention in women. Journal of the American College of Cardiology 43:5, 900-921
CrossRef2638
Arvind Modawal, Saba Ansari, Shazia Fazili. (2004) Management of Geriatric endocrine disorders. Comprehensive Therapy 30:1, 10-17
CrossRef2639
Folke Lindgärde, Miyaray Benavente Ercilla, Laura Retamozo Correa, Bo Ahrén. (2004) Body Adiposity, Insulin, and Leptin in Subgroups of Peruvian Amerindians. High Altitude Medicine & Biology 5:1, 27-31
CrossRef2640
Hannele Yki-J��rvinen. 2004. Glucose Toxicity. .
CrossRef2641
Maren T. Scheuner, Paula W. Yoon, Muin J. Khoury. (2004) Contribution of Mendelian disorders to common chronic disease: Opportunities for recognition, intervention, and prevention. American Journal of Medical Genetics 125C:1, 50-65
CrossRef2642
Robert S. Lindsay, Barbara V. Howard. (2004) Cardiovascular risk associated with the metabolic syndrome. Current Diabetes Reports 4:1, 63-68
CrossRef2643
Jaime Guevara-Aguirre, Marco Guevara, Jeannette Saavedra, Marko Mihic, Pankaj Modi. (2004) Beneficial Effects of Addition of Oral Spray Insulin (Oralin) on Insulin Secretion and Metabolic Control in Subjects with Type 2 Diabetes Mellitus Suboptimally Controlled on Oral Hypoglycemic Agents. Diabetes Technology & Therapeutics 6:1, 1-8
CrossRef2644
Sherita Hill Golden, Rachel Chong. (2004) Are there specific components of the insulin resistance syndrome that predict the increased atherosclerosis seen in type 2 diabetes mellitus?. Current Diabetes Reports 4:1, 26-30
CrossRef2645
Connie Van Vrancken, Christopher M. Bopp, Jared P. Reis, Katrina D. DuBose, Karen A. Kirtland, Barbara E. Ainsworth. (2004) The Prevalence of Leisure-Time Physical Activity Among Diabetics in South Carolina. Southern Medical Journal 97:2, 141-144
CrossRef2646
J. Pinkney, D. Kerrigan. (2004) Current status of bariatric surgery in the treatment of type 2 diabetes. Obesity Reviews 5:1, 69-78
CrossRef2647
Andrew J. Palmer, Stéphane Roze, William J. Valentine, Giatgen A. Spinas, Jonathan E. Shaw, Paul Z. Zimmet. (2004) Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clinical Therapeutics 26:2, 304-321
CrossRef2648
Richard S. Legro, V. Daniel Castracane, Robert P. Kauffman. (2004) Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls. Obstetrical & Gynecological Survey 59:2, 141-154
CrossRef2649
Paul Nestel. (2004) Metabolic syndrome: the new cardiovascular target. Current Opinion in Lipidology 15:1, 1-3
CrossRef2650
A. Ben-Haroush, Y. Yogev, M. Hod. (2004) Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabetic Medicine 21:2, 103-113
CrossRef2651
Susan D Driscoll, Gary E Meininger, Mark T Lareau, Sara E Dolan, Kathleen M Killilea, Colleen M Hadigan, Donald M Lloyd-Jones, Anne Klibanski, Walter R Frontera, Steven K Grinspoon. (2004) Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients. AIDS 18:3, 465-473
CrossRef2652
Ann M. Coulston, Virginia Peragallo-Dittko. (2004) Insulin resistance syndrome: a potent culprit in cardiovascular disease. Journal of the American Dietetic Association 104:2, 176-179
CrossRef2653
Alan Cass, Joan Cunningham, Paul Snelling, Zhiqiang Wang, Wendy Hoy. (2004) Exploring the pathways leading from disadvantage to end-stage renal disease for Indigenous Australians. Social Science & Medicine 58:4, 767-785
CrossRef2654
Manny Noakes, Peter Clifton. (2004) Weight loss, diet composition and cardiovascular risk. Current Opinion in Lipidology 15:1, 31-35
CrossRef2655
Maurizio Marra, Luca Scalfi, Franco Contaldo, Fabrizio Pasanisi. (2004) Fasting Respiratory Quotient as a Predictor of Long-Term Weight Changes in Non-Obese Women. Annals of Nutrition and Metabolism 48:3, 189-192
CrossRef2656
Alexander Tenenbaum, Enrique Z Fisman. (2004) Impaired Glucose Metabolism in Patients with Heart Failure. American Journal of Cardiovascular Drugs 4:5, 269-280
CrossRef2657
R Lee Kennedy, Kamal Chokkalingham, Ramalingam Srinivasan. (2004) Obesity in the elderly: who should we be treating, and why, and how?. Current Opinion in Clinical Nutrition and Metabolic Care 7:1, 3-9
CrossRef2658
Bulent O Yildiz, Olcay Gedik. (2004) Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome. Reproductive BioMedicine Online 8:6, 649-656
CrossRef2659
Hye Soon Park, Su Jung Sim, Jung Yul Park. (2004) Effect of Weight Reduction on Metabolic Syndrome in Korean Obese Patients. Journal of Korean Medical Science 19:2, 202
CrossRef2660
Andr?? J Scheen. (2004) Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System. Drugs 64:22, 2537-2565
CrossRef2661
M. C. Gulliford, D. Mahabir, B. Rocke. (2004) Diabetes-related inequalities in health status and financial barriers to health care access in a population-based study. Diabetic Medicine 21:1, 45-51
CrossRef2662
Nicolaas P Pronk, Jackie Boucher, Robert W Jeffery, Nancy E Sherwood, Raymond Boyle. (2004) Reducing the Incidence of Type 2 Diabetes Mellitus. Disease Management & Health Outcomes 12:4, 249-258
CrossRef2663
Kittichai Promrat, Glen Lutchman, Gabriel I. Uwaifo, Renee J. Freedman, Alejandro Soza, Theo Heller, Edward Doo, Marc Ghany, Ahalya Premkumar, Yoon Park, T. Jake Liang, Jack A. Yanovski, David E. Kleiner, Jay H. Hoofnagle. (2004) A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39:1, 188-196
CrossRef2664
Dick C Chan, Hugh P R Barrett, Gerald F Watts. (2004) Dyslipidemia in Visceral Obesity. American Journal of Cardiovascular Drugs 4:4, 227-246
CrossRef2665
James R Sowers, Edward D Frohlich. (2004) Insulin and insulin resistance:. Medical Clinics of North America 88:1, 63-82
CrossRef2666
Hans Hauner. (2004) Managing Type 2 Diabetes Mellitus in Patients with Obesity. Treatments in Endocrinology 3:4, 223-232
CrossRef2667
Arshag D Mooradian. (2004) Towards Single-Tablet Therapy for Type 2 Diabetes Mellitus. Treatments in Endocrinology 3:5, 279-287
CrossRef2668
Jason M Langheier, Ralph Snyderman. (2004) Prospective medicine: the role for genomics in personalized health planning. Pharmacogenomics 5:1, 1-8
CrossRef2669
Howard Leventhal, Michael A. Friedman. (2004) Does Establishing Fidelity of Treatment Help in Understanding Treatment Efficacy? Comment on Bellg et al. (2004).. Health Psychology 23:5, 452-456
CrossRef2670
Sean Carroll, Mike Dudfield. (2004) What is the Relationship Between Exercise and Metabolic Abnormalities?. Sports Medicine 34:6, 371-418
CrossRef2671
Richard W Grant, James B Meigs. (2004) Should the Insulin Resistance Syndrome be Treated in the Elderly?. Drugs & Aging 21:3, 141-151
CrossRef2672
Trinh Hermanns-L??, Andr?? Scheen, G??rald E Pi??rard. (2004) Acanthosis Nigricans Associated with Insulin Resistance. American Journal of Clinical Dermatology 5:3, 199-203
CrossRef2673
Kai I Cheang, John E Nestler. (2004) Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?. Reproductive BioMedicine Online 8:4, 440-447
CrossRef2674
Fevzi Akinci, Joseph Coyne, Bernard Healey, Joni Minear. (2004) National Performance Measures for Diabetes Mellitus Care. Disease Management & Health Outcomes 12:5, 285-298
CrossRef2675
Carlos A Aguilar-Salinas, Rosalba Rojas, Francisco J Gómez-Pérez, Victoria Valles, Juan Manuel Rı́os-Torres, Aurora Franco, Gustavo Olaiz, Juan A Rull, Jaime Sepúlveda. (2004) High prevalence of metabolic syndrome in Mexico. Archives of Medical Research 35:1, 76-81
CrossRef2676
Michael Brownlee. (2003) A radical explanation for glucose-induced β cell dysfunction. Journal of Clinical Investigation 112:12, 1788-1790
CrossRef2677
Marie Thearle, Louis J Aronne. (2003) Obesity and pharmacologic therapy. Endocrinology & Metabolism Clinics of North America 32:4, 1005-1024
CrossRef2678
Jason M Hui, Archana Sud, Geoffrey C Farrell, Priyanka Bandara, Karen Byth, James G Kench, Geoffrey W McCaughan, Jacob George. (2003) Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 125:6, 1695-1704
CrossRef2679
Carol A Maggio, F.Xavier Pi-Sunyer. (2003) Obesity and type 2 diabetes. Endocrinology & Metabolism Clinics of North America 32:4, 805-822
CrossRef2680
Raymond A Plodkowski, Sachiko T St. Jeor. (2003) Medical nutrition therapy for the treatment of obesity. Endocrinology & Metabolism Clinics of North America 32:4, 935-965
CrossRef2681
Cynthia L Ogden, Margaret D Carroll, Katherine M Flegal. (2003) Epidemiologic trends in overweight and obesity. Endocrinology & Metabolism Clinics of North America 32:4, 741-760
CrossRef2682
Pierre Chue, Christopher S Kovacs. (2003) Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management. Bipolar Disorders 5:s2, 62-79
CrossRef2683
B Guerci, P Drouin, V Grangé, P Bougnères, P Fontaine, V Kerlan, P Passa, Ch Thivolet, B Vialettes, B Charbonnel. (2003) Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes & Metabolism 29:6, 587-594
CrossRef2684
(2003) The dietitians challenge: the implementation of nutritional advice for people with diabetes. Journal of Human Nutrition and Dietetics 16:6, 421-452
CrossRef2685
Thomas A Wadden, Meghan L Butryn. (2003) Behavioral treatment of obesity. Endocrinology & Metabolism Clinics of North America 32:4, 981-1003
CrossRef2686
Guy De Backer, Ettore Ambrosioni, Knut Broch-Johnsen, Carlos Brotons, Renata Cifkova, Jean Dallongeville, Shah Ebrahim, Ole Faergeman, Ian Graham, Guiseppe Mancia, Volkert Manger Cats, Kristina Orth-Gom??r, Joep Perk, Kalevi Py??r??l??, Jos?? L. Rodicio, Susana Sans, Vedat Sansoy, Udo Sechtem, Sigmund Silber, Troels Thomsen, David Wood. (2003) European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European Journal of Cardiovascular Prevention and Rehabilitation 10:Supplement 1, S1-S78
CrossRef2687
Q. Qiao, J. Lindstrom, T. T. Valle, J. Tuomilehto. (2003) Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia. Diabetic Medicine 20:12, 1027-1033
CrossRef2688
Lorrene D. Ritchie, Sujatha Ganapathy, Gail Woodward-Lopez, Dana E. Gerstein, Sharon E. Fleming. (2003) Prevention of type 2 diabetes in youth: Etiology, promising interventions and recommendations. Pediatric Diabetes 4:4, 174-209
CrossRef2689
Annika K. Schröder, Sascha Tauchert, Olaf Ortmann, Klaus Diedrich, Jürgen M. Weiss. (2003) Die Insulinresistenz beim polyzystischen Ovar-Syndrom. Wiener Klinische Wochenschrift 115:23, 812-821
CrossRef2690
Stephen M. Setter, Jason L. Iltz, Jason Thams, R.Keith Campbell. (2003) Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy. Clinical Therapeutics 25:12, 2991-3026
CrossRef2691
George A Bray. (2003) Risks of obesity. Endocrinology & Metabolism Clinics of North America 32:4, 787-804
CrossRef2692
Ralph Snyderman, R Sanders Williams. (2003) Prospective Medicine: The Next Health Care Transformation. Academic Medicine 78:11, 1079-1084
CrossRef2693
J BLICKLE. (2003) Physiopathologie du diabète de type 2 : quelles implications thérapeutiques ?Type 2 diabetes mellitus pathogenesis: new therapeutic managements?. La Revue de Médecine Interne 24:11, 709-710
CrossRef2694
Harriette R. Mogul, Stephen J. Peterson, Bernard I. Weinstein, Jianyu Li, A Louis Southren. (2003) Long-Term (2???4 Year) Weight Reduction With Metformin Plus Carbohydrate-Modified Diet in Euglycemic, Hyperinsulinemic, Midlife Women (Syndrome W). Heart Disease 5:6, 384-392
CrossRef2695
(2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension 21:11, 1983-1992
CrossRef2696
G. Faulkner, A. A. Soundy, K. Lloyd. (2003) Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatrica Scandinavica 108:5, 324-332
CrossRef2697
Suma Vupputuri, Dale P Sandler. (2003) Lifestyle risk factors and chronic kidney disease. Annals of Epidemiology 13:10, 712-720
CrossRef2698
P.-J Guillausseau, M Laloi-Michelin. (2003) Physiopathologie du diabète de type 2. La Revue de Médecine Interne 24:11, 730-737
CrossRef2699
Guntram Schernthaner. (2003) Fortschritte in der Prävention des Typ-2-Diabetes. Wiener Klinische Wochenschrift 115:21-22, 745-757
CrossRef2700
Andrew Neil. (2003) Diabetes and cardiovascular disease. Diabetes, Obesity and Metabolism 5:s1, s11-s18
CrossRef2701
M DUMORTIER, F BRANDOU, A PEREZMARTIN, C FEDOU, J MERCIER, J BRUN. (2003) Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome. Diabetes & Metabolism 29:5, 509-518
CrossRef2702
P. Botas, E. Delgado, G. Castano, C. Diaz de Grenu, J. Prieto, F. J. Diaz-Cadorniga. (2003) Comparison of the diagnostic criteria for diabetes mellitus, WHO-1985, ADA-1997 and WHO-1999 in the adult population of Asturias (Spain). Diabetic Medicine 20:11, 904-908
CrossRef2703
Irene S. Hoffmann, Magaly Roa, Fatima Torrico, Luigi X. Cubeddu. (2003) Ondansetron and Metformin-Induced Gastrointestinal Side Effects. American Journal of Therapeutics 10:6, 447-451
CrossRef2704
Anastassios G. Pittas, MD. (2003) Prevention of Type 2 Diabetes. Laboratory Medicine 34:11, 790-795
CrossRef2705
J BLICKLE. (2003) Les études de prévention médicamenteuse du diabète de type 2 doivent-elles nous amener à changer nos prescriptions?. Diabetes & Metabolism 29:5, 547-553
CrossRef2706
J. H. Hays, A. DiSabatino, R. T. Gorman, S. Vincent, M. E. Stillabower. (2003) Effect of a High Saturated Fat and No-Starch Diet on Serum Lipid Subfractions in Patients With Documented Atherosclerotic Cardiovascular Disease. Mayo Clinic Proceedings 78:11, 1331-1336
CrossRef2707
Raj S Padwal, Diana Rucker, Stephanie K Li, Cintia Curioni, David CW Lau, Raj S Padwal. 2003. Long-term pharmacotherapy for obesity and overweight. .
CrossRef2708
Jonathan Shaw, Gary Dowse, Paul Zimmet, K.G.M.M. Alberti. 2003. Screening for Diabetes and Glucose Intolerance. .
CrossRef2709
(2003) Position of the American Dietetic Association: Integration of medical nutrition therapy and pharmacotherapy. Journal of the American Dietetic Association 103:10, 1363-1370
CrossRef2710
Elise Zimmerman, Judith Wylie-Rosett. (2003) Nutrition therapy for hypertension. Current Diabetes Reports 3:5, 404-411
CrossRef2711
Brent A. Neuschwander-Tetri, Elizabeth M. Brunt, Kent R. Wehmeier, Dana Oliver, Bruce R. Bacon. (2003) Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone. Hepatology 38:4, 1008-1017
CrossRef2712
PETER T. KATZMARZYK, ARTHUR S. LEON, JACK H. WILMORE, JAMES S. SKINNER, D. C. RAO, TUOMO RANKINEN, CLAUDE BOUCHARD. (2003) Targeting the Metabolic Syndrome with Exercise: Evidence from the HERITAGE Family Study. Medicine & Science in Sports & Exercise 35:10, 1703-1709
CrossRef2713
A. K. Jenum, C. Lorentzen, S. A. Anderssen, K. I. Birkeland, I. Holme, P. G. Lund-Larsen, Y. Ommundsen, T. Raastad, D. S. Thelle, R. Bahr. (2003) Promoting physical activity in a multi-ethnic district - methods and baseline results of a pseudo-experimental intervention study. European Journal of Cardiovascular Prevention & Rehabilitation 10:5, 387-396
CrossRef2714
Walter F. DeNino, Judith Korner, Louis J. Aronne. (2003) Central control of energy homeostasis. Current Opinion in Endocrinology & Diabetes 10:5, 330-333
CrossRef2715
Gerald M Devins, David C Mendelssohn, Paul E Barré, Yitzchak M Binik. (2003) Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. American Journal of Kidney Diseases 42:4, 693-703
CrossRef2716
(2003) The implementation of nutritional advice for people with diabetes. Diabetic Medicine 20:10, 786-807
CrossRef2717
T. Jorgensen, K. Borch-Johnsen, T. F. Thomsen, H. Ibsen, C. Glumer, C. Pisinger. (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). European Journal of Cardiovascular Prevention & Rehabilitation 10:5, 377-386
CrossRef2718
JASON M HUI, GEOFFREY C FARRELL. (2003) Clear messages from sonographic shadows? Links between metabolic disorders and liver disease, and what to do about them. Journal of Gastroenterology and Hepatology 18:10, 1115-1117
CrossRef2719
Frank M. Biro. (2003) Body morphology and its impact on adolescent and pediatric gynecology, with a special emphasis on polycystic ovary syndrome. Current Opinion in Obstetrics and Gynecology 15:5, 347-351
CrossRef2720
Stuart T. Haines. (2003) The Diabetes Epidemic: Can We Stop the Spread?. Pharmacotherapy 23:10, 1227-1231
CrossRef2721
(2003) A Comparison of Outcomes with Angiotensin-converting Enzyme. Current Hypertension Reports 5:5, 362-363
CrossRef2722
(2003) Low-Carbohydrate Diets as Compared with Low-Fat Diets. New England Journal of Medicine 349:10, 1000-1002
Full Text2723
Bo Isomaa. (2003) A major health hazard: The metabolic syndrome. Life Sciences 73:19, 2395-2411
CrossRef2724
P.J. Grant. (2003) Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes & Metabolism 29:4, 6S44-6S52
CrossRef2725
P. Zimmet, J. Shaw, K. G. M. M. Alberti. (2003) Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabetic Medicine 20:9, 693-702
CrossRef2726
J. L. Andersen, P. Schjerling, L. L. Andersen, F. Dela. (2003) Resistance training and insulin action in humans: effects of de-training. The Journal of Physiology 551:3, 1049-1058
CrossRef2727
X.M. Leverve, B. Guigas, D. Detaille, C. Batandier, E.A. Koceir, C. Chauvin, E. Fontaine, N.F. Wiernsperger. (2003) Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. Diabetes & Metabolism 29:4, 6S88-6S94
CrossRef2728
Mary Courtney Moore, Alan D Cherrington, David H Wasserman. (2003) Regulation of hepatic and peripheral glucose disposal. Best Practice & Research Clinical Endocrinology & Metabolism 17:3, 343-364
CrossRef2729
R. Giannarelli, M. Aragona, A. Coppelli, S. Del Prato. (2003) Reducing insulin resistance with metformin: the evidence today. Diabetes & Metabolism 29:4, 6S28-6S35
CrossRef2730
Amale A. Lteif, Kieren J. Mather, Charles M. Clark. (2003) Diabetes and Heart Disease. Cardiology in Review 11:5, 262-274
CrossRef2731
Gerald M. Reaven. (2003) The insulin resistance syndrome. Current Atherosclerosis Reports 5:5, 364-371
CrossRef2732
D Schuster, T Gaillard, S Rhinesmith, D Habash, K Osei. (2003) The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study. Metabolism 52:9, 1211-1217
CrossRef2733
Joseph J. Carlson, Veronica Monti. (2003) The Role of Inclusive Dietary Patterns for Achieving Secondary Prevention Cardiovascular Nutrition Guidelines and Optimal Cardiovascular Health. Journal of Cardiopulmonary Rehabilitation 23:5, 322-333
CrossRef2734
R.F. Schäfers. (2003) Do effects on blood pressure contribute to improved clinical outcomes with metformin?. Diabetes & Metabolism 29:4, 6S62-6S70
CrossRef2735
P. Vague. (2003) Is metformin more than an oral hypoglycaemic agent?. Diabetes & Metabolism 29:4, 6S5-6S7
CrossRef2736
C Pan. (2003) Efficacy of acarbose in Chinese subjects with impaired glucose tolerance. Diabetes Research and Clinical Practice 61:3, 183-190
CrossRef2737
Jerry Radziuk, Susan Pye. (2003) Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions. Best Practice & Research Clinical Endocrinology & Metabolism 17:3, 323-342
CrossRef2738
Marek H. Dominiczak. (2003) Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine. Clinical Chemistry and Laboratory Medicine 41:9, 1266-1278
CrossRef2739
M. A. Tambascia, B. Geloneze, E. M. Repetto, S. R. Geloneze, M Picolo, D. O. Magro. (2003) Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double-blind, randomized, placebo-controlled trial. Diabetes, Obesity and Metabolism 5:5, 338-344
CrossRef2740
Whadi-ah Talip, Nelia P Steyn, Marianne Visser, Karen E Charlton, Norman Temple. (2003) Development and validation of a knowledge test for health professionals regarding lifestyle modification. Nutrition 19:9, 760-766
CrossRef2741
Antonio Pantaleo, Joel Zonszein. (2003) Using Insulin as a Drug Rather Than as a Replacement Hormone During Acute Illness. Heart Disease 5:5, 323-333
CrossRef2742
Perry Hookman, Jamie S. Barkin. (2003) Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach:. Lin HZ, Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease in obese, Leptin-deficient Micenat Med 2000;6:998-1003. The American Journal of Gastroenterology 98:9, 2093-2097
CrossRef2743
G. Slama. (2003) The potential of metformin for diabetes prevention. Diabetes & Metabolism 29:4, 6S104-6S111
CrossRef2744
Tammy Utset. 2003. Nutritional Issues in Arthritis and Rheumatic Disease. , 309-323.
CrossRef2745
Jenny Ledikwe, Helen Smiciklas-Wright, Janet Friedmann, Gordon Jensen. 2003. Nutritional Considerations of Older Women. , 155-181.
CrossRef2746
Robin Whittemore, Patricia S. Bak, Gail D'Eramo Melkus, Margaret Grey. (2003) Promoting Lifestyle Change in the Prevention and Management of Type 2 Diabetes. Journal of the American Academy of Nurse Practitioners 15:8, 341-349
CrossRef2747
Tandy Aye, Lynne L. Levitsky. (2003) Type 2 diabetes: an epidemic disease in childhood. Current Opinion in Pediatrics 15:4, 411-415
CrossRef2748
P. Zimmet, C. R. Thomas. (2003) Genotype, obesity and cardiovascular disease - has technical and social advancement outstripped evolution?. Journal of Internal Medicine 254:2, 114-125
CrossRef2749
Inga Reynisdottir, Gudmar Thorleifsson, Rafn Benediktsson, Gunnar Sigurdsson, Valur Emilsson, Anna Sigurlin Einarsdottir, Eyrun Edda Hjorleifsdottir, Gudbjorg Th. Orlygsdottir, Gudrun Thora Bjornsdottir, Jona Saemundsdottir, Skarphedinn Halldorsson, Soffia Hrafnkelsdottir, Steinunn Bjorg Sigurjonsdottir, Svana Steinsdottir, Mitchell Martin, Jarema P. Kochan, Brian K. Rhees, Struan F.A. Grant, Michael L. Frigge, Augustine Kong, Vilmundur Gudnason, Kari Stefansson, Jeffrey R. Gulcher. (2003) Localization of a Susceptibility Gene for Type 2 Diabetes to Chromosome 5q34–q35.2. The American Journal of Human Genetics 73:2, 323-335
CrossRef2750
Paul D. Thompson, Vivien Lim. (2003) Physical activity in the prevention of atherosclerotic coronary heart disease. Current Treatment Options in Cardiovascular Medicine 5:4, 279-285
CrossRef2751
Lennart Welin, Lars E. Bres??ter, Henry Eriksson, Per O. Hansson, Catharina Welin, Annika Rosengren. (2003) Insulin resistance and other risk factors for coronary heart disease in elderly men. The Study of Men Born in 1913 and 1923. European Journal of Cardiovascular Prevention & Rehabilitation 10:4, 283-288
CrossRef2752
Claudia Panzer, Andreas Brieke, Neil Ruderman. (2003) Prevention of type 2 diabetes and its macrovascular complications: whom, when, and how should we treat?. Current Opinion in Endocrinology & Diabetes 10:4, 229-236
CrossRef2753
Russ Mason. (2003) Cultivating Qi and Activating the Healer Within: An Interview with Roger Jahnke, O.M.D.. Alternative and Complementary Therapies 9:4, 176-182
CrossRef2754
Kathy Berra. (2003) Treatment Options for Patients With the Metabolic Syndrome. Journal of the American Academy of Nurse Practitioners 15:8, 361-370
CrossRef2755
Mark O Goodarzi, Stanley G Korenman. (2003) The importance of insulin resistance in polycystic ovary syndrome. Fertility and Sterility 80:2, 255-258
CrossRef2756
Shari S. Bassuk, JoAnn E. Manson. (2003) Physical activity and the prevention of cardiovascular disease. Current Atherosclerosis Reports 5:4, 299-307
CrossRef2757
M Mensink. (2003) Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Diabetes Research and Clinical Practice 61:1, 49-58
CrossRef2758
Selma F Witchel, Ram N Trivedi, Candace Kammerer. (2003) Frequency of the T228A polymorphism in the SORBS1 gene in children with premature pubarche and in adolescent girls with hyperandrogenism. Fertility and Sterility 80:1, 128-132
CrossRef2759
Maren T. Scheuner. (2003) Genetic evaluation for coronary artery disease. Genetics in Medicine 5:4, 269-285
CrossRef2760
T. Costacou, E.J. Mayer-Davis. (2003) N
UTRITION AND PREVENTION OF TYPE 2 DIABETES . Annual Review of Nutrition 23:1, 147-170
CrossRef2761
Carol J. Homko, E. Albert Reece. (2003) Development of early-onset type 2 diabetes in the young: Implications for child bearing. Current Diabetes Reports 3:4, 313-318
CrossRef2762
C.J Glueck, Ranganath Papanna, Ping Wang, Naila Goldenberg, Luann Sieve-Smith. (2003) Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52:7, 908-915
CrossRef2763
Kathryn M. Hill. (2003) Update: The Pathogenesis and Treatment of PCOS. The Nurse Practitioner 28:7, 8-17
CrossRef2764
Andrea Kriska. (2003) Can A Physically Active Lifestyle Prevent Type 2 Diabetes?. Exercise and Sport Sciences Reviews 31:3, 132-137
CrossRef2765
David C. Sloane, Allison L. Diamant, LaVonna B. Lewis, Antronette K. Yancey, Gwendolyn Flynn, Lori Miller Nascimento, William J. Mc Carthy, Joyce Jones Guinyard, Michael R. Cousineau, . (2003) Improving the Nutritional Resource Environment for Healthy Living Through Community-based Participatory Research. Journal of General Internal Medicine 18:7, 568-575
CrossRef2766
Charles J. Glueck, Naila Goldenberg, Patricia Streicher, Ping Wang. (2003) Metformin and gestational diabetes. Current Diabetes Reports 3:4, 303-312
CrossRef2767
Hitoshi Kawabata, Kinji Ishikawa. (2003) Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts-comparison of the effects of pioglitazone and metformin. Diabetes/Metabolism Research and Reviews 19:4, 299-305
CrossRef2768
J TUOMILEHTO. (2003) Reducing coronary heart disease associated with type 2 diabetes: lifestyle intervention and treatment of dyslipidaemia. Diabetes Research and Clinical Practice 61, S27-S34
CrossRef2769
M. Mensink, E. J. M. Feskens, M. Kruijshoop, T. W. A. de Bruin, W. H. M. Saris, E. E. Blaak. (2003) Subscapular skinfold thickness distinguishes between transient and persistent impaired glucose tolerance: Study on Lifestyle-Intervention and Impaired Glucose Tolerance Maastricht (SLIM). Diabetic Medicine 20:7, 552-557
CrossRef2770
R. I. G. Holt, J. R. Goddard, P. Clarke, M. A. G. Coleman. (2003) A postnatal fasting plasma glucose is useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance test. Diabetic Medicine 20:7, 594-598
CrossRef2771
Arne Astrup. 2003. Treatment of Obesity. .
CrossRef2772
Michael Stumvoll. (2003) Thiazolidinediones – some recent developments. Expert Opinion on Investigational Drugs 12:7, 1179-1187
CrossRef2773
Prakash C. Deedwania. (2003) Mechanisms of endothelial dysfunction in the metabolic syndrome. Current Diabetes Reports 3:4, 289-292
CrossRef2774
JEAN-PATRICE BAILLARGEON, MARIA J. IUORNO, JOHN E. NESTLER. (2003) Insulin Sensitizers for Polycystic Ovary Syndrome. Clinical Obstetrics and Gynecology 46:2, 325-340
CrossRef2775
David M. Kendall, Burton E. Sobel, Ann M. Coulston, Anne L. Peters Harmel, Barry K. McLean, Virginia Peragallo-Dittko, John B. Buse, Vivian A. Fonseca, James O. Hill, Richard W. Nesto, Xavier F. Pi Sunyer. (2003) The insulin resistance syndrome and coronary artery disease. Coronary Artery Disease 14:4, 335-348
CrossRef2776
O ZIEGLER, C SIMON. (2003) Le point de vue des diabétologues français sur la prévention du diabète de type 2. Un sondage d'opinion à l'occasion du congrès de l'ALFEDIAM, Bordeaux 2003. Diabetes & Metabolism 29:3, 307-314
CrossRef2777
A. Gordon Smith, Mark B. Bromberg. (2003) A Rational Diagnostic Approach to Peripheral Neuropathy. Journal of Clinical Neuromuscular Disease 4:4, 190-198
CrossRef2778
K. Kasila, M. Poskiparta, P. Karhila, T. Kettunen. (2003) Patients' readiness for dietary change at the beginning of counselling: a transtheoretical model-based assessment. Journal of Human Nutrition and Dietetics 16:3, 159-166
CrossRef2779
Dawn K. Wilson, Alan M. Delamater. (2003) Opportunities in behavioral diabetes research. Annals of Behavioral Medicine 25:3, 161-162
CrossRef2780
S PFEIFER, M DAYAL. (2003) Treatment of the adolescent patient with polycystic ovary syndrome. Obstetrics and Gynecology Clinics of North America 30:2, 337-352
CrossRef2781
Martha Belury. 2003. Conjugated Linoleic Acids in Type 2 Diabetes Mellitus. .
CrossRef2782
Bonow, Robert O., Eckel, Robert H., . (2003) Diet, Obesity, and Cardiovascular Risk. New England Journal of Medicine 348:21, 2057-2058
Full Text2783
Anne Daly, Hope Warshaw, Joyce Green Pastors, Marion J. Franz, Marilynn Arnold. (2003) Diabetes Medical Nutrition Therapy: Practical Tips to Improve Outcomes. Journal of the American Academy of Nurse Practitioners 15:5, 206-211
CrossRef2784
Eugène Sobngwi, Philippe Boudou, Franck Mauvais-Jarvis, Hervé Leblanc, Gilberto Velho, Patrick Vexiau, Raphaël Porcher, Samy Hadjadj, Richard Pratley, P Antonio Tataranni, Fabien Calvo, Jean-François Gautier. (2003) Effect of a diabetic environment in utero on predisposition to type 2 diabetes. The Lancet 361:9372, 1861-1865
CrossRef2785
B. Sinha, P. Brydon, R. S. Taylor, A. Hollins, A. Munro, D. Jenkins, F. Dunne. (2003) Maternal ante-natal parameters as predictors of persistent postnatal glucose intolerance: a comparative study between Afro-Caribbeans, Asians and Caucasians. Diabetic Medicine 20:5, 382-386
CrossRef2786
Lyndal Harborne, Richard Fleming, Helen Lyall, Jane Norman, Naveed Sattar. (2003) Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. The Lancet 361:9372, 1894-1901
CrossRef2787
Paul Poirier, Jean-Pierre Després. (2003) Waist Circumference, Visceral Obesity, and Cardiovascular Risk. Journal of Cardiopulmonary Rehabilitation 23:3, 161-169
CrossRef2788
Samy I. McFarlane, John J. Shin, Tanja Rundek, J. Thomas Bigger. (2003) Prevention of type 2 diabetes. Current Diabetes Reports 3:3, 235-241
CrossRef2789
Paul Angulo. (2003) Current best treatment for non-alcoholic fatty liver disease. Expert Opinion on Pharmacotherapy 4:5, 611-623
CrossRef2790
John N. Harvey. (2003) Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes. Current Opinion in Nephrology and Hypertension 12:3, 317-322
CrossRef2791
Kathleen L. Wyne, David S.H. Bell, Seth Braunstein, Andrew J. Drexler, Jeffrey L. Miller, James G. Nuckolls. (2003) Trends in Management of Type 2 Diabetes. The Endocrinologist 13:Sup 1, S1-S21
CrossRef2792
Sharon H. Saydah, Frederick L. Brancati, Sherita Hill Golden, Judith Fradkin, Maureen I. Harris. (2003) Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes/Metabolism Research and Reviews 19:3, 202-208
CrossRef2793
Tara E. O’Brien, Joel G. Ray, Wee-Shian Chan. (2003) Maternal Body Mass Index and the Risk of Preeclampsia: A Systematic Overview. Epidemiology 14:3, 368-374
CrossRef2794
Sheldon L. Spector, Marc E. Surette. (2003) Diet and asthma: has the role of dietary lipids been overlooked in the management of asthma?. Annals of Allergy, Asthma & Immunology 90:4, 371-377
CrossRef2795
Linda C. Pearce. (2003) New Evidence-Based Diabetes Nutrition Recommendations. Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional 21:4, 249-257
CrossRef2796
H. Robert Superko. (2003) Sophisticated Tests for Susceptibility to Atherosclerosis:An Added Value for Heart Hospitals. The American Heart Hospital Journal 1:2, 135-140
CrossRef2797
James Lawrence, Anthony Robinson. (2003) Screening for Diabetes in General Practice. Preventive Cardiology 6:2, 78-84
CrossRef2798
J. L. Chan, M. J. Abrahamson. (2003) Pharmacological Management of Type 2 Diabetes Mellitus: Rationale for Rational Use of Insulin. Mayo Clinic Proceedings 78:4, 459-467
CrossRef2799
R. S. Weinstock. (2003) Treating Type 2 Diabetes Mellitus: A Growing Epidemic. Mayo Clinic Proceedings 78:4, 411-413
CrossRef2800
F. Zangeneh, Y. C. Kudva, A. Basu. (2003) Insulin Sensitizers. Mayo Clinic Proceedings 78:4, 471-479
CrossRef2801
J. E. Gerich. (2003) Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus. Mayo Clinic Proceedings 78:4, 447-456
CrossRef2802
Yoshiko Yanagisawa, Terue Kawabata, Osamu Tanaka, Masanobu Kawakami, Kyoko Hasegawa, Yasuo Kagawa. (2003) Improvement in blood lipid levels by dietary sn-1,3-diacylglycerol in young women with variants of lipid transporters 54T-FABP2 and -493g-MTP. Biochemical and Biophysical Research Communications 302:4, 743-750
CrossRef2803
Terry T-K. Huang, Michael I. Goran. (2003) Prevention of type 2 diabetes in young people: a theoretical perspective. Pediatric Diabetes 4:1, 38-56
CrossRef2804
Tom A.B. Sanders. (2003) High- versus low-fat diets in human diseases. Current Opinion in Clinical Nutrition and Metabolic Care 6:2, 151-155
CrossRef2805
Tony Hung, John L. Sievenpiper, Augustine Marchie, Cyril W.C. Kendall, David J.A. Jenkins. (2003) Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease. Current Opinion in Clinical Nutrition and Metabolic Care 6:2, 165-176
CrossRef2806
M. C. Adriaanse, F. J. Snoek, J. M. Dekker, A. M. W. Spijkerman, G. Nijpels, H. M. van der Ploeg, R. J. Heine. (2003) Perceived risk for Type 2 diabetes in participants in a stepwise population-screening programme. Diabetic Medicine 20:3, 210-215
CrossRef2807
J. Lidfeldt, P. Nyberg, C. Nerbrand, G. Samsioe, B. Schersten, C. D. Agardh. (2003) Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes, Obesity and Metabolism 5:2, 106-112
CrossRef2808
(2003) Highlights of the Autumn 2002 meeting of the Association of British Clinical Diabetologists. Practical Diabetes International 20:2, 73-76
CrossRef2809
Joshua I. Barzilaym, Eric S. Freedland. (2003) Inflammation and Its Relationship to Insulin Resistance, Type 2 Diabetes Mellitus, and Endothelial Dysfunction. Metabolic Syndrome and Related Disorders 1:1, 55-67
CrossRef2810
Elizabeth A. Walker, Jennifer A. Usher. (2003) Understanding and enhancing adherence in adults with diabetes. Current Diabetes Reports 3:2, 141-148
CrossRef2811
Cheryl Ritenbaugh, Nicolette I Teufel-Shone, Mikel G Aickin, Jennie R Joe, Steven Poirier, D.Clay Dillingham, David Johnson, Susanne Henning, Suzanne M Cole, David Cockerham. (2003) A lifestyle intervention improves plasma insulin levels among Native American high school youth. Preventive Medicine 36:3, 309-319
CrossRef2812
Judith Korner, Louis J. Aronne. (2003) The emerging science of body weight regulation and its impact on obesity treatment. Journal of Clinical Investigation 111:5, 565-570
CrossRef2813
K. Borch-Johnsen, T. Lauritzen, C. Glumer, A. Sandbaek. (2003) Screening for Type 2 diabetes-should it be now?. Diabetic Medicine 20:3, 175-181
CrossRef2814
Jesica Pagano-Therrien, David L. Katz. (2003) The Low-Down on Low-Carbohydrate Diets. The Nurse Practitioner 28:3, 5-6
CrossRef2815
A RIVELLESE, S LILLI. (2003) Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. Biomedecine & Pharmacotherapy 57:2, 84-87
CrossRef2816
Gerald Reaven, Philip S Tsao. (2003) Insulin resistance and compensatory hyperinsulinemia. Journal of the American College of Cardiology 41:6, 1044-1047
CrossRef2817
Michael S. Lauer. (2003) Is Heart Rate Recovery a Modifiable Risk Factor?. Journal of Cardiopulmonary Rehabilitation 23:2, 88-89
CrossRef2818
R.W Simpson, J.E Shaw, P.Z Zimmet. (2003) The prevention of type 2 diabetes — lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Research and Clinical Practice 59:3, 165-180
CrossRef2819
Masaru Yamakoshi, Mamoru Takahashi, Takuji Kouzuma, Shigeyuki Imamura, Isami Tsuboi, Shoji Kawazu, Fumio Yamagata, Makoto Tominaga, Masayuki Noritake. (2003) Determination of urinary myo-inositol concentration by an improved enzymatic cycling method using myo-inositol dehydrogenase from Flavobacterium sp.. Clinica Chimica Acta 328:1-2, 163-171
CrossRef2820
Jill Crandall, Nir Barzilai. (2003) Treatment of Diabetes Mellitus in Older People: Oral Therapy Options. Journal of the American Geriatrics Society 51:2, 272-274
CrossRef2821
Frank Vinicor, Barbara Bowman, Michael Engelgau. (2003) Diabetes: prevention needed. The Lancet 361:9357, 544
CrossRef2822
Maureen A. Murtaugh, David R. Jacobs, Brenda Jacob, Lyn M. Steffen, Leonard Marquart. (2003) Epidemiological support for the protection of whole grains against diabetes. Proceedings of the Nutrition Society 62:01, 143-149
CrossRef2823
P. Nilsson, J-A. Nilsson, B. Hedblad, K-F. Eriksson, G. Berglund. (2003) Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: The Malmo Preventive Project. Journal of Internal Medicine 253:2, 136-145
CrossRef2824
Bertram L. Kasiske, Jon J. Snyder, David Gilbertson, Arthur J. Matas. (2003) Diabetes Mellitus after Kidney Transplantation in the United States. American Journal of Transplantation 3:2, 178-185
CrossRef2825
Liz Lightstone. (2003) Preventing renal disease: The ethnic challenge in the United Kingdom. Kidney International 63:s83, 135-138
CrossRef2826
David B. Allison, Mary T. Weber. (2003) Treatment and prevention of obesity: What works, what doesn’t work, and what might work. Lipids 38:2, 147-155
CrossRef2827
Arne Astrup. (2003) Weight loss and increased mortality: epidemiologists blinded by observations?. Obesity Reviews 4:1, 1-2
CrossRef2828
G. Riccardi. (2003) NMCD is growing up: short thoughts on a teenager's life. Nutrition, Metabolism and Cardiovascular Diseases 13:1, 1
CrossRef2829
Frank B. Hu. (2003) Overweight and Obesity in Women: Health Risks and Consequences. Journal of Women's Health 12:2, 163-172
CrossRef2830
D. Yang, K. R. Fontaine, C. Wang, D. B. Allison. (2003) Weight loss causes increased mortality: cons. Obesity Reviews 4:1, 9-16
CrossRef2831
Stephen D. Hursting, Jackie A. Lavigne, David Berrigan, Susan N. Perkins, J. Carl Barrett. (2003) Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to Humans*. Annual Review of Medicine 54:1, 131-152
CrossRef2832
Perry Hookman, Jamie S. Barkin. (2003) Current biochemical studies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach. Lin Hz, Yang SQ, Chuckaree C, et al., Metformin's Reverses Fatty Liver Disease in Obese Leptin-Deficient Mice, Nature Medicine 2000;6(8):998-1003. The American Journal of Gastroenterology 98:2, 495-499
CrossRef2833
GEOFFREY C FARRELL. (2003) Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region?. Journal of Gastroenterology and Hepatology 18:2, 124-138
CrossRef2834
Frank B. Hu. (2003) Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids 38:2, 103-108
CrossRef2835
Solomon, Caren G., . (2003) Reducing Cardiovascular Risk in Type 2 Diabetes. New England Journal of Medicine 348:5, 457-459
Full Text2836
C. Tissa Kappagoda. (2003) Type 2 Diabetes and Preventive Cardiology: Talking the Talk and Walking the Walk?. Preventive Cardiology 6:1, 5-7
CrossRef2837
Todd Gilmer, Patrick J O???Connor. (2003) Cost Effectiveness of Diabetes Mellitus Management Programs. Disease Management & Health Outcomes 11:7, 439-453
CrossRef2838
Thomas A. Wadden, Leslie G. Womble, David B. Sarwer, Robert I. Berkowitz, Vicki L. Clark, Gary D. Foster. (2003) Great Expectations: "I'm Losing 25% of My Weight No Matter What You Say".. Journal of Consulting and Clinical Psychology 71:6, 1084-1089
CrossRef2839
Eliot A. Brinton. (2003) Lipid abnormalities in the metabolic syndrome. Current Diabetes Reports 3:1, 65-72
CrossRef2840
K M Venkat Narayan, Alka M Kanaya, Edward W Gregg. (2003) Lifestyle Intervention for the Prevention of Type 2 Diabetes Mellitus. Treatments in Endocrinology 2:5, 315-320
CrossRef2841
Mark W. Stolar, Robert J. Chilton. (2003) Type 2 diabetes, cardiovascular risk, and the link to insulin resistance. Clinical Therapeutics 25, B4-B31
CrossRef2842
Soren Snitker, Braxton D Mitchell, Alan R Shuldiner. (2003) Physical activity and prevention of type 2 diabetes. The Lancet 361:9351, 87-88
CrossRef2843
Lucia L Kaiser, Marciel A Klenk, Anna C Martin, Anna Olivares, Amy B Joy, Hugo Quiñonez-Melgar. (2003) Diabetes-related health beliefs explored in low-income Latinos. California Agriculture 57:1, 8-12
CrossRef2844
Carla Pelusi, Renato Pasquali. (2003) Polycystic Ovary Syndrome in Adolescents. Treatments in Endocrinology 2:4, 215-230
CrossRef2845
Nicola Abate, Manisha Chandalia. (2003) The impact of ethnicity on type 2 diabetes. Journal of Diabetes and its Complications 17:1, 39-58
CrossRef2846
Thomas A. Buchanan. (2003) Pancreatic beta-cell loss and preservation in type 2 diabetes. Clinical Therapeutics 25, B32-B46
CrossRef2847
Odd E Johansen, K??re I Birkeland. (2003) Preventing Macrovascular Disease in Patients with Type 2 Diabetes Mellitus. American Journal of Cardiovascular Drugs 3:4, 283-297
CrossRef2848
Andre J Scheen. (2003) Current Management Strategies for Coexisting Diabetes Mellitus and Obesity. Drugs 63:12, 1165-1184
CrossRef2849
K.R. MERIKANGAS. (2003) Implications of Genomics for Public Health: The Role of Genetic Epidemiology. Cold Spring Harbor Symposia on Quantitative Biology 68:1, 359-364
CrossRef2850
James B. Meigs. (2003) Epidemiology of the insulin resistance syndrome. Current Diabetes Reports 3:1, 73-79
CrossRef2851
Hitoshi KAWABATA, Kinji ISHIKAWA. (2003) Cardioprotection by Metformin Is Abolished by a Nitric Oxide Synthase Inhibitor in Ischemic Rabbit Hearts.. Hypertension Research 26:1, 107-110
CrossRef2852
Daniel Kramer, Annaswamy Raji, Jorge Plutzky. (2003) Prediabetes mellitus and its links to atherosclerosis. Current Diabetes Reports 3:1, 11-18
CrossRef2853
Fevzi Akinci, Bernard J Healey, Joseph S Coyne. (2003) Improving the Health Status of US Working Adults with Type 2 Diabetes Mellitus. Disease Management & Health Outcomes 11:8, 489-498
CrossRef2854
Leonard Jack. (2003) Diabetes Self-Management Education Research. Disease Management & Health Outcomes 11:7, 415-428
CrossRef2855
Andr?? J Scheen. (2003) Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?. Drugs 63:10, 933-951
CrossRef2856
Andreas Maetzel, J??rg Ruof, Melva Covington, Anne Wolf. (2003) Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus. PharmacoEconomics 21:7, 501-512
CrossRef2857
Ingemar F Petersson, Lennart T.H Jacobsson. (2002) Osteoarthritis of the peripheral joints. Best Practice & Research Clinical Rheumatology 16:5, 741-760
CrossRef2858
N. Finer. (2002) Pharmacotherapy of obesity. Best Practice & Research Clinical Endocrinology & Metabolism 16:4, 717-742
CrossRef2859
Paolo Moghetti. (2002) Insulin resistance: what is its role in the polycystic ovary syndrome?. Current Opinion in Endocrinology & Diabetes 9:6, 444-450
CrossRef2860
Jim Mann. (2002) Discrepancies in nutritional recommendations: the need for evidence based nutrition. Asia Pacific Journal of Clinical Nutrition 11:s3, S510-S515
CrossRef2861
R KLEIN. (2002) Prevention of Visual Loss From Diabetic Retinopathy. Survey of Ophthalmology 47, S246-S252
CrossRef2862
Boyd Swinburn. (2002) Sustaining dietary changes for preventing obesity and diabetes: lessons learned from the successes of other epidemic control programs. Asia Pacific Journal of Clinical Nutrition 11:s3, S598-S606
CrossRef2863
Imani Ma'at, Michelle Owens, Marlisa Hughes. (2002) Observations from the CDC: REACH 2010 Coalitions: Reaching for Ways to Prevent Cardiovascular Disease and Diabetes. Journal of Women's Health 11:10, 829-839
CrossRef2864
G LI, Y HU, W YANG, Y JIANG, J WANG, J XIAO, Z HU, X PAN, B HOWARD, P BENNETT. (2002) Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study. Diabetes Research and Clinical Practice 58:3, 193-200
CrossRef2865
Tim Gill. (2002) Importance of preventing weight gain in adulthood. Asia Pacific Journal of Clinical Nutrition 11:s3, S632-S636
CrossRef2866
Pekka Puska. (2002) Nutrition and global prevention on non-communicable diseases. Asia Pacific Journal of Clinical Nutrition 11:s9, S755-S758
CrossRef2867
J WEISWASSER, E NYLEN, S ARORA, M WAKEFIELD, A SIDAWY. (2002) Syndrome X and diabetes: What is the mystery?. Seminars in Vascular Surgery 15:4, 216-224
CrossRef2868
I. J. Perry. (2002) Healthy diet and lifestyle clustering and glucose intolerance. Proceedings of the Nutrition Society 61:04, 543-551
CrossRef2869
Neil J. Stone, Linda Horn. (2002) Therapeutic lifestyle change and adult treatment panel III: Evidence then and now. Current Atherosclerosis Reports 4:6, 433-443
CrossRef2870
Paul Poirier, Robert H. Eckel. (2002) Obesity and cardiovascular disease. Current Atherosclerosis Reports 4:6, 448-453
CrossRef2871
Matthias B. Schulze, Frank B. Hu. (2002) Dietary patterns and risk of hypertension, type 2 diabetes mellitus, and coronary heart disease. Current Atherosclerosis Reports 4:6, 462-467
CrossRef2872
André J Scheen. (2002) Acarbose for type 2 diabetes prevention. The Lancet 360:9344, 1516
CrossRef2873
Yvonne Linne, Britta Barkeling, Stephan Rossner. (2002) Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG: An International Journal of Obstetrics and Gynaecology 109:11, 1227-1231
CrossRef2874
J. D. Krebs, S. Evans, L. Cooney, G. D. Mishra, G. Fruhbeck, N. Finer, S. A. Jebb. (2002) Changes in risk factors for cardiovascular disease with body fat loss in obese women. Diabetes, Obesity and Metabolism 4:6, 379-387
CrossRef2875
C. C. Case, P. H. Jones, K. Nelson, E. O'Brian Smith, C. M. Ballantyne. (2002) Impact of weight loss on the metabolic syndrome. Diabetes, Obesity and Metabolism 4:6, 407-414
CrossRef2876
Ingrid Mühlhauser. (2002) Acarbose for type 2 diabetes prevention. The Lancet 360:9344, 1517
CrossRef2877
Charles J Glueck, Naila Goldenberg, Patricia Streicher, Ping Wang. (2002) The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin. Expert Opinion on Pharmacotherapy 3:11, 1557-1568
CrossRef2878
Nathan, David M., . (2002) Initial Management of Glycemia in Type 2 Diabetes Mellitus. New England Journal of Medicine 347:17, 1342-1349
Full Text2879
S Norris, A Avenell, B Bowman, T Brown, E Gregg, M Serdula. 2002. Long-term weight loss interventions for type 2 diabetes in adults. .
CrossRef2880
Ayman Koteish, Anna Mae Diehl. (2002) Animal models of steatohepatitis. Best Practice & Research Clinical Gastroenterology 16:5, 679-690
CrossRef2881
Roopa Sathyaprakash, Robert R. Henry. (2002) Preventing diabetes by treating aspects of the metabolic syndrome. Current Diabetes Reports 2:5, 416-422
CrossRef2882
Jennifer C. Lovejoy. (2002) The influence of dietary fat on insulin resistance. Current Diabetes Reports 2:5, 435-440
CrossRef2883
Cathy Mullooly. (2002) Cardiovascular fitness and type 2 diabetes. Current Diabetes Reports 2:5, 441-447
CrossRef2884
Marion J. Franz. (2002) Fitness decreases risk of all-cause and cardiovascular disease mortality whereas thinness does not. Current Diabetes Reports 2:5, 433-434
CrossRef2885
Diane E.J. Stafford, Catherine M. Gordon. (2002) Adolescent androgen abnormalities. Current Opinion in Obstetrics and Gynecology 14:5, 445-451
CrossRef2886
Lalita Khaodhiar, George L. Blackburn. (2002) Obesity treatment: factors involved in weight-loss maintenance and regain. Current Opinion in Endocrinology & Diabetes 9:5, 369-374
CrossRef2887
Manson, JoAnn E., Greenland, Philip, LaCroix, Andrea Z., Stefanick, Marcia L., Mouton, Charles P., Oberman, Albert, Perri, Michael G., Sheps, David S., Pettinger, Mary B., Siscovick, David S., . (2002) Walking Compared with Vigorous Exercise for the Prevention of Cardiovascular Events in Women. New England Journal of Medicine 347:10, 716-725
Full Text2888
George P. N. Samraj, Louis Kuritzky. (2002) Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care. Comprehensive Therapy 28:3, 208-221
CrossRef2889
Helen M Colhoun. (2002) The big picture on obesity and insulin resistance**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 40:5, 944-945
CrossRef2890
K. Borch-Johnsen. (2002) IGT and IFG. Time for revision?. Diabetic Medicine 19:9, 707-707
CrossRef2891
, N. Unwin, J. Shaw, P. Zimmet, K. G. M. M. Alberti. (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Medicine 19:9, 708-723
CrossRef2892
JI Mann. (2002) Diet and risk of coronary heart disease and type 2 diabetes. The Lancet 360:9335, 783-789
CrossRef2893
Massie, Barry M., . (2002) Obesity and Heart Failure — Risk Factor or Mechanism?. New England Journal of Medicine 347:5, 358-359
Full Text2894
Elliot Sternthal, Neil Ruderman. (2002) Insulin: Promise and problems at 80 years. Current Opinion in Endocrinology & Diabetes 9:4, 283-284
CrossRef2895
Jean-Patrice Baillargeon, Maria J. Iuorno, John E. Nestler. (2002) Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome. Current Opinion in Endocrinology & Diabetes 9:4, 303-311
CrossRef2896
Janine Nuver, Andries J Smit, Aleida Postma, Dirk Th Sleijfer, Jourik A Gietema. (2002) The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures. Cancer Treatment Reviews 28:4, 195-214
CrossRef2897
Emelia J Benjamin, Sidney C Smith, Richard S Cooper, Martha N Hill, Russell V Luepker. (2002) Task Force #1—magnitude of the prevention problem: opportunities and challenges. Journal of the American College of Cardiology 40:4, 588-603
CrossRef2898
Robert J. Norman, Michael J. Davies, Jonathan Lord, Lisa J. Moran. (2002) The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology & Metabolism 13:6, 251-257
CrossRef2899
Ping Wang, Patricia Streicher, Charles J Glueck. (2002) Treatment of polycystic ovary syndrome with insulin-lowering agents. Expert Opinion on Pharmacotherapy 3:8, 1177-1189
CrossRef2900
G. Frost, F. Lyons, C. Bovill-Taylor, L. Carter, J. Stuttard, A. Dornhorst. (2002) Intensive lifestyle intervention combined with the choice of pharmacotherapy improves weight loss and cardiac risk factors in the obese. Journal of Human Nutrition and Dietetics 15:4, 287-295
CrossRef2901
R Padwal, SK Li, DCW Lau. 2002. Long-term pharmacotherapy for obesity and overweight. .
CrossRef2902
Ann M. Coulston. (2002) Diabetes Mellitus in 2002. Nutrition Today 37:4, 163-166
CrossRef2903
Estella A. West, Gloria R. Brown, Nancy I. Feldnian, Connie L. Garrett, Anna Martin, Anna Olivares, Edwina U. Williams, Christine M. Bruhn, Marciel A. Klenk. (2002) Focus groups show need for diabetes awareness education among African Americans. California Agriculture 56:4, 139-143
CrossRef2904
Sheila A Doggrell. (2002) Metformin & lifestyle intervention prevent Type 2 diabetes: lifestyle intervention has the greater effect. Expert Opinion on Pharmacotherapy 3:7, 1011-1013
CrossRef2905
Judith Wylie-Rosett, Yasmin Mossavar-Rahmani, Kim Gans. (2002) Recent Dietary Guidelines to Prevent and Treat Cardiovascular Disease, Diabetes, and Obesity. Heart Disease 4:4, 220-230
CrossRef2906
(2002) Diabetes Prevention. New England Journal of Medicine 346:23, 1829-1830
Full Text2907
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet 359:9323, 2072-2077
CrossRef2908
Steven M Haffner. (2002) Glucose-tolerance testing in acute myocardial infarction. The Lancet 359:9324, 2127-2128
CrossRef2909
Stephen F. Dierdorf. (2002) Anesthesia for patients with diabetes mellitus. Current Opinion in Anaesthesiology 15:3, 351-357
CrossRef2910
Penny Owen, Marc Evans. (2002) Therapy and clinical trials: type 2 diabetes: lifestyle and beyond. Current Opinion in Lipidology 13:3, 351-353
CrossRef2911
Richard E. Pratley, Christian Weyer. (2002) Progression from IGT to type 2 diabetes mellitus: The central role of impaired early insulin secretion. Current Diabetes Reports 2:3, 242-248
CrossRef2912
John R Petrie, Colin G Perry. (2002) Insulin-sensitising agents: beyond thiazolidinediones. Expert Opinion on Emerging Drugs 7:1, 165-174
CrossRef2913
Richard R. Rubin, Mark Peyrot. (2002) Was Willis right? Thoughts on the interaction of depression and diabetes. Diabetes/Metabolism Research and Reviews 18:3, 173-175
CrossRef2914
Arne Astrup. (2002) Dietary fat is a major player in obesity - but not the only one. Obesity Reviews 3:2, 57-58
CrossRef2915
David G. Blackburn, MALD. (2002) Establishing an Effective Framework for Physical Activity Counseling in Primary Care Settings. Nutrition in Clinical Care 5:3, 95-102
CrossRef2916
Andrew S Greenberg, Anastassios G Pittas. (2002) Thiazolidinediones in the treatment of Type 2 diabetes. Expert Opinion on Pharmacotherapy 3:5, 529-540
CrossRef2917
M. A. F. Singh. (2002) Exercise Comes of Age: Rationale and Recommendations for a Geriatric Exercise Prescription. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57:5, M262-M282
CrossRef2918
Remuzzi, Giuseppe, Schieppati, Arrigo, Ruggenenti, Piero, . (2002) Nephropathy in Patients with Type 2 Diabetes. New England Journal of Medicine 346:15, 1145-1151
Full Text2919
Dympna Leonard, Robyn McDermott, Kerin O'Dea, Kevin G. Rowley, Poi Pensio, Edna Sambo, Aletia Twist, Raima Toolis, Simone Lowson, James D. Best. (2002) Measuring Prevalence: Obesity, diabetes and associated cardiovascular risk factors among Torres Strait Islander people. Australian and New Zealand Journal of Public Health 26:2, 144-149
CrossRef2920
Anne Peters Harmel. (2002) Considerations for treating dyslipidemia in special diabetic populations. Diabetes/Metabolism Research and Reviews 18:2, 88-95
CrossRef2921
&NA;. (2002) Metformin or intensive lifestyle intervention can prevent type 2 diabetes. Inpharma Weekly &NA;:1325, 16
CrossRef2922
S DINNEEN. (2002) What's new in & Diabetes prevention and delivery of care. Medicine 30:1, i-iii
CrossRef2923
??ngels Costa, Ignacio Conget, Ramon Gomis. (2002) Impaired Glucose Tolerance. Treatments in Endocrinology 1:4, 205-210
CrossRef2924
Gloria J. Nichols-English, Melanie Provost, Dayin Koompalum, Hua Chen, Masood Athar. (2002) Strategies for Pharmacists in the Implementation of Diabetes Mellitus Management Programs. Disease Management & Health Outcomes 10:12, 783-803
CrossRef2925
Thomas A. Wadden, Kelly D. Brownell, Gary D. Foster. (2002) Obesity: Responding to the global epidemic.. Journal of Consulting and Clinical Psychology 70:3, 510-525
CrossRef2926
Mohamad H. Horani, Arshag D. Mooradian. (2002) Management of Obesity in the Elderly. Treatments in Endocrinology 1:6, 387-398
CrossRef2927
W BRAUN. 2000. Cardiovascular and Other Noninfectious Complications after Renal Transplantation in Adults. , 1009-1033.
CrossRef
- Letters
